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This section provides a medium through which Canadian 
surgeons can declare themselves, briefly and informally, on 
the day-to-day affairs of surgery.
Retrohepatic Vena Caval Surgery
Surgical approaches to the retrohepat­
ic vena cava have always been chal­
lenging—not for the “faint of heart”. 
Whereas penetrating or blunt trauma 
used to be the only reason to operate 
in that area, tumours are now being 
resected from this site with increas­
ingly successful results. With the ad­
vent of better noninvasive investiga­
tions, including ultrasonography, 
computed tomography, digital sub­
traction angiography, duplex scanning 
and magnetic resonance imaging, 
asymptomatic tumours are being dis­
covered. These sophisticated investi­
gative techniques offer the chance to 
resect these tumours, even with 
planned inclusion of the vena cava.
David and colleagues in this issue 
(pages 219 and 220) describe a new 
technique, using the Biomedicus 
pump to perform a cavoatrial circula­
tory bypass, that facilitates resection 
of the retrohepatic vena cava. Tu­
mours in the retrohepatic area rarely
arise from the vena cava but rather 
from the kidney, adrenal, liver and 
mesothelial structures. A number of 
the adrenal tumours may be second­
ary neoplasms. The factor limiting 
resection may not be the tumour itself 
but the vena caval involvement. 
When a mass appears resectable ex­
cept for vena caval adherence, inva­
sion or ingrowth, the surgeon must be 
fully prepared in proceeding with the 
planned resection. One should never 
operate on tumours in the retrohepat­
ic space unless one is ready for all 
eventualities, and the assistance of 
surgeons from multiple surgical disci­
plines may be required. Full prepara­
tion must anticipate possible venoa- 
trial bypass or full cardiopulmonary 
bypass with possible hypothermia and 
exsanguination, especially in children. 
Usually, a selection of vascular 
clamps will suffice for proximal and 
distal caval control, but if the situa­
tion should get out of hand technical­
ly, a planned bypass may be lifesav­
ing.
David and colleagues point out that 
experience gained in liver transplanta­
tion, with venoatrial bypass when 
needed, has made resection and even 
replacement of the vena cava feasible, 
safer and at times relatively bloodless. 
Inferior vena caval blood returning to 
the heart can be well controlled with 
minimal anticoagulation, and hepatic 
venous outflow can be interrupted for 
periods long enough to accomplish 
cavotomy and embolectomy, resec­
tion and repair, or even button graft­
ing with reanastomosis of the hepatic 
veins to the vena cava.
I also prefer the abdominal ap­
proach with a partial or full mediasti­
nal sternotomy. This wide exposure 
allows full dissection of the liver at 
the porta and the diaphragm, and the 
liver can be rotated to the left, expos­
ing adequately the retrohepatic vena 
cava from the atrium (or diaphragm)
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well down to the renal veins. Large 
renal tumours, adrenal tumours and 
mesothelial growths can be dissected 
carefully with excellent control, he­
mostasis and a full, unimpeded view 
of the anatomy.
My experience has been that, with 
persistent dissection, final resection of 
the vena cava and tumour can usually 
be accomplished with a large Satinsky 
clamp, proximal and distal caval con­
trol and simple suture repair of the 
vessel. On one occasion a venoatrial 
shunt was used in a patient with a 
malignant pheochromocytoma and
once cardiopulmonary bypass with 
hypothermia and exsanguination was 
needed in a child with a large liver 
tumour.
Resection of renal, adrenal, hepatic 
and mesothelial tumours in the re- 
trohepatic area, when possible, is still 
the best chance for cure. No curative 
radiotherapy or chemotherapy is ef­
fective. Since malignant tumours in 
the area often extend via the renal or 
adrenal veins into the vena cava with­
out actual invasion, a safe method of 
operating inside the vena cava is now 
available.
The technique described by David 
and associates is an excellent ap­
proach to the problem. It will help to 
increase the success rate of surgery in 
the retrohepatic space.
Nis Sc h m id t , m d , m sc , fr csc
Clinical Professor,
Department of Surgery,
Director of Surgical Education,
St. Paul’s Hospital,
University of British Columbia,
Vancouver, BC 
V6Z 1Y6
The Piriformis Syndrome
First described 60 years ago,1 the 
piriformis syndrome is a rare and 
disputed entity. Entrapment of the 
sciatic nerve behind the hip by the 
piriform muscle causes localized ten­
derness in the buttock. The pain is 
made worse by hip abduction and 
internal rotation.
We have seen three cases of this 
syndrome, in two patients with spas­
ticity due to cerebral palsy and in one 
after trauma to the buttock. All had 
classic symptoms and signs. Because 
the pain persisted for 12 months, 18 
months and 12 years we managed all 
three patients surgically by decom­
pression with division of the piriform 
muscle. Each patient obtained imme­
diate relief of pain.
The cause of this condition is ob­
scure. Buttock trauma has been held 
responsible,2 but how this could cause 
the syndrome is unclear. It has not 
previously been described in patients
with spasticity, although it is under­
standable how this could happen. If 
the external rotator muscles of the 
hip, including the piriform muscle, 
are constantly active then it is not 
surprising that the sciatic nerve 
should eventually become irritated.
Treatment by injection of local 
anesthetic and steroid into the piri­
form muscle has been described,3 but 
the proximity of the sciatic nerve 
renders this approach hazardous.
Surgical release of the piriform 
muscle with relief of symptoms in 12 
of 14 cases has been reported.2-4'6 The 
problem with this syndrome, in which 
no objective evidence such as positive 
electromyelographic findings has been 
produced, is knowing if it is a true 
entity or simply buttock pain cured by 
a placebo operation. The symptoms 
and signs, however, seem quite clear- 
cut and this syndrome is probably 
more common than the literature in­
dicates.
H. U. C a m e r o n , m b , ch  b, fr csc
Assistant Professor,
Staff Orthopedic Surgeon
F r a n k  N o f ta l , m d
Clinical Fellow
The Orthopaedic & Arthritic Hospital,
43 Wellesley St. E,
Toronto, Ont.
M4Y 1H1
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SURGEONS’ UPDATE
What's new in surgery is the subject of this column. The short items are designed to let readers know 
who's doing what and why. Surgeons are interested in what other surgeons are doing in 
research, education, practice and administration. Surgery is a vibrant specialty, and, as 
its practitioners, you must be the source as well as the readers of this column.
Changes in The Hospital for Sick Children’s 
Orthopedic Department
As of Jan. 1, 1988, John Wedge, MD, 
FRCSC, former Chairman of the De­
partment of Surgery at the University 
of Saskatchewan, became Head of the 
Department of Orthopaedics at The 
Hospital for Sick Children in Toron­
to. He is in familiar surroundings, 
having spent a year at the hospital as 
a clinical research fellow in the early 
1970s.
The large number of patients treat­
ed at the Hospital for Sick Children 
allows for a wide variety of orthope­
dic problems to be seen, says Dr. 
Wedge, and “HSC has trained more 
paediatric orthopaedic surgeons than 
any other institution in North Amer-
F1G. 1—John Wedge, MD, FRCSC, 
Head, Department of Orthopedics, The 
Hospital for Sick Children.
Contributions to this column are welcome. 
Please send your material to: Miss Laurel 
Williamson, Canadian Journal o f Surgery, 
PO Box 8650, Ottawa, Ont. K1G 0G8.
doubling of space and addition of 
three new x-ray rooms, which will 
enable staff to treat twice as many 
patients comfortably and efficiently. 
The department also plans to hire 
three more orthopedic surgeons in the 
near future. Presently, the offices of 
all but one surgeon are outside the 
hospital, creating problems in com­
munication, patient inconvenience 
and unnecessary travelling time. By 
relocating surgeons’ offices within the 
building Dr. Wedge predicts much 
time will be saved—time that could 
be devoted to research.
Cartilage healing, biologic behavi­
our of children’s bones, epidemiologic 
studies of pediatric fractures and or­
thopedic diseases, and transplants for 
bone cancer are four areas of study 
that will be given particular attention.
Another departmental aim Dr. 
Wedge outlines is to perform an in­
creasing number of surgical proce­
dures on an outpatient basis and to 
shorten hospital stays, since patients 
are more comfortable and their lives 
less disrupted when they are at home.
New Peer-Review Organization
The American Medico-Legal Foun­
dation in Philadelphia has been creat­
ed to perform independent peer re­
view for hospital trustees and medical 
staffs in cases in which a hospital-staff 
physician’s competence has come 
under question. The Foundation’s 
board includes members from both 
the medical and medicolegal profes­
sions, who, at a hospital’s request, will 
appoint a medical specialist to review 
the patient care provided by the staff 
physician or department. This evalua­
tion will be followed by the review of 
a physician-attorney in the specialty 
to determine medicolegal implica­
tions. The Foundation recognizes the 
difficulty in obtaining a balance be­
tween patient safety and the individu­
al rights of the staff physician. If 
hospital leaders act too early on alle­
gations, they risk doing injustice to 
the physician, but, on the other hand, 
if they delay action until there is a 
malpractice suit, they are not protect­
ing the patient and are faced with 
legal expenses.
New Dean of Medicine at 
Queen’s University
The former Dean of Arts and Sci­
ences at Queen’s University in Kings­
ton, Duncan Sinclair, will become 
Dean of Medicine on July 1, 1988. 
Vice-Dean responsible for clinical af­
fairs will be Robert Maudsley, an 
obstetrician and gynecologist and, for 
many years, Director of the Office of 
Training and Evaluation of the Royal 
College of Physicians and Surgeons of 
Canada.
Screening Program for Breast 
Cancer
A pilot project for the early detec­
tion of breast cancer has been given a 
grant of $365 000 by the British Co­
lumbia Ministry of Health. The Can­
cer Control Agency of British Colum­
bia together with the British Colum­
bia Medical Association and British 
Columbia Radiological Society plan 
to establish a clinic, which will be 
operated both on a walk-in (for 
women over 40 years) and referral 
(for all women) basis. It is estimated 
that screening costs, which are depen­
dent on volume, could be cut with the 
establishment of the program, and 
cost-effectiveness achieved with 40 
mammograms being done with each 
machine each day.
continued on page 267
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REVIEW ARTICLE
A.C. D erby , m d , frcsc
Wounds of the Abdomen. Part 1: In War
Until the turn of the 20th century, 
penetrating wounds of the abdomen in 
war were treated conservatively, with 
a very high death rate. Survivors were 
those who recovered from or escaped 
hemorrhage and shock, were fortunate 
enough to avoid vital organ injury and 
lived in spite of wounds of the viscera 
complicated by a high incidence of 
sepsis. Laparotomy could not be justi­
fied as the treatment of choice until 
World War I when anesthesia, intrave­
nous administration of fluids, blood for 
transfusion and antisepsis were avail­
able. Even so, death rates at the close 
of that war were 60%.
It has become increasingly apparent 
with each successive war that the 
progressive reduction in morbidity and 
mortality in penetrating abdominal 
wounds depends not only on the quali­
ty of the surgery but also on advanced 
life support on the battlefield and ear­
ly, direct evacuation to field hospitals 
where intensive resuscitation, skilled 
anesthesia and comprehensive postop­
erative care are available.
Jusqu'au tournant du 20e siecle, les 
plaies penetrantes de Tabdomen en 
temps de guerre etaient traitees de 
facon conservatrice et entrafnaient 
une mortalite elevee. Les survivants 
etaient ceux qui echappaient a 
I'hemorragie et au choc ou s'en reta- 
blissaient, ceux qui etaient assez 
chanceux pour eviter une blessure a un 
organe vital et ceux qui parvenaient a 
vivre en depit de lesions viscerales que 
venait compliquer une forte incidence 
de sepsie. La laparotomie ne put se 
faire justice comme traitement de pre­
mier choix qu'a I'occasion de la Pre­
miere Guerre Mondiale alors qu'appa-
Accepted for publication Dec. 10, 1987
Reprint requests to; Dr. A.C. Derby, 1969 
GarfieldAve., Ottawa, Ont. K2C 0W7
rurent Tanesthesie, I'administration de 
liquides par voie intraveineuse, des 
quantites limitees de sang pour trans­
fusion et I'antisepsie. Meme alors, la 
mortalite vers la fin de la guerre attei- 
gnait encore 60%.
II est devenu de plus en plus clair 
avec chacune des guerres qui suivi- 
rent, que la reduction progressive de la 
morbidite et de la mortalite reliees aux 
plaies penetrantes de Tabdomen ne 
dependent pas uniquement de la quali­
ty de la chirurgie de sauvetage, mais 
egalement de la disponibilite, sur le 
champ de bataille, d'equipement de 
survie perfectionne et sur la capacite 
d'evacuer les blesses vers des hopi- 
taux de campagne ou on peut disposer 
de systemes de reanimation intensive, 
d'anesthesistes experimentes et de 
soins postoperatoires complets.
The treatment of abdominal wounds 
in war accents the high drama of 
military surgery. No other war wound 
presents a greater challenge to the 
surgeon. Furthermore, it is a recount­
ing of the remarkable success of the 
surgeon’s art and medical military 
science.
The soft underbelly has ever been 
an attractive target for the foeman’s 
zeal, and with the introduction of 
firearms at the Battle of Crecy in 
1346, more frequent and destructive 
abdominal wounds were seen.1 Such 
surgery as was practised before the 
20th century with any success was 
limited to the occasional repair of a 
lacerated portion of prolapsed gas­
trointestinal tract, returning it to the 
abdomen. The patient occasionally re­
covered with nonoperative measures 
and until the 20th century laparotomy 
with gastrointestinal repair was con­
demned by the great surgeons of the 
times. Their reasoning was that the 
morbidity and mortality of intra- 
peritoneal abdominal gunshot wounds 
left those so wounded with little
hope of survival, and surgery only 
added to the miseries of the dying 
soldier. Nevertheless, by the mid-19th 
century there were dissenters.
Wars of the 19th Century
Bounders, during the French Algeri­
an War in 1830, performed two lapa­
rotomies and enterorrhaphies; one of 
his patients recovered.2 He made an­
other contribution during the Crime­
an War (1853-1856), when he recom­
mended the introduction of a finger 
or a small sponge through the en­
larged abdominal wound to determine 
the presence of blood, feces or a 
bubble of gas. If any were present, he 
recommended laparotomy. The Rus­
sian surgeon, Pirogoff, also performed 
laparotomy for abdominal gunshot 
wounds during the Crimean War but 
believed this to be an act of despera­
tion.
In the American Civil War (1861- 
1865), the treatment of abdominal 
gunshot wounds remained conserva­
tive. However, the benefit of laparoto­
my was recorded by two surgeons, 
Guthrie and Otis, in The Medical and 
Surgical History o f the War o f the 
Rebellion, published in 1876.
The contributions of Claquet, 
Lembert and Dupuytren to the study 
of intestinal suture, the advent of 
ether and chloroform and the intro­
duction of antisepsis into surgical 
practice in the latter half of the 19th 
century led to successful laparotomy 
in civilian surgery.3 As a result, in the 
first years of the South African War 
(1899-1902), laparotomy was advised 
by the British for all cases of penetrat­
ing abdominal gunshot wounds. Un­
fortunately, of 26 soldiers who under­
went laparotomy, 18 (69%) died.2 As a 
result, William MacCormac, the chief 
consulting surgeon, was responsible 
for the dictum that a man wounded in 
the abdomen dies if operated on and 
remains alive if he is left in peace.
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This became known as “MacCormac’s 
aphorism” and governed the manage­
ment of abdominal war wounds for 
the first 15 years of the 20th century. 
The failure of surgery in the South 
African War was in no small measure 
related to the fact that it was carried 
out in a large unsettled country. Many 
casualties inevitably reached field 
hospitals long after injury, and unwise 
late interference in a penetrating ab­
dominal wound only disturbed the 
natural process of walling off and 
repair in those who had survived.
World War I
When World War I broke out in 
1914, the treatment policy for abdom­
inal wounds followed in the South 
African War continued to hold sway. 
The usual therapy was to put the 
patient in Fowler’s position, withhold 
food and water and administer mor­
phine, saline enemas and mouth 
washes.4 The results were deplorable. 
By the beginning of 1915, a group of 
British surgeons led by Cuthbert Wal­
lace, Owen Richard and others, un­
willing to accept the appalling mortal­
ity, performed laparotomy and gas­
trointestinal suture with some success. 
By June 1915, as a result of the 
findings at surgery and the observa­
tions made at 68 autopsies,4 two con­
clusions were reached. First, hemor­
rhage not sepsis was the chief cause 
of early death; most soldiers with 
abdominal wounds died on the battle­
field from shock and hemorrhage. It is 
estimated that of the 1 850 000 sol­
diers killed outright in World War I, 
10% died of abdominal wounds be­
fore they could be operated on. Sec­
ond, the new destructive bullets did 
not allow spontaneous recovery as did 
the smaller bullets used in the South 
African War. As a result, priority was 
given to attempts to speed up the 
evacuation of all patients with pene­
trating abdominal wounds to casualty 
clearing stations, and laparotomy be­
came the treatment of choice in most 
cases.
Shock was a frequent sequela of 
penetrating abdominal wounds in 
many wars. However, treatment was 
rarely tried and any attempt was in­
variably unsuccessful. By the turn of 
the 20th century, many ingenious 
causes of shock were advanced. Un­
fortunately, no successful treatment 
resulted. In 1908, Henderson5 stated 
that the cause of shock was hypovo­
lemia, which could be corrected by 
blood-volume replacement. This was 
later confirmed by Keith.6 As a result, 
Bayliss7 advocated intravenous infu­
sion of normal saline and later gum
acacia with saline as replacement flu­
ids. Unfortunately, there was a limit­
ed amount that could be administered 
safely, and although this regimen was 
life-saving in many cases, it failed to 
fulfil expectations. Then attention 
turned to blood transfusions. The dis­
covery of blood typing led to blood 
transfusions being used in a limited 
amount beginning in 1908 by Sir 
Berkley Monahan. The war provided 
surgeons with a unique opportunity 
for its use. In 1916 and 1917, three 
Canadian surgeons, Robertson, Archi­
bald and Guiou, popularized the indi­
rect method of transfusion,8 and later 
Guiou was among the surgeons who, 
in 1917 and 1918, carried transfu­
sions to the field ambulance level.9 
Unfortunately, during World War I 
blood transfusion was in its infancy. 
Blood had to be drawn on the spot 
and there were no storage facilities or 
any organization to supply large quan­
tities from civilian sources. The limi­
tation of successful resucitation by 
blood transfusions during this war is 
demonstrated by the fact that the pa­
tient was considered to be in irrever­
sible shock if there was no response 
after two transfusions (1500 ml).
The most popular anesthetic agent 
was nitrous oxide.4 Ether and chloro­
form were contraindicated in shock 
and sepsis as they tended to lower 
blood pressure. Long paramedian in­
cisions were the most popular. Small- 
bowel perforations were dealt with in 
a variety of ways, mostly by direct 
suture, since resection with either 
end-to-end or side-to-side anastomo­
ses often failed with resulting perito­
nitis. Large bowel was sutured — exte­
riorization being reserved for those 
cases in which closure was not possi­
ble. Duodenal wounds were sutured 
but were lethal. The wounded spleens 
were removed. Partial or complete 
nephrectomy was performed to con­
trol renal hemorrhage. Pancreatic 
wounds were often missed. Bladder 
wounds were treated in a variety of 
ways, by suture and drainage or 
suprapubic cystostomy. Results were 
poor. Liver wounds were sutured or 
packed to control hemorrhage but 
were complicated by secondary 
hemorrhage and peritonitis. Thoraco­
abdominal wounds were treated in a 
variety of ways. In 101 cases4 the 
death rate was 64%, the cause of 
death being secondary hemorrhage, 
lung involvement and peritonitis. 
Both intra- and extraperitoneal 
wounds of the rectum had a high 
death rate since proximal colostomy, 
when undertaken, was not of the di­
verting type and the transverse colon 
was used.
Late causes of death were, in most 
cases, from either sepsis or injuries 
other than abdominal ones.4 A series 
of autopsies performed by McNee and 
Dunn showed that retroperitoneal in­
fection (especially in colonic injuries) 
and gas gangrene (mostly of the poste­
rior abdominal wall) were responsible 
for many deaths.4 Other important 
causes of death were chest complica­
tions, postoperative ileus and small- 
bowel obstruction. The question of 
operation was largely interwoven with 
the process of resuscitation. Early in 
the war approximately 20% of soldiers 
who reached the casualty clearing sta­
tion were considered moribund and 
inoperable. Later because of the im­
provement in resuscitation more of 
the moribund patients were operated 
on; on the other hand, with a reduced 
lag period more desperate cases 
reached the casualty clearing station, 
so the figure of 20% for those consid­
ered inoperable remained constant.
The death rate was high. Of 4766 
patients with abdominal wounds who 
reached the casualty clearing station 
in the British sector4 the death rate, 
including the 20% moribund cases, 
was over 60%* and excluding mori­
bund cases 53%. The mortality on the 
American front was reported as 66%. 
The high mortality could be attribut­
ed largely to problems of evacuation 
and limited resuscitation. A study of 
591 cases was compiled, dividing the 
lag period into 2-hour intervals.4 Up 
to 6 hours, the chances were in favour 
of the patient; after that they were 
almost always against him.
Spanish Civil War
Three critical advances made dur­
ing the Spanish Civil War (1936— 
1939) greatly influenced both the 
medical and surgical conduct of 
World War II.
Surgeons were plagued in World 
War I by the delay in getting injured 
soldiers to surgery. Most of the emer­
gency surgery was done in the casual­
ty clearing station with little opportu­
nity to select patients. Belly wounds 
suffered particularly as a result. D.W. 
Jolly10 a New Zealand surgeon who 
worked with the Republican Army for 
2 years from 1936 to 1938 operated 
on 5000 casualties of which 970 had 
abdominal wounds. Jolly realized that 
patients must be selected for surgery, 
and to reduce the period from wound­
ing to operation he devised the “three 
point forward system”. The clearing 
station was divided into a casualty 
classification post, one hospital for 
the most urgent cases and a second
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for the less urgent cases. Thus, triage 
was born.
Of Jolly’s 970 cases of abdominal 
injury, complete statistics are avail­
able for only the last 243; the mortali­
ty was 49%, an improvement of 11% 
over the rate for World War I. Jolly 
attributes these results to reduced lag 
period as a result of triage and the 
availability of blood.10
Lip service only had been paid to 
the principles of debridement of 
wounds through many previous wars. 
As a result, gross infection and partic­
ularly gas gangrene continued through 
World War I with unacceptably high 
amputation rates. Professor J. Trueta 
of Madrid11 advocated and practised 
thorough early debridement of all 
wounds followed by delayed primary 
closure. His results were satisfactory. 
Finally, the answer to gas gangrene 
and the infected wound had arrived.
One of the most important devel­
opments in the treatment of war 
wounds was the introduction, during 
the Spanish Civil War, of units for 
collecting, storing and donating blood 
from the civilian population for use in 
the combat area. One of the first units 
was the Canadian Spanish Blood 
Transfusion Services of which Nor­
man Bethune was a founding mem­
ber.
World War II
The advanced surgical centre 
(ASC),12 a refinement of the three- 
point system of the Spanish Civil 
War, was introduced in World War 
II.13 The ASCs were situated as far 
forward as possible to facilitate early 
surgery. They consisted of a casualty 
clearing station or field ambulance as 
the parent unit, with field surgical and 
field transfusion units attached. The 
last two were small independent units 
with facilities complete in personnel 
and equipment (including canvas and 
transportation) for forward surgery or 
resuscitation. The great advantage 
was that they could quickly be at­
tached to or detached from the parent 
unit and moved as tactics demanded.
All patients coming from the front 
were screened in the ASC. Those with 
penetrating abdominal wounds were 
invariably admitted to the resuscita­
tion ward. Entrance and exit wounds 
were noted, and the diagnosis of in­
jured abdominal viscera was con­
firmed along with an evaluation of 
associated wounds.
A nasogastric tube was introduced. 
Penicillin was given and x-ray films 
were obtained. Life-saving measures 
were instituted and blood-volume def­
icits rapidly restored if possible with
whole blood, plasma and electrolyte 
solutions before surgery.
The success of the blood transfu­
sion service in the Spanish Civil War 
stimulated the British to organize a 
similar system. It grew to such an 
extent that eventually all theatres of 
operation, including the home front, 
were served. Refrigerated blood and 
its derivatives were flown to base 
transfusion units and taken from 
there to the field transfusion unit in 
refrigerator trucks. Only group O 
blood was used.
The most frequently used anesthet­
ic agent was nitrous oxide and ether, 
or ether with the oxford vaporizer and 
Pentothal.
The abdomen was opened through 
a generous paramedian incision and 
closed in layers with the addition of 
stay sutures. Wounds of entrance and 
exit were debrided followed by de­
layed primary suture.
The most important advance in 
surgical technique was the exterioriza­
tion of colonic wounds as advocated 
by Sir Heneage Ogilvie from his expe­
rience in the desert. Lives saved as a 
result are estimated not in the hun­
dreds but in the thousands, according 
to Gordon Taylor.3 Removal of the 
coccyx and incision of the fascia of 
Waldeyer in extraperitoneal wounds 
of the rectum along with a diverting 
colostomy was advocated by Naunton 
Morgan.3 Resection with end-to-end 
anastomosis of small-bowel wounds 
was done as indicated, and more con­
servative methods of treating wounds 
of the kidney were used. These ad­
vances in technique yielded divi­
dends. In thoracoabdominal wounds, 
the surgery undertaken was governed 
by the direction of the wound and the 
nature of the abdominal and thoracic 
injures — the last consideration usual­
ly being the deciding one. If thoracot­
omy was indicated, the chest was first 
dealt with; then, if injury to viscera 
was suspected, the abdomen was ap­
proached through the diaphragm or 
a separate paramedian incision. If 
thoracotomy was not required and 
injured viscera were suspected, the 
abdomen was opened through a para­
median incision.
Postoperative care consisted of 
Levin-tube suction, fluids adminis­
tered intravenously and blood as re­
quired. Chemotherapy was continued 
and chest problems were handled, as 
far as possible, with oxygen, bronchial 
toilet and repeated chest aspirations. 
Patients with no complications were 
walking 2 to 3 days after operation. 
Patients with abdominal injuries, 
however, travelled poorly and were 
not evacuated until after postopera­
tive day 10 (ideally in a pressurized 
aircraft).
Gordon Taylor3 reported an overall 
death rate of 29% in 5015 abdominal 
and thoracoabdominal wounds in 
commonwealth theatres of war in 
World War II. MacFarlane15 quoted a 
report of 725 cases of abdominal and 
thoracoabdominal cases from the 
North West Europe Campaign. The 
death rate was 30% in uncomplicated 
cases and 36% in those associated 
with other injuries.
Parker reviewed the death rate in 
94 cases, dividing them according to 
the lag period (Table I).14
In a series of 210 cases published 
by Rob and Blackburn, the death rate 
was 28.7%.14 Of the 78 patients who 
died, 48 died of shock and hemorrh­
age, 9 of generalized peritonitis, 3 of 
pulmonary embolism and 8 of other 
pulmonary complications. The causes 
of death in the remainder varied. It 
would seem, then, that the marked 
improvement in the results of abdom­
inal surgery in World War II related 
less to any remarkable change in oper­
ative technique than to earlier sur­
gery, a limitless supply of blood and 
blood derivatives, the sulfonamides 
and, later, penicillin, improved anes­
thesia and nasogastric suction.
Korean War
In the Korean War, a limited heli­
copter service was introduced, provid­
ing more rapid and comfortable eva­
cuation of severely wounded patients, 
many of whom had belly wounds.
Seventy-five patients with abdomi­
nal wounds were followed up by 
Bronwell and colleagues.16 The aver­
age time from injury to surgery was 
6.3 hours compared with 8.9 hours in 
a comparable group from World War 
II. Of those 75 patients, 40 were 
evacuated by ambulance and 27 by 
helicopter; in 8 the method of trans­
portation was not stated. The death 
rate was 12%.
Surgical technique followed the ex­
perience of surgeons from World War 
II. Two areas — the cecum and right 
colon — were given special consider­
ation. Because of unsatisfactory treat­
ment in World War II, tube cecosto- 
my was used in Korea, suturing the
T a b le  1— D eath  R ate  A c c o rd in g  to  Lag T im e
in 9 4  C ases R e v ie w e d  b y  P a rk e r’ 4
L ag  t im e , h N o. o f  cases M o r ta lity ,  %
0 -  6 21 19
6 - 1 2 2 0 2 5
1 7 - 2 4 9 5 5
O ve r 2 4 9 6 7
N o t re cord e d 3 5 —
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cecum to the anterior abdominal wall 
in smaller wounds. In larger wounds 
of the cecum and ascending colon, a 
resection was done with an end-to- 
side ileotransverse colostomy and a 
single-barrelled colostomy of the 
proximal colon. Zeperman recom­
mended a rectal examination in all 
patients with abdominal wounds.16 
Blood on the examining finger was 
proof of a perforating wound of the 
rectum. Extraperitoneal wounds were 
debrided and the coccyx was removed 
to ensure better drainage. Intra- 
peritoneal wounds were closed or a 
sleeve resection was done with a di­
verting sigmoid colostomy in each 
instance.
The death rate in 384 casualties 
who sustained abdominal wounds in 
the Korean War was reported by Sako 
and colleagues17 to be 10.68% com­
pared with 20.51% for a similar group 
of 1185 casualties treated by the sec­
ond auxiliary surgical group in World 
War II.
The same group17 reported 129 pa­
tients who sustained thoracoabdomi­
nal wounds with a mortality of 13.1% 
compared with 27% for 88 such pa­
tients from World War II.
Stravitz18 performed 35 autopsies 
on soldiers, many of whom had suf­
fered abdominal wounds. Of the early 
deaths, the majority were caused by 
irreversible shock or uncontrolled he­
morrhage. Late causes of death were 
sepsis, secondary hemorrhage, chest 
complications and other associated 
injuries with or without successful 
treatment of acute renal insufficiency. 
Teschan and colleagues19 pointed out 
that there is a much higher incidence 
of acute renal insufficiency in patients 
with abdominal wounds than in the 
general military casualty population.
The lowered mortality in the Kor­
ean conflict may be ascribed to a 
number of factors. The shorter, 
smoother evacuation, the administra­
tion of large quantities of resuscitative 
fluids pre- and postoperatively, the 
introduction of new antibiotics to 
combat gram-negative organisms, bet­
ter monitoring of electrolytes, the 
availability of the flame photometer 
and the establishment of a renal cen­
tre behind the Mobile Army Surgical 
Hospital (MASH) units, where sol­
diers who had oliguria were evacuated 
by helicopter. Of these patients, 50% 
were treated successfully by conserva­
tive measures; of the remaining 50% 
who required dialysis, 47% survived, 
the overall survival rate being 73%.
Vietnam War
Most soldiers wounded in Vietnam 
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were brought to fixed army hospitals 
directly by helicopter from or near the 
site of injury; the helicopters could 
carry up to nine patients depending 
on the number of stretchers.20 This 
eliminated the multiple stops and 
transfers of previous wars. There was 
a marked improvement in these hos­
pitals. Modern laboratory and clinical 
materials were available to monitor 
and treat shock and postoperative 
complications; in fact, supplies and 
equipment were comparable to those 
of a modern city hospital in North 
America.
The seriously wounded reached the 
operating room 1 to 2 hours after 
injury, the average evacuation time 
being 35 minutes. As a result, many 
patients, particularly those with ab­
dominal wounds, reached hospitals in 
extremis (previously they would prob­
ably have died en route).
Often patients with severe abdomi­
nal wounds were unresponsive to re­
suscitative measures because of con­
tinued bleeding and were taken imme­
diately to the operating room. This 
situation proved a real challenge to 
the surgeon. The liver was a classic 
example.
Livers shattered by high-velocity 
weapons looked like the severe dis­
ruptive wounds in major blunt trau­
ma. The death rate of patients with 
such wounds was usually high, but 
varied from 12% to 80%.
Simple lacerations, the wound most 
frequently seen,21-24 were controlled 
by suture. The macerated stellate type 
often required hepatic segmentectomy 
or lobectomy with debridement and 
control of hemorrhage. A thoracoab­
dominal incision was sometimes 
needed to control the vena cava tem­
porarily above and below the dia­
phragm along with temporary occlu­
sion of the porta hepatis to control 
bleeding from the hepatic veins. A 
variety of ingenious methods was 
used to re-establish venous return to 
the right atrium. Sump drainage was 
used with T-tube drainage of the com­
mon duct. Complications, particularly 
if the colon was also injured, were 
abdominal abscesses, chest problems 
and rebleeding.
Surgical procedures were not appre­
ciably changed from previous wars. 
Two improvements, however, are 
worth mentioning. First, the midline 
incision was used with layer closure 
and wire retention sutures, leaving the 
skin open for secondary closure. Sec­
ond, right hemicolectomy was prac­
tised for large wounds of the cecum 
and ascending colon for the first 3 
years of the war. Complication rates 
from sepsis or anastomotic leaks were
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reported in 58% of 75 patients.21 The 
final conclusion was that a matured 
ileostomy, a right colonic resection 
and a mucous fistula of the colon 
produced few complications in right 
colonic wounds in the later years of 
the war.25
Of considerable importance was 
that finally there was sufficient surgi­
cal, medical and anesthetic potential 
at each hospital to deal with all types 
of wounds.20 As well as fully trained 
general surgeons, there were repre­
sentatives in the major surgical disci­
plines. In this way, patients with mul­
tiple wounds could, if necessary, be 
operated on at one time by more than 
one surgical team. Physicians were 
invaluable both in resuscitation and 
postoperative care.
Postoperative management was of 
great importance. By diligent care, the 
prevention, recognition and treatment 
of complications seen in previous 
wars were more successfully dealt 
with. New and unknown complica­
tions, however, became apparent, par­
ticularly in badly traumatized patients 
who had miraculously lived. A price, 
it seemed, had to be paid for survival 
which meant, in reality, vital organ 
damage.
Vital organ failure has always 
plagued the military surgeon. Circula­
tory failure from trauma, hemorrhage 
and shock was unsuccessfully treated 
until World War II. The successful 
treatment of traumatic shock in 
World War II led to failure of another 
organ — the kidney. No successful 
treatment for post-traumatic renal 
failure was forthcoming and in estab­
lished cases the patients almost al­
ways died. In the Korean War post- 
traumatic renal failure was dealt with 
successfully by the establishment of a 
renal centre where dialysis could be 
carried out.
However, from the renal centre in 
Vietnam, Butkus26 reported 215 cases 
of post-traumatic renal failure with a 
mortality of 65% while in Fischer’s27 
series of 96 casualties the rate was 
77%. In Vietnam, post-traumatic 
renal failure was seen in soldiers who 
had a multiplicity of complications 
after their injury, and the condition 
often became manifest only after sev­
eral days. Frequently, death occurred 
not from failure, for dialysis had re­
stored renal function in many cases, 
but from the complications of severe 
trauma.
In the Korean experience, on the 
other hand, the patient who suffered 
post-traumatic renal failure did so 
immediately after injury, having sus­
tained severe, prolonged hypotension, 
treated often by massive transfusions.
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Thus, it is true to say that post- 
traumatic renal failure as seen in 
Korea was virtually nonexistent in 
Vietnam. This was undoubtedly due 
to early adequate resuscitation of the 
patient and maintenance of adequate 
tissue perfusion.
In Vietnam, where moribund pa­
tients were evacuated to hospitals 
early and rapidly, the serious problem 
of acute pulmonary insufficiency 
arose. A review of patients with this 
condition who died disclosed that all 
had received at least 10 units of blood 
with sodium bicarbonate.21 Most had 
been in severe shock and most had a 
good urinary output and specific grav­
ity. Early hypoxia with decreased oxy­
gen tension and chest films showing 
fluffy exudate were noted. The patho­
logical findings were compatible with 
acute respiratory distress syndrome. 
Treatment was unsuccessful until Gei­
ger and Gielchinsky28 were able to 
reduce mortality and morbidity with 
the following treatment: (a) reduced 
intake of sodium-containing fluids; 
(b) close attention to fluid and electro­
lyte balance with allowances for en­
dogenous water; (c) administration of 
a rapid-acting diuretic and (d) use of a 
volume respirator.
T a b le  II— Causes o f D ea th  in 1 0 0  Cases 
R ev ie w e d  b y  M cN a m a ra  and S tre m p le 32
Cause N o. o f  deaths
H em orrhage  
A c u te  hem orrhage  and 
sh ock  (d ied during  
re s u s c ita tio n  or
47
o pera tion )
S u dden  p o s to p e ra tive
3 9
h em orrhage 4
B le ed ing  tra c h e o s to m y 1
S tre s s  ulcer 3
P u lm o n a ry  in su ffic ie n cy  
P rogress ive  in su ffic ie n cy  
(p o s t-tra u m a tic  
p u lm o n a ry  in su ffic ie n cy ,
2 9
w e t lung, e tc .) 2 2
Fat e m b o lism 5
A s p ira tio n  w ith  ja w  w ire d 1
P lugged tra c h e o s to m y 1
Sepsis
P e rito n it is  a fte r a bd om ina l
16
in ju ry
M a ss ive  lo w e r e x tre m ity
9
a n d  p e lv ic  in ju ry 4
C ere b ritis
S e p tice m ia  (s ite  n o t c learly
1
id e n tifie d ) 2
M isce lla ne o us 
Late  in tracran ia l
8
c o m p lica tio n s
P a n cre a titis
3
(p o s t-tra u m a tic ) 
A p la s tic  anem ia
1
(C hlorom ycetin) 
U ne xp la in e d  (p a tie n ts  w ith  
m assive  m u ltis y s te m
1
in juries) 3
Another complication was oozing 
coagulopathy. Two reports29-30 demon­
strated that diffuse oozing occurs fre­
quently after massive trauma and ex­
tensive blood transfusions. It is virtu­
ally always reversible with fresh whole 
blood, usually requiring five units 
given sequentially. The mechanism of 
the coagulopathy remains obscure. 
The data favour a qualitative abnor­
mality of platelet function, although 
intravascular coagulation could also 
be the mechanism.
Frequently, in patients who sur­
vived long enough, other organ dam­
age developed, such as hepatic dys­
function, gastrointestinal mucosal 
bleeding, coagulation defects, nutri­
tional deficiencies and cardiac failure. 
It was not, however, until the early 
1970s that the similarity of the organ 
failures, whether in a sequential or 
progressive manner, suggested com­
mon causative factors that led to rec­
ognition of the multiple organ failure 
syndrome.31
Reoperation was carried out most 
commonly for sepsis — pelvic and 
subphrenic abscesses being the most 
prevalent. Other causes included 
missed intra-abdominal wounds both 
before and during surgery. Secondary 
hemorrhage occurred early from the 
liver and later from septic erosions 
into large vessels. Stress ulcers and 
small-bowel obstructions were less 
common causes for secondary opera­
tions.
McNamara and Stremple32 re­
viewed the causes of 100 consecutive 
deaths in an evacuation hospital from 
October 1968 to August 1969 (Table 
ID-
No official mortality figures for 
abdominal wounds are available for 
the Vietnam conflict. However, a 
number of series have been reported 
in which the rates vary from 2.4% to 
10%. Sunshine reported two series; 
one of 135 cases with a mortality of 
10%33 and the other of 358 cases with 
a mortality of 2.4%.34 Heaton and 
associates35 also reported two series: 
556 cases with a mortality of 9.3% 
and 201 cases with a mortality of 
8.5%. Hardaway36 reported one series 
of 1350 cases in which the death rate 
was 4.5%.
War in Northern Ireland
At the time of the outbreak of 
hostilities in Vietnam in 1969, anoth­
er war was beginning many miles 
away with entirely different logistics 
— that in Northern Ireland. There, 
14 000 casualties were treated be­
tween 1969 and 1975, and an addi­
tional 2000 were shot to death. Of
these casualties, 9000 were treated at 
the Royal Victoria Hospital in Belfast 
which is the main accident reception 
centre for the Belfast area and is 
situated within the most troubled area 
o f the city.37 As a result, casualties 
usually arrived at the hospital very 
shortly after wounding (as early as 10 
minutes in some cases). As in Viet­
nam, many catastrophically injured 
patients reached hospital alive. Most 
of these casualties had bomb wounds 
in contrast to bullet wounds in Viet­
nam.
Johnston and Kennedy38 reported a 
series of 209 penetrating abdominal 
wounds from 1969 to 1975. The 
wounds were due to bullets and bomb 
explosions. The mortality (15%) was 
higher than in Vietnam. They pointed 
out that death in patients with pene­
trating abdominal wounds is usually 
due to hemorrhage or sepsis and is 
uncommon unless there are multiple 
injuries. In patients with injury to 
four or more structures, the expected 
death rate was 40%.
Parks39 reported on 88 patients 
with gunshot wounds of the colon 
from 1969 to 1975 with a death rate 
of 18%. He emphasized that no pa­
tient with an isolated colonic or rectal 
injury died. Those who died had an 
average of 3.8 intra-abdominal organ 
injuries. Boyd40 reported 56 penetrat­
ing abdominal wounds from 1972 to 
1974 in the military with a death rate 
of 14%. In each case, the reporting 
surgeons followed the well-established 
military principles of resuscitation 
and surgery. Each emphasized that all 
penetrating abdominal wounds must 
be explored.
Recent C onflicts
In the Arab Israeli War of October 
1973,41 a different approach was 
taken in an  attempt to achieve resus­
citation and  surgery. Evacuation hos­
pitals with the capacity to undertake 
triage, resuscitation, surgery and post­
operative care were located behind a 
fluid front line. Patients evacuated by 
helicopter from the front line were 
triaged a t the evacuation hospital. 
The seriously injured were resuscita­
ted and, i f  their condition stabilized, 
evacuated by helicopter with the 
minor wounded to civilian hospitals 
in the a rea , 3 to 4 hours away- No 
patients d ied  during evacuation- Pa­
tients w ho remained unstable were 
operated o n  at the evacuation hospi­
tal. Klein m an and Rosin42 reported 
151 c«es o f  abdominal injury treated 
in this m anner. Thirty patients were 
operated o n  at the evacuation hospi­
tal; 6 (20%) of them died. The other
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121 received intensive resuscitation 
and were then evacuated to the rear 
where surgery was done; of these, 9 
(5%) died. These authors stated that 
the versatility of the evacuation hos­
pital to function as a sorting facility 
for the rear hospital yet to have up­
dated equipment and the ability to 
perform most complicated operations 
was without parallel in any other 
medical force.
Nine years later, Danon and associ­
ates43 reported 1561 battle casualties 
from the war in Lebanon of 1982 in 
which 75% of the wounded were evac­
uated directly to rear hospitals by air, 
only 25% being treated in the evacua­
tion hospital first. The average length 
o f time involved in transporting the 
severely wounded (including those 
with abdominal injuries) from the 
battlefield to the rear hospital was 2 
to 3 hours.
Light casualty loads were reported 
in small conflicts such as that in 
Oman, the French experience in Chad 
and the British in the Falkland Is­
lands. Few abdominal wounds were 
reported and little added to our pres­
ent knowledge. The Iran-Iraq hostili­
ties began in 1981. The Stockholm 
International Peace Research Institute 
reported that up to 1986, 350 000 
people had been killed and 650 000 
wounded. Unfortunately, no pub­
lished reports are available even 
though some knowledge of the meth­
ods of handling abdominal wounds 
would be o f value.
In 1966 a white paper prepared by 
the National Academy of Sciences/ 
National Research Council Commit­
tee on Shock and Trauma,44 drew 
attention to the fact that the numbers 
o f  civilian injuries from gunshot 
wounds and motor vehicle and indus­
trial accidents were increasing and 
were associated with an unacceptably 
high morbidity and mortality. With 
no systematic method of evacuation 
and treatment it was necessary to 
develop better organized civilian 
community care. Thus began the de­
velopment of the trauma/emergency 
medical service (T/EMS). It was to the 
military that the initiators of this 
service turned for help. In Vietnam, 
97.5% of patients reaching medical 
facilities survived, proving the effica­
cy of the military concepts and tech­
niques, which were also potentially 
useful in peacetime. They are now the 
basis of the T/EMS.
The improvements in the treatment 
o f  penetrating abdominal wounds in 
Peace from the inception of the 
T/EMS in the late 1960s to the pres­
ent will be the subject of a subsequent 
Paper (part 2). It will show that the
methods and results of the T/EMS 
have a significant contribution to 
make to military surgery — a unique 
event in peacetime.
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Resection of Retrohepatic Inferior Vena Caval Tumours: a 
New Technique Using the Biomedicus Pump
Management of tumours o f the re­
trohepatic inferior vena cava presents 
a serious challenge for the surgeon. 
Involvement of the vessel has often 
precluded resection of a potentially 
curable malignant lesion.1-2
Recent experience with venoatrial 
bypass in liver transplantation has 
made resection and replacement of 
the retrohepatic vena cava safe and 
relatively bloodless. A centrifugal 
pump (Biomedicus Inc., Minneapolis, 
Minn.) has simplified the procedure 
by readily controlling return of inferi­
or vena caval blood to the heart using 
minimal anticoagulation.3 Previously, 
tumours of the retrohepatic vena cava 
have been resected using cardiopul­
monary bypass (with full anticoagula­
tion), with or without total circulatory 
arrest and profound hypothermia,4-5 
clamping of the vena cava and occa­
sionally the descending aorta6 or, 
more simply, by blind tumour thromb­
ectomy with a balloon catheter.7-8 We 
describe a new technique, using the 
Biomedicus pump, to aid in the resec­
tion of two renal cell carcinomas (one 
right, one left), both of which extend­
ed through the renal veins into the 
inferior vena cava and up to the level 
of the diaphragm.
Case Reports
Case 1
Intravenous pyelography on a 62-year-old 
man with left flank pain and hematuria 
demonstrated a right renal tumour, and
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ultrasonography revealed extension 
through the right renal vein into the inferi­
or vena cava to the level of the highest 
hepatic vein. Computed tomography and 
inferior cavography confirmed that the 
extrarenal spread of tumour was confined 
to the lumen of the vena cava. Angiograph­
ic renal artery embolization was performed 
a day before operation.
At surgery the patient was placed in the 
right anterolateral position. Through a tho­
racoabdominal incision at the right sev­
enth intercostal space the diaphragm was 
detached circumferentially and the liver 
mobilized by dividing the suspensory liga­
ments, thereby exposing the lateral aspect 
of the retrohepatic vena cava. The pericar­
dium was opened longitudinally, anterior 
to the phrenic nerve, and the right com­
mon femoral vein was exposed in the 
groin. After nephrectomy and resection of 
the intracaval tumour, utilizing the Bi­
omedicus pump, the patient made an un­
complicated recovery and was discharged 
home 7 days after operation. He was 
clinically well and free of disease 7 months 
later.
Case 2
A 36-year-old man experienced sudden 
onset of painless hematuria. Intravenous 
pyelography demonstrated a left renal tu­
mour, and ultrasonography indicated 
spread into the left renal vein and the 
inferior vena cava up to the level of the 
diaphragm. Computed tomography and 
venography confirmed that the extrarenal 
spread of the tumour was limited to the 
lumen of the vena cava. Angiographic 
renal artery embolization was performed 
the day before surgery.
The tumour was approached through a 
combined midline laparotomy and ster­
notomy. The central tendon of the dia­
phragm was divided to expose the cavo- 
atrial junction. The left lobe of the liver 
was mobilized and the lesser sac entered, 
fully exposing the retrohepatic vena cava. 
The duodenum was elevated by the Ko- 
cher maneuver, laying bare the infrahepat- 
ic vena cava. The right common femoral 
vein was exposed in the groin. The tumour 
was resected, utilizing the Biomedicus 
pump. The patient was discharged home 8
days after operation. He required surgery 
for small-bowel obstruction caused by ad­
hesions 4 months later, but was clinically 
free of disease at 6 months.
Surgical Technique
When the vena cava is exposed, 
low-dose heparin (100 IU/kg) is given 
with supplemental doses o f 30 IU/kg 
to maintain the activated clotting 
time (ACT) at approximately 350 sec­
onds. The Biomedicus pump is 
primed with 1000 ml o f lactated 
Ringer’s solution and 100 ml o f  25% 
albumin. The common femoral vein 
is cannulated with a no. 28 thoracic 
catheter (Argyle; Sherwood Medical 
Industries, St. Louis, Mo.) and the 
right atrial appendage cannulated 
with a curved no. 40 venous cannula 
(USCI, Bard Inc., Santa Ana., Calif.). 
After venoatrial bypass is established, 
the uninvolved renal vein, portal tri­
ad, suprahepatic and inferior vena 
cava are clamped. The inferior vena 
caval return to the heart is main­
tained with the Biomedicus pump at 
flows of 1.3 to 2 L/min, maintaining 
right atrial pressure at 5 to 8 mm Hg 
(Fig. 1).
A lateral longitudinal cavotomy
FIG. 1—Circuit diagram showing femoral 
vein and right atrial cannulation sites, op­
tion portal vein cannulation site, pump cir­
cuit and cross-clamp sites.
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and circumferential incision of the 
right renal vein orifice was used in the 
first case and a medial longitudinal 
cavotomy with circumferential inci­
sion of the left renal vein orifice in 
the second. The tumour itself was not 
adherent to the endothelium and was 
shelled out of the vena cava with 
blunt dissection under direct vision. 
The cavotomy is repaired with run­
ning 5-0 polypropylene suture. Caval 
flow was re-established in each case 
after cross-clamp times of approxi­
mately 20 minutes. After decannula- 
tion, the heparin action is reversed 
with protamine sulfate. The renal ar­
tery and ureter are then ligated and 
divided and the kidney is excised.
Comment
To facilitate safe resection of tu­
mours of the retrohepatic vena cava, 
two conditions must be met: (a) a 
reasonably bloodless field must be 
provided and (b) venous return to the 
heart maintained. Our technique ful­
filled both conditions and the tumour 
was removed under direct vision with 
minimal blood loss.
The standard procedure has been to 
retrieve the tumour mass through an
infrahepatic cavotomy, using a bal­
loon catheter,7 8 but with this method 
there is little control of blood loss, a 
high risk of tumour embolization and 
the surgeon cannot be sure that all 
tumour has been removed. The high 
rate of metastatic recurrence may be 
related to this technique.1-2 There was 
no evidence of lung metastases in 
either of our patients.
Although clamping the vena cava 
above and below the tumour may 
allow direct visualization and preven­
tion of tumour emboli, the risk of 
profound hypotension secondary to 
reduced venous return is great.1’27’8 
The inclusion of aortic cross-clamping 
adds the risk of acidosis and declamp­
ing shock and would impose a time 
constraint on the resection.6 Cardi­
opulmonary bypass and, occasionally, 
circulatory arrest with profound hypo­
thermia, satisfies the above-men­
tioned requirements and can thus be a 
valuable technique for removing tu­
mours that extend into the right atri­
um.4-5 However, much larger doses of 
heparin are required and coagulopa­
thy related to profound hypothermia 
and prolonged pump times increase 
the risk of bleeding. We believe that 
this technique is not necessary for
isolated caval tumour extension. If 
cross-clamp times longer than 30 min­
utes are necessary (e.g., for vena caval 
replacement) we suggest additional 
cannulation of the portal vein using a 
right-angle no. 20 Pacifico cannula 
(DLP Inc., Grand Rapids, Mich.) for 
mesenteric venous return.
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SESAP V Question
225. A 60-year-old man who had an aortic bifurcation graft placed two years 
previously has a rectal hemorrhage that ceases. One week later bleeding 
recurs. Upper gastrointestinal endoscopy and colonoscopy fail to reveal any 
source of bleeding. An aortic graft-enteric fistula is suspected. The diagnos­
tic modality of choice is
(A) small bowel series
(B) labeled red blood cell scan
(C) computed tomographic (CT) scan
(D) arteriography
(E) surgical exploration
For the incomplete statement above, select the one completion that is best of 
the five given.
For the critique of Item 225 see page 247.
(Reproduced by permission from SESAP V Syllabus; Surgical Education and 
Self-Assessment Program No. 5. For enrolment in the Surgical Education and 
Self-Assessment Program No. 5, please apply to the American College of 
Surgeons, 55 East Erie St., Chicago, IL 60611.)
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I consider it an honour to deliver this 
presidential address. Since I am the 
first francophone president of our 
young society and our guest lecturer is 
a distinguished surgeon from Mar­
seille, I think it is appropriate to 
consider the French contribution to 
our discipline.
We are all aware of the tremendous 
achievements in vascular surgery dur­
ing the last 35 years and as North 
Americans we can take pride in the 
contributions by DeBakey, Cooley, 
Gross, Szilagyi and many others. Sur­
geons on the other side of the Atlantic 
have also contributed to the develop­
ment of our specialty and today I 
would like to evoke the memory of 
some of them.
A remarkable French school, the 
School of Lyon, dominated the field 
of vascular surgery at the beginning of 
the 20th century. Mathieu Jaboulay 
was the first to achieve success with 
arterial suturing and, with his pupil 
Briau, published in Le Lyon Medical 
in 1896 his research work on the 
subject.1
Experiments on 10 dogs were as 
follows: the common carotid artery on 
one side was ligated close to the 
thorax and divided immediately 
above the ligature. The other common 
carotid artery was ligated close to its 
bifurcation and divided distal to the 
ligature. The resulting two long arteri­
al segments were easily anastomosed
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in front of the trachea. Interrupted, 
full-thickness, U-shaped stitches were 
inserted with the knots outside the 
lumen, thus apposing endothelium to 
endothelium.
The dogs were killed 4 to 5 days 
later and the vessels examined. No 
clots were evident at the suture lines 
but had formed where there had been 
compression, proximally and distally 
during the anastomosis. Jaboulay was 
aiming for three results: re-establish- 
ment of circulation, absence of he­
morrhage at the suture line and the 
absence of clots and lesions of the 
endothelium. What he foresaw at that 
time is interesting: “the suture of a 
carotid artery in an emergency would 
allow such accidents as a hemiplegia 
to be prevented. An arterial graft 
would provide us with a means of 
treating those gangrenes of arterial 
origin against which we are defence­
less. The treatment of the aneurysms, 
of the wounds of major arteries and of 
peripheral atheroma would be trans­
formed.” The last sentence in their 
article is prophetic: “The preceding 
considerations can apply to the ve­
nous system and we must hope to see 
one day a lateral anastomosis between 
the portal vein and the inferior vena 
cava in certain cases of hepatic cirrho­
sis.”
Jaboulay was also a pioneer in sur­
gery of the sympathetic nervous sys­
tem. He observed that while dissect­
ing a major artery to an extremity 
there was a warming of the distal part. 
In 1899, he recommended2 the treat­
ment of certain trophic problems of 
the foot by the “denudation of the 
femoral artery and the distension of 
the vascular nerves”.
Jaboulay met an untimely death in 
a railroad accident in 1913 but he had 
a brilliant student, Alexis Carrel. The 
anastomoses that we now routinely 
perform are based on the principles 
Carrel described at the turn of the 
century. He became interested in sur­
gery of the blood vessels fortuitously. 
After delivering a speech at a public 
banquet in Lyon, June 24, 1894, the 
President of France, Sadi Carnot, was 
stabbed by an Italian anarchist. The 
assassin’s knife lacerated Carnot’s 
portal vein. At that time, such 
wounds could not be repaired, and 
Carrel, then an intern, watched his 
chief operate unsuccessfully on the 
president. Carrel remarked: “We
only need to learn to repair blood 
vessels as well as any other body 
tissue”.3
Deciding to work on the problem, 
Carrel is said to have taken lessons on 
how to make the finest sutures from 
the most famous lacemaker in Lyon. 
He developed great skill, and by coat­
ing his instruments, needles and 
threads with paraffin jelly avoided 
local blood clotting. In 1902, his first 
successes in suturing blood vessels 
were reported.4
This classic method is known as the 
triangulation technique. Here is how 
Carrel described it. “The end-to-end 
anastomosis is effected by bringing 
the extremities of the vessels into 
contact. The ends are united by three 
retaining stitches located at three 
equidistant points of their circumfer­
ence. By traction of the threads, the 
circumference of the artery can be 
transformed into a triangle, and the 
perimeter can be dilated at will. Then 
the edges of each side of the triangle 
are united by a continuous suture 
whilst they are under tension.”
In spite of this brilliant achieve­
ment, Carrel found his future univer­
sity career blocked by local opposi­
tion. He left Lyon and after a year of 
advanced medical studies in Montreal 
went to the University of Chicago, in 
1904, where he resumed, with Guth­
rie, his work in blood vessel surgery.
His surgical skill, bold experimen­
tation and technical originality won 
him an appointment, in 1906, as a 
member of the Rockefeller Institute in
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New York, where he applied his tech­
nique to renal transplants in animals. 
In the Journal of the American Medi­
cal Association in 1908, Carrel wrote: 
“The idea of replacing diseased or­
gans by sound ones is doubtless very 
old. The performance of such opera­
tions, however, was completely pre­
vented by the lack of a method for 
uniting vessels.”5
In 1912, he received a Nobel prize 
in recognition of his work on vascular 
sutures and organ transplantation.
One of Carrel’s disciples was Rene 
Leriche who continued work on the 
sympathetic nervous system and in 
1913 revived Jaboulay’s operation, 
calling it periarterial sympathectomy.6 
In separating an artery from its ad­
ventitia for a distance of 6 to 10 cm, 
there is an immediate spasm of the 
denuded vessel lasting from 5 to 8 
hours that Jaboulay had not observed. 
This is followed by a period of vasodi­
latation with a warming of the ex­
tremity. Leriche erroneously believed 
that the nerve fibres reached distal 
vessels by way of the adventitial net­
work.
Later, in studying the nature of 
segmental arterial occlusions, he be­
lieved that removal of the occluded 
segment would have a beneficial ef­
fect on distal circulation. In 1917 he 
resected, for the first time, an occlud­
ed arterial segment and wrote: “This 
segment behaves as a vasoconstrictive 
nerve. Its resection produces a vasodi- 
latory effect.”7 Segmental arterial re­
section gradually supplanted periar­
terial sympathectomy.
Les bulletins et memoires de la 
Societe de Chirurgie de Paris in No­
vember 1923, carried a report of two 
patients who had no pulses in the 
lower extremities.8 This phenomenon 
was attributed to a vasomotor or con­
genital problem called “ micros­
phygmia”, because at operation the 
femoral arteries were found to be very 
small.
At the next meeting of the Society 
on Dec. 5, 1923, Leriche, discussing 
these two cases, made the observation 
of what would become his syndrome: 
“It is absolutely certain that these 
problems are not vasomotor and that 
these symptoms are caused by a true 
arterial occlusion. I have seen two 
identical cases. We have a sure way to 
differentiate arterial occlusions from 
spasms: during the war we showed 
that, in a case of spasm, a hot bath 
brings back the oscillations in the 
extremity. On the contrary, in a case 
of occluded artery, the hot bath do­
esn’t change anything in the oscil­
lometry. In my two cases, as the hot 
bath test didn’t bring back the oscilla­
tions, I made the diagnosis of arterial 
occlusion and as the problem was 
bilateral, I was forced to admit that 
the obliteration was at the termina­
tion of the aorta. Evidently, I didn’t 
have the anatomical confirmation: 
but think about it, it cannot be other­
wise. Obviously, perifemoral sympa­
thectomy cannot do any good. In my 
opinion we should go straight to the 
lesion and explore the aortic bifurca­
tion...we could try a sympathectomy 
higher but the ideal treatment would 
consist of a resection of the obliterat­
ed zone and re-establishment of ar­
terial permeability if possible. Unfor­
tunately it seems to me unlikely that 
this ideal will become feasible.”9 
Leriche waited 16 years before operat­
ing on such cases.
His original article on the subject, 
published in 1940, described the clas­
sic symptoms very clearly.10 He wrote: 
“What I have seen since 1923 has 
now to be recognized as a true syn­
drome.”
The goal of the arteriectomy was to 
stop the possible fatal spread of 
thrombosis. At the same time, vaso­
constrictor impulses originating in the 
aortic wall and resulting in vasospasm 
of the remaining free channels ought 
to disappear.
It was recommended that lumbar 
ganglionectomy be done proximally 
(at the LI level) because it seemed 
desirable to avoid as many collaterals 
as possible and also by operating as 
high as possible the lumbar arteries 
and those of lower limbs underwent 
vasodilatation.
The patient described in the origi­
nal article10 was a 61-year-old man, 
referred to Leriche with early gan­
grene in the left foot and severe bilat­
eral leg pain. In 1936, a bilateral 
perifemoral sympathectomy had been 
performed, resulting in improvement 
for 2 years. In December 1938, the 
periarterial sympathectomy was re­
peated, with subsequent aggravation 
of symptoms. At the time of referral, 
the patient’s left foot was cold and 
cyanotic with gangrenous spots. A 
translumbar aortogram showed a neat 
block of the dye at the L3 level.
Leriche noted: “The diagnosis is 
clear; a bilateral lumbar sympathecto­
my would appear to be useless. In 
order to try and relieve the pain and 
stop the spread of the disease, I will 
attempt an aortectomy despite the 
fact that the left foot is lost.”10
Under spinal anesthesia the opera­
tion was performed on July 24, 1939, 
using a left iliac incision and an ex- 
traperitoneal approach. The aortic bi­
furcation was resected and a bilateral 
sympathectomy performed. Postoper­
atively, the right foot was normal and 
the patient pain-free. However, cya­
nosis extended in the left leg and a 
mid-thigh amputation was performed 
2 weeks later. Leriche wrote: “At the 
end of August 1939, healing had hard­
ly begun at the site of the amputation. 
Owing to war and to the evacuation of 
the hospitals of Strasbourg, we do not 
know what has become of this patient. 
It is possible that he is dead. But from 
our point of view, this does not alter 
the fact that circulation in the right 
lower limb was considerably im­
proved by aortectomy, with preserva­
tion of the leg and foot on this side.”10
Many years later, in 1948, Leriche 
published his results in the North 
American literature11 in an almost 
exact translation of his original in 
French. Nevertheless, it is probably 
this paper that drew the attention of 
North American physicians to this 
syndrome.
Before his death in 1955, Leriche 
witnessed another important contri­
bution by one of his assistants, Jean 
Kunlin. Leriche’s observation of the 
segmental localization of the athero­
sclerotic process was confirmed after 
the introduction of arteriography by 
Reynaldo Dos Santos in 1929. In 
occlusive disease of the femoral ar­
tery, Kunlin reasoned that it should 
be possible to aid nature’s efforts at 
restoring circulation around the ob­
structed segment.
Goyanes from Madrid, in 1906, 
was the first to remove a popliteal 
aneurysm and replace it with a short 
segment of popliteal vein,12 but this 
operation was not adopted and the 
graft length was never more than a 
few centimetres, nor was it tried in 
arteritis.
Two achievements paved the way 
for Kunlin to try a long graft—the 
discovery of heparin in 1916 and the 
technique of thromboendarterectomy 
devised by Dos Santos in 1947.13 
Kunlin reasoned as follows: “It seems 
to us that instead of taking away an 
old thrombus with part of the arterial 
wall, it would be more logical to 
interpose a vascular segment har­
vested elsewhere. It should not be 
more difficult to keep open a freshly 
harvested vein, even one of long 
length, than to prevent postoperative 
thrombosis of a segment of artery 
stripped of its endothelium.”14
Kunlin discussed the chances of 
success of such an operation with 
Leriche who was curiously skeptical. 
Because of Leriche’s attitude, Kunlin 
developed the technique alone and 6 
months later, on June 3, 1948, in 
Leriche’s absence, inserted the first 
femoropopliteal graft.15 The patient
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had already undergone a lumbar sym­
pathectomy, a femoral arteriectomy 
and an amputation of the first toe of 
the left foot in which the wound was 
not healing. Kunlin used 26.5 cm of 
reversed saphenous vein. The result 
was spectacular, and Leriche, on his 
return, was surprised by the result.
Since Kunlin could not anticipate 
the eventual outcome of the graft, he 
ended his article with the sentence: 
“It seems to me that it is unwise with 
the current state of our knowledge, to 
first attempt a venous graft. It is 
preferable to do a sympathectomy.”15 
His technique was rapidly and univer­
sally adopted.
In the meantime, in 1948, Robert 
Gross at the Boston Children’s Hospi­
tal had successfully used arterial ho- 
mografts in the treatment of congeni­
tal cardiac diseases.16 Learning of 
these spectacular results, Jacques 
Oudot in Paris thought it might be 
possible to answer the wishes ex­
pressed by Leriche in 1923. Place­
ment of an aortic bifurcation graft 
might be possible. In 1951, he report­
ed the case of a 51-year-old woman.17 
Using a left extraperitoneal iliac ap­
proach, with resection of the 10th and 
11 th ribs, Oudot resected the aor- 
toiliac bifurcation and interposed a 
human homograft taken out 3 weeks 
earlier. The distal anastomoses were 
performed at the external iliac vessels, 
the right anastomosis being tedious 
due to the exposure. The left side 
remained patent but the right side 
thrombosed in such a way that Oudot 
remarked: “This partially successful 
operation is interesting because it al­
lows us to compare the results of an 
operation which corresponds to an 
arteriectomy on the right side to one 
that corresponds to the reconstitution 
of the main stream on the left side.”
As expected, the patient returned 
some months later with rest pain of 
the right foot. Oudot planned another 
homograft for that side, but due to the
fibrosis at operation he found it easier 
to do a bypass between the left and 
right external iliac arteries; this was 
the first extra-anatomic bypass.
It was just a matter of time before 
this operation was extended to resec­
tion of an aneurysm. That step was 
taken by Charles Dubost18 in 1951. 
The patient, a 50-year-old man, was 
referred because of a pulsatile abdom­
inal mass. A translumbar aortogram 
showed an infrarenal aneurysm to­
gether with dilatation of the right 
common iliac artery and a thrombosis 
of the left common iliac artery. Du­
bost used a left thoracoabdominal in­
cision with resection of the 11th rib 
and an extraperitoneal approach. The 
aneurysm was excised with difficulty 
and a segment of the sac was left 
adherent to the vena cava. The homo- 
graft had been removed from the 
thoracic aorta of a 20-year-old woman 
3 weeks earlier.
The homograft, a straight tube, was 
interposed between the aorta and the 
right common iliac artery. An endar­
terectomy was performed on the left 
common iliac artery which, after liga­
tion of the hypogastric artery to gain 3 
cm, was anastomosed to the side of 
the graft.
Dubost published his article in the 
North American literature in 1952.19 
In the same issue, Geza De Takats20 
reviewed the literature relating to a 
different treatment of aneurysmal dis­
ease at that time, without, of course, 
mentioning the resection. The new 
technique was described in detail a 
few pages further on in the journal.
Surgery has no boundaries; we 
must build bridges between us as only 
by doing so will we be able to truly 
learn from each other and achieve the 
goal of excellence that we all desire.
In conclusion I would like to quote 
Santayana—an American philosopher 
of Spanish origin— who wrote “Those 
who cannot remember the past are 
condemned to repeat it.”
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Reoperation Within 2 Years of Aortofemoral Bypass
The  authors analysed 2 67  consecutive 
prim ary aortofemoral grafts to identify 
the reasons for reoperation w ithin the 
first 2  years postoperatively. Forty-one 
(8% ) of the 521 lim bs required a se c ­
ond operation.
Precursors to reoperation were: oc­
c lusion  of a superficial femoral artery 
(12% ), gangrene (27%) and severe 
acute  ischemia (35%). The rationale 
for reoperation w a s  classified as 
technical 11, questionable selection 
(candidates for percutaneous trans­
lum inal angioplasty or inappropriate 
operation) 9, d isease progress 11, re­
sidua l sym ptom s 9, contralateral 
sym p to m s 1. The com m onest techni­
cal problem w as blind endarterectomy 
w h ich  preceded seven reoperations, 
five for throm bosis of the graft or a 
superficial femoral artery which w a s  
patent initially. A lthough 2 1 8  limbs 
had an occluded or severely stenosed 
superficial femoral artery, only 26  
(1 2% ) required reoperation w ithin the 
first 2  years. The authors believe that 
the  incidence of reoperation after aor­
tofem oral bypass can be reduced by 
identifying the lim bs at risk, by appro­
priate selection for percutaneous trans­
lum inal angioplasty, avoiding blind 
outflow  endarterectomy and consider­
ing concom itant femoropopliteal by­
p a ss  w hen gangrene is present.
Les auteurs ont analyse 2 67  pontages 
aorto-fem oraux dans le but d 'identifier 
le s c a u se s  de reintervention chirurgi-
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cale dans les 2  ans qui suivent la 
premiere operation. Quarante-et-un 
(8%) des 521 m em bres ont necessite  
une seconde operation.
Les facteurs ayant precede la 
deuxieme intervention sont les sui- 
vants: obliteration d 'une artere femo- 
rale superficielle (12%), gangrene 
(27% ) et ischemie aigue grave (35%). 
Les motifs de reintervention ont ete 
classifies com m e suit: technique 11, 
choix douteux (candidats a une angio- 
plastie transluminale percutanee ou 
operation inadequate) 9, evolution de 
la maladie 11, sym ptom es residuels 9, 
sym ptom es controlateraux 1. Le pro- 
bleme technique le plus frequent etait 
lie a une endarterectomie a I'aveugle 
qui preceda sept reinterventions, dont 
cinq pour thrombose d 'un  greffon ou 
d 'une  artere femorale superficielle qui 
etaient permeables initialement. 
M e m e  si 2 18  m em bres avaient une 
obliteration ou une stenose grave 
d 'une  artere femorale superficielle, 
seulement 26  (12%) ont necessite une 
deuxieme operation au cours des 2 
premieres annees. Les auteurs croient 
que la frequence des reinterventions 
peut etre dim inuee par une identifica­
tion des m em bres menaces, un bon 
choix des candidats a I'angioplastie 
translum inale percutanee, en evitant 
les endarterectomies a I'aveugle et en 
envisageant un pontage femoro-popli- 
te concomitant lorsqu'il y a gangrene.
Aortofemoral bypass is the accepted 
gold standard of therapy for aortoiliac 
occlusive disease. Although the graft 
is durable, a second operation is 
sometimes necessary to obtain the 
desired result. This paper analyses all 
vascular reoperations done within 2 
years of an initial aortofemoral bypass 
at St. Paul’s Hospital, Vancouver, 
over a 5-year period. We have classi­
fied the reason for each additional 
procedure and have identified four 
standard management principles 
which should reduce the frequency of 
early reoperation.
Patients and Methods
Since 1967, all vascular operations 
done at St. Paul’s Hospital, Vancou­
ver have been recorded on a compre­
hensive computer form1 and stored in 
the University of British Columbia’s 
mainframe computer. Using these 
data we have analysed the cases of 
267 consecutive patients (182 men, 85 
women) in whom primary aortofem­
oral grafts were placed during the 
5-year period from Jan. 1, 1979 to 
Dec. 31, 1983. The patients’ ages 
ranged from 34 to 91 years (mean 60 
years). The presenting complaint was 
claudication in 72%, rest pain or gan­
grene in 20% and acute ischemia in 
8%. The aortic anastomosis was end 
to side in 223 patients (84%). The 
remaining 44 grafts were anastomosed 
end to end because of aneurysmal 
disease in 17 and severe aortic occlu­
sive disease in 27. The distal end of 
the graft was taken to a femoral artery 
in 521 limbs. Two bifurcation grafts 
were inserted into the femoral artery 
on one side and the common iliac on 
the other and 11 of the grafts were 
unilateral. Hospital morbidity (30 
day) included thrombosis with reoper­
ation in five patients (1.9%), wound 
infection in four (1.5%), amputation 
in two (0.7%), and two patients died 
(Table I). Two of the reoperations 
were for occlusion of a previously 
patent superficial femoral artery. 
There was no wound infection, ampu­
tation or death in those whose pre­
senting symptom was claudication. 
This group provided the pool for 
study and only one was lost to follow­
up. All vascular operations occurring 
within the subsequent 2 years were 
analysed using computer-generated 
data, a review of the operative report 
and a blinded assessment of the ar­
teriograms. We classified the reason 
for each secondary operation under 
one of the following headings: techni­
cal, questionable selection, disease 
progress, residual symptoms, contra­
lateral symptoms. Reoperations oc-
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curring within a year were arbitrarily 
classified as technical and those there­
after were considered disease prog­
ress. Outflow management was coded 
under concomitant procedures on the 
computer form (Fig. 1). Blind deep 
femoral endarterectomy was identi­
fied by reviewing the operative report
CO NCOM ITANT PROCEDURES
1 No (type, patch)
2 Prof undoplasty R 
Profundoplasty L3
56End y / patch (state) __
4 In flo w
5 O u tflo w  R 5 7 __
6 O u tflo w  L
5 87 Sym pathectom y R
8 Sym pathectom y L 59
A Incidental aneurysmectomy
8 Throm bectom y
Em boleciom y
6 0
C
D Op arteriogram
9 Other (state)
INCIDENTS DURING  OPERATION
1 No
2 Anastimosis Revised
6 1
3 Thrombosis, throm bectom y
6 24 Blood loss over 2000 ccs
9 Other (state)
OPERATING  TIME
Minutes
Skm To Skin ____________
6 3  6 4  6 5
FIG. 1—Portion of computer form filled 
out on each patient at St. Paul’s Hospital. 
Management of isolated deep femoral out­
flow tract (Table II) was classified by codes 
1, 2 and 3 and review of operative reports by 
codes 5 and 6 for blind endarterectomy.
on the 57 patients who had an out­
flow procedure because of occlusion 
or 85% stenosis of the superficial 
femoral artery. In addition to the 
hospital morbidity and mortality, two 
graft infections, two amputations and 
six deaths occurred during the 2-year 
interval.
Results
During the 2 years after the original 
aortofemoral grafting, there were 41 
reoperations involving 38 patients. 
They were: graft replaced intra- 
abdominally 1, thrombectomy or 
crossover 8 (including thrombectomy 
of a concomitant femoropopliteal
Table II -  Reason and Timing of Reoperation
Postop year
Reason 1 2
Technical 11(5)* -
Questionable selection 6 3
Disease progress 11
Residual symptoms 8 1
Contralateral symptoms 1
‘ Brackets indicate acute occlusion of graft
or patent outflow tract 
admission (Table V).
on initial hospital
Table I -  Comparative Hospital (30 Day) Morbidity and Mortality (%)
Revision
thrombectomy Infection Amputation Death
CSVS audit, 1983 2.5 1.2 2.0 2.3
CSVS audit, 1984 * 1.7 2.2 1.0 2.0
Present series 1.8 1.4 0.7 0.7
Table III -  Management of Outflow Tract in 218 Limbs With Occlusion of Superficial Femoral
Artery or 85% Stenosis
Outflow management
No. of 
limbs
Reoperation within 
1 yr, no. (%)
Nil 103 8 (8)
Femoral endarterectomy or graft tip into orifice of deep 
femoral artery 51 4 (8)
Profundaplasty 51 5(10)
Concomitant femoropoliteal bypass 7 1 (14)
Deep femoral endarterectomy, blind or open, with or 
without patch 6 2(33)
Table IV -  Reoperation Within 2 Years Related to Presenting Symptom of Worst Leg
No. of
No. (%) 
of patients
Symptom patients reoperated on
Claudication 196 24 (12)
Ischemia 39 4(10)
Gangrene
Acute ischemia requiring
11 3 (27)*
Elective operation 4 2(50)
Emergency operation 17 5 (30)
Totals 267 35 (13)
'Includes concomitant femoropopliteal bypass; 4 of 10 patients with gangrene and an occluded 
superficial femoral artery had a femoropopliteal bypass within 2 years.
graft), revision or profundaplasty 
(without thrombectomy) 6 and femo­
ropopliteal bypass 26. Two additional 
femoropopliteal bypasses were done 
for aortofemoral limb occlusion to 
increase outflow. Reasons for these 
operations were classified as technical 
11, questionable selection 9, disease 
progress 11, residual symptoms 9, 
contralateral symptoms 1. Six patients 
had iliac lesions that might have been 
treated by dilatation rather than by­
pass, and three patients had femoro- 
tibial bypasses for disabling claudica­
tion. These nine limbs are listed 
under questionable selection. The 
classification and timing of reopera­
tions are tabulated in Table II. Ten 
secondary femoropopliteal grafts were 
done for notable residual symptoms 
and five for disease progress. We as­
sessed outcome on the basis of the 
status of the superficial femoral artery 
outflow tract. Of 218 limbs that had 
an occluded or an 85%-stenosed su­
perficial femoral artery, 20 (9%) re­
quired reoperation within the first 
year and 6 more (3%) in the second 
year. The remaining 303 limbs had a 
patent superficial femoral artery and 
had reoperation rates of 2% in the 
first year and 3% in the second year. 
Management of the isolated deep fem­
oral outflow tract is documented in 
Table III. The two occlusions after 
blind endarterectomy occurred imme­
diately postoperatively. When pa­
tients’ limbs were classified according 
to symptoms, reoperation was more 
frequent in limbs presenting with gan­
grene (27%) or acute ischemia (30%) 
(Table IV).
Discussion
Although aortofemoral bypass graft­
ing may at present be the treatment of 
choice for aortoiliac occlusive disease, 
a number of questions remain to be 
answered, and more recent alterna­
tives must be considered before re­
sorting to surgery. Early morbidity 
and the chance of reoperation are 
important considerations. The hospi­
tal (30 day) mortality and morbidity 
in this series compares well with the 
Canadian Society for Vascular Sur­
gery national audit (Table I),2’3 and is 
lower than the rates from earlier re­
ports in the areas of death and infec­
tion.4-7 This trend is underlined by 
historic reports comparing early and 
more recent periods of aortoiliac sur­
gery.68 Today aortofemoral bypass is 
a safe procedure, applicable to select­
ed patients with claudication.911 Per­
cutaneous transluminal dilatation, hot 
tip angioplasty and extra-anatomic 
bypass are reasonable alternatives in
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selected patients. Patency rates ap­
proximating 85% and 75% at 2 and 5 
years respectively are reported follow­
ing iliac transluminal dilatation.12 At 
2 years, 65% is probably a more 
realistic rate for the limbs that have 
an occluded superficial femoral ar­
tery.13
In this series, 14 grafts (2.7%) 
thrombosed or stenosed during the 
2-year follow-up. It is well established 
that an isolated deep femoral artery 
provides sufficient outflow to main­
tain the patency of an aortofemoral 
graft.4-14-15 Generally we concentrate 
on the deep femoral artery rather than 
adding a femoropopliteal bypass at 
the initial operation. If a 4-mm dila­
tor can be passed easily into the deep 
femoral artery, with no obvious steno­
sis, we consider this acceptable; other­
wise an orifice procedure or profun- 
daplasty is added. Following profun- 
daplasty, limbs were improved to the 
level of a normal isolated deep femo­
ral artery, but this did not prevent 
reoperation, usually femoropopliteal 
reconstruction, for important residual 
symptoms. When multilevel disease is 
encountered, successful iliac dilata­
tion may provide adequate inflow and 
obviate the need for or postpone a 
second operative procedure if a femo­
ropopliteal reconstruction is neces­
sary. Six of the nine patients catego­
rized as questionable selection would 
today be considered good candidates 
for dilatation.
There were 16 secondary opera­
tions for thrombosis (Table V). Of the 
five acute graft or superficial femoral 
artery occlusions that occurred in hos­
pital, four were associated with blind 
endarterectomy of the deep or super­
ficial femoral artery or deep femoral 
endarterectomy without a patch. 
Blind “picking” procedures are dan­
gerous, particularly in an isolated 
deep femoral outflow tract. Disease 
progress after aortofemoral bypass is 
difficult to assess. In some of the 
limbs classified here as disease prog­
ress, the condition may have been 
related to placement of the distal end 
of the graft into a small or diseased 
common femoral artery close to the 
femoral bifurcation (Fig. 2). We pre­
fer to take the tip of the graft into an 
outflow artery in these cases.6 Eleven 
limbs (2%), were classified as disease 
progress during the second year, for a 
total limb reoperation rate of 8% (14% 
of patients) in the first 2 years. Baird 
and colleagues7 reported a 14% inci­
dence of “downstream repair” after 
aortofemoral grafting at an average 
follow-up of 2.5 years. The long-term 
durability of the operation is well 
established, reoperation being much
less frequent after the second year.7-9 
From our study it would seem that 
about half the early reoperations 
could be avoided by careful attention 
to technique and selection (Table II). 
Of the 28 secondary femoropopliteal 
bypass procedures, only 15 were re­
quired because of residual symptoms 
or disease progress.
Eleven limbs were gangrenous. One 
was the result of a distal embolus 
from an iliac artery in the presence of 
a patent superficial femoral artery. 
Four of the 10 limbs with superficial 
femoral artery occlusion required fe­
moropopliteal bypass within 2 years. 
In two of these a concomitant femoro­
popliteal bypass was done at the time 
of aortofemoral graft placement. The 
philosophy of taking the head of pres­
sure distally initially, for salvage, is 
controversial. We believe that con­
comitant femoropopliteal bypass is 
sometimes indicated for gangrene if 
an appropriate surgical team can be 
assembled. However, 88% of the 
limbs that demonstrated superficial 
femoral occlusion or severe stenosis 
did not require subsequent down-
FIG. 2—Left iliac stenosis, associated 
with superficial femoral and popliteal artery 
occlusion causing rest pain. Transluminal 
dilatation rather than aortofemoral bypass 
would probably have provided inflow for 
femorotibial bypass that was required 1 
month later because of lack of improvement. 
This limb was classified as questionable 
selection.
stream reconstruction. Although there 
is a correlation between an occluded 
superficial femoral artery and reoper­
ation, routine femoropopliteal recon­
struction is not justified without more 
specific indication of which limbs will 
continue to give rise to symptoms.
On the basis of this study we be­
lieve that aortofemoral bypass is the 
best long-term treatment for aortoiliac 
occlusive disease. Operative morbidi­
ty, mortality and results have im­
proved, and it is possible to reduce 
the incidence of early reoperation by 
adhering to the following principles:
•  Identify the limbs at greater risk 
for a second operation and reoperate 
on these patients electively within the 
first 6 months after aortofemoral by­
pass.
•  Select for transluminal dilatation 
those cases of dilatable iliac stenosis 
when multilevel disease is present.
•  Manage the outflow procedure 
carefully, avoiding blind endarterecto­
my.
•  Consider concomitant femoro­
popliteal bypass in the presence of 
gangrene.
FIG. 3—Stenosis of origins of superficial 
and deep femoral arteries. Patient presented 
with claudication 14 months after aortofem­
oral bypass. This limb was classified as 
disease progress, but condition may have 
been related to placing tip of anastomosis 
too close to femoral bifurcation.
Table V  -  T im ing o f  R eoperations fo r  Th rom bosis
T im e
A o rto fem o ra l 
gra ft (n =  521)
O utflo w  tra c t
Fem oropop litea l 
(n =  8)
Superficial 
fem ora l 
(n =  303)
In hospita l 2 1 2
In 1st year 4 - 2
In 2nd year 2 3
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Factors Influencing Results of Femoropopliteal Bypass 
Operations for Lower Limb Ischemia
An ideal way to assess the effective­
ness of femoropopliteal bypass proce­
dures is to standardize patient- and 
surgeon-related variables by random­
ization. Through statistical analysis of 
multiple factors influencing patency, 
limb loss, death rate and hospital stay, 
the authors reviewed retrospectively 
136 bypass procedures performed 
over 5 years.
Variables that contributed signifi­
cantly to the results were: preopera­
tive symptoms (p = 0.037), graft ma­
terial used (p = 0.01 6), age of the 
patient (p = 0.007), adequacy of run­
off (p = 0.041) and smoking postoper- 
atively (p = 0.013).
Autogenous vein grafts were supe­
rior to prosthetic grafts, the cumula­
tive patency at 5 years being 67.5% 
and 38.2% respectively.
The authors emphasize that all pa-
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tients needing vascular surgery should 
be advised to stop smoking, since in 
this study postoperative smoking in­
creased the probability of limb loss and 
adversely affected the cumulative pat­
ency rate by interaction with other 
variables such as preoperative symp­
toms, graft material and age.
Un moyen ideal d'evaluer I'efficacite 
des pontages femoropoplites consiste 
a standardiser les variables reliees aux 
patients et chirurgiens par voie de ran­
domisation. Les auteurs ont etudie en 
retrospective, grace a une analyse sta- 
tistique des multiples facteurs influen- 
cant la permeabilite, la perte des 
membres, la mortalite et la duree du 
sejour a I'hopital, 136 operations de 
derivation effectuees au cours d'une 
periode de 5 ans.
Les variables ayant contribue signi- 
ficativement aux resultats sont les sui- 
vants: symptomes preoperatoires (p = 
0.037), materiel utilise pour la greffe 
(p = 0.016), age du patient (p =
0.007), capacite circulatoire (p =
0.041) et tabagisme postoperatoire (p 
= 0.013).
Les greffes de veines autogenes ont 
ete superieures aux greffes prostheti- 
ques, les taux cumulatifs de permeabi­
lite de 5 ans etant respectivement de 
67.5% etde 38.2%.
Les auteurs soulignent I'interet d'in- 
viter les patients qui necessitent une 
chirurgie vasculaire a cesser de fumer;
cette etude retrospective a montre que 
le tabagisme augmente le risque de la 
perte d'un membre et affecte negati- 
vement le taux cumulatif de permeabi­
lite par interaction avec d'autres varia­
bles telles que les symptomes pre­
operatoires, le materiel utilise pour la 
greffe et I'age.
Results o f femoropopliteal bypass op­
erations are influenced by multiple 
variables—the type o f graft used,1-10 
the indications for operation,1-511 site 
of distal anastomosis,1-2-4-6-10-12 arterial 
run-off,111-13 and previous arterial re­
construction.1-3 Retrospective analysis 
of one variable while ignoring the 
others makes statistical interpretation 
difficult. Standardization o f patient- 
and surgeon-related variables through 
randomization is an ideal solution to 
this problem.6-7 Some nonrandomized 
retrospective studies have compared 
effectiveness of different types of 
grafts at constant levels o f  other varia­
bles.1-2
In this retrospective study we as­
sessed critically the effectiveness of 
bypass procedures by statistical analy­
sis o f multiple factors influencing pat­
ency, limb loss, mortality and dura­
tion of hospitalization.
Patients and Methods
Between January 1980 and Decem-
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ber 1985, 136 femoropopliteal bypass 
grafts were placed in 121 patients for 
lower limb ischemia. The mean pa­
tient age was 65 ± 10 (±SD) years 
(range from 34 to 89 years). Seventy 
(58%) patients were men and 51 
(42%) women. Of the 136 operations, 
52 (38%) were done for claudication 
and 84 (62%) for limb salvage. Diabe­
tes was present in 16 (13%) patients 
and a history of hypertension in 54 
(45%). Ninety-nine (82%) were smok­
ers and 60 (50%) continued to smoke 
postoperatively.
Preoperative evaluation included 
physical examination, Doppler 
studies, transcutaneous measurement 
of oxygen tension (Ptco2) and arteri­
ography. The status of the infrapop- 
liteal vessels was determined by care­
ful review of angiograms. Those with 
diameters 25% or more of normal 
were classified as viable. “Poor run­
off’ was defined as the presence of 
one or no viable distal vessel and 
“good run-off’ as the presence of two 
to three viable distal vessels. This 
classification of run-off is widely 
used,2'6 and we adopted it to make our 
report consistent with others. Howev­
er, in our opinion, a more meaningful 
classification of run-off should be 
based on contrast arteriographic visu­
alization of the entire leg and foot 
including the pedal arches. In 85% of 
our cases run-off was poor and in 15% 
it was good. Autologous saphenous 
vein (ASV) was used for grafting in 
47%, polytetrafluoroethylene (PTFE) 
in 47%, umbilical vein in 5% and 
Dacron in 1% of cases. For the pur­
pose of analysis, grafts were divided 
into two groups: ASV and prosthetic 
(PTFE, umbilical vein and Dacron) 
grafts. Sixty-nine percent of grafts 
were anastomosed below and 31% 
above the knee joint; 4% were anas­
tomosed to infrapopliteal vessels.
Morbidity and mortality occurring 
within 30 days of operation were 
considered as complications. In the 
first postoperative year patients were 
seen three to four times and thereaf­
ter, once a year. At follow-up, graft 
patency was established by objective 
clinical evidence (pulses) and if neces­
sary Doppler studies and arteriogra­
phy. The first postoperative occlu­
sion, regardless of further interven­
tion, was considered as graft failure. 
Post-thrombectomy patency was de­
fined as the period of patency until 
the first occlusion. In cases of death, 
loss to follow-up or major amputa­
tions, patency intervals were ended 
and the limb was withdrawn from 
further analysis.
Computer analysis was performed14 
on all data. Standard life-table analy­
sis15 was used to determine cumula­
tive patency rates (CPRs), limb loss 
rates (LLRs) and cumulative survival. 
The log rank test15 was used for an 
overall comparison of two or more 
cumulative rates. The Krusbal-Wallis 
one-way analysis of variance test 
(K-W)16 and the Spearman rank corre­
lation coefficient (r)16 were used as 
measures of associations involving 
nonparametric variables. We chose p 
= 0.05 as the level of statistical signif­
icance. The effects of smoking on 
CPRs and LLRs and its interaction 
with other variables were analysed 
and presented in two separate studies 
(unpublished data).
Results
Complications
Death (1%) or complications of the 
operation (15%) were noted in 16% of 
cases. The complications included 
myocardial infarction (1%), stroke 
(4%), graft thrombosis (9%) and am­
putation (1%). There was a strong 
association (K-W, p < 0.001) between 
patient age and operative complica­
tions.
Cumulative Patency Rates
Figure 1 shows primary, post­
thrombectomy and ultimate CPRs.
Primary and ultimate CPRs 1 
month postoperatively were 90.4% 
and 94.8% respectively. Post-throm- 
bectomy patency at 1 year was 55.2%. 
At 5 years, primary and ultimate 
CPRs were 52.3% and 68.1% respec­
tively. At 4 years, post-thrombectomy
FIG. 1—Primary (crosses, n = 136), 
post-thrombectomy (closed circles, n = 29) 
and ultimate (open circles, n =  136) cumu­
lative patency rates from 1 month to 5 years 
postoperatively. Standard errors and num­
ber of patent grafts are shown at each 
interval.
patency was 41.4%. The biggest drop 
in the primary CPR was between 1 
month and 1 year postoperatively 
when 25 occlusions (45% of the total) 
occurred. Thirteen (87% of post­
thrombectomy occlusions) occurred 
in grafts during the first year of fol­
low-up.
Over the study period, CPRs of 
limbs treated for claudication were 
generally better than those operated 
on to salvage the limb (log rank, p = 
0.037); however, at 5 years the differ­
ence was only 7.9% (Fig. 2).
The CPR for ASV grafts was 67.5% 
at 5 years compared with 38.3% for 
prosthetic grafts (log-rank, p = 0.016) 
(Fig. 3). But when grafts were subdi­
vided according to patient age, we 
found that ASV grafts showed better 
5-year CPRs than prosthetic grafts 
only in patients 64 years of age or 
younger (76.9% versus 23.1%; log 
rank, p = 0.007) (Fig. 4). For patients 
older than 64 years, the overall differ­
ence in CPR between two types of
FIG. 2—Cumulative primary patency 
rates for grafts placed for treatment of 
claudication (closed circles, n = 52) and 
grafts placed in order to salvage limb (open 
circles, n = 84). Standard errors and num­
ber of patent grafts are shown at each 
interval.
FIG. 3—Cumulative primary patency 
rates for autogenous saphenous vein (ASV) 
(closed circles, n =  64) and prosthetic (open 
circles, n = 72) grafts. Standard errors and 
number of patent grafts are shown at each 
interval.
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graft was not statistically significant 
(log-rank, p = 0.46) (Fig. 5).
Good run-off was associated with 
significantly (log-rank, p = 0.041) 
higher CPRs than poor run-off for 
patients with ASV grafts. This associ­
ation did not hold for patients with 
prosthetic grafts (log-rank, p = 0.94).
Limb Loss
The overall LLR at 5 years was 16% 
(14 limbs). At 5 years, 2 limbs (LLR 
8.1%) were lost by claudicants and 12 
limbs (LLR 20.6%) by limb salvage 
patients (log-rank, p = 0.038).
At 5 years LLR for ASV grafts was 
11.3% compared with 19.4% for pros­
thetic grafts. This difference was not 
statistically significant (log-rank, p = 
0.32).
With ASV grafts claudicants had a 
5-year LLR of 0% compared with 
21.3% for limb salvage patients (log- 
rank, p = 0.039). For patients with 
prosthetic grafts, the 5-year LLR of 
limb salvage patients was 20% com­
pared with 18% for claudicants (log- 
rank, p = 0.36).
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FIG. 4—Cumulative primary patency 
rates for ASV (closed circles, n = 26) and 
prosthetic grafts (open circles, n = 31) in 
patients 64 years of age or younger. Stan­
dard errors and number of patent grafts are 
shown at each interval.
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FIG. 5—Cumulative primary patency 
rates for ASV (closed circles, n = 38) and 
prosthetic (open circles, n = 41) grafts for 
patients older than 64 years. Standard er­
rors and number of patent grafts are shown 
at each interval.
Effects of Smoking on Cumulative 
Patency and Limb Loss
In separate analyses (unpublished 
data) we examined the effects of 
smoking postoperatively on the CPR 
and LLR. Our results showed that by 
smoking more than 15 cigarettes per 
day the patient increased the proba­
bility of limb loss approximately five 
times at 2 years and three times at 5 
years (p = 0.013). Cumulative paten­
cy rates were also adversely affected 
through multiple interactions with 
variables like preoperative symptoms, 
graft material and age. In patients 
with severe ischemia, smoking post­
operatively was associated with a 23% 
reduction (p = 0.045) in CPR and a 
30.5% reduction (p = 0.009) in limb- 
salvage rate at 5 years.
Mortality
The operative death rate was 0.7% 
and the overall 5-year cumulative rate 
was 30%. Table I shows the causes of 
death occurring more than 30 days 
postoperatively. Late death (more 
than 30 days) was significantly associ­
ated with age (K-W, p < 0.018) and 
operative complications (K-W, p < 
0.001), but there was no significant 
difference in late deaths between clau­
dicants and limb-salvage patients (log- 
rank, p = 0.99).
Length o f Hospitalization
The mean hospital stay was 13 days 
overall, and for those with operative 
complications it was 21 days (K-W, p 
< 0.001). There was a positive corre­
lation between age and hospital stay 
(excluding patients with complica­
tions) (r = 0.26, p = 0.027).
Discussion
It is generally agreed that the long­
term results of lower limb ASV bypass 
grafts are better than those of pros­
thetic grafts.‘’2'4’5'7'9 Our results were 
similar; ASV and prosthetic grafts had 
similar CPRs for 1 year and diverged 
thereafter (Fig. 3). The cumulative 
patency rates of prosthetic grafts were
Table I -  Causes of Long-Term Death 
(N = 121)
Cause No. (%) of patients
Cardiac 11 0)
Cerebrovascular 4(3)
Vascular 1 (D
Malignant (lung cancer) 5(4)
Other 4(3)
Unknown 7(6)
found to be critically affected by the 
site of distal anastomosis, with poor 
success rates for bypasses to infrapo- 
pliteal arteries.2-6’9-17
The gap between the CPR differ­
ence and the LLR difference at 5 
years means that primary graft failure 
is not the only factor that determines 
limb loss. Another finding that sup­
ports this conclusion is that at 5 years 
the LLR was 15.8% and the primary 
graft failure rate was 47.7%. Graft 
failure does not mean inevitable am­
putation because revisions can pro­
long limb survival substantially. Veith 
and colleagues6 found that limb-sal­
vage rates in patients who received 
bypass grafting for critical ischemia of 
the leg were significantly higher than 
graft primary patency rates. Reopera­
tion on failed grafts was considered a 
factor in this difference. In our study 
the contribution of reoperation is sup­
ported by higher ultimate CPRs than 
primary CPRs (Fig. 1). In addition, 
comparison of the 5-year ultimate 
CPRs of ASV versus prosthetic grafts 
shows a difference of only 11.4%, very 
close to the 5-year LLR difference of 
8.1% between the two types of grafts.
Since only 4% of our grafts were 
anastomosed to infrapopliteal vessels 
we could not make a meaningful com­
parison between popliteal and in­
frapopliteal sites.
The age of a patient coupled with 
the type of graft used seemed to 
influence the CPR. For patients who 
were 64 years of age or younger there 
was a marked overall difference be­
tween CPRs of ASV versus prosthetic 
grafts. For patients older than 64 
years, the 5-year CPR difference be­
tween ASV and prosthetic grafts was 
only 10% (Fig. 5).
Brewster and associates1 and Qui- 
nones-Baldrich and colleagues11 
showed that, for patients with pros­
thetic grafts, claudicants had higher 
CPRs than limb-salvage patients. For 
patients with ASV grafts, Brewster’s 
group1 and Taylor and associates18 
failed to show a significant difference 
in CPR between claudicants and 
limb-salvage patients. Our results 
showed better overall cumulative pat­
ency for claudicants than for limb-sal­
vage patients (p = 0.037). When ASV 
and prosthetic grafts were analysed 
separately, claudicants demonstrated 
higher CPRs than limb-salvage pa­
tients in both categories. However, 
because of small samples the differ­
ences fell short of statistical signifi­
cance.
Limb-salvage patients had a signifi­
cantly (p = 0.038) higher LLR than 
claudicants and this difference oc­
curred mainly in those receiving ASV
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grafts (p = 0.039). None of the claudi- 
cants with ASV grafts lost a limb 
whereas two with prosthetic grafts 
did.
The adequacy of arterial run-off on 
CPRs has been a controversial issue. 
Naji and colleagues,13 Quinones-Bal- 
drich and associates,11 DeWeese and 
Rob19 and Cutler’s group20 all demon­
strated the detrimental effects of poor 
run-off on patency rates. Brewster and 
associates1 found that although the 
CPRs of patients with prosthetic 
grafts were adversely affected by poor
run-off, patients with ASV grafts were 
not. Our results differ from these 
findings in that patients with ASV 
grafts and poor run-off had signifi­
cantly lower CPRs than patients with 
good run-off. On the other hand, Ka­
minski and associates21 and Rams- 
burgh and colleagues22 did not dem­
onstrate lower patencies for patients 
with poor run-off.
Since cigarette smoking is recog­
nized as a major risk factor for ath­
erosclerotic peripheral vascular disea­
se,23-25 our findings of the adverse
effect of smoking on CPRs and LLRs 
are not surprising. The critical num­
ber of cigarettes influencing postoper­
ative limb loss was 15/d; smoking 
more than this significantly increased 
the probability of limb loss. The criti­
cal number of cigarettes affecting 
CPRs was only 5/d. Thus, the effect of 
cigarette smoking on results of femo- 
ropopliteal bypass operation for lower 
limb ischemia is dose-dependent.
Raviola and colleagues26 showed 
that early thrombosis of bypass grafts 
prolonged hospital stay by an average
»* r-
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of 12 days. Rhodes and associates27 
found age of patients and distal anas­
tomotic site correlated with the peri­
od in hospital. In this study, the 
length of hospital stay was significant­
ly prolonged with increasing age (p = 
0.027) and operative complications (p 
< 0.001), independently of each oth­
er.
Most long-term deaths were caused 
by cardiovascular disease or lung can­
cer (Table I), likely caused by smoking 
which was part of the medical history 
in 82% of our patients.
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BOOK REVIEWS
FINE NEEDLE ASPIRATION OF THE 
BREAST. Yolanda C. Oertel. 203 pp. 
Illust. Butterworth and Co. (Publishers) 
Ltd., London; Butterworth Publishers, 
Stoneham, Mass., 1987. $48.00 (US). 
ISBN 0-409-95192-7.
This small monograph is intended to intro­
duce surgical pathologists and trainees to 
the technique of fine-needle aspiration of 
solid lesions of the breast, the staining of 
the smears so obtained, their interpreta­
tion and the establishment of a specialized 
unit to provide this service.
The author has produced a beautifully 
organized, delightfully readable book, 
which succeeds admirably in its purpose. 
Most surgeons who do fine-needle aspira­
tion for breast lesions have accepted the 
fact that 20% of their slides will be unsatis­
factory. That this can be reduced to 0.7% 
in the hands of an expert such as the 
author should stimulate all surgeons to 
read the lucid, short chapter on fine-needle 
aspiration technique and modify their own 
accordingly. The author strongly believes 
that patients requiring aspiration cytology 
should be referred to a pathologist for this 
service. However, most patients with a 
lump in the breast have aspiration per­
formed at the time of their first visit to a 
surgical consultant to determine whether 
the lesion is cystic or solid. It would be 
much more practical and efficient to up­
grade the skills of the surgeons, who 
should have the required equipment for 
solid-cell aspiration at hand in their con­
sulting office.
The chapters on interpretation of the 
smears are equally well organized and easy 
to read. The photomicrographs, especially 
the colour plates, are a delight. To have 
only one false-positive diagnosis in 692 
malignant aspirates demonstrates a level of 
expertise that will be duplicated in few, if 
any, centres. The fact that 226 mastecto­
mies were performed without the addition­
al safeguard of frozen-section confirmation 
of the diagnosis is a further tribute to the
confidence of her surgical colleagues in the 
reliability of the author and her team in 
this field. However, even one mastectomy 
performed on the basis of a false-positive 
cytology report could lead to a medicolegal 
nightmare for the pathologist, surgeon and 
hospital. In almost all other centres, the 
level of expertise demonstrated by the 
author will not be available and surgeons 
who do mastectomies without frozen-sec­
tion confirmation of the diagnosis will be 
doing so at their peril.
This book should be in every hospital 
library, not only for the benefit of patholo­
gists, but also for surgeons, especially those 
who see a large number of breast lesions.
Leo Mahoney, md, ms, frcsc, facs
Ste. 403,
55 Queen St. E,
Toronto, Ont.
M5C1R6
RADIATION THERAPY OF GYNECO­
LOGICAL CANCER. Edited by Datta- 
treyuda Nori and Basil S. Hilaris. 431 
pp. Illust. Alan R. Liss, Inc., New York, 
1987. $69.50 (US). ISBN 0-8451- 
4219-4.
This new text offers short introductions to 
radiobiologic and physical aspects of treat­
ment by radiation as well as relevant 
details on planning and dosimetry. It is not 
surprising that, since both editors are from 
the Department of Radiation Oncology at 
the Sloan-Kettering Cancer Center, there is 
more focus on remote afterloading with 
high-dose-rate techniques.
The new TNM classification with subdi­
vision of preclinical invasive cervical can­
cer must have come too late to be included 
in the chapter on staging and work-up 
procedures. This chapter, as well as other 
sections in which histopathologic features 
are discussed, could have been more de­
tailed concerning the relation between the
size of cervical cancer, microscopic spread 
and prognosis.
The role of external beam treatment in 
endometrial cancer and its role in the rate 
of complications experienced by the large­
ly elderly population of patients suffering 
from this disease could have been dis­
cussed more critically.
The chapter on ovarian cancer, by Fuks, 
Yahalom and Brenner, is outstanding in its 
clarity and philosophical analysis of the 
role of second-look surgery. The curative 
potential of the limited dose of radiation 
that can be directed to the whole abdo­
men, a discussion of the results of relevant 
radiobiologic experiments and the ratio­
nale for low doses of radiotherapy for 
microscopic aggregates of cancer cells 
should have been included.
The discussion of the role of radiothera­
py in trophoblastic disease is thorough but 
could have described the role of smaller 
versus larger daily doses for metastases to 
the brain and less-aggressive chemotherapy 
protocols, in regard to their risk of in­
tracerebral hemorrhage.
It is surprising that the prognostic im­
portance of the frequency of mitoses in the 
histopathology of uterine sarcomas was 
given little attention. Analysis of the ratio­
nale for postoperative radiotherapy to the 
pelvis in patients with uterine sarcomas, 
although necessarily based on retrospective 
results only, is interesting and convincing. 
This cannot be said of the discussion on 
indications for radiotherapy to the para­
aortic nodes in cervical cancer.
In the section that covers technical as­
pects of planning for radiotherapy to the 
pelvis, the role of the daily dose of external 
beam therapy in causing complications 
could have been emphasized, as well as the 
need for four-field set-ups in treating 
women with relatively small anteroposteri­
or pelvic separation, even when parallel 
opposing fields and the use of a higher 
photon energy would not cause the so- 
called edge effect.
continued on page 238
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ORIGINAL ARTICLES
D. G o r d o n  A ll a n , m d ;* D.C. R e id , m d , m  chcorth ), f r c s q I  L in d a  Sa b o e , m c p a , b p t |
Off-Road Recreational Motor Vehicle Accidents: 
Hospitalization and Deaths
There is increasing concern over the 
unregulated use o f recreational o ff­
road m otor vehicles. A  rev iew  o f 207 
patien ts a d m itte d  to  a te rtia ry  care 
hospital over a 5-year period, as well 
as deaths due to  use o f recreational 
vehicles, e lic ited  th e  fo llow in g  in for­
m ation. Recreational accidents pre­
dom inantly involved men in th e ir m id ­
tw en ties . C hildren younger than 16 
years w ere  m ore frequen tly  involved in 
a ll-te rra in  veh ic le  (ATV) or d irt-b ike  
accidents and con s titu te d  m ore than 
one-th ird  o f the  to ta l. There w as a 
ninefold increase in ATV accidents 
over the  s tudy period, so th a t by 1985 
ATVs w ere  the  prim ary cause of o ff­
road in juries (52%). The m usculoskele­
ta l system  w a s m ost frequen tly  injured 
(66%) fo llow ed  by th e  head and face 
(25%). There w a s  perm anent disability  
in 10.6%, and 33% o f the  recreational 
deaths w ere  in children younger than 
16 years. The inherent in s tab ility  of 
ATVs w as confirm ed by the  finding 
th a t in 60% o f accidents the  vehicle 
had rolled or flipped. S tric te r licensing 
requirem ents should be im plem ented, 
and public education is required to 
draw  a tten tio n  to  the  danger of these 
vehicles, pa rticu la rly  to  children. There 
is a need fo r proper safe ty equipm ent
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and driver tra in ing . The issue o f veh i­
cle design m ust also be addressed by 
the  industries concerned.
On s 'inq u ie te  de plus en plus de I'ab- 
sence de reg lem enta tion  destinee a 
d isc ip line r ( 'u tilisa tion  des vehicules 
recreatifs  hors-route. C e tte  etude 
re trospective porte sur 207  patien ts 
qui fu re n t accueillis  au cours d 'une 
periode de 5 ans a un hopita l de soins 
de tro is iem e ligne. En plus des don- 
nees re la tives aux deces relies a ( 'u t ili­
sation des vehicules recreatifs, I 'e tude  
a perm is de m e ttre  a jo u r I'in fo rm ation  
suivante. Les accidents relies aux acti- 
v ites recreatives concernaients su rtou t 
des hom m es au m ilieu de la vingta ine. 
Les enfants de m oins de 16 ans 
e ta ien t le plus souvent im pliques dans 
des accidents de vehicules tous te r­
rains (VTT) ou de b icyc le ttes de p is te  
e t representa ient plus du tie rs  des 
accidentes. Au cours de la periode 
etudiee, on a consta te  que le nom bre 
des accidents de ce genre s 'e ta it  m ul- 
t ip lie  par neuf, de sorte qu'en 1985  
ces vehicules e ta ien t la principale 
cause des blessures subies hors-route 
(52%). Le system e m uscu lo-sque le tti- 
que e ta it le plus souvent touche (66%), 
suivi de la te te  e t du visage (25%). Une 
incapacity  perm anente a ffec ta it 10.6%  
des pa tien ts  e t 33% des deces lies aux 
a c tiv ite s  recreatives toucha ient des 
enfants de m oins de 16 ans. L 'instab i- 
lite  propre aux VTT se vo it confirm ee 
par le fa it que dans 60% des accidents, 
le vehicule s 'e ta it  souleve ou ava it 
roule sur lu i-m em e. II y a lieu d 'e ta b lir 
des exigences plus s tric tes  pour I'ob- 
te n tio n  des perm is e t le public do it 
etre in form e au danger que represen- 
te n t ces vehicules, to u t particu liere- 
m en t pour les enfants. II existe  aussi 
un besoin en m atie re  d 'equ ipem ent de 
securite  e t de fo rm ation  des conduc-
teurs. F ina lem ent, les cons tru c teu rs  
devra ient revo ir la concep tion  de leurs 
vehicules.
Off-road motor vehicles made their 
appearance in the late 1960s and early 
1970s and have rapidly gained accep­
tance. With their rise in popularity, 
the frequency of accidents attribut­
able to them also has risen.12 There 
were 3000 off-road injuries in the 
United States in 1979, 26 900 in 1983 
and 85 900 in 1985.3 The predomi­
nant factor has been the commercial 
success of the three-wheel all-terrain 
vehicle (ATV). Annual sales of ATVs 
in the US in 1972 were 12 000 but 
rose to 780 000 by 1985.4 With the 
market domination of the ATVs, sales 
of other off-road motor vehicles have 
declined; nevertheless, there are over 
2 million snowmobiles in use in the 
US and a larger number per capita in 
Canada.
Both the American and Canadian 
pediatric societies, as well as a num­
ber of consumer advocacy groups, 
have expressed their concern about 
the number of children injured in 
off-road motor vehicle accidents.5 
Their concern extends to the market­
ing strategies directed at the young 
rider, the public’s misconception of 
the stability and safety of these vehi­
cles and the paucity of legislation 
regulating the vehicles.
We surveyed off-road motor vehi­
cle injuries by examining those vic­
tims requiring hospitalization in a 
tertiary referral hospital. The princi­
pal area of concern was the use of 
off-road motor vehicles for recreation­
al purposes — three- and four-wheel 
ATVs, snowmobiles, dirt-bikes, dune 
buggies and go-carts — however, non- 
recreational injuries are included for 
contrast. Three areas were of particu-
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lar interest: the involvement of chil­
dren and adolescents, the type and 
severity of injury and the impact of 
the rising popularity of ATVs. The 
object of this study was to heighten 
awareness of the severity of these 
injuries and to illustrate the high cost 
to the individual and society as a 
whole of unregulated use of off-road 
motor vehicles.
Materials and Methods
A chart review of people injured in 
off-road motor vehicle accidents who 
required hospitalization at the Uni­
versity of Alberta Hospital, Edmon­
ton, between 1981 and 1985 was con­
ducted. A total of 207 patients met 
the criteria for inclusion.
Information was collected on the 
type of vehicle, mechanism of injury, 
age and sex of the patient, work ver­
sus recreational use, involvement of 
alcohol and the use of safety equip­
ment. The injuries were tabulated ac­
cording to anatomic region and sever­
ity. Hospital stay and stay in the 
intensive care unit were recorded 
along with the number of blood trans­
fusions required, surgery performed 
and degree of permanent disability.
A qualitative and quantitative as­
sessment of the injuries was made 
using the Injury Severity Score (ISS) 
and the Total Abbreviated Injury 
Scale (TAIS)A8 The scoring was done 
using the trauma chart described by 
Greenspan and colleagues.8
Statistical analysis was performed
using the x2 test or the t-test for 
comparing two means. In all statistcal 
tests, a p value of less than 0.05 was 
considered significant.
Findings
The results were considered accord­
ing to the type of vehicle involved: 
ATVs, snowmobiles, dirt-bikes, vehi­
cles used in a nonrecreational capaci­
ty (tractors, earthmovers and skid- 
ders) and a miscellaneous group that 
included dune buggies, golf carts and 
go-carts.
Age and Sex
Most off-road motor vehicle acci­
dents involved young males (Table I). 
A considerable percentage of the rec­
reational accidents involved children 
or adolescents, the highest percent­
ages being seen in the dirt-bike (41%) 
and ATV (36%) categories (Table I).
Driver or Passenger
All injuries in this series involving 
ATVs and dirt-bikes occurred in driv­
ers only. Although ATVs are intended 
for a single rider, others10 have report­
ed up to 20% of injuries occurring in 
passengers. In approximately 15% of
Table I— Sex and Age Distribution
Averageage' yr____  % children
Vehicle % male Male Female under 16 yr*
ATVs 92 24.6 34.7 36
Snowmobiles 85 25.7 21.3 22
Dirt-bikes 91 19.8 22.0 41
Other 92 24.8 13.0 23
Nonrecreational 93 45.8 18.0 0
Average 90.6 28.1 21.8 24.4
•Average age 11.8 yr. 
ATVs =  all-terrain vehicles.
Table II— Frequency of Admission by Vehicle and Year 
Admissions, no. (%)
Vehicle 1981 1982 1983 1984 1985 Totals
ATVs 2 (6) 2 (5) 8(22) 10(21) 25 (52) 47 (23)
Snowmobiles 24 (75) 34(77) 17(47) 21 (45) 15(31) 111 (54)
Dirt-bikes 2 (6) 3 (7) 7(19) 9(19) 1 (2) 22 (11)
Other 2 (6) 4 (9) 2 (6) 3 (6) 2 (4) 13 (6)
Nonrecreational 2 (6) 1 (2) 2 (6) 4 (9) 5(10) 14 (7)
Totals 32(15) 44 (21) 36(17) 47 (23) 48 (23) 207 (100)
Table III— Site of Injury
Vehicle
Site, no. (%)
External
Head 
and face Neck Thorax Abdomen Spine Musculoskeletal
ATVs, n =  47 8(17) 9(19) 3(6) 6(13) 2 (4) 6(13) 30 (64)
Snowmobiles, n = 111 16(14) 30 (27) 3(3) 10 (9) 14(13) 10 (9) 72 (65)
Dirt-bikes, n =  22 5(23) 4(18) 0 1 (5) 1 (5) 1 (5) 14(64)
Other, n =  13 3(23) 5 (38) 0 1 (8) 1 (8) 0 10(77)
Nonrecreational, n =  14 3(21) 3(21) 0 6(43) 1 (7) 1 (7) 10(71)
Table IV-— Severity of Injury by Site Using the Total Abbreviated Injury Scale
Vehicle
Site
External
Head 
and face Neck Thorax Abdomen Spine Musculoskeletal
ATVs 1.37 2.67 2.00 2.17 3.50 3.00 2.63
Snowmobiles 1.53 2.83 2.67 2.40 2.79 2.90 2.97
Dirt-bikes 1.80 2.00 0 3.00 2.00 3.00 2.86
Other 1.33 3.60 0 3.00 3.00 0 2.50
Nonrecreational 1.00 2.67 0 3.67 1.00 3.00 2.60
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the remaining categories passengers 
were involved. They either rode on 
the machine or were towed behind the 
vehicle.
Frequency of Admission
Hospital admissions resulting from 
ATV injury increased to 52% of all 
off-road admissions in 1985, up from 
6% in 1981, whereas the frequency of 
admissions due to snowmobile inju­
ries has decreased from 75% in 1981 
to 31% in 1985. There was no statisti­
cally significant change in the fre­
quency of hospital admission in the 
remaining groups (Table II).
Frequency of Injury by Anatomic 
Region and Vehicle
The frequency of injury in the vari­
ous anatomic regions was similar to 
that in most serious motor vehicle 
accidents (Table III). One striking ex­
ception was the rate of thoracic injury 
associated with nonrecreational acci­
dents (43%) compared with the recre­
ational accidents. This was due main­
ly to the frequent crushing component 
of the nonrecreational injury. The 
musculoskeletal system was most fre­
quently damaged followed by the 
head and face.
There were 288 regional injuries in
the 207 patients. Many patients sus­
tained multiple injuries to a particular 
region, which is reflected in the TAIS 
(Table IV).
Severity of Injury
Injury severity was assessed using a 
number of methods. The average 
TAIS was calculated for each anatom­
ic region for the various types of 
off-road vehicles (Table IV). External 
injuries due to dirt-bike accidents 
were significantly (p < 0.01) more 
severe than those due to nonrecrea­
tional vehicles. This difference may 
be due to the mechanism of injury.
Significantly longer (p < 0.05) aver­
age hospital stays resulted from ATV 
(15.5 days) and nonrecreational (14.8 
days) injuries than from dirt-bike in­
juries (6.5 days). In terms of the TAIS 
score, nonrecreational injuries (4.5) 
were significantly higher than snow­
mobile (3.6) and dirt-bike (3.0) inju­
ries.
Admission to the intensive care 
unit was required in 14% of nonre­
creational injuries for an average stay 
of 24 days (Table V). Patients with 
dirt-bike injuries were unlikely to re­
quire intensive care admission. One 
or more surgical procedures were re­
quired in 57% of patients admitted 
with injuries from ATVs; this percent­
age is higher in the other categories 
(Table VI). In total, 71% of all off­
road motor vehicle victims received 
orthopedic care.
Mechanism of Injury
The mechanism of injury varied 
considerably between types of vehi­
cles (Table VII). Riders were more 
likely to fall off dirt-bikes (73%) and 
snowmobiles (42%) but were more apt 
to roll or flip their ATV (60%) or 
dune buggy (54%). Being crushed be­
neath the vehicle or against an im­
movable object was the predominant 
mode of nonrecreational injury (36%). 
Colliding with a similar vehicle or 
another form of vehicle occurred 
most commonly with snowmobiles 
(20%) and dirt-bikes (19%), and such 
accidents tended to produce more se­
vere injuries.
Alcohol Use
The involvement of alcohol was 
recorded in 15% of snowmobile acci­
dents, but blood alcohol levels were 
not routinely obtained and patients 
generally had to be obviously intoxi­
cated before mention of alcohol was 
made in the chart.
Permanent Disability and Death
Permanent partial disability was re­
corded in 21% of patients involved in 
nonrecreational accidents and 23% of 
those in the “other” category (Table 
VIII). Neurologic disability, either 
central or peripheral, was the most 
frequent permanent disability seen 
(64%) with involvement of the muscu­
loskeletal system in 27% of cases. Of 
the patients admitted to hospital after 
off-road motor vehicle accidents 
10.6% were left with a permanent 
disability. Only major, obviously per­
manent, disability was noted in this 
review, so less obvious, less severe 
permanent disability was likely over­
looked.
Details of recreational off-road 
motor vehicle deaths in Alberta were 
obtained from the office of the chief 
medical examiner. Snowmobiles and
Table V— Injury Severity and Length of Stay in Intensive Care Unit (ICU) and Hospital
Vehicle
TAIS,
mean
(SD)
ISS,
mean
(SD)
%
requiring
admission
Mean 
stay in 
ICU, d
Hospital stay 
(d),
mean (SD)
ATVs 3.6 (2.6) 8.0 (4.8) 4 16 15.5 (23.9)
Snowmobiles 3.6 (1.9) 8.7 (6.3) 5 8 11.7 (18.7)
Dirt-bikes 3.0 (1.3) 6.6 (3.4) 0 0 6.5 (5.5)
Other 4.1 (2.2) 7.8(4.51 8 6 8.2 (7.9)
Nonrecreational 4.5 (2.1) 10.7 (7.4) 14 24 14.8(15.5)
TAIS =  Total Abbreviated Injury Score, ISS =  Injury Severity Score.
Table VI— Treatment by Transfusion and Surgery
Transfused, Mean units Surgery,
Vehicle no. (%) of blood no. (%)
ATVs, n = 47 7(15) 5.0 27 (57)
Snowmobiles, n = 111 19(17) 5.4 70(63)
Dirt-bikes, n =  22 1 (5) 2.0 15 (68)
Other, n =  13 3(23) 5.3 10(77)
Nonrecreational, n =  14 4(29) 5.7 10(71)
Table VII— Mechanism of Injury
Vehicle
Mechanism, no. (%)
Fell off
Rolled/
flipped
Struck
object
Struck by 
similar vehicle
Struck by 
car/truck
Caught
foot
Crush
injury
ATVs, n =  47 6(13) 28 (60) 4 (8) 1 (2) 3(6 ) 2(4) 0
Snowmobiles, n =  111 47 (42) 8 (7) 21 (19) 12(11) 10(9) 4(4) 0
Dirt-bikes, n =  22 16(73) 0 0 3(14) 1 (5) 0 0
Other, n =  13 2(15) 7(54) 2(15) 0 0 0 2(15)
Nonrecreational, n =  14 1 (7) 4(29) 4(29) 0 0 0 5(36)
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ATVs were responsible for 44% and 
33% of the deaths, respectively (Table 
VIII); the majority were in males 
(89%) whose age on average was 29.3 
years. Only two females died, and 
both were under 13 years of age; 17% 
of those killed were passengers with 
an average age of 10.3 years. Children 
16 years of age and under (mean 10.2 
years) constituted 33% of all fatalities.
Discussion
The inherent instability of ATVs 
(60% in our study either rolled lateral­
ly or flipped backwards), combined 
with poor driver judgement, appear to 
be responsible for most off-road vehi­
cle accidents.49"10 The Engineering 
Sciences Division of the US Consum­
er Product Safety Commission4 has 
determined that the instability of 
ATVs is multifactorial, related to the 
high centre of gravity and the lack of 
independent suspension and rear- 
wheel differential. Fixed-axle rear 
wheel rotation necessitates the shift­
ing of a rider’s weight when turning, 
which further destabilizes the vehicle 
and requires operator skill.11-13
These problems of instability are 
compounded by the driver’s excessive 
use of alcohol in many cases. A survey 
of participants in a four-wheel drive 
rally revealed that 75% drank alcohol 
before driving.14 In one study in 
which blood alcohol levels were mea­
sured, it was found that 31% of ATV 
riders admitted to hospital had been 
drinking.2 Due to the lack of blood 
sampling, the figures in our study 
likely underestimate the true picture, 
but suggest that up to 15% of accident 
victims were grossly intoxicated at the 
time of admission.
Throughout North America gener­
ally there is a paucity of legislation 
regulating the use of off-road motor 
vehicles.10 In Canada, these vehicles 
fall under provincial jurisdiction; in 
Alberta they are included in the 
Snowmobile Act. They must be regis­
tered, licensed and insured, but driv­
ers need not be licensed providing 
they are 14 years of age or 12 years 
old and operating under adult super­
vision. The off-road use of these vehi­
cles, particularly on private property, 
renders enforcement of the act ex­
tremely difficult.
As a result of this and other studies, 
several recommendations concerning 
off-road vehicles can be made. Imple­
mentation of stricter licensing re­
quirements may reduce the incidence 
of injury to children.1215-17 Forbidding 
children younger than 16 years to 
operate or to be a passenger on off­
road vehicles does not seem excessive­
ly restrictive when the consequences 
of accidents in this age group are 
examined.1 Since enforcement of leg­
islation is difficult, parents, in partic­
ular, and drivers must be made aware 
of the dangers involved as the majori­
ty of accidents are due to poor driver 
judgement. The use of helmets prov­
iding facial protection must be en­
couraged, as this study demonstrated 
that the head and face was the second 
most common area of injury.
Improvements in the design of off­
road vehicles, specifically ATVs, must 
be addressed by the manufacturers. 
Roberts and colleagues18 carried out a 
biomechanical impact study using 
dummies strapped to snowmobiles. 
The impact generated when a snow­
mobile was dropped only 1.2 m ex­
ceeded the force required to produce 
compression fracture of the spine. 
They showed that the seat and sus­
pension of the vehicle were inade­
quate to cushion the axial forces pro­
duced by the drop; the dummy was 
still deforming the seat to the maxi­
mum as the suspension was rebound­
ing. Provocative advertising showing 
these vehicles “leaping” through the 
air and the increasing occurrence of 
spinal fractures dictate that certain 
aspects of design must be carefully 
scrutinized.10-19-20 Furthermore, the 
addition of a cage would protect the 
driver in the event of a roll-over or 
collision. Admittedly, manufacturers 
have introduced models incorporating 
some or all of these recommenda­
tions, but there is still no assurance of 
a safer design. Government guidelines 
concerning vehicle design will there­
fore be necessary.
Table VIII— Permanent Disability or Death
Permanent Deaths (1983-1985),
Vehicle disability, % no. (%)t
ATVs, n =  47 13 6(33)
Snowmobiles, n =  111 8* 8(44)
Dirt-bikes, n =  22 9 3(17)
Other, n =  13 23 1 (6)
Nonrecreational, n =  14 21 —
•Includes 2 in-hospital deaths.
fData obtained from Chief Medical Examiner for the Province of Alberta. Does not include 
information on nonrecreational causes.
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New Clinical Test for Fracture of the Scaphoid
The authors noted that in patients with 
scaphoid fractures pronation of the af­
fected wrist followed by ulnar devia­
tion produces pain in the anatomic 
snuff box that is not present in those 
without a scaphoid fracture. They 
therefore evaluated this test prospec­
tively in 73 patients. The test gave a 
52% positive predictive value and a 
100% negative predictive value. They 
recommend that the test may be used 
with confidence in the emergency de­
partment to exclude a scaphoid frac­
ture in patients with clinical features 
suggesting scaphoid injury but a nor­
mal x-ray film. Use of this test would 
reduce the number of patients whose 
wrists are needlessly immobilized in a 
scaphoid cast.
Les auteurs ont observe chez les pa­
tients souffrant d'une fracture de I'os 
scaphoide, qu'une pronation du poi- 
gnet accompagnee d'une deviation cu- 
bitale provoquait une douleur dans le 
creux interdigital entre le pouce et 
I'index, douleur que Ton ne rencontre 
pas chez ceux qui n'ont pas de fractu­
re. De maniere prospective, ils ont 
evalue cette epreuve chez 73 patients. 
L'epreuve a eu une valeur previsionnel- 
le positive de 52% et une valeur previ- 
sionnelle negative de 100%. Ils font 
done valoir que ce test peut etre utilise 
avec confiance au service d'urgence 
pour exclure le diagnostic de fracture 
du scaphoide chez les patients qui 
presentent un tableau Clinique evoca- 
teur d'une lesion scaphoide mais qui 
ont une radiographie normale. L'utili- 
sation de ce test reduirait le nombre de 
cas oil le poignet est inutilement im­
mobilise dans un platre.
From the Division o f Orthopedics, Depart­
ment o f Surgery, Toronto Western Hospi­
tal, University o f Toronto, Toronto, Ont.
Accepted for publication Dec. 14, 1987
Reprint requests to: Dr. G.J. Lloyd, Frazer 
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Probably no other upper-limb fracture 
has given rise to such an abundance 
of literature as the fractured scaphoid, 
first described by Cousin and Destot 
in 1898.1 Because of the frequently 
catastrophic long-term sequelae asso­
ciated with nonunion of this bone, 
controversy surrounds the early diag­
nosis and treatment of the fractured 
scaphoid. The diagnosis is usually 
confirmed by an initial comprehen­
sive radiologic examination,2 but a 
fracture line may not be evident for 2 
to 3 weeks after injury or until there is 
evidence of bone healing.3
Watson-Jones4 proposed that in 
every case of closed wrist injury with 
no obvious deformity, a scaphoid 
fracture must be considered present 
until there is radiologic proof to the 
contrary. It is customary, therefore, 
for a clinician to “play safe” in such 
cases and immobilize the wrist until it 
becomes asymptomatic or until the 
x-ray films confirm the fracture. 
Thus, the rate of scaphoid casting 
with no subsequent radiologic proof 
of fracture is high. Recent studies,5-6 
including our own, have shown that 
the wrists of 62% of patients with 
clinical symptoms of scaphoid frac­
ture are needlessly immobilized in 
casts.
We describe and evaluate a clinical 
test for scaphoid fracture which may 
eliminate the need for a cast in some 
patients with clinical features suggest­
ing a scaphoid injury but with normal 
x-ray films.
Clinical Tests
The most common clinical sign of 
scaphoid fracture is tenderness in the 
anatomical snuff box. This sign is 
amplified by a number of clinical 
tests—axial compression along the 
index and middle fingers,7 percussion 
on the tip of the thumb8 or extended 
thumb,9 forced dorsiflexion of the 
hand,1011 and active pronation of the 
hand against manual resistance.12 Re­
cently, Kondoyannis13 added a 
“clamp” sign formed by the thumb
and index finger of the opposite hand 
which embrace the scaphoid area.
In the emergency department we 
have noticed that pronation of the 
wrist followed by gentle ulnar devia­
tion produces pain in the anatomical 
snuff box in patients with a fracture 
of the scaphoid. The pain is readily 
localized by the patient. We have 
been impressed by the patients’ lack 
of pain in cases in which subsequent 
x-ray films do not demonstrate a frac­
tured scaphoid.
To evaluate its accuracy, one of us 
(G.J.L.) performed this test prospec­
tively on 73 consecutive patients in 
whom the emergency physician could 
not clinically and radiologically ex­
clude a scaphoid fracture (Fig. 1). It 
had already been decided to immobi­
lize the wrist. Without seeing the 
x-ray films, the examiner scored the 
test as either positive or negative; he 
was not informed of the final diagno­
sis until after a 3-month follow-up 
period.
Results
Of the 73 patients tested, the diag­
nosis was negative in 35 and positive 
in 38. Examination 3 months later 
revealed that none of the 35 patients 
who tested negative had a scaphoid 
fracture. Twenty of the 38 patients 
who tested positive were subsequently
FIG. 1—Scaphoid fracture test. Patient's 
hand is pronated and gently stressed in 
ulnar plane; usually patient will indicate 
anatomical snuff box as area of maximum 
tenderness.
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found to have a fracture. In the other 
18 there was no evidence of fracture.
This test correctly identified 20 pa­
tients with a fracture. There were 18 
false-positive but no false-negative re­
sults. Statistical analysis (sensitivity- 
specificity predictive values)14 re­
vealed a 52% positive predictive value 
for the scaphoid fracture test and a 
100% negative predictive value. In 
this series a negative test accurately 
excluded a fracture of the scaphoid. 
The average wrist immobilization pe­
riod was -3 weeks in the 53 patients 
who did not have a fracture.
Anatomical Basis for the Test
There are three groups of intrinsic 
and extrinsic volar ligaments respon­
sible mainly for anchoring the scaph­
oid and guiding its position through­
out the range of wrist motion.15 The 
proximal pole is stabilized by the 
radioscapholunate and the scapholu- 
nate ligaments; the distal pole is guid­
ed by the radial collateral and the 
deltoid intercarpal (capitoscaphoid) 
ligaments, and the waist of the scaph­
oid is held by the radioscaphocapitate 
ligament which acts as a pivotal stabi­
lizer. During pronation12 and gentle 
ulnar flexion, the integrity of this 
system is lost and shear forces are 
produced which may be combined 
with lateral scaphoid separation, giv­
ing rise to localized pain.
Discussion
Although the Watson-Jones dogma 
for the treatment of suspected scaph­
oid fractures is still followed, especial­
ly by surgeons in training, recent 
studies5-6-16 question its validity, 
pointing out the economic, social and 
medical problems associated with 
needless immobilization of a wrist, 
usually in the young, fit, working male 
patient.17
Our simple clinical test will not 
decrease the incidence of nonunion of 
the fractured scaphoid, but we believe 
its adoption will reduce unnecessary 
immobilization of the wrist. In our 
series, 53 patients (73%) were subse­
quently proven to have had the wrist 
needlessly immobilized; 35 (66%) 
with no fracture could have been 
spared a cast if our procedure had 
been in practice.
Other tests of scaphoid fracture are 
useful, but none has been subjected to 
a critical and statistical appraisal. 
When radiologic findings are equivo­
cal, ultrasonography,18 macroradiogra­
phy,19 transpiral tomography20 and ra­
dioisotope scanning21 have all been 
recommended, but there are obvious
238
disadvantages to their use—availabili­
ty and expert application and inter­
pretation. Although some series2-5-6 
have suggested that the initial x-ray 
films will reveal the scaphoid fracture 
in 98% of cases, these assessments 
were performed retrospectively under 
ideal circumstances by experienced 
clinicians—conditions that are not al­
ways available in an emergency situa­
tion.
This simple clinical test of scaphoid 
fracture may be used with confidence 
to eliminate unnecessary immobiliza­
tion of the wrist in some cases of 
possible scaphoid injury when there is 
no radiologic evidence of scaphoid 
fracture.
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BOOK REVIEWS 
continued from page 232
It was pleasing to encounter important 
contributions on the treatment of breast 
cancer in this otherwise gynecologically 
oriented book. The chapter by Shank and 
Heilman on preservative surgery and radi­
ation therapy for early breast cancer is 
excellent and one of the highlights.
The special chapters on primary gyneco­
logic lymphomas and the management of 
lymphoma associated with pregnancy are 
helpful and practical since it is hard to find 
good reviews of these difficult oncologic 
problems. Saigo’s chapter on the interpre­
tation of cervicovaginal smears after radio­
therapy will be welcome to pathologists 
and cytologists with limited experience in 
this difficult area.
Occasional spelling mistakes, discrepan­
cies between text and illustrations and 
imperfect labelling should be corrected in 
a second printing. Purnell’s illustrations of 
regional and juxtaregional lymph nodes 
are excellent, but some reproductions of 
diagnostic scans do not do justice to the 
excellent detail offered by present diagnos­
tic images. The varying quality of paper 
used for this edition is partly responsible.
In spite of these criticisms, this text will 
be a welcome addition to the library of 
anyone interested in the treatment of gyne­
cologic malignant disease.
Adalei A. Starreveld, md
Director, Radiation Oncology,
Cross Cancer Institute,
11560 University Ave.,
Edmonton, Alta.
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SMALL-BOWEL TRANSPLANTATION.
Edited by E. Deltz, A. Thiede and H.
Hamelmann. 272 pp. Illust. Springer-
Verlag, New York, 1986. Price not stat­
ed. ISBN 3-540-16336-0.
This book contains transcripts of various 
communications delivered during an inter­
national meeting on small-intestinal trans­
plantation, which took place in Kiel in 
October 1985.
The volume is well organized: manu­
scripts are grouped in 10 sections, which 
cover all aspects of the subject — experi­
mental models, physiology, immunology 
and immunosuppression, surgical tech­
niques and clinical considerations. Indica­
tions for small-bowel grafting are discussed 
in a separate section.
The manuscripts are authored by world­
wide experts on the subject who have 
made many previous contributions to this 
field. Unlike similar collections, the edito­
rial work has been thorough. The style is 
uniform so that these “chapters” are con­
cise and easy to read, even when dealing 
with such specific subjects as “potential 
markers for rejection of small-bowel allo­
grafts” or “functional adaptation of the 
small-intestinal mucosa” . Moreover, a 
clear summary is presented by the chair­
man of the session after each section.
Illustrations are clear and helpful and 
continued on page 242
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A carbapenem, representing a totally new class of antibiotics <+
■
The broadest spectrum single-agent antibiotic
possessing bactericidal activity against a great 
majority of clinically significant pathogens
PRIMAXIN* offers the activity of
the penicillins against gram-positive aerobes -  
including coverage of Streptococcus faecalis
plus
the aminoglycosides and 3rd generation cephalosporins 
against gram-negative aerobes -
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Single-agent antibiotic for 
documented and empiric 
therapy in many importan 
infections
including
□ infections usually treated with combination 
therapy
□ infections complicated by underlying 
disease
□ nosocomial infections
Imipenem and cilastatin sodium are present in a 1:1 ratio in PRIMAXIN* I.V. 
Imipenem is the sole antibacterial component. The role of cilastatin sodium is to 
prevent the inactivation of imipenem in the kidney and obtain antibacterial 
concentrations of imipenem in the urine.
+Caused by organisms susceptible to PRIMAXIN* I.V.
Clinical efficacy in many 
important infections
EFFICACY IN INTRAABDOMINAL INFECTIONS
91% cure or 
improvement
in 164 evaluable patients
1. Kager, L., Nord, C.E.: Imipenem/ 
cilastatin in the treatment of intra­
abdominal infections: A review of 
worldwide experience, Rev Infect Dis 
7 (Suppl 3): S518-S521, July-August 
1985.
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85% cure or 
improvement
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patients
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S522-S527, July-August 1985.
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PRIMAXIN* l.V. offers management , 
advantages over combination therapy 
that includes an aminoglycoside
* h
Generally well tolerated -  
safety profile 
sim ilar to cefazolin ’
h I
S  1723 patients, including the severely ill, have received therapy in clinical trials.
The incidence of the most common adverse experience (nausea) was no greater 
than 2%.
0  Avoids the potential nephrotoxicity or ototoxicity experienced with w
aminoglycosides.
a Avoids the potential hypoprothrombinemia and clinical bleeding experienced 
with cephalosporins with MTTf side chain.
□ Avoids the potential disulfiram-like effect experienced with metronidazole and 
cephalosporins with MTT side chain.
Convenience of a single agent
The broadest spectrum  single­
agent antibiotic representing 
a transform ation of parenteral 
antibiotic therapy
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■* adherence to recommended dosage schedules 
is urged, especially in patients with known factors 
that predispose to seizures.
„ ACTION
Imipenem exerts a bactericidal action by inhibiting 
cell wall synthesis in aerobic and anaerobic gram­
positive and gram-negative bacteria.
a PRIMAXIN* consists of tw o com ponents: 
(1) imipenem, a derivative o f th ienamycin, a 
carbapenem antibiotic; and (2) cilastatin sodium, a 
specific inhibitor of dehydropeptidase-l a renal 
enzyme w hich metabolizes and inactiva tes 
*  imipenem. Cilastatin blocks the metabolism of 
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antibacterial levels of imipenem to be attained in the 
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•  Klebsiella
•  Morganella morganii
•  Neisseria
•  Proteus (indole positive and indole negative 
strains)
•  Providencia
•  Pseudomonas aeruginosa
•  Serratia marcescens
Gram-positive Anaerobes
•  Clostridium (excluding C. difficile)
•  Peptococcus
•  Peptostreptoccus
Gram-negative Anaerobes
•  Bacteroides fragilis
•  Bacteroides (non-fragilis)
CONTRAINDICATIONS
PRIMAXIN* (imipenem and cilastatin sodium for 
injection) is contraindicated in patients who have 
shown hypersensitivity to either component of this 
product.
WARNINGS
PRIMAXIN* (imipenem and cilastatin sodium for 
in jec tion) SHOULD BE ADMINISTERED WITH 
CAUTION TO ANY PATIENT WHO HAS DEMONS­
TRATED SOME FORM OF ALLERGY, PARTICULARLY 
TO STRUCTURALLY-RELATED DRUGS. IF AN 
ALLERGIC REACTION TO PRIMAXIN* OCCURS, 
DISCONTINUE THE DRUG. SERIOUS HYPER­
SEN SITIVITY  REACTIONS MAY REQUIRE 
EPINEPHRINE AND OTHER EMERGENCY 
MEASURES.
Pseudomembranous colitis
Pseudomembranous colitis has been reported with 
the use of PRIMAXIN*. Therefore it is important to 
consider this diagnosis in patients who develop 
diarrhea during or after therapy. This colitis may 
range from mild to life threatening in severity.
Mild cases of pseudomembranous colitis may 
respond to drug discontinuance alone. In more 
severe  cases, m anagem en t m ay in c lu d e  
sigm oidoscopy, approp ria te  bacte rio log ica l 
studies, flu id, electrolyte and protein supple­
mentation, and the use of a drug such as oral 
vancomycin, as indicated. Other causes of colitis 
should also be considered.
PRECAUTIONS
General
Prolonged use of PRIMAXIN* (imipenem and 
cilastatin sodium for in jection) may result in 
overgrowth of resistant organisms. Repeated 
evaluation of the patient's condition is essential. If 
superinfection occurs during therapy, appropriate 
measures should be taken.
CNS adverse experiences such as myoclonic 
activity, confusionaFstates, or seizures have been 
reported with PRIMAXIN* especially when recom­
mended dosages based on renal function and body 
weight were exceeded. These experiences have 
occurred most commonly in patients with CNS 
disorders (e.g., brain lesions or history of seizures) 
and/or who have compromised renal function. 
However, there were rare reports in which there was 
no recognized or documented underlying CNS 
disorder. Close adherence to recommended dosage 
schedules is urged especially in patients with 
known factors that predispose to seizures (see 
DOSAGE AND A D M IN IS TR A TIO N ). A n t i­
convulsant therapy should be continued in patients 
with a known seizure disorder. If focal tremors, 
myoclonus, or seizures occur, patients should be 
evaluated neurologically and placed on an ti­
convulsant therapy if not already instituted. If CNS 
symptoms continue, the dosage of PRIMAXIN* 
should be decreased or discontinued.
Use in Patients with Impaired Renal Function
Dosage in patients with impaired renal function is 
based on the severity of infection but the maximum 
daily dose varies with the degree of renal functional 
im pa irm en t (see DOSAGE AND A D M IN IS ­
TRATION - Dosage in Patients with Renal 
Insufficiency).
Use in Pregnancy
The use of PRIMAXIN* in pregnant women has not 
been studied, therefore, PRIMAXIN* should be used 
during pregnancy only if clearly needed. Use of this 
drug in women of childbearing potential requires 
that the anticipated benefits be weighed against 
possible hazards.
Reproduction studies with bolus I.V. doses suggest 
an apparent intolerance to PRIMAXIN* (including 
emesis, inappetence, body weight loss, diarrhea
and death) at doses equivalent to the average 
human dose in pregnant rabbits and cynomolgus 
monkeys that is not seen in non-pregnant animals in 
these or other species. In other studies, PRIMAXIN* 
was well tolerated in equivalent or higher doses (up 
to 11 times the average human dose) in pregnant 
rats and mice (see REPRODUCTION STUDIES 
under TOXICOLOGY in the complete monograph).
Nursing Mothers
It is not known whether PRIMAXIN* is excreted in 
milk. If the use of PRIMAXIN* is deemed essential, 
the patient should stop nursing.
Pediatric Use
Efficacy and tolerability in infants under the age of 
3 months have not yet been established; therefore, 
PRIMAXIN* is not recommended in the pediatric 
age group below the age of 3 months.
Drug Interactions
Concomitant administration of PRIMAXIN* and 
probenecid results in only minimal increases in 
plasma levels of imipenem and plasma half-life. It is 
not recommended that probenecid be given with 
PRIMAXIN*.
PRIMAXIN* should not be mixed with or physically 
added to other antibiotics. PRIMAXIN* has been 
administered concomitantly with some antibiotics, 
such as aminoglycosides.
There is no evidence to suggest that association of 
PRIMAXIN* with any other beta-lactam antibiotics 
has any therapeutic advantage.
ADVERSE REACTIONS
PRIMAXIN* (imipenem and cilastatin sodium for 
injection) is generally well tolerated. The following 
adverse reactions were reported on 1,723 patients 
treated in clinical trials. Many of these patients were 
severely ill and had multiple background diseases 
and physiological impairments, making itd ifficu ltto  
determ ine causal re lationship of adverse ex­
periences to therapy with PRIMAXIN*.
Local Adverse Reactions
Adverse local clinical reactions that were reported 
as possibly, probably or definitely related to therapy 
with PRIMAXIN* were:
Incidence (%)
Phlebitis/thrombophlebitis 1.7
Infused vein pain 0.6
Vein induration 0.2
Infused vein infection 0.1
Systemic Adverse Reactions
Adverse clinical reactions that were reported as 
possib ly , probab ly , or d e fin ite ly  re la ted to  
PRIMAXIN* were:
Incidence (%)
Gastrointestinal
nausea 2.0
diarrhea 1.7
vomiting 1.6
tongue papillar hypertrophy 0.2
pseudomembranous colitis 
(see WARNINGS) 0.1
hemorrhagic colitis <0.1
gastroenteritis <0.1
abdominal pain <0.1
glossitis <0.1
heartburn <0.1
pharyngeal pain <0.1
increased salivation <0.1
CNS
fever 0.4
dizziness 0.3
seizures 0.2
(see PRECAUTIONS) 
somnolence 0.2
confusion 0.2
myoclonus 0.1
vertigo 0.1
headache 0.1
encephalopathy <0.1
paresthesia <0.1
Special Senses
transient hearing loss in 
patients with impaired hearing <0.1 
tinnitus <0.1
Respiratory TABLE 1 Dosage in Infants and Children
dyspnea 0.1
hyperventilation <0.1
thoracic spine pain <0.1
Cardiovascular
hypotension 0.4
palpitations 0.1
tachycardia <0.1
Renal
oliguria/anuria <0.1
polyuria <0.1
Skin
rash 0.9
pruritus 0.3
urticaria 0.2
skin texture changes 0.1
candidiasis 0.1
erythema multiforme <0.1
facial edema <0.1
flushing <0.1
cyanosis <0.1
hyperhidrosis <0.1
pruritus vulvae <0.1
Body as a whole
polyarthralgia <0.1
asthenia/weakness <0.1
Adverse Laboratory Changes
Adverse laboratory changes, without regard to drug 
relationship, that were reported during clinical trials 
were:
Hepatic: Increased SGPT, SGOT, alkaline phospha­
tase, bilirubin and LDH.
Hemic: Increased eosinophils, positive Coombs 
test, decreased WBC and neutrophils, increased 
WBC, increased platelets, decreased platelets, 
decreased hemoglobin and hematocrit, increased 
monocytes, abnormal prothrombin time, increased 
lymphocytes, increased basophils.
Electrolytes: Decreased serum sodium, increased 
potassium, increased chloride.
Renal: Increased BUN, creatinine.
Urinalysis: Presence of urine protein, urine red 
blood cells, urine white blood cells, urine casts, 
urine bilirubin, and urine urobilinogen.
TREATMENT OF OVERDOSAGE
There are no data available on overdosage.
PRIMAXIN* (imipenem and cilastatin sodium for 
injection) is cleared by hemodialysis.
DOSAGE AND ADMINISTRATION
The dosage recommendations for PRIMAXIN* 
(imipenem and cilastatin sodium for injection) 
represent the quantity of imipenem to be ad­
ministered by I.V. infusion only. An equivalent 
amount of cilastatin is also present in the solution.
The dosage of PRIMAXIN* should be determined by 
the severity of the infection, renal function, body 
weight, the antibiotic susceptibility of the causative 
organism(s) and the condition of the patient. Doses 
cited are based on body weight of 70 kilos.
The median duration of treatment with PRIMAXIN* 
in clinical trials for infections of the various body 
systems ranged from 6 to 10 days except for 
endocarditis and bone and joint infections for which 
the median duration of treatment was 4 weeks.
Dosage in Adults
The recommended daily dose is 1 to 2 g adminis­
tered in equally divided doses every 6 to 8 hours 
(see Table 1).
Dosage in Elderly Patients
The recommended dosageof PRIMAXIN* in elderly 
patients with normal renal function is the same as 
given for adults above. Renal status of elderly 
patients may not be accurately portrayed by 
measurement of BUN or creatinine alone. Deter­
mination of creatinine clearance is suggested to 
provide guidance for dosing in such patients.
ADULT DOSAGE OF PRIMAXIN*
I.V . A d m in is t ra t io n
S e v e r it y  
o f in f e c t io n
D o s e
(m g  o f im ip e n e m )
D o s a g e
In te rv a l
D a ily
D o s e
Mild 250 mg 6 h 1.0 g
Moderate 500 mg 8 h 1.5 g
Severe (fully 
susceptible)
500 mg 6 h 2.0 g
Severex infections
due to less
susceptible
organisms
or life threatening
conditions
1000 mg 
1000 mg
8 h 
6 h
3.0 g
4.0 g
x Primarily some strains of Ps. aeruginosa.
The maximum daily dose should not exceed 4 g or 
50 mg/kg, which ever is less.
Dosage in Patients with Renal Insufficiency
P a tie n ts  w ith  c re a t in in e  c le a ra n c e s  o f 
<5 mL/min/1.73 m? «0 .08  mL/s/1.73m2) should 
not receive PRIMAXIN* unless hemodialysis is 
instituted within 48 hours. Both imipenem and 
cilastatin are cleared from the circulation during 
hem odia lys is . The pa tie n t should  receive 
PRIMAXIN* after hemodialysis and at 12 hour 
intervals timed from the end of that hemodialysis 
session. Dialysis patients, especially those with 
background CNS disease, should be carefully 
m o n ito re d ; fo r  pa tie n ts  on hem odia lys is , 
PRIMAXIN* is recommended only when the benefit 
outweighs the potential risk of seizures (see 
PRECAUTIONS). Currently, there are inadequate 
data to recommend the use of PRIMAXIN* in 
patients undergoing peritoneal dialysis.
TABLE 2
MAXIMUM DOSAGE OF PRIMAXIN* 
IN RELATION TO RENAL FUNCTION
R EN AL
F U N C T IO N
C R E A T IN IN E
C L E A R A N C E
m L /m in /1 .7 3  m 2 
(m L /$ /1 .7 3  m 2)
D O S E
(g)
D O S A G E
IN T E R V A L
(h)
M A X IM U M
T O T A L
D A IL Y
D O S A G E
(g)
M ild
im p a irm e n t 3 1 - 7 0
( 0 .5 2 - 1 . 1 7 )
0.5 6 - 8 1 . 5 - 2
M o d e ra te
im p a irm e n t 2 1 - 3 0  
(0 .3 5  -  0 .5 0 )
0.5 8 - 1 2 1 - 1 . 5
Severe*
im p a irm e n t 0 - 2 0
( 0 - 0 . 3 3 )
0 . 2 5 - 0 .5 12 0.5  -  1 .0 XX
Patients w ith  cre a tin in e  clearance of 6 to 
20 mL/min/1.73 m2 (0.1 -0.3 mL/s/1.73 n-p) should 
be treated with 250 mg (or 3.5 mg/kg whichever is 
lower) every 12 hours for most pathogens. When 
the 500 mg dose is used in these patients, there may 
be an increased risk of seizures.
xx The highest dose is only recommended for 
infections due to  less susceptible organisms 
primarily some strains of Ps. aeruginosa.
When only the serum creatinine level is available, 
the following formula (based on sex, weight, and 
age of the patient) may be used to convert this value 
into creatinine clearance (mL/min). The serum 
creatinine should represent a steady state of renal 
function.
Males: Weight (kg) x (140 - age)
72 x serum creatinine (mg/100 mL) 
Females: 0.85 x above value.
When using the International System of units (SI), 
the estimated creatinine clearance (mL/s) in males 
can be calculated as follows:
(lean body weight, kg) x (140 - age, years) x 1.4736 
(72) x (serum creatinine concentration, pmol/L)
and in females the estimated creatinine clearance 
(mL/s) is:
(lean body weight, kg) x (140 - age, years) x 1.2526 
(72) x (serum creatinine concentration, pmol/L)
PRIMAXIN* is cleared by hemodialysis. After each 
dialysis session the dosage schedule should be 
restarted.
The recommended total daily dosage of PRIMAXIN* 
in children and infants 3 months of age and older is 
60 to 100 mg/kg of body weight divided into 4 equal 
doses given at six hour intervals. The higher 
dosages should be used for infants and young 
children. The total daily dosage should not exceed 
2 gram s. C lin ica l data are in s u ffic ie n t to  ,, 
recommend an optimum dose for infants and 
children with impaired renal function.
Administration
CAUTION: CONTENTS OF VIALS NOT FOR -  
DIRECT INFUSION.
Each reconstituted 250 mg or 500 mg dose should 
be given by intravenous infusion over twenty to 
th irty  minutes. Each 1000 mg dose should be ^ 
infused over 40 to 60 minutes. In patients who 
develop nausea during the infusion, the rate of 
infusion may be slowed. *
RECONSTITUTION
*
Contents of the 13 mL vials must be suspended and 
transferred to 100 mL of an appropriate infusion 
solution.
A suggested procedure is to transfer approximately 
10 mL from the 100 mL of the appropriate infusion * 
solution to the vial (see list of diluents under 
COMPATIBILITY AND STABILITY). Shake well. 
Return the resulting 10 mL of suspension to the 
remaining 90 mL of the infusion solution.
Repeat, using 10 mL of the diluted suspension, to 
ensure complete transfer of the contents of the vial 
to the infusion solution.
CAUTION: CONTENTS OF VIALS NOT FOR 
DIRECT INFUSION.
COMPATIBILITY AND STABILITY
List of diluents
0.9% Sodium Chloride Injection 
5% or 10% Dextrose Injection 
5% Dextrose Injection with 0.02% sodium 
bicarbonate solution
5% Dextrose and 0.9% Sodium Chloride 
Injection
5% Dextrose Injection with 0.225% or 0.45% 
saline solution 
NORMOSOL-M in D5-W 
5% Dextrose Injection with 0.15% potassium 
chloride solution 
Mannitol 2.5%, 5% and 10%
Reconstituted solutions
Solutions of PRIMAXIN* range from colourless to 
yellow. Variations of colour within this range do not 
affect the potency of the product.
PRIMAXIN*, as supplied in vials and reconstituted r. 
as above maintains satisfactory potency for four 
hours at room temperature and for 24 hours under 
refrigeration (4°C). PRIMAXIN* has been found to 
be stable in 0.9% Sodium Chloride Injection for 
10 hours at room temperature and 48 hours under _ 
refrigeration.
DOSAGE FORMS 
AVAILABILITY
PRIMAXIN* is supplied as a sterile powder mixture * 
in vials containing imipenem anhydrous and 
cilastatin sodium as follows:
3514Ca - 250mgimipenemequivalentand250mg 
cilastatin equivalent in vials. <
3516Ca - 500 mg imipenem equivalent and 500 mg 
cilastatin equivalent in vials.
STORAGE
The dry powder should be stored at a temperature "* 
below 30° C.
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Les polypes malins du colon: la polypectomie est-elle un
traitement adequat?
Apres exerese endoscopique de 641 
adenomes, 35 ont presente une image 
histologique de transformation mali- 
gne, in situ dans 16 cas (2.5%) et 
invasive dans 19 (3%). Douze de ces 
19 patients ont ete subsequemment 
operes et des foyers de cancer residuel 
ont ete retrouves dans la paroi colique 
chez 3 (25%), dont 1 avec un ganglion 
metastatique. Le facteur de risque 
commun a ces trois cas fut la presence 
de cancer a la marge de section micro- 
scopique. D'autres facteurs de risque 
comme I'angio-invasion et I'exerese 
macroscopiquement incomplete 
ont ete retrouves au total chez neuf 
patients mais aucun ne demontra de 
cancer residuel en I'absence de mar­
ges macroscopiquement envahies.
La polypectomie seule n'est done 
pas toujours adequate comme traite­
ment d'un adenome presentant des 
foyers de transformation maligne avec 
invasion. La presence de cancer au 
niveau des marges de section apparait 
comme le facteur de risque le plus 
important. Devant une incidence de 
cancer residuel de 33%, une resection 
est indiquee en presence de facteurs 
de risque, a moins que le risque chirur- 
gical ne soit plus eleve.
The management of patients with en- 
doscopically removed malignant intes­
tinal polyps is controversial. The risk of 
residual disease should be assessed 
against the risk of a surgical operation.
Du departement de chirurgie, Universite de Montreal, Service de chirurgie digestive, Hopital Saint-Luc, Montreal, PQ
Travail presente a une session conjointe de TAssociation des chirurgiens generaux du Canada et de I'Association canadienne de gastroenterologie lors du Congres du Col­lege royal des medecins et chirurgiens du Canada, Winnipeg, Man., le 13 septembre 1987
Accepte pour publication le 14 decembre 1987
Les demandes de tires a part doivent etre adressees au: Dr Denis Bernard, Departe­ment de chirurgie, Hopital Saint-Luc, 1058, rue Saint-Denis, Montreal, PQ H2X 3J4
The authors report 35 cases of malig­
nant polyps (5.5% of 641 colonoscopi- 
cally removed adenomas). Sixteen pa­
tients had carcinoma in situ and re­
ceived no further treatment and 19 
had invasive carcinoma (sessile in 6, 
pedunculated in 13). Of these 19, 7 
did not undergo surgery — because of 
old age in 2, minimal invasion in 3, a 
low rectal location in 1 and refusal in 
1. Twelve patients (3 with sessile, 9 
with pedunculated polyps) underwent 
a surgical resection, and residual dis­
ease was present in 3 (25%), 1 with 
positive nodes. Reported criteria of in­
creased risk of residual disease — can­
cer in lymphatics or veins, incomplete 
excision, tumour at resection margin, 
sessile and villous tumours — were 
present in nine. All three patients with 
residual disease had microscopically 
involved margins of resection. The au­
thors believe that the increased risk of 
recurrence justifies the risk associated 
with subsequent surgical resection un­
less the patient is otherwise a poor 
operative risk.
Un consensus semble etabli sur le 
potentiel de transformation maligne 
des adenomes colo-rectaux et sur le 
concept que la majorite sinon la tota­
lity des adeno-carcinomes colo-rec­taux ont leur origine dans un adeno­
me preexistant.1-2 Cependant tous les adenomes ne genereront pas un 
adenocarcinome. Le taux de transfor­mation maligne se situe entre 5% et 
1 l%i-3-s et varie considerablement de
moins de 1 % a 46% selon la taille et la structure histologique de l’adenome (tableaux I et II145). La facility 
d’exerese des polypes adenomateux par coloscopie4-3 a relance le debat 
concernant les polypes qui presentent 
des foyers histologiques de transfor­mation maligne. La controverse quant 
a la conduite therapeutique a tenir dans ces cas oppose les tenants de la resection colique et ceux de l’obser- 
vation du patient avec des examens 
repetes. L’intervention chirugicale a pour objectif d’eliminer tout risque de 
neoplasie residuelle dans la paroi du 
colon et dans les ganglions lympha- tiques regionaux et de prevenir une 
recidive ou une extension de la mala- die pouvant amener le deces eventuel du patient.6-10 Par contre d’autres au­
teurs pretendent que ce taux de neo­plasie residuelle est bas, inferieur au 
risque operatoire, rendant non justi- 
fiee une intervention chirugicale.11-15 Certains adenomes possedent des 
alterations cellulaires, epitheliales ou glandulaires identifies par le patholo- 
giste comme des signes de transforma­tion maligne mais limites a la mu- 
queuse et son chorion (lamina pro­
pria), ne depassant pas la muscularis 
mucosae et n’envahissant pas la sous- 
muqueuse. Ces modifications sont 
communement appelees carcinomes in-situ131617 et nous les designerons 
ainsi. L’invasion se definit par la 
presence de cellules neoplasiques ou de glandes au-dela de la muscularis 
mucosae (i.e., dans la sous-muqueuse 
oil leur contact avec les capillaires
Tab leau  1— Taux (%) de ca n ce r in v a s if dans les a d e n o m e s  se lon  leu r ta ille
T a ille , cm
Serie <  1 1 -  2 >  2
M o rs o n , 1 9 7 6 ' 1 .3 9 .5 4 6 .0
G illesp ie  e t c o lla b o ra te u rs , 1 9 7 9 “ 0 .2 5 .5 1 5 .5
S h inya  e t W o lf f ,  1 9 7 9 5 0 .5 6 .7 2 8 .7
Tab leau  II— T a u x  (%) de cance r in v a s if dans les a d e n o m e s  se lo n  le ty p e  h is to lo g iq u e
Serie T u b u la ire T u b u lo -v ille u x  V ille u x
M o rs o n , 1 9 7 6 ' 4 .8 2 2 .5  4 0 .7
G illesp ie  e t c o lla b o ra te u rs , 1 9 7 9 “ 2 .2 5 .8  1 8 .0
S h inya  e t W o lf f ,  1 9 7 9 s 2 .8 8 .4  9 .5
VOLUME 31, NO. 4 JULY 1988 /  THE CANADIAN JOURNAL OF SURGERY 239
sanguins et lymphatiques rend possi­
ble la dissemination metastatique).18 
L’invasion peut se limiter a la tete du 
polype, atteindre le pedicule, penetrer 
les capillaires veineux ou lymphati­
ques, s’etendre jusqu’a la tranche de 
section ou meme au-dela, dans les 
couches profondes de la paroi intesti- 
nale. Parfois les ganglions sont at- 
teints et il peut meme exister des 
metastases a distance. Nous ne pos- 
sedons pas encore de methode precise 
pour determiner la presence de foyers 
de cancer residuel dans la paroi du 
colon ou dans les ganglions a la suite 
d’une polypectomie. La palpation au 
doigt n’est pas sans erreur et se limite 
a l’examen rectal.19 L’inspection en- 
doscopique ne permet d’examiner que 
la muqueuse et les techniques d’ima- 
gerie des ganglions lymphatiques du 
meso-colon par lymphoscintigraphie 
isotopique sont encore a l’etape de 
leur evaluation.20'21 Ainsi les seuls 
elements permettant d’evaluer si la 
polypectomie sera adequate nous 
viennent du polype lui-meme: sa 
forme macroscopique, sa structure 
histologique, le degre de differencia- 
tion, l’exerese endoscopique com­
plete, la presence d’invasion et sur- 
tout la profondeur de l’invasion. 
L’existence d’un pedicule constitue 
d’une muqueuse et d’une sous- 
muqueuse normales procure theori- 
quement a un polype enleve endosco- 
piquement une marge de tissu sain 
plus importante que si la lesion est
sessile oil la marge d’excision est en 
general plus mince. A cause de toutes 
ces considerations nous avons fait le 
releve de nos cas traites et l’etude des 
polypes malins enleves en coloscopie 
afin de tenter d’en tirer certaines con­
clusions permettant de predire si la 
polypectomie seule peut etre suffisante.
Materiel clinique
Au cours de 2281 coloscopies effec- 
tuees depuis 1980, nous avons enleve 
641 adenomes chez 472 patients. 
Deux cent soixante-cinq (41.3%) 
avaient une taille inferieure a 1 cm, 
257 (40.1%) entre 1 et 2 cm et 110 
(17.2%) superieure a 2 cm. La dimen­
sion n’a pas ete determinee pour les 
neufs autres polypes. Quatre-vingt 
pourcent presentaient une structure 
histologique de type tubulaire, 12.5% 
tubulo-villeuse et 7.5% villeuse. L’exa­
men histo-pathologique de 35 de ces 
adenomes a revele des foyers de trans­
formation maligne: in situ chez 16 et 
avec invasion chez 19 soit respective- 
ment 2.5% et 3% de tous les adeno­
mes. Nous n’avons pas inclus dans 
cette compilation les cas ou une inter­
vention chirurgicale a ete pratiquee 
d’emblee pour une lesion polypoide 
oil l’endoscopiste avait juge qu’une 
resection etait plus appropriee. Nous 
avons egalement exclus les cas 
d’exerese par voie transanale parce 
que cette technique chirurgicale pro­
cure une marge d’excision plus impor­
tante dans toutes les directions, ce qui 
peut influencer une decision thera- 
peutique subsequente. Pour chaque 
adenome transforme nous avons exa­
mine les elements suivants: age du 
patient, site anatomique, taille, forme 
macroscopique (sessile ou pediculee), 
type histologique, differentiation, 
degre d’invasion, presence ou absence 
d’angio-invasion et marges de section. 
De plus, pour chaque cas subsequem- 
ment opere, la presence d’une neopla- 
sie residuelle dans la paroi du colon, 
dans les ganglions lymphatiques ou a 
distance a ete relevee.
Resultats
Dans les 16 cas d’adenome avec 
foyers de carcinome in situ (10 tubu- 
laires et 6 tubulo-villeux) l’exerese 
endoscopique a ete complete. Tous 
etaient bien differencies et aucun ne 
fut opere. Pour les 19 cas d’adenome 
avec foyers de cancer invasif, le ta­
bleau III expose en detail pour chacun 
les elements etudies, la decision thera- 
peutique et son resultat. Sept patients 
de ce groupe n’ont pas subi de resec­
tion pour les motifs suivants: une 
resection abdomino-perineale aurait 
ete requise chez une; deux ont ete 
juges trop ages et presentant un risque 
operatoire trop grand; et un a prefere 
ne pas etre opere. Chez les trois autres, 
le degre d’invasion etait minime, limi­
te a la portion superficielle de la
Tableau III— Detail de chaque cas de polype malin invasif
Cas Age,
no Sexe an
Marge de 
section
CA
Colectomie
Taille, Exerese  Mai veine CA Metastase
Site cm Histologief Macroscopie$ incomplete§ envahie§ differencie§ lymph§ residuel§ ganglion§ Remarques
1 F 50 S 2 TV P — — — — — —
2 F 41 S 3 TV P + — — — — —
3 M 47 S 1 TV P — — — — — —
4 F 51 R 1 T s NR NR Indication de 
resection 
antero-posterieur
5 M 44 D 3 CA P — + — + + +
6 F 45 S 2 V P — + — + — —
7 M 75 S 1.5 V P — — — — NR NR Micro-invasion
8 F 37 D 1.5 TV P — — — — — —
9 F 45 R 1.5 T s ? + — — — —
10 M 68 D 3 TV s — + — — — —
11 M 54 S 1 CA p — — — — — —
12 F 47 S 5 T p — — — — NR NR Micro-invasion
13 F 79 TR 3.5 TV s + — — — NR NR Age, risque 
operatoire
14 M 71 S 2.5 TV p — + — — + —
15 F 74 s 1 TV p — — — — NR NR Age
16 M 66 A 1 TV s — + — — + —
17 M 60 R 3 TV s + — — — NR NR Micro-invasion
18 F 76 S 2 TV p — + — — — —
19 M 72 S 3.5 V p — — — — NR NR A refuse operation
*R =  rectum, S =  sigmoide, D =  descendant, TR =  transverse, A = ascendant. 
fT  =  tubulaire, TV = tubulo-villeux, V =  villeux, CA =  pas d'adenome residuel. 
f  s =  sessile, p =  pedicule.
§+ =  presence, —  = absence, ? =  douteuse, NR =  non reseque.
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sous-muqueuse dans la tete du polype 
avec pedicule et les marges de section 
etaient saines.
Douze patients ont subi une resec­
tion colique; chez 3 (25%) on retrouva 
un foyer residuel de cancer dans la 
paroi du colon, associe a un ganglion 
metastatique dans 1 cas. Dans ces 
trois cas, les tranches de section 
etaient envahies microscopiquement. 
Parmi ces 12 cas operes, 9 pos- 
sedaient a la polypectomie un ou 
plusieurs elements consideres comme 
criteres de risque de cancer residuel: 
une exerese macroscopiquement in­
complete ou douteuse, des marges 
microscopiques envahies ou une an- 
gio-invasion. Nos trois patients avec 
du cancer residuel se retrouvaient 
dans ce groupe. Trois n’avaient pas 
revele de tels criteres et aucun foyer 
residuel de cancer ne fut retrouve.
Discussion
Incidence
L’incidence de cancer invasif dans 
notre serie d’adenomes est de 3%. Ce 
chiffre peut sembler inferieur aux 10% 
habituellement cites.15 L’avenement 
de la coloscopie permet d’enlever un 
nombre plus considerable d’adenomes 
de petite taille a tous les niveaux du 
colon. Ceci reduit le taux relatif de 
cancer dans les polypes comme le 
revelent les series de coloscopies 
recentes avec des taux de 1.6%, 2.7% 
et 4.8%.4’22’23
Cancer in situ
Tous les auteurs s’entendent sur la 
definition de cancer in situ, sur sa 
signification clinique, sur l’absence 
de risque de metastase et sur son 
traitement adequat par polypectomie 
simple.6-10-13’24
Cancer invasif
Le traitement adequat des adeno- 
mes avec foyer de cancer invasif est 
plus debattu. Seule revolution clini­
que peut en eflfet determiner si la 
polypectomie seule a ete un traite­
ment adequat. Plusieurs series se ser- 
vent de cet argument retrospectif 
qu’est revolution pour proposer la 
polypectomie seule. Le resultat d’un 
traitement insuffisant par polypecto­
mie se manifestera par une recidive 
locale ou des metastases au cours des 
mois ou des annees subsequentes. 
Morson et collaborateurs14 et Cranley 
et collaborateurs23 ont rapporte des 
resultats de polypectomie seule avec 
recul minimum de 5 ans et de 4 ans 
respectivement sans aucune evidence 
de maladie recidivante ou metasta­
tique lorsque la polypectomie n’avait 
pas demontre de cancer a la tranche 
de section. Par ailleurs, plusieurs 
etudes ont ete faites pour rechercher 
l’incidence d’un cancer residuel apres 
une resection colique pour polypes 
malins. Les taux de cancer residuel 
varient generalement selon la pre­
sence ou l’absence de certains criteres 
de gravite retrouves a l’examen histo- 
pathologique du polype enleve. La 
presence de foyers de cancer au ni­
veau de la tranche de section du 
polype apparait comme le facteur de 
risque le plus important. Cranley et 
collaborateurs23 rapportent sur 19 pa­
tients qui presentaient des marges en­
vahies; ils ont retrouve soit du cancer 
residuel soit des metastases chez 8 
(42%). Langer et collaborateurs9 ont 
retrouve du cancer residuel chez qua- 
tre des six patients dont les marges 
etaient envahies. Richards et collabo­
rateurs,10 de leur cote, mentionnent 
que dans 10 cas oil il y avait du 
cancer residuel les marges de section 
n’etaient pas saines chez 6. Nos resul­
tats concordent avec ces trois der- 
nieres etudes. Nos trois patients 
operes, chez qui on a retrouve du 
cancer residuel, avaient des marges 
envahies.
Morson et collaborateurs14 ont etu- 
die la question des marges de section 
en les classifiant en trois types: mar­
ges saines, marges douteuses oil des 
cellules neoplasiques sont presentes 
au niveau de la ligne de brulure elec- 
trothermique, et marges envahies lors­
que l’excision macroscopique ou mi- 
croscopique du polype est manifeste- 
ment incomplete. Base sur une evolu­
tion de 5 ans sans recidive le taux de 
cancer residuel dans le colon reseque 
fut de 0/40 dans les cas d’excision 
complete avec marges saines, de 0/9 
avec des marges douteuses et de 2/11 
lorsque l’excision avait ete jugee 
incomplete.14 Haggitt et collabora­
teurs,24 dans une etude de 129 polypes 
malins, decrivent cinq niveaux d’in- 
vasion: niveau 0, cancer in situ; ni­
veau 1, invasion limitee a la tete du 
polype; niveau 2, invasion a la jonc- 
tion de la tete et du pedicule; niveau 
3, invasion du pedicule; et niveau 4, 
invasion de la sous-muqueuse de la 
paroi colique. L’invasion dans une 
lesion sessile etablit automatiquement 
un niveau 4. Selon ces auteurs les 
lesions de niveau 4 presentent un 
risque de cancer residuel de 25% 
(7/28). Un seul des 10 patients avec 
un niveau 3 est decede (10%). Haggitt 
comme Morson semble attacher de 
l’importance a l’effet destructeur de la 
brulure electrothermique et ne recom- 
mande pas de resection meme si la 
marge du pedicule montre de l’inva­
sion. Nos propres donnees contre- 
disent cette attitude et il nous appa­
rait presomptueux d’etre aussi certain 
que la lesion de brulure aura pour 
effet de detruire tout foyer residuel 
sans connaitre exactement la profon- 
deur de l’invasion.
La nature sessile d’un polype malin 
comme facteur de gravite reunit aussi 
un certain consensus chez la majorite 
des auteurs qui rapportent des foyers 
de cancer residuel variant de 10% a 
40%.3'7'u’23-23 De plus il arrive 
frequemment qu’une lesion sessile se 
situe au rectum. Une resection radi- 
cale dans ces circonstances peut neces- 
siter une colostomie definitive. Cepen- 
dant il est possible de proceder a une 
reexcision locale d’epaisseur totale 
avec des marges plus importantes afin 
d’obtenir une excision vraiment com­
plete et epargner au patient une colos­
tomie definitive. Cette conduite est 
appuyee par les travaux de Morson et 
collaborateurs,26 Steams et collabora­
teurs27 et Hermanek.28
On n’accorde pas autant d’impor- 
tance a un degre de differentiation 
pauvre ou a l’angio-invasion (vein- 
euse ou lymphatique). Ce sont des 
phenomenes plus rares qui se retrou- 
vent encore plus rarement isoles. Mal- 
gre un traitement radical, une lesion 
maligne mal differenciee signifie gene­
ralement, mais non invariablement, 
un pronostic pauvre, les metastases 
etant souvent deja presentes.10'14'23 24 
Nous n’avons pas rencontre de tu- 
meur mal differenciee mais deux de 
nos patients presentaient de l’angio- 
invasion et notre unique cas de metas­
tases ganglionnaires fut retrouve chez 
l’un d’eux.
Notre etude ne permet pas d’aider 
a solutionner deux autres aspects du 
probleme: l’invasion d’un pedicule 
avec marges saines et le cancer poly- 
poide pedicule. Plusieurs auteurs dont 
Christie,25 Nivatvongs et Goldberg,7 
Colacchio et collaborateurs8 et Ri­
chards et collaborateurs10 font de l’in­
vasion limitee au pedicule un facteur 
de risque en se basant sur quelques 
exemples retrouves dans leur ex­
perience. Trois des 10 patients de 
Richards et collaborateurs10 chez qui 
ils ont retrouve du cancer residuel 
sous forme de ganglions metasta- 
tiques, presentaient un envahissement 
du pedicule mais avec tranche de 
section saine. Par ailleurs, Morson et 
collaborateurs,14 Haggitt et collabora­
teurs,24 Lipper et collaborateurs13 et 
Cranley et collaborateurs23 n’ont pas 
rencontre dans ces cas de cancer resi­
duel et nient que ce soit possible. 
Autrefois le cancer polypoide etait con­
siders comme une lesion differente 
(i.e., un cancer survenant de novo
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sans passer par l’etape d’une lesion 
benigne et on lui attribuait une agres- 
sivite plus marquee necessitant une 
resection). Morson1 a demontre que le 
cancer polypoide n’est autre chose 
qu’un polype ou le cancer a complete- 
ment remplace l’adenome et que les 
memes principes s’appliquent a son 
traitement. II considere qu’en presence 
de marge saine la polypectomie est 
adequate. Cranley et collaborateurs,23 
Lipper et collaborateurs13 et Haggitt et 
collaborateurs24 partagent cette opi­
nion. Chez un de nos deux cas de 
cancer polypoide, nous n’avons pas 
retrouve de cancer residuel et l’autre 
presentait aussi une angio-invasion et 
des marges de resection envahies. Fi- 
nalement une revue de la litterature 
medicale de langue anglaise faite en 
1984 par Wilcox et collaborateurs29 a 
permis de compiler plusieurs series 
totalisant 347 cas avant l’ere de la 
coloscopie et 188 cas depuis l’ere de la 
coloscopie. Dans ces deux groupes 
l’incidence de cancer residuel lorsque 
les foyers de transformation maligne 
apparaissaient limites a un polype 
avec des marges saines etait de 10.4% 
et 10.1% respectivement.
Conclusions
La polypectomie seule n’est pas tou- 
jours suffisante pour traiter un polype 
malin. Si ce dernier presente un ou 
plusieurs criteres de risque de cancer 
residuel, une resection colique est in- 
diquee a moins que le risque opera- 
toire ne soit trap grand. Le plus im­
portant critere de risque est l’invasion 
de la tranche de section du polype.
L’invasion du pedicule avec marges 
de section saines, et l’invasion mas­
sive de la tete d’un polype avec un 
pedicule intact (cancer polypoide) re­
presented des criteres dont la signifi­
cation clinico-pathologique n’est pas 
resolue et oil l’indication chirurgicale 
demeure controversee.
Dans tous les cas, revaluation glo- 
bale de la situation doit comporter 
une discussion avec le pathologiste 
afin que chaque critere de gravite soit 
evalue. Toute decision therapeutique 
doit ensuite tenir compte du patient, 
de son age, du site du polype et de 
sa capacite de subir une resection 
colique.
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include numerous photomicrographs of ex­
cellent quality.
This well-written book is enjoyable to 
read and covers all aspects of small-intesti­
nal transplantation. Although this is obvi­
ously a very specific subject, readers with 
even a passing interest in the field will find 
it a pleasant addition to their library.
Denis Bernard, md, frcsc 
Ramses Wassef, md, frcsc
Department of Surgery,
Hopital St-Luc,
1058, rue Saint-Denis,
Montreal, PQ 
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UROLOGY ANNUAL, 1987. Volume 1. 
Edited by Stephen N. Rous. 277 pp. 
Illust. Appleton-Century-Crofts, Nor­
walk, Conn., 1987. $65.00 (US). ISBN 
0-8385-9318-6.
The stated aim of this series is to serve as a 
yearly compendium of what is important 
and timely to the practising urologist and 
to serve as a reference book for resident 
urologists. The first volume has achieved 
its goal admirably.
In an era of rapidly expanding knowl­
edge and techniques, it is increasingly 
difficult to keep up to date. In written 
form, one has to rely either on textbooks 
where the information is sometimes out of 
date at the time of publication or on 
searching the ever-increasing number of 
specialty journals. The Urology Annual 
series should help to eliminate this dilem­
ma by presenting new clinical findings and 
recent progress in diagnosis and treatment.
In this volume, 13 topics of current 
interest have been selected for review by 
acknowledged experts in each area. The 
two articles on urolithiasis are among the 
best. Four chapters deal with new thera­
peutic approaches to tumours of the geni­
tourinary tract. Two chapters are devoted 
to innovative reconstructive surgery of the 
urinary tract. Other topics include the 
treatment of erectile dysfunction, renal 
trauma, the role of magnetic resonance 
imaging and lasers in urology, and the 
ever-changing spectrum of antibiotics.
The experts were chosen with care and 
the editor is to be congratulated for having 
achieved a writing style that is clear and 
uniform despite the number of contribu­
tors. A minor criticism would be the inclu­
sion of a number of intraoperative black- 
and-white photographs which do little to 
embellish the text. Do they ever?
I enjoyed the book thoroughly and look 
foward to future issues. Matching the first 
volume in excellence will be a challenge.
A.H. Irvine, md, frcsc
Professor and Chairman,
Division of Urology,
University of Ottawa,
Ottawa Civic Hospital,
Ottawa, Ont.
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Urinary Diversion Using the Kock Ileal Reservoir in Patients
With Irradiated Bowel
The creation of a Kock ileal reservoir is 
the most common method of continent 
urinary diversion. The procedure uti­
lizes a metre of distal small bowel. 
Preoperative pelvic irradiation in pa­
tients who are to undergo radical cys­
tectomy for invasive bladder cancer 
frequently results in thickening of the 
bowel and its mesentery. This change 
makes construction of the Kock reser­
voir somewhat more difficult and could 
theoretically increase the potential for 
complications. The authors have 
found, in a series of 1 6 such cases, 
that there is no increased complication 
rate as a result of preoperative irradia­
tion and that this should not be consid­
ered a contraindication to the Kock 
procedure.
La construction d'un reservoir ileal de 
Kock est la methode la plus frequem- 
ment utilisee pour retablir une conti­
nence urinaire. Cette intervention re- 
quiert un metre d'intestin grele dans 
sa partie distale. Chez les patients qui 
doivent subir une cystectomie radicale 
pour un cancer invasif de la vessie, 
I'irradiation pelvienne preoperatoire 
cause souvent un epaississement de 
I'intestin et de son mesentere. Ceci 
rend quelque peu plus difficile la cons­
truction d'un reservoir de Kock et peut, 
theoretiquement, accroTtre les possibi­
l i ty  de complications. Sur une serie 
de 16 cas, les auteurs n'ont decouvert 
aucune augmentation du taux de com­
plication pouvant resuiter d'une irra­
diation preoperatoire. Celle-ci ne doit
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done pas etre consideree comme une 
contre-indication a une operation de 
Kock.
In 1971, Nils Kock1 first described his 
method for creating an ileal reservoir 
for fecal diversion in patients under­
going total proctocolectomy, primari­
ly for inflammatory bowel disease. 
Revision of the procedure, involving 
the addition of a second, intussuscept- 
ed, nonreflexing nipple valve to pro­
duce an intra-abdominal continent 
urinary reservoir, was described in 
1982.2 This was in turn revised during 
the course of a large clinical experi­
ence by Skinner and associates3 at the 
University of Southern California; it 
has gained prominence as an alterna­
tive to standard ileal conduit urinary 
diversion. We report our initial expe­
rience with 16 patients who under­
went radical cystectomy and Kock 
continent ileal reservoir urinary diver­
sion. All patients in the series had 
received high-dose external beam ra­
diotherapy preoperatively as part of 
the treatment protocol for malignant 
disease of the bladder. Our initial 
concern that the preoperative radio­
therapy might increase the number 
and severity of postoperative compli­
cations has proved to be unfounded.
Patients and Methods
Between May 1985 and November 
1986, 16 patients (12 men, 4 women) 
underwent interval cystectomy and 
urinary diversion for high-grade, inva­
sive, transitional cell carcinoma of the 
bladder after first receiving radiother­
apy (40 Gy in 4 weeks). Their ages 
ranged from 43 to 73 years (mean 61 
years). Follow-up ranged from 2 to 23 
months (mean 11 months). None of 
the patients had undergone urinary 
diversion before. Other methods of 
urinary diversion, including a stan­
dard ileal conduit with external appli­
ances, were discussed with patients 
before they consented to the Kock 
procedure. In addition to other appro­
priate investigations, preoperative
renal function was assessed by mea­
suring the serum urea nitrogen and 
creatinine levels; in no patient did the 
serum creatinine level exceed 120 
Mmol/L. All patients underwent radi­
cal cystectomy, without lymphadenec- 
tomy, because of preoperative pelvic 
irradiation. No male patient had in­
continuity urethrectomy performed.
Surgical Technique (Figs. 1 to 9)
We used the technique of Skinner 
and colleagues4 with modifications as 
follows:
•  We use a longer segment of 
ileum than that originally described 
by Kock and revised by Skinner. As a 
result of the preoperative irradiation, 
we noted that the bowel wall was 
slightly thickened and contracted so 
we increased the length of both affer­
ent and efferent limbs to 19 cm. The 
pouch is created from two 22-cm 
segments (Fig. 1). An additional 5-cm 
segment of proximal bowel with its 
mesentery is excised to permit greater 
mobility of the afferent limb of the 
pouch.
•  Approximately 8 cm of mesen­
tery is stripped from both the afferent 
and efferent limbs so that no mesen­
tery is included in the intussuscepted 
nipple valve, thus allowing much 
more stable construction of the valve 
(Fig. 4).
•  Four vertical rows of 4.8-mm 
AMS staples are applied in each quad­
rant of the intussuscepted segment, 
using the TA-55 automatic stapler 
(Fig. 6). To avoid stone formation on 
exposed staples at the tip of the nip­
ple, staple cartridges are partially pre­
fired to exclude five staples from the 
end opposite the stabilizing pin.
•  An absorbable Vicryl mesh collar 
is sutured around the afferent and 
efferent limbs at the base of the nipple 
to stablize it further and prevent slip­
ping; the inflammatory response also 
helps in stabilization. Erosions into 
the pouch when nonabsorbable Mar- 
lex collars were used,4 has not been a 
problem in our series (Fig. 7).
•  It is essential to obtain water-
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tight closure of the pouch with a 
double layer of continuous 3-0 Vicryl 
sutures to prevent urinary leakage 
(Fig. 8).
•  The ureters are anastomosed, 
end to side, to the efferent limb of the 
pouch and stented with no. 8 infant 
feeding tubes passed into the pouch 
and left for 2 weeks.
•  A large calibre (no. 26 to no. 30 
French) Medina drainage tube is in­
serted into the pouch, secured and left 
in place for 2 weeks. Excessive mu­
cous production during the immedi­
ate postoperative period requires fre­
quent pouch irrigations; it decreases 
considerably with time.
•  A one-inch Penrose drain re-
FIG. 1—Portions of distal ileum used for 
reservoir. Proximal 5 cm is discarded. Mes­
enteric defect created allows increased mo­
bility to afferent limb of pouch.
FIG. 2—Two 22-cm segments are anas­
tomosed side to side with 3-0 Vicryl, then 
opened longitudinally 5 mm from suture 
line.
FIG. 3—Mucosa is approximated with 
double layer of 3-0 Vicryl.
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mains in the left lower quadrant until 
the patient is catheterizing the pouch 
intermittently without leakage, 2 to 3 
weeks postoperatively.
•  If there is no urinary leakage, 
indwelling ureteral stents are re­
trieved endoscopically after 2 weeks
FIG. 4—Mesenteric “window” is formed 
by denuding 8 cm of bowel of its mesentery.
FIG. 5—Nipple valves are formed by 
intussuscepting denuded bowel. Mesenteric 
window minimizes volume of intussuscepted 
tissue and reduces chance of slipping.
FIG. 6—Four rows of staples are placed 
using TA-55 automatic stapler. Five staples 
are excluded by partially pre-firing car­
tridge; this avoids stone formation at tip of 
nipple.
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and training of patients started on 
intermittent self-catheterization. If 
urinary leakage is prolonged, the pa­
tient is discharged home and readmit­
ted later for stent removal and cathe­
ter training. Antibacterial medication 
has not been required. Patients are
FIG. 7—Nipple is further stabilized by 
suturing Vicryl cuff to serosal surface of 
intussuscepted bowel.
FIG. 8—Pouch is closed in opposite di­
rection to which it was opened, using two 
layers of 3-0 Vicryl.
FIG. 9—Efferent limb is sutured to ab­
dominal wall fascia using 0 Dexon “U” 
suture.
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followed up every 3 months to check 
for recurrent cancer and renal func­
tion.
Results
The operation time ranged from 5 
to 7 hours (mean just under 6 hours), 
approximately 2 hours longer than for 
cystectomy combined with a standard 
ileal conduit urinary diversion. The 
operation is not technically difficult 
but is tedious.3 Hospital stays ranged 
from 10 to 51 days (mean 24 days). 
Early in our series we were extremely 
conservative, keeping patients with 
postoperative urinary leakage in hos­
pital. We now discharge them on 
home care and place collection de­
vices over the Penrose drains. There 
were no perioperative deaths related 
to this operation.
Two of the 16 patients died of 
cancer, one at 2 months and the other 
1 year after operation. Both had good 
function of the Kock reservoir at the 
time of death. Six patients had pro­
longed urinary leakage (2 to 4 weeks) 
through their Penrose drains; this re­
solved spontaneously. Three patients 
with persistent urinary incontinence 
due to failed efferent nipple valves 
required reoperation 4 to 7 months 
after initial surgery; two of them 
needed complete replacement of the 
efferent limb. The third patient had 
the efferent limb repaired without 
additional bowel resection, by reintus­
susception, stapling of the nipple 
valve and replacement of the external 
Vicryl cuff. One patient required a 
skin-level stomal revision for a con­
tracted stoma.
Table I lists the overall results to 
date. The reoperation rate was 25% 
and the minor complication rate 37%. 
These are, we believe, within the ac­
cepted range for major surgical proce­
dures on the urinary tract. Hyper­
chloremic acidosis, moderate in sever­
ity, was encountered in only one pa­
tient. It was readily corrected by oral 
administration of Shohl’s solution. 
Renal function remained adequate in 
all patients, with no significant change 
in serum urea nitrogen or creatinine 
levels. Two patients demonstrated 
unilateral partial ureteroileal obstruc­
tion as a delayed complication 4 to 6 
months postoperatively. Contrast ex­
amination of the Kock pouch revealed 
mild (grade 1) unilateral reflux in two 
patients. There was one case of pyelo­
nephritis.
Catheterization
The capacity of the ileal reservoir 
varied from 400 ml to 1400 ml. We 
encouraged patients to catheterize the 
pouch a minimum of three times 
daily to prevent overdistension. Most 
elected to do so every 4 to 6 hours 
during the day and every 6 to 8 hours 
during the night. Some chose to awak­
en once during the night to catheter­
ize their stomas.
A no. 22 or no. 24 French latex 
catheter was used, and some patients 
found that a coude tip catheter of­
fered greater ease of catheterization. 
A small number of patients experi­
enced difficulty in catheterizing their 
pouches initially, but these problems 
generally resolved with reassurance 
and experience. Some of our obese 
patients had difficulty catheterizing 
the reservoir when they were in the 
upright position. This may be related 
to slight redundancy in the efferent 
limb and was resolved by assuming a 
semirecumbent position. If the pouch 
becomes overfilled, the patient has a 
distinct sense of abdominal fullness 
and mild cramping. We encouraged 
patients to adopt a “catheter by the
clock” routine, emptying the reservoir 
every 4 to 6 hours.
Discussion
Our early experience with this pro­
cedure indicates that it is a viable 
alternative to other methods of uri­
nary diversion. It is superior to the 
ileal conduit in that it represents a 
continent diversionary procedure. 
The reservoir eliminates the need for 
an external collection device with its 
concomitant leaking problem and 
minimizes the psychologic effect of 
altered body image. The nonrefluxing 
nature of the Kock reservoir should, 
theoretically, protect the upper uri­
nary tracts from infection and deteri­
oration of renal function.
The cost to be paid for these bene­
fits includes increased operating time 
and risk of complications, some of 
which are major and necessitate reop­
eration. Skinner and colleagues5 re­
ported that preoperative radiotherapy 
did not alter their complication rate 
when compared with the overall rate. 
Our results confirm that this proce­
dure can safely be done in patients 
who have received 40 Gy of preopera­
tive pelvic irradiation. However, the 
thickened mesentery and reduced 
bowel compliance can increase the 
technical difficulty of the procedure 
and long-term effects of such treat­
ment are unclear.
We do not believe that all cystecto­
my patients are candidates for Kock 
reservoir urinary diversion, and we 
selected for this operation those pa­
tients who wished to avoid external 
collection devices and who seemed 
capable of withstanding the added 
rigour of a prolonged operative proce­
dure. With increasing experience we 
may extend our indications.
We believe the continent internal 
ileal reservoir, as developed by Kock 
and refined by Skinner and col­
leagues, is an important addition to 
the urologist’s armamentarium and 
offers a viable alternative for patients 
requiring urinary diversion.
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T a b le  1 -  R e s u lts  o f  K o c k  R e s e rv o ir  U r in a ry  D iv e rs io n
P a tie n t F o llo w -u p ,
n o. m o C o m p lic a tio n s O u tc o m e
1 2 3 D eep  v e in  th ro m b o s is ,  p o s to p  leak A liv e  NED
2 2 P o s to p  leak D ead  o f  d is e a s e
3 14 P o s to p  leak A liv e  NED
4 14 In c o n tin e n c e R e o p e ra tio n , a live  NED
5 12 - D ead o f  d is e a s e
6 14 D ee p  v e in  th ro m b o s is A liv e  NED
7 11 S to m a l s te n o s is R e o p e ra tio n , a live  NED
8 10 In c o n tin e n c e R e o p e ra tio n , a live  NED
9 10 P o s to p  leak A liv e  NED
10 9 P o s to p  leak A liv e  NED
11 9 P a rtia l in c o n tin e n c e , p o s to p  leak R e o p e ra tio n , a live  NED
12 8 - A liv e  NED
13 18 - A liv e  NED
1 4 7 P e rio p e ra tiv e  s e p s is A liv e  NED
15 7 W o u n d  in fe c tio n A liv e  NED
16 6 D ee p  v e in  th ro m b o s is A liv e  NED
NED = no  e v id e n c e  o f  d ise a se .
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Right Testicular Pain: Unusual Presentation of Obstruction
of the Ureteropelvic Junction
The authors report a case of right 
ureteropelvic junction obstruction in an 
otherwise healthy 31 -year-old man. 
Because of previous surgical manipu­
lation of the right testicle, the diagno­
sis was obscured, delaying therapeutic 
intervention. Renal pain often refers to 
the testicle and groin, and testicular 
pain to the flank. Therefore evaluation 
of organs in the primary referral distri­
bution must be considered in cases of 
obscure intractable pain in this area.
Les auteurs decrivent un cas d e s ­
truction de la jonction pyelo-ureterale 
chez un homme de 31 ans, par ailleurs 
en bonne sante. A cause d'une mani­
pulation chirurgicale anterieure du tes- 
ticule droit, le diagnostic etait masque, 
ce qui retarda ^intervention therapeu- 
tique. La douleur renale irradie souvent 
au testicule et a I'aine, alors que la 
douleur testiculaire est projetee vers le 
flanc. En consequence, une evaluation 
des organes situes dans I'aire d'irra- 
diation primaire doit etre envisagee 
dans tous les cas de douleur irreducti- 
ble ressentie dans cette region.
The referral pattern for pain of renal 
origin includes the flank, anterior ab­
dominal wall, testicle, labia and ante­rior thigh. We present a case of ob­
struction at the right ureteropelvic 
junction in which the patient present­
ed with the sole symptom of right testicular pain. Previous scrotal sur­
gery delayed consideration of other 
sites as the cause of the symptom.
Case Report
A 31-year-old man presented in March
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1985 for bilateral vasectomy. The proce­
dure was complicated by a right-sided 
hematoma and sperm granuloma forma­
tion. The wound opened spontaneously
FIG. 1—Diuretic-supplemented ul­trasonogram obtained before intervention and injection of Lasix. No dilatation of collecting system is apparent.
and a draining fistula developed. Scrotal 
exploration, debridement and closure of 
the fistula were successful. Because of scro­
tal pain shortly after the vasectomy, how-
FIG. 2—Sagittal view, post-void image, 15 minutes after injection of Lasix. There is 50% increase in diameter of renal pelvis.
FIG. 3—Transverse and sagittal images, after pyeloplasty, 15 minutes after injection of Lasix. There is no dilatation of collecting system.
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ever, the patient had to change employ­
ment and became exposed to high temper­
atures, which necessitated substantial in­
crease in his fluid intake. He continued to 
have severe, intermittent right testicular 
and cord pain unresponsive to either sper­
matic cord blocks using local anesthetic or 
multiple courses o f antibiotics. After 18 
months of pain, a second opinion was 
obtained.
Examination at this time revealed a 
normal-appearing right testicle with a min­
imally indurated right vas deferens. Inves­
tigations included intravenous pyleography 
and ultrasonography o f the kidneys and 
testicles; all findings were within normal 
limits. Cystoscopy and right retrograde 
pyelography were then performed. Retro­
grade injection o f the right ureter repro­
duced the right testicular pain. There was 
no associated discomfort in the right flank 
or anterior abdominal wall. Drainage x-ray 
films revealed a partial obstruction of the 
ureteropelvic junction with gross disten­
sion of the right collecting system. Diuret­
ic-supplemented ultrasonography1 was 
later performed; this study precipitated the 
patient’s symptoms and confirmed the 
presence of a right ureteropelvic junction 
obstruction (Figs. 1 and 2).
The patient underwent a right percuta­
neous pyeloplasty with complete resolution 
of his symptom. Diuretic-supplemented ul­
trasonography 3 months after surgery re­
vealed no evidence o f obstruction (Fig. 3) 
and he remained asymptomatic.
Discussion
With both structures having a simi­
lar embryologic site o f origin, the 
nerve supply to the renal pelvis and 
testicle emanates from the T12 to L2 
nerve-root distribution.2 Renal pain 
often refers to the testicle and groin, 
and testicular pain may refer to the 
flank.3 This patient’s history was com­
plicated by previous testicular surgery 
and the absence of pain in the flank 
area. The pain or clinical manifesta­
tion of the obstruction at the right 
ureteropelvic junction appears to 
have been triggered by the increased 
fluid intake that occurred with a 
change in the work environment. His 
scrotal surgery appears to have influ­
enced the thinking of previous inves­
tigators, deterring them from pursuing 
alternative causes for the pain when 
their treatment was unsuccessful. We 
therefore recommend that in the in­
vestigation of obscure testicular pain, 
consideration be given to the primary 
referral patterns.
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The exam inations of the Royal Co llege
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SESAP V Critique
ITEM 225
Although each o f the nonoperative studies listed may occasionally reveal a 
graft-enteric fistula, none of them can be relied on to exclude the diagnosis. 
Whenever such a diagnosis is suspected, surgical exploration with full 
mobilization of the duodenum from the underlying aorta and graft is 
required.
1]
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Snapping Scapula: a Review of the Literature and 
Presentation of 14 Patients
The syndrome of pain at the vertebral 
edge of the scapula and snapping as­
sociated with movement of the shoul­
der that occurs spontaneously after 
trauma or surgical procedures to the 
shoulder girdle is relatively common. 
The snapping is described in the litera­
ture as being due to an exostosis on 
the undersurface of the vertebral angle 
of the scapula, which rides across the 
rib cage. The pain has been reported to 
be the result of inflamed bursae locat­
ed between the scapula and adjacent 
thorax or over the scapular exostosis.
This retrospective study of a small 
group of patients with the syndrome 
attempts to define, by detailed x-ray 
studies, the presence or absence of 
exostosis at the vertebral angle. In 
none of these cases was a bony abnor­
mality or exostosis identified clinically 
or radiologically. The irritating symp­
toms can be relieved by physiotherapy; 
surgery is unnecessary.
Apres un traumatisme ou une opera­
tion de la ceinture scapulaire, il est 
relativement frequent d'observer un 
syndrome douloureux du bord vertebral 
de I'omoplate, accompagne d'un bruit 
sec tors des mouvements de I'epaule. 
Dans la presse medicale, on decrit ce
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bruit sec comme etant du a une exos- 
tose a la surface de Tangle vertebral de 
I'omoplate qui traverse la cage thoraci- 
que. La douleur a ete attribuee a ('in­
flammation des bourses sereuses si- 
tuees entre I'omoplate et le thorax 
adjacent ou au dessus de I'exostose 
scapulaire.
Cette etude retrospective d'un petit 
groupe de patients souffrant de ce 
syndrome vise a etablir grace a des 
etudes radiologiques poussees la 
presence ou I'absence d'exostoses de 
Tangle vertebral. Dans tous les cas, 
aucune anomalie osseuse ou exostose 
n'a ete identifiee cliniquement ou ra- 
diologiquement. Les symptomes d'irri- 
tation sont soulages par la physio- 
therapie; la chirurgie n'est pas neces- 
saire.
The scapulothoracic syndrome (or 
“snapping scapula”), also described 
by Moseley1 as the superior scapular 
syndrome, has not been well covered 
in the literature.
Milch2 4 and Strizak and Cowen5 
credited Boinet6 as being the first to 
describe this syndrome in 1867. Since 
then, several studies have been report­
ed,78 but the etiology is controversial. 
Most authors have attributed the 
snapping to a scapular exostosis, rib 
abnormality or the tubercle of Lusch- 
ka, a bony or fibrocartilagous protru­
sion at the superior angle of the scap­
ula. Codman9 believed the problem 
was related not to bony changes but to 
altered muscle tone, scapular tilting 
and inflammation of several bursae 
located about the scapula. Bateman10 
believed the condition resulted from 
altered muscle tone, causing an abnor­
mal scapulothoracic rhythm; over a 
long period, minute periosteal tears 
along the vertebral border of the scap­
ula may lead to the formation of a 
traction osteophyte or enthesis.
We retrospectively studied 14 pa­
tients with this problem in an attempt 
to identify the true etiology of the 
syndrome and to review the various 
modes of treatment.
Anatomy
Because the scapulothoracic syn­
drome is intimately related to the 
anatomy of the scapula, a review of 
the anatomical features of the region 
is appropriate. The triangular shape 
of the scapula provides a large area 
for the attachment of 10 muscles. The 
bone is curved and contoured to the 
dorsal thoracic wall, permitting it to 
slide easily over the upper eight ribs, 
forming a functional physiologic artic­
ulation. The vertebral (medial) and 
superior borders are relatively thin 
and sharp while the lateral border is 
thick and rounded. There are three 
bony protruberances—the spine of the 
scapula with the acromion, the cora­
coid process and the glenoid neck and 
fossa. These structures provide attach­
ments for an additional six muscles. 
The scapula acts as a stable platform 
for the shoulder joint, providing a 
dynamic lever for functional activities 
of the upper extremity. It also in­
creases positions available to the hand 
in space by permitting variation in 
the location of the proximal humer­
us.11'12
The muscles that seem to play a 
major role in scapular pain insert into 
its medial aspect, notably the levator 
scapulae at the superior vertebral bor­
der and the major and minor rhom­
boid muscles distally. The snapping 
could occur from either the friction of 
a bony prominence or a postural tilt­
ing of the scapula causing it to drag 
across the underlying rib cage. The 
sound is amplified by the thoracic 
cavity, which acts as a resonance 
chamber as in the body of a string 
instrument.10 The sound may be 
transmitted laterally along the spine 
of the scapula to the tip of the acrom­
ion.
A bursa is a potential space lined 
by synovial membrane and is usually 
found in areas of motion with fric­
tion. Several bursae described about 
the scapula are inconsistent or adven­
titious (“accidental or acquired; not 
natural or hereditary. Found out of
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the usual or normal place”13). Cod- 
man9 described three relevant bur­
sae—one at the superior medial bor­
der of the scapula (the subscapular 
bursa), another at the inferior angle of 
the scapula (the infraserratus bursa) 
and an inconsistent third (sub­
trapezoid) bursa located over the me­
dial aspect of the spine of the scapula, 
which he thought was the true source 
of snapping or pain. Recent standard 
textbooks of anatomy13-17 make no 
mention of such bursae, and presum­
ably those described by Codman are 
adventitious.
Patients and Methods
Fourteen patients with snapping 
scapula seen between 1980 and 1985 
were recalled to the Sports Medicine 
Clinic, University of Arizona, for clin­
ical and radiologic reassessment. They 
had presented with pain or a snapping 
(often audible to others), or both, near
Table -  Age and Sex Distribution
Age, yr Male Female Totals
1 0 -  19 0 1 1
2 0 - 2 9 0 3 3
3 0 - 3 9 3 5 8
> 4 0 2 0 2
Totals 5 9 14
Table II - Precipitating Activ ities '
Activ ity No. o f patients
Swimming 4
W eight training 3
Gymnastics 1
Football 1
Softball 1
'Sym ptom s were idiopathic in 4 patients.
Table III -  Clinical Signs
Sign No. of patients
Tenderness at or 
adjacent to  medial 
border o f scapula; no 
palpable or audible 
crepitus 0
As above +  palpable 
crepitus but no audible 
snapping 3
As above +  palpable 
crepitus and slightly 
audible snapping 7
As above +  grossly 
audible snapping 4
Table IV - Site of Tenderness
Site No. o f patients
Levator scapulae 9
Trapezius 5
Rhomboid muscles 4
or at the vertebral border of the scap­
ula, but occasionally the sound was 
transmitted to the lateral aspect of the 
acromion.
Findings
The sex and age distribution of the 
14 patients are shown in Table I. The 
age range of the men was 30 to 59 
years (mean 38.4 years) and of the 
women 16 to 39 years (mean 30 
years).
Duration of symptoms varied from 
1 month to 3 years. In addition to 
physical examination, information 
was sought on the following: onset 
and duration of symptoms, history of 
trauma, aggravating and relieving fac­
tors, past and present activity, history 
of shoulder or neck problems, medica­
tions taken and treatment offered. 
Patients usually presented with pain 
and discomfort at the superomedial 
angle of the scapula, often accompa­
nied by grating or snapping. On exam­
ination they were asked to reproduce 
the snap by actively moving the 
shoulder girdle and to localize the 
pain.
Activities precipitating the symp­
toms are seen in Table II and the 
clinical signs in Table III. Range of 
motion studies of the shoulder, neck 
and back and neurologic examination 
in each case provided additional data. 
Sites of local tenderness were noted 
(Table IV): two patients had pain 
both in levator scapulae and rhom-
FIG. 1—Routine tangential view of scap­
ula. Note excellent clarity of inner aspect of 
scapula obtained by this view.
boid muscles, while two had pain in 
both the trapezius and levator scapu­
lae. All patients had normal chest 
expansion measured by chest wall 
movement at the T4 circumference 
level during deep inspiration.
Scapular winging, measured at the 
most dorsal point of the scapula at 
rest and at resisted forward arm 
flexion (versus the normal side), oc­
curred in 7 of the 14 patients. It was 
slight (less than 5 mm) in three pa­
tients, moderate (5 to 10 mm) in three 
and severe (17 mm) in one patient. In 
three patients, winging was greater in 
the uninvolved scapula.
Twelve of the 14 patients were 
right handed; snapping occurred on 
the dominant side in 12 patients. 
Three had neurologic symptoms, pre­
senting as subjective tingling in the 
involved hand. One of these patients 
had a spinal cord tumour, one had 
been involved in a motor vehicle 
accident and in the third the condi­
tion was nontraumatic in origin. Ten 
had symmetrical musculature and of 
the other 4, 2 had slight atrophy on 
the symptomatic side and 2 had atro­
phy on the uninvolved side.
Radiologic Assessment
Regular anteroposterior, lateral and 
tangential views of the scapula (Fig. 1) 
were obtained for all patients and 
were interpreted by the same radiolo­
gist. The tangential view was taken 
with the patient’s arm adducted 
across the superior aspect of the chest, 
thus rotating the scapula away from 
the chest wall and projecting its ante­
rior surface with clarity. Anteropost­
erior and lateral views alone often 
miss exostoses, rib angles and the 
presence of a tubercle of Luschka. 
None of the patients in this study 
demonstrated any bony abnormalities 
either in the rib cage or the scapula.
Treatment
Ultrasonography (phonoporesis), 
nonsteroid anti-inflammatory drugs 
and transcutaneous nerve stimulation 
helped reduce pain, but posture and 
strengthening exercises seemed to be 
more effective in eliminating the 
snapping. With these exercises, a 
more normal scapulothoracic rhythm 
could be established, reducing the 
shearing forces on the undersurface of 
the scapula. Abduction of the scapula 
increases the tension on the underly­
ing tissues, especially when it glides 
over and around the posterior angle of 
the ribs, where the curve and contact 
areas are more prominent. Improper
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movements, malalignment, direct 
trauma and weakness of specific mus­
cle groups can all lead to degenerative 
soft-tissue changes, pain and snapping 
(Table V).
Surgery was carried out in one case 
(not included in this study due to 
inadequate follow-up), but no exosto­
sis was found. A number of case 
reports3-5 have indicated relief of 
symptoms after excision of the verte­
bral border of the scapula.
The present status of patients is 
shown in Table VI.
Discussion
Abduction and elevation of the 
scapula cause increased pressure on 
the underlying soft tissues and strain 
on the attached muscles and tendons. 
Rapid, energetic, overhead arm move­
ments, such as swimming or throwing, 
may induce microtearing, resulting in 
inflammation (tendinitis) of the mus­
cle insertion at the medial scapular 
border, thus compounding the prob­
lem. Occasionally, the symptoms may 
develop with a loss of muscle tone or 
after surgical procedures in the area, 
causing a disturbance of normal sca- 
pulothoracic rhythm.
Our clinical and radiologic studies
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failed to reveal bony abnormalities; 
hence, we believe that the source of 
pain in this series was the supporting 
musculature, possibly from overuse or 
from poor posture and chronic muscle 
strain. We support the thesis that loss 
of muscle tone and alteration of the 
normal scapulothoracic rhythm may 
lead to increased friction between the 
vertebral border of the scapula and 
rib cage, resulting in the crepitus or 
snapping. 10 Others4-57810 have de­
scribed bony exostoses or the tubercle 
of Luschka as the sources of the snap­
ping.
On examination, it is relatively 
easy to locate the areas of tenderness. 
Occasionally, a firm myofascial con­
tracture may be felt, but it bears no 
relation to the severity of pain. These 
areas, described as “trigger points”, 
are generally attributed to myofascii- 
tis. 110 When injected with hydrocorti­
sone there is good, but usually only 
temporary, relief of pain.
Although we do not have the histo­
logic evidence, we believe that the 
pain of snapping scapula is due to 
microtrauma or tendinitis of the mus­
cles inserting into the scapula (the 
“tennis elbow” of the shoulder). The 
syndrome is sometimes seen in teen­
age girls just after skeletal maturity, 
and we suspect it is postural in origin. 
It may also follow surgical procedures 
to the shoulder girdle, leading to an 
alteration of shoulder biomechanics.
Irritation and thickening of the soft 
tissues about the scapula can also be a 
source of pain and crepitus. Many of 
our patients produced snapping or 
crepitus by circumducting the scapu­
la. The onset of symptoms was related 
to swimming and weight training in
Table V -Treatment
Method
No. of 
patients
Nonsteroid anti-
inflammatory drugs 7
Muscle relaxants 2
Hydrocortisone injection 3
Collar 1
Physical therapy 
(ultrasonography, 
phonophoresis, neck 
and shoulder 
exercises,
transcutaneous nerve 
stimulation and 
biofeedback) 14
Table VI -  Current Status of Patients
Result No. of patients
Residual pain 2
Pain and snapping 2
Snapping 1
No further symptoms 9
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one half of our patients. To relieve 
symptoms, some surgeons3-5-8-10 have 
carried out resection of the vertebral 
border of the scapula, with good re­
sults. The one patient in our series 
who underwent operation demon­
strated no bony abnormalities.
Conclusions
Snapping scapula (scapulothoracic 
syndrome) is a relatively common 
clinical condition. It appears to be 
caused by repetitive shoulder girdle 
stress (overuse) and loss of postural 
muscle tone, resulting in an abnormal 
scapulothoracic rhythm. Trauma or 
surgical procedures to the shoulder 
girdle may also initiate the syndrome.
No one therapy has proven to be 
permanently effective, but nonsteroid 
anti-inflammatory drugs and hydro­
cortisone injections offer some relief. 
Physical therapy plays an important 
role in long-term resolution of the 
problem. Surgery, recommended by 
some authors, appears to be of limited 
value.
We thank Dr. Philip H. Krutzsch, De­
partment of Anatomy, University of Arizo­
na College of Medicine, who reviewed the 
anatomic descriptions in this article.
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Primary Pulmonary Fibrous Histiocytoma: Report of Three
Cases
Since 1969, fibrous histiocytoma has 
been recognized as a distinct entity. It 
occurs in benign and malignant forms. 
The authors describe two cases of the 
malignant pulmonary variety, which is 
considered very rare, and one case of 
benign pulmonary fibrous histi­
ocytoma. All patients were treated 
successfully by local excision; there 
was no recurrence or metastases after 
a postoperative follow-up of 1 month,
8 years and 7 years respectively.
The diagnosis is confirmed histolog­
ically according to criteria set forth by 
the World Health Organization. Treat­
ment is by early complete surgical 
excision. Further study is needed to 
determine the merits of radiotherapy 
and chemotherapy postoperatively.
Depuis 1969, on reconnait I'histiocy- 
tome fibreux comme entite distincte. II 
peut prendre une forme benigne ou 
maligne. Les auteurs decrivent deux 
cas du type pulmonaire malin, une 
forme tres rare, et un cas d'histiocyto- 
me fibreux pulmonaire benin. Tous les 
patients ont ete traites avec succes 
par excision regionale. On n'a observe 
ni recidive ni metastase, respective- 
ment 1 mois, 8 ans et 7 ans a pres 
^intervention chirurgicaie.
Le diagnostic est confirme a I'histo- 
logie selon les criteres etablis par I'Or- 
ganisation mondiale de la sante. Le 
traitement est par excision chirurgica­
ie complete et precoce. Des etudes 
supplementaires seront necessaires 
pour etablir le pour et le contre d'une 
radiotherapie et d'une chimiotherapie 
postoperatoires.
Fibrous histiocytomas are thought to 
arise from histiocytes1 or from primi­
tive mesenchymal cells.2 Both benign
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and malignant varieties are recog­
nized. The tumours comprise cells 
that show partial fibroblastic and his­
tiocytic differentiation as reflected by 
collagen formation and occasional 
phagocytic activity. Often the cells are 
arranged in a storiform or cartwheel 
pattern, admixed with inflammatory, 
foam and giant cells. The variable 
morphologic and cytologic character­
istics have confused the classification 
of these tumours. Until stringent crit­
eria were introduced by the World 
Health Organization in 1969, the tu­
mours were misdiagnosed as pleomor­
phic forms of rhabdomyosarcoma, li- 
posarcoma or fibrosarcoma. Since 
then, fibrous histiocytoma has been 
recognized as a distinct entity. Previ­
ous reports attesting to the rarity of 
this tumour were rectified by Weiss 
and Enzinger3 who, in 1978, reviewed 
200 cases of sarcoma using the new 
criteria and showed that the malig­
nant variant of fibrous histiocytoma 
was the most common sarcoma in 
adults. The most frequent primary 
sites were the extremities (68%), re- 
troperitoneum (16%) and abdominal 
cavity. No primary pulmonary sarco­
mas were noted.
Bronchopulmonary sarcomas are 
still considered very rare. Cameron4 
has estimated that there are 500 car­
cinomas for every sarcoma of the 
lung. Bedrossian and colleagues5 were 
the first to report a primary malignant 
fibrous histiocytoma of the lung. 
Since then, fewer than 25 such cases 
have been reported.6 We describe two 
cases of primary pulmonary malig­
nant fibrous histiocytoma and one of 
its benign variant.
Method
The three cases of primary pulmo­
nary fibrous histiocytoma were found 
from a review of patient and tumour 
registry files at the Halifax Cancer 
Institute for the 10 years from 1977 to 
1987. During the same period, 4271
cases of lung carcinoma were record­
ed at the institute.
Clinical data, radiologic evidence, 
gross and microscopic findings and 
follow-up information were analysed. 
A review of the available morphologic 
material confirmed that the histopa­
thologic diagnosis was made accord­
ing to accepted criteria.
A Medline search was done to sup­
plement and compare our findings 
with those in the literature.
Case Reports
Case 1
In 1980, a 64-year-old man, who had 
smoked a packet of cigarettes daily for 40 
years, underwent routine chest x-ray exam­
ination. A left lung shadow, which had not 
been present 4 months earlier, was visible 
on the film. Further definition by tomogra­
phy localized the 4-cm diameter opacity to 
the mid-mediastinum.
Physical examination and laboratory 
studies, including cytologic examination of 
sputum, gave normal results. Bronchosco­
py revealed an indefinable abnormality in 
the superior segment of the right lower 
lobe bronchus. Preoperative investigation, 
including abdominal ultrasonography, 
upper gastrointestinal series and sig­
moidoscopy, disclosed no possible source 
for this abnormality. Subsequent right tho­
racotomy revealed a greyish white, firm 
nodule (4 X 1.5 X 1 cm in dimension) 
localized to the superior segment of the 
right lower lobe. A right lower lobectomy 
was performed. His postoperative course 
was smooth.
Histologic examination of the mass 
showed a benign fibrous histiocytoma of 
the lung. The mediastinal and hilar nodes 
were free of disease. No further treatment 
was considered necessary and he was fol­
lowed up at regular intervals.
In June 1984, a squamous cell carcino­
ma (T3N1M0) of the right pyriform sinus 
was diagnosed. The patient was treated 
with cisplatinum, 5-fluorouracil and radio­
therapy at the Nova Scotia Cancer Insti­
tute.
In October 1986, the cancer recurred at 
the base of the patient’s tongue. He under­
went a commando procedure in February 
1987 and died shortly thereafter. There 
was no evidence of metastases at autopsy.
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Case 2
In July 1987, a 46-year-old man, a non- 
smoker, complained of fever of 2 weeks’ 
duration, malaise, weight loss of 4.5 kg 
associated with progressive pain and swell­
ing of the hands, feet, ankles and knees. 
Physical examination revealed clubbing of 
the fingers, subungual erythema and bilat­
eral pitting edema in the lower extremities. 
Chest x-ray films and tomograms showed a 
“coin lesion” (5 cm in diameter) in the 
lower lobe of the left lung (Fig. 1). No 
previous chest x-ray films were available 
for comparison. Cytologic examination of 
bronchial washings and sputum gave nega­
tive results and a percutaneous needle 
aspiration specimen was diagnosed as low- 
grade malignant fibrous histiocytoma. 
Computed tomography revealed normal 
liver, spleen, kidneys and nodes with no 
evident metastases. No other tumour was 
discovered.
Segmental excision of the affected left 
lower lobe was performed, removing a 
firm, irregular, purple pedunculated mass 
(10 cm diameter), which arose entirely 
within the parenchyma of the lung and 
extended 4.2 cm beneath the pleural sur­
face. The mass was not adherent to any 
surrounding structures, and the hilar 
lymph nodes were unremarkable. The pa­
tient’s postoperative course was uncompli­
cated. Histologic examination confirmed 
that the mass was a malignant fibrous 
histiocytoma (Fig. 2).
All presenting symptoms disappeared 
within 24 hours of surgery. The patient 
was discharged on postoperative day 6 and 
was well when seen 8 months later. Insuffi­
cient time has elapsed to determine wheth­
er chemotherapy or radiotherapy is indi­
cated.
Case 3
A 21-year-old man, a nonsmoker, com­
plained that for 2 months he had suffered 
from dull chest pain, chills, night sweats, 
anorexia (weight loss of 4.5 kg) and lethar­
gy. Extensive investigations to exclude a 
recurrence of Hodgkin’s disease, diagnosed 
3 years previously (Stage IIA, nodular, 
sclerosing) included a chest x-ray which 
showed a solitary opacity 3 cm in diameter 
in the upper lobe of the right lung. This 
lesion had not been noted 29 months 
earlier when he received 72 Gy of cobalt to 
the chest and abdomen.
Bronchoscopy revealed a polypoid le­
sion in the right upper lobe bronchus. At 
thoracotomy a 3-cm firm solitary plug of 
tumour was seen, extending from the right 
upper lobe bronchus to the right main- 
stem bronchus. A right upper lobectomy 
was performed. Histologic examination re­
vealed malignant fibrous histiocytoma. 
Proximal peribronchial lymph nodes were 
not involved.
The immediate postoperative course 
was smooth. However, 2 weeks after dis­
charge from hospital he experienced symp­
toms similar to those previously noted and 
a week later all 10 fingers became swollen, 
warm, tender and painful to movement. 
The symptoms progressed to involve both
wrists, ankles, right elbow and right knee. 
Extensive investigation showed no active 
disease and within 72 hours of examina­
tion all symptoms disappeared. This phe­
nomenon was diagnosed as virally induced 
inflammatory arthritis.
He remained well for the next 9 months, 
but during the 10th month he complained 
of recurrent chest discomfort. Investiga­
tions included tomography, bronchoscopy 
and gallium scanning of the chest, abdo­
men and pelvis; the findings of all investi­
gations were normal and no recurrence of 
the histiocytoma or Hodgkin’s lymphoma 
was evident. The chest discomfort resolved 
72 hours after its onset. When last seen 8 
years postoperatively, he was well and in 
complete remission.
Discussion
The three primary pulmonary fi­
brous histiocytomas in this report had 
histologic features identical to the 
nonpulmonary variety. Distinction 
between the benign and the malignant
cases was not difficult as the latter 
showed far more pleomorphism, mi­
totic activity and necrosis.
A literature review revealed 27 
cases of benign fibrous histiocytomas 
of the respiratory tract;7 23 cases in­
volved the lung parenchyma, 3 in­
volved the trachea and 1 case was 
endobronchial. The cases were evenly 
distributed between the sexes and 
ages ranged from 5 to 70 years (medi­
an 25.6 years). Presenting symptoms 
included mild cough, chest pain and 
scant hemoptysis. Chest x-ray films 
revealed solitary circumscribed opaci­
ties, varying in size from 1 to 13 cm, 
within the lung parenchyma. No cal­
cifications, cavitations, hilar abnor­
malities or pleural effusions were not­
ed. All patients were managed suc­
cessfully by surgical resection of the 
tumour. These findings correlate with 
data on nonpulmonary benign fibrous 
histiocytomas. Enzinger and Weiss8 
described the typical course of these
Fig. la Fig. lb
FIG. 1—Case 2. (a) Posteroanterior view and (b) lateral view showing “coin lesion” in 
lower lobe of left lung.
FIG. 2—Case 2. Microscopic section of tissue removed from lung shows fibrous 
histiocytoma (hematoxylin and eosin, X 200).
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tumours as a disease of adult onset 
(20 to 40 years old), affecting women 
more often than men and presenting 
asymptomatically in the dermis and 
subcutis and sporadically in the pa­
renchyma of organs. Local excision is 
the treatment of choice and is cura­
tive. No further treatment is neces­
sary and prognosis is excellent.
Malignant fibrous histiocytomas 
may initially appear as innocuous as 
the benign variant morphologically, 
but biologically it is a fully malignant 
sarcoma. Weiss and Enzinger3 showed 
that this is the commonest soft-tissue 
tumour seen in late adult life. Their 
comprehensive study outlines its fea­
tures. It affects primarily adults 50 to 
70 years old, men more than women, 
arises on the extremities (68%), in the 
retroperitoneum (16%) and abdomen 
and usually involves deep fascia or 
skeletal muscle. Unusual signs and 
symptoms have been associated with 
it;8 they include episodic hypoglyce­
mia, rapid enlargement of the tumour 
during pregnancy, fever, neutrophilia, 
pulmonary thromboembolism and in­
farction9 and, as seen in our case 2, 
symptoms suggestive of hypertrophic 
pulmonary osteoarthropathy. (Unfor­
tunately, radiologic evidence was not 
available to diagnose this syndrome.) 
Only one other such presentation has 
been reported—that by Daly and col­
leagues10 who described the syndrome 
of hypertrophic pulmonary osteoar­
thropathy in a 43-year-old man with a 
malignant fibrous histiocytoma in the 
right knee and lung metastases. The 
clinical presentation was exactly the 
same as in our case, but in our patient 
the symptoms resolved completely 
immediately after excision of the tu­
mour. This has never been reported 
before. Similar symptoms, diagnosed 
as “inflammatory arthritis”, were 
noted in our case 3, but the temporal 
sequence relating to presentation of 
symptoms and tumour removal was 
reversed.
Another interesting feature of this 
tumour is its association with multi­
ple tumours. In Weiss and Enzinger’s 
study3 13% of patients had a second 
neoplasm at the time of initial presen­
tation. In case 1, although not a syn­
chronous tumour, a squamous cell 
carcinoma of the pyriform fossa de­
veloped within 4 years of removal of 
the fibrous histiocytoma. The latter 
lesion was benign, and, in view of the 
age of the patient, this association 
may not be relevant.
Malignant fibrous histiocytoma is 
also associated with many hemopoiet­
ic diseases, including Hodgkin’s dis­
ease,11 non-Hodgkin’s lymphoma, 
multiple myeloma, leukemia and ma­
lignant histiocytosis. This association 
may be due to the extensive radio­
therapy that these patients require. 
Enzinger and Weiss8 described two 
such cases of possible radiotherapeuti- 
cally induced tumour. In one patient 
with multiple myeloma a malignant 
fibrous histiocytoma developed 8 
years after radiotherapy. In the other 
patient with Hodgkin’s disease the 
tumour developed 16 years after ra­
diotherapy. Chowdhury and col­
leagues12 also noted the association 
with malignant tumour formation in 
the lung of a patient with malignant 
lymphoma, 7 years after irradiation of 
the chest. Our data from case 3, the 
patient with Hodgkin’s disease, also 
demonstrate an interesting temporal 
association of radiotherapy and devel­
opment of the tumour 3 years later.
The diagnosis of fibrous histi­
ocytoma is strictly histologic based on 
stringent criteria set by the World 
Health Organization. Electron micros­
copy is sometimes needed to confirm 
the histologic diagnosis. The differen­
tial diagnoses include pleomorphic li- 
posarcoma, fibrosarcoma and rhab­
domyosarcoma.
Because of its aggressive nature, the 
treatment of choice in patients with 
fibrous histiocytoma is early and com­
plete surgical removal. The benefit of 
adjuvant radiotherapy and chemo­
therapy remains to be determined. 
Leite and colleagues13 reported a 33% 
response rate to combined radiothera­
py and chemotherapy in 23 patients, a 
rate similar to that seen with other 
sarcomas. Further studies are needed 
to assess which treatment is most 
beneficial.
Follow-up studies8 have shown that 
the 2-year survival rate for patients 
with malignant fibrous histiocytoma 
is 60%, the recurrence rate 44% and 
the rate of metastatic spread 42% 
(82% to lungs). Thus, one-third of 
patients surviving 2 years may be 
expected either to suffer or die from 
recurrent disease.8
Prognosis depends on the initial 
depth and size of the tumour and its 
cellular components.14 Depth is the 
most reliable predictor of metastatic 
potential.14
Fibrous histiocytomas can be found 
at various sites, and as more reports 
are published, re-evaluating data with 
the latest criteria, we then may deter­
mine the true incidence, biologic po­
tential and appropriate therapy for 
this tumour.
We thank Dr. Don Murphy for provid­
ing the photograph of the histologic speci­
men and Carmel Fitzpatrick, Janet Manu­
al and Lois Sheppard for technical assis­
tance.
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VASCULAR SURGICAL EMERGEN­
CIES. Edited by John J. Bergan and 
James S.T. Yao. 549 pp. Illust. Grune & 
Stratton, Inc., Orlando, Fla.; Academic 
Press Canada, Don Mills, Ont., 1986. 
$129.95. ISBN 0-12-790565-0.
This is another volume in an excellent 
series that has emanated from Chicago. It 
covers a wide spectrum of vascular emer­
gencies, both venous and arterial. All chap­
ters are well written by experts in their 
fields, and there is good international rep­
resentation. They have drawn on their 
wide expertise and have written the chap­
ters in a succinct fashion. It is of particular 
interest that there are chapters on basic 
scientific implications of vascular emer­
gencies, which are crucial to the final 
outcome of the treated patient. A chapter 
of great practical value is one on litigation, 
and, although the implications are not 
necessarily valid in Canada, this chapter 
should be read carefully by anyone han­
dling vascular emergencies. Although the 
reasons for a suit against the physician are 
well documented, there is no statement as 
to how many of the suits were successful.
The importance of diagnostic aids— 
arteriography, computed tomography, 
magnetic resonance imaging and noninva- 
continued on page 269
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Aneurysm of a Common Digital Artery: Case Report and
Literature Review
The authors' recent experience of a 
46-year-old woman with an aneurysm 
of a common digital artery led them to 
review the appropriate treatment for 
this rare condition. They found only 
one other reported case. In most re­
ports on aneurysms of hand vessels, 
the aneurysm is of traumatic origin, 
but this was not the case in their 
patient.
For such a rare condition, the au­
thors emphasize the need for acute 
awareness of its possibility, angiogra­
phy to evaluate the collateral circula­
tion and early excision to relieve symp­
toms and avoid neurologic damage.
Confrontes a un cas recent d'anevris- 
me d'une artere digitale palmaire com­
mune chez une femme de 46 ans, les 
auteurs ont ete amenes a passer en 
revue le traitement approprie de cette 
lesion rare. Ms n'ont pu trouver qu'un 
seul autre cas rapporte. Dans la plu- 
part des cas signales d'anevrisme des 
vaisseaux de la main, celui-ci est d'ori- 
gine traumatique. Ce n'etait toutefois 
pas le cas de ieur patiente.
Pour une affection aussi rare, les 
auteurs soulignent la necessite d'etre 
aux aguets d'une telle eventualite, d'u- 
tiliser I'angiographie pour evaluer la 
circulation collaterale et de pratiquer 
I'excision dans les plus brefs delais 
afin de soulager les symptomes et 
d'eviter les dommages neurologiques.
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Aneurysms of the hand, especially 
distal to the superficial and deep pal­
mar arches, are rare. Only nine such 
cases have been reported in the litera­
ture,1-9 with only one involving a 
common digital artery.4 These aneu­
rysms are usually the result of trau­
ma,10 but, although the frequency of 
trauma to the hands is high (not 
surprising considering how much we 
use our hands), the condition is rare. 
We report a case of a nontraumatic 
aneurysm of a common digital artery.
Case Report
A pulsatile lump was discovered in the 
right hand of a 46-year-old woman during 
a visit to a palmist 6 weeks earlier. At that 
time the lump was asymptomatic, but 3 
weeks later the patient noted that it had 
increased in size and was tender. There 
was no history of trauma, her work as a 
parapsychologist did not require the use of 
machinery or repetitive hand action and 
there was no manual involvement in the 
hobbies or sports in which she participat­ed.
A pulsatile nodule 1 cm in dimension 
was found on the volar aspect of the right 
hand at the level of the metacarpal heads 
to the index and middle fingers. Both 
hands were warm and pink. Allen’s test 
gave a negative result and there was no 
audible bruit. Sluggish filling of the radial 
digital artery to the middle finger was 
noted along with hypoesthesia of the same 
area. Examination of the rest of the hand 
was negative.
Arteriography revealed a saccular aneu­
rysm with proximal dilatation of the com­
mon digital artery supplying the middle and index fingers. Collateral circulation 
was present in both fingers. Doppler ul­
trasonography revealed normal wave 
forms throughout the vessel.
Under general anesthesia the aneurysm, 
which was close to the radial digital nerve, 
was excised (Fig. 1). Microscopic study of 
the aneurysm revealed remnants of arterial 
wall in the aneurysmal sac, hence a diagno­
sis of “true” aneurysm (Fig. 2).
Discussion
On reviewing the literature (Table 
I), we noted that the first reported 
case of a digital artery aneurysm was 
in 1973.9 Since then only one case has 
been reported involving a common 
digital artery.4 A history of trauma 
was present in all cases except one.3 
There are two types of arterial aneu­
rysms—true and false, the latter being 
more frequent.46-9 True aneurysms, 
however, do occur in the small arter­
ies of the hand.3-5 This is the first 
report of a true aneurysm of a com­
mon digital artery with no history of 
trauma.
Localized pain1-24' 9 a noticeable 
swelling,36 8-9 numbness1-3 5 and diffi­
culty in gripping objects2-5 are the 
most common symptoms and signs. It 
is interesting that in only half of the 
reported cases was the palpable nod­
ule pulsatile.‘-3-7
Acute awareness will lead to inves­
tigation and diagnosis of this rare 
condition. Hall and W att1 have point­
ed out that these masses are often 
erroneously diagnosed as an abscess. 
Others have misdiagnosed them as a 
neuroma2 or foreign body granuloma.8 
Arteriography is the investigation of 
choice. It will solidify the diagnosis, 
give the precise anatomical location
FIG. 1—True aneurysm of common digi­tal artery to right index and middle finger after dissection of surrounding tissue. Prox­imal blood supply to aneurysmal sac is visible.
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and allow assessment of collateral 
flow, hence determining the need for 
microsurgical repair. Angiography 
was used preoperatively in half of the 
reported cases (Table I). Doppler ul­
trasonography has not been very help­
ful in the diagnosis.
Treatment by excision and mi- 
crovascular end-to-end anastomosis 
has been carried out in only 214 of the 
10 cases. It has been suggested that if 
the gap left from the excised segment 
is too long to permit direct anastomo­
sis, vein grafting be carried out, but to 
date this has not been tried. In our 
case, the presence of adequate collat­
eral circulation allowed simple liga­
tion and excision of the aneurysm.
The presence of permanent hypoes- 
thesia in one case3 resulted in the 
recommendation for early surgery. 
This is supported by Green10 who 
recommended early excision of all 
aneurysms of the hand to relieve 
symptoms and prevent neurologic 
changes.
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FIG. 2—Section of aneurysm with remnants of arterial wall in aneurysmal sac. Lumen 
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Clinical Results With an Uncemented Plastic Tibial 
Component in Unicompartmental Knee Replacement
To determine the role of unicompart­
mental knee replacement in knee ar­
throplasty and, in particular, the de­
sign and function of the ICLH (Finsbury 
Prosthetics Ltd., London, UK) knee 
prosthesis, the authors report their ex­
perience with 18 patients (15 women 
and 3 men, mean age 73 years), who 
underwent unicompartmental knee re­
placement with this prosthesis. The 
prosthesis failed in five (27.8%) cases, 
but in the remainder the results were 
good to excellent over a follow-up ex­
tending to 6 years (mean 4.5 years). 
The main problem with the ICLH pros­
thesis is the linear wear of the plastic 
of the tibial component, caused by a 
sharp radius at the edge of the femoral 
component. This leads to fracture and 
breakdown of the tibial portion. Be­
cause the short-term results are good 
but the long-term results are poor, the 
authors suggest that the ICLH unicom­
partmental knee prosthesis should be 
reserved for use in patients whose life 
expectancy is short.
Dans le but de determiner quel rdle 
peut jouer le remplacement unicom- 
partimental du genou dans I'arthro- 
plastie de cette articulation et, en par- 
ticulier, afin d'evaluer le concept et le 
fonctionnement de la prothese ICLH 
(Finsbury Prosthetics Ltd., Londres,
RU) les auteurs decrivent les resultats 
qu'ils ont obtenus chez 18 patients (1 5 
femmes et 3 hommes, age moyen de 
73 ans) ayant recu cette prothese du
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genou. II y eut cinq echecs (27.8%); 
chez les autres, les resultats vont de 
bons a excellents sur une periode d'ob- 
servation post-therapeutique allant 
jusqu'a 6 ans (moyenne de 4 .5 ans). Le 
principal probleme des protheses ICLH 
est I'usure lineaire du plastique de la 
composante tibiale due a une forte 
courbure en bordure de la composante 
femorale. Ceci entrafne la fracture, 
puis la rupture de la partie tibiale. 
Commes les resultats a court terme 
sont bons, mais que ceux a long terme 
sont mauvais, les auteurs suggerent 
que la prothese unicompartimentale 
ICLH du genou soit reservee aux pa­
tients dont I'esperance de vie est 
courte.
The place of unicompartmental re­
placement in knee arthroplasty is un­
clear. Tibial osteotomy is usually rec­
ommended for unicompartmental dis­
ease in patients under the age of 60 
years;1 however, contraindications, 
such as a fixed flexion deformity 
greater than 10°, do exist. In the 
1950s, Macintosh and McKeever in­
troduced the metal hemiarthroplasty, 
the overall results of which have been 
satisfactory,2 but because the initial 
results were inferior to those with 
cemented unicompartmental knee 
prostheses, the technique never be­
came popular and was supplanted by 
unicompartmental knee replacement.3
The success of this replacement 
procedure over the last 10 years has 
varied from 30% to 90%.4-6 Advan­
tages of the procedure over total knee 
replacement are that recovery tends to 
be faster, the average range of move­
ment is greater and there is less bone 
resection. However, should the uni­
compartmental procedure fail, the 
next step is generally total knee re­
placement and, as long as the amount 
of bone resected to perform a unicom­
partmental procedure is a few mil­
limetres less than that required for a 
total knee replacement, the amount of 
bone resected is irrelevant. When the 
unicompartmental knee is cemented 
in place and loosening occurs on the
tibial side, the amount of bone lost by 
granulation from the broken cement 
bed could make revision to a resurfac­
ing type of total knee replacement 
difficult. Reoperation might be easier 
and more conservative if the bone 
loss could be minimized by using an 
uncemented component that, if it 
loosens, tends to result in less bone 
resorption.
We reviewed our experience with 
an uncemented unicompartmental 
prosthesis—the ICLH prosthesis 
(Finsbury Prosthetics Ltd., London, 
UK)—inserted in 27 cases, to see if 
any conclusions could be drawn about 
the design and function of this pros­
thesis
Patients and Methods
The Prosthesis
The ICLH unicompartmental knee 
prosthesis was developed by Free­
man7 and introduced into Canada in 
1980. It consists of a relatively thick 
(8 mm) femoral component (Figs. 1 
and 2) that is cemented in place. To 
increase the contact area between 
metal and plastic, the articulating sur­
face is almost flat, resulting in a 
relatively sharp curvature at the edge 
of the implant and thus a potential for 
linear wear of the plastic should mala­
lignment occur. The tibial component 
(Fig. 3) is a thin, wedge-shaped block 
of ultra high-molecular-weight poly­
ethylene, measuring 8 mm at the 
thickest point and 4 mm at the thin­
nest. It is held in place by a ridged 
plastic peg which provides initial sta­
bility; the flat cut surface of the inter­
condylar eminence provides rotatory 
stability. The component is oversized 
to allow trimming at the time of 
operation to ensure full coverage of 
the tibial plateau. It is inserted with­
out bone cement.
Patients
The senior author inserted the 
ICLH unicompartmental knee pros­
thesis in 24 patients. Three patients
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were excluded from the review be­
cause bicompartmental units were 
used after they had undergone patel­
lectomy. Two patients died and one 
was lost to follow-up, which left 18 
patients (3 men, 15 women) for re­
view. The mean age of the patients 
was 73 years. Replacement of the 
medial compartment was carried out 
in 17 and of the lateral compartment 
in 1.
Indications
One patient had rheumatoid arthri­
tis, one had a failed unicompartmen­
tal prosthesis and the remainder had 
primary osteoarthritis. The unicom­
partmental knee prosthesis was used 
principally in patients over 65 years
of age. In younger patients a high 
tibial osteotomy was generally pre­
ferred. The final decision, however, 
was made at operation. Some loss of 
sheen of the articular cartilage and 
minor fibrillation over an area a few 
millimeters in diameter was consid­
ered acceptable for the good side. If 
the damage was more severe, a total 
knee replacement was chosen. The 
patellofemoral joint was generally ig­
nored unless pain was produced by 
patellofemoral pressure, when a total 
knee replacement was preferred.
Patient Assessment
The 18 patients were followed up 
clinically and radiologically at 
6-month intervals for 3 to 6 years
FIG. 1—Comparison of ICLH (Finsbury Prosthetics Ltd., London, UK) (left), Mod II 
(Richards Manufacturing Co., Memphis, Tenn.) (centre) and Savastano (Howmedica Inc., 
Rutherford, NJ) (right) femoral components. ICLH has much thicker posterior and distal 
surface than others, which are more commonly used. These components had all been 
revised and some cement is still adherent.
FIG. 2—Axial view of ICLH component 
shows relatively flat bearing surface with 
short, and therefore sharp, radius of curva­
ture at edge.
FIG. 3—Lateral view of ICLH prosthesis 
in place. Tibial component is thin, wedge- 
shaped block of plastic and thus is radiolu- 
cent. Outline of retaining central plastic peg 
can be seen.
(mean 4.5 years). The clinical rating 
system used was the Hospital for Spe­
cial Surgery system.8 This scores 30 
points for pain relief, 50 for function 
and 20 for correction of deformity. 
Radiologic studies included “three- 
foot standing films”, and lateral and 
skyline views. An attempt was made 
to define ant' measure sinkage from 
the alteration of alignment as seen in 
the standing film, but this was found 
to be unreliable as it could be greatly 
influenced by minor degrees of rota­
tion.
Operative Technique
After the knee has been opened and 
inspected, a Cobb elevator is used to 
free the capsule from the proximal 
tibia. With a saw, a flat segment of 
bone is resected from the tibial pla­
teau. The preferred depth of cut 
leaves some eburnated bone on the 
tibial surface at the site of maximal 
bone loss. Care is taken to ensure that 
the cut surface of the intercondylar 
eminence is vertical in the sagittal 
plane.
A tensor is inserted to make certain 
that the tibial cut is at right angles to 
the floor and that ligament release is 
adequate. A spacer block allows the 
femur to be resected in both flexion 
and extension.
A trial femoral component is insert­
ed and a plastic wedge pushed in until 
proper tracking and correction are 
achieved. The peg hole is then drilled, 
the anteroposterior and mediolateral 
dimensions of the tibial plateau are 
measured and the tibial component is 
trimmed accordingly with bone-cut­
ting forceps. By rotating the tibia 
forward the tibial component can be 
driven in without cement. The femo­
ral component is then cemented in 
place.
Patients are allowed full weight­
bearing and knee flexion within 2 
days of operation.
Results
In five (27.8%) patients, the pros­
thesis failed. There was severe linear 
wear of the plastic in three cases, 
leading to fracture of the tibial com­
ponent between 3 and 5 years,9 but 
until the fracture occurred the knees 
were asymptomatic. One tibial com­
ponent sank at 3 years and the single 
lateral unicompartmental knee never 
relieved the patient’s pain. The re­
maining knees (72.2%) all scored good 
or excellent, according to the Hospital 
for Special Surgery rating system. 
Movement in all cases was greater 
than 120° of flexion.
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Although minor sinkage was diffi­
cult to determine, one patient defi­
nitely had sinkage of the tibial compo­
nent, estimated at about 3 mm, but 
was asymptomatic. Measurement of 
alignment on the three-foot films 
showed that the mechanical axis (a 
line drawn between the centre of the 
femoral head and the centre of the 
ankle) in the majority of cases passed 
either through the centre of the knee 
or slightly toward the replaced side 
(Fig. 4). Minor hip rotation considera­
bly altered the position of this line 
with respect to the knee, and judge­
ment was needed in interpreting the 
results. An attempt was also made to 
measure, in full extension, the align-
FIG. 4—Three-foot standing anteropost­
erior film of knee shows preferred position 
of axis of load just crossing central edge of 
replaced side.
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ment of the components with respect 
to each other. All components were 
found to be aligned within 5°, with 
one exception, which was malaligned 
by almost 20°. This knee continues to 
function well although linear wear has 
almost certainly occurred (Fig. 5). 
Malalignment could not be measured 
in flexion from the x-ray films avail­
able.
The failures were all managed by 
total knee replacement, usually with 
an uncemented ingrowth type of tibial 
component and minor bone grafting 
of the tibia.
The majority of knees showed sub­
stantial patellofemoral wear at the 
time the prosthesis was inserted, but 
with the exception of the patient who 
received a lateral prosthesis, the de­
generation was not a source of pain 
postoperatively.
Discussion
The main problem with the ICLH 
unicompartmental knee prosthesis 
was the excessive linear wear of the 
plastic, leading to fracture; this was 
caused by a sharp area at the edge of 
the femoral component. In only one 
of our patients were the components 
malaligned, as measured with the 
knee in full extension. In knees with 
broken tibial components, examina­
tion at the time of revision suggested 
some malalignment, leading to edge 
loading in flexion. Since all the 
healthy knee ligaments were retained, 
the normal roll back tended to occur 
on the replaced side, the contact point 
shifting posteriorly in flexion. With 
the plastic tibial wedge-shaped com­
ponent, malalignment in extension re­
sults in edge loading on a relatively 
thick piece of plastic, whereas mala­
lignment in flexion results in edge 
loading on the very thin aspect. Al­
though a similar depth of wear might 
have occurred, it is obviously more 
critical where the plastic is thin.
FIG. 5—Femoral component is mala­
ligned with respect to tibial component, 
leading to edge loading. At 5 years, some 
wear of plastic is obvious, although patient 
was asymptomatic.
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With a straight, relatively flat femo­
ral component articulating on a flat 
tibial surface, edge loading in either 
flexion or extension inevitably occurs 
during the normal anatomical track­
ing of the femur. This is less likely if a 
curved femoral component articulates 
with a concave tibial component. 
However, unless the two surfaces 
match perfectly, which is undesirable 
because of increased constraint at the 
articular surface, linear contact is 
present. With slight wear of the plas­
tic, the components “lap in” or mate 
better with a consequent increase in 
surface area. Obviously, the plastic 
must be thick enough to allow for 
this.
The greater the contact area, the 
less contact stress there is and, there­
fore, the less linear wear in the plastic. 
In a unicompartmental knee prosthe­
sis, however, the contact area is limit­
ed, because if the femoral component 
is made too broad it will impinge on 
the patella. Linear wear of the plastic 
will, therefore, be higher with a uni­
compartmental knee than a total knee 
prosthesis. Obviously, the plastic 
should be as thick as possible, but if it 
is made too thick, the required bone 
resection may compromise a subse­
quent total knee replacement. The 
metal backing of the tibial component 
may help to prevent fracture of the 
plastic.
Because the failure rate associated 
with the ICLH unicompartmental 
knee prosthesis was so high, it is now 
seldom used. Initial results in terms of 
pain relief and function were excel­
lent. In the long term, however, linear 
wear of the plastic usually causes the 
prosthesis to fail, suggesting that the 
device should be used only in those 
with a limited life expectancy.
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Management of General Surgical Problems After Cardiac
Transplantation
Over a 6-year period at the University 
Hospital in London, Ont., 101 patients 
underwent heart transplantation and 5 
heart-lung transplantation. The au­
thors review the general surgical prob­
lems identified from the charts of 13 of 
these patients.
In the early postoperative period 
(within 30 days), laparotomy was re­
quired for pancreatitis (one), perforat­
ed peptic ulcer (two), cholecystectomy 
(one), pancreatic cyst (one) and appen­
dicitis (one). In addition, a spontane­
ous colocutaneous fistula and sponta­
neous pneumoperitoneum occurred; 
both were managed conservatively.
Later, three patients required chole­
cystectomy; one underwent a below- 
knee and a Symes amputation for dry 
gangrene and one surgical correction 
of a lymphocele.
The incidence of surgical problems 
(13%) indicates an increased suscepti­
bility in this group of patients. Four of 
the 13 patients died.
Pancreatitis is a well-recognized 
complication of cardiac surgery; it is 
frequently associated with a normal or 
only slightly elevated serum amylase 
level, making a definitive diagnosis 
without laparotomy almost impossible. 
Persistence of abdominal signs should 
signal the need for exploratory surgery.
During the early postoperative pe­
riod and in the absence of multiorgan 
failure, immediate operation for an 
acute abdomen is usually successful.
Despite the additional risk, cardiac 
transplantation does not preclude later 
surgery, but immunosuppression must 
be continued and carefully monitored.
Au cours d'une periode de 6 ans, 101 
patients ont subi une transplantation 
cardiaque et 5 une greffe coeur-pou-
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mon au University Hospital de London, 
Ont. Les auteurs passent en revue les 
problemes chirurgicaux generaux qui 
ont ete identifies dans les dossiers 
medicaux de 13 de ces patients.
Durant la periode postoperatoire im­
mediate (30 jours), une laparotomie 
dut etre pratiquee pour pancreatite (un 
cas), ulcere gastro-intestinal perfore 
(deux), cholecystectomie (un), kyste 
pancreatique (un). appendicite (un). II 
y eut en plus, une fistule colo-cutanee 
et un pneumoperitoine spontanes. Les 
deux furent traites de facon conserva- 
trice.
Ulterieurement. trois patients ont 
necessity une cholecystectomie, un 
patient dut subir une amputation sous 
le genou droit et une amputation de 
Symes du cote gauche pour gangrene 
seche, et un troisieme subit une cor­
rection chirurgicale pour un lympho­
cele.
L'incidence des problemes chirurgi­
caux (13%) indique une predisposition 
plus grande chez ce groupe de pa­
tients. Quatre des 13 patients sont 
decedes.
La pancreatite est une complication 
bien connue de la chirurgie cardiaque; 
elle est frequemment associee a une 
amylasemie normale ou tres legere- 
ment augmentee, ce qui rend le dia­
gnostic definitif presque impossible 
sans laparotomie. La persistance de 
signes abdominaux signale la necessi­
te d'une chirurgie exploratrice.
En general, durant la periode posto­
peratoire immediate et en I'absence 
d'insuffisance plurifonctionnelle, une 
intervention chirurgicale immediate 
pour un abdomen aigu donne des 
resultats satisfaisants.
La greffe cardiaque n'ecarte pas la 
possibility d'une chirurgie ulterieure 
malgre le risque accru que cela impli- 
que. Le traitement immunosuppres- 
seur doit toutefois etre poursuivi et 
surveille de pres.
Cardiac transplantation is now an ac­
cepted treatment for terminal cardiac 
failure. In 1985 almost 1000 trans­
plantations were performed world­
wide, with an early (30 days) mortali­
ty of 12% and a 5-year overall surviv­
al of 75%.'
As more cardiac transplantations 
are undertaken, general surgical com­
plications will increase. This report 
describes our experience with various 
surgical problems that arose in cardi­
ac transplant patients.
Patients
Between April 1981 and April 
1987, at University Hospital in Lon­
don, Ont., 101 patients received 105 
orthotopic heart transplants and 5 
underwent heart-lung transplanta­
tion. There were 79 men and 27 
women with a mean age of 36 years. 
A chart review identified 13 patients 
(10 men, 3 women, mean age 43 
years) who had 14 general surgical 
problems after transplantation; 1 of 
these had received a heart-lung trans­
plant (Table I).
After transplantation, patients were 
electively ventilated in the intensive 
care unit, where they generally stayed 
less than 48 hours. Immunosuppres­
sion consisted of antilymphocyte 
globulin (ALG) (15 mg/kg daily) and 
methylprednisolone (1 mg/kg daily), 
both administered intravenously and 
started immediately after operation. 
After extubation, oral cyclosporine 
therapy (5 mg/kg daily) was begun. 
When satisfactory levels of cyclospo­
rine were achieved, ALG was discon­
tinued. Steroid immunosuppression 
was with prednisone (1 mg/kg daily), 
taken orally. It was reduced by 10 mg 
every 3 days to a dose of 30 mg/d and 
thereafter tapered more slowly to a 
maintenance dose of 5 to 10 mg/d. 
Serial monitoring of rejection through 
endomyocardial biopsy was begun on 
postoperative day 7 and repeated 
weekly for 4 weeks, then biweekly for 
another 3 months.
Results
In seven patients, acute abdominal 
complications developed within 30 
days of transplantation. In two pa­
tients (nos. 1 and 2) acute pancreatitis
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developed within 14 days of surgery. 
Patient no. 1 was on a high dosage of 
inotropic drug preoperatively. Two 
days after surgery, abdominal disten­
sion and left lower quadrant tender­
ness developed; colonoscopy revealed 
ischemic proctitis and colitis. On day 
14 there were signs of generalized 
peritonitis, but his body temperature 
and serum amylase level were both 
normal. Abdominal computed tomog­
raphy showed ascites, an indistinct 
pancreatic outline and an adjoining 
tissue mass. The findings at laparoto­
my were pancreatitis with extensive 
surrounding fat necrosis. Appropriate 
drainage was instituted. Three weeks 
later hepatic dysfunction developed. 
Repeat abdominal scanning showed 
diffuse ascites which on needle aspira­
tion was found to be pus. A second 
laparotomy revealed severe pancreati­
tis, with multiple abscesses. He died 2 
weeks later of multiorgan failure. At 
autopsy, additional findings were co­
lorectal ischemia and upper gastroin­
testinal ulceration.
Patient 2, on inotropic support at 
the time of transplantation, was venti­
lated and remained well for 5 days, 
when abdominal distension and ten­
derness developed and his serum 
amylase level became elevated (650 
U/L). Renal dysfunction, which was 
noted preoperatively, became more 
marked and he required hemodialysis. 
Right lower lobe pneumonia then de­
veloped, progressing to empyema and 
lung abscess. He suffered multiorgan 
failure and as a desperate measure, on 
postoperative day 39 we performed a
right thoracotomy, lower and partial 
middle lobectomy and decortication 
of the upper lobe. He died 3 days 
later. Multiple visceral abscesses were 
found at autopsy. Cultures of the lung 
grew Legionella pneumophilia.
Two patients (nos. 3 and 4) suf­
fered perforation of an acute peptic 
ulcer, both on postoperative day 9, 
and underwent operation. In patient 4 
who had a history of a peptic ulcer 
believed to be healed at preoperative 
endoscopic examination, postopera­
tive renal dysfunction developed, re­
quiring early dialysis. His course was 
complicated by multiple episodes of 
sepsis unrelated to his abdominal sur­
gery and most likely immunosuppres­
sive in nature. Five weeks postopera- 
tively, when renal function was re­
turning and all antibiotics had been 
discontinued, he experienced an acute 
hemodynamic collapse and died. 
Death was most likely due to acute 
rejection, the severity of which was 
not appreciated on examination of the 
biopsy taken immediately before that 
time.
Patient 5 had acute acalculous 
cholecystitis and underwent urgent 
cholecystectomy. Patient 6—the 
heart-lung transplant recipient—suf­
fered an acute abdomen on postopera­
tive day 18. He underwent urgent 
laparotomy. The only abnormal find­
ing was a pancreatic cyst (serum amy­
lase level 450 U/L), which was 
drained percutaneously. Recovery was 
delayed by a persistent draining pan­
creatic fistula and difficulties with 
nutrition. He was discharged from
hospital 3 months after transplanta­
tion, but recurrent acute cholecystitis 
with gallstones required elective cho­
lecystectomy 10 months later. The 
last of the group with acute abdomi­
nal complications (patient 8) had 
acute appendicitis 30 days after trans­
plantation. Her postappendectomy 
course was complicated by a pelvic 
abscess which was drained percutane­
ously.
Two other patients had problems, 
which were not acute, within 30 days 
of transplantation. Patient 7 had 
made satisfactory progress for 3 weeks 
after cardiac transplantation when a 
chest x-ray film demonstrated unsus­
pected subdiaphragmatic air. Abdom­
inal examination and an upper gas­
trointestinal series using barium con­
trast were normal, and he was success­
fully managed conservatively. After 
retransplantation for graft failure, pa­
tient 9 had a colocutaneous fistula 
(possibly surgically related) which 
healed spontaneously.
During the later post-transplant pe­
riod (more than 30 days) five patients 
(nos. 1, 10, 11, 12, 13) had surgical 
problems.
Patient 10, discharged from hospi­
tal 35 days postoperatively, was ad­
mitted 2 days later with upper ab­
dominal pain, diarrhea and signs of 
fluid retention. Findings on ul­
trasonography and computed tomog­
raphy of the abdomen were normal. 
Endomyocardial biopsy showed no 
evidence of rejection. A leukocytosis 
then developed, the patient became 
hypotensive and was transferred to
T a b le  1 -  Patient Data
Patient A ge , Tim e
no. y r Sex D iagnosis C om plica tions and outcom e postop
1 3 9 M C oronary arte ry  disease A bdom ina l d is ten s io n , le ft lo w e r quadrant tenderness, hypotension , 14 d
leuko cytos is . Serum am ylase level normal. La paro tom y, pancrea titis  
Stable hem odynam ically. Repeat laparotom y, in fected  pancrea titis . M ultiorgan 42  d
failure. D ied p o s to p  day 50
2 21 M Viral ca rd iom yopathy A bdom inal d is ten s io n , tenderness. Pancreatitis. Serum  am ylase level 6 5 0  U /L. 
Renal fa ilure . Pneumonia and right-sided em pyem a. Lung abscess. Right 
th o ra co to m y, lo w e r lo b e c to m y and decortica tion  on day 39 . Died p o s to p  day 
42
Perforated duodenal ulcer. S im ple closure. S m ooth  re covery
5 d
3 37 M Idiopath ic card iom yopathy 9 d
4 3 2 M Idiopath ic  card iom yopathy Perforated duodenal ulcer. S im ple closure. Died p o s to p  day 4 7  o f  re jection 9 d
5 59 M Idiopath ic ca rd iom yopathy A cu te  ch o le cys titis . C holecystectom y. Specimen sho w e d  acute and chronic 27 d
cho le cys titis , cho lestero los is
6 3 6 M Eisenm enger's syndrom e Pancreatic c y s t. S im ple drainage. Recurrent pancreatitis , p e rs is ten t fistu la 18 d
(congenita l ventricular 
septal defect)
(gallbladder norm al a t laparotom y)
7 5 5 M C oronary a rte ry  disease N ew  appearance o f subdiaphragm atic air on chest x-ray film . U pper 21 d
gastro in testina l series norm al. Recovery uncom plicated
8 5 5 F Id iopath ic  ca rd iom yopathy A cu te  append ic itis . A p p e nde ctom y. Pelvic abscess 3 0  d
9 55 M C oronary a rte ry  disease. None 14 d
Failed g ra ft (14  d) C olocutaneous fistu la  a fte r repeat surgery -  c losed spontaneously
10 4 5 F V alvu lar heart disease A bdom inal pa in , diarrhea, hypotension, cardiac arrest. C ho lecys tec tom y. Died 37  d
11 4 0 M C oronary a rte ry  disease A cu te  ch o le cys titis  and pancreatitis. Treated conserva tive ly 6  mo
12 4 2 F A cu te  viral m yocard itis Bilateral lo w e r lim b gangrene. Le ft Symes, right b e lo w -knee  am puta tions. 35  d
Successfu lly  rehabilitated
13 4 9 M Idiopath ic  ca rd iom yopathy Lym phocele r ig h t groin (fem oral bypass) 6 mo
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the intensive care unit. Planned diag­
nostic laparotomy was delayed be­
cause the patient had a cardiac arrest 
from which she was successfully resus­
citated. When the abdomen was even­
tually explored the only finding was 
edema of the gallbladder, which was 
excised and found to contain a single 
stone. She failed to survive surgery. 
At autopsy a perforated posterior py­
loric ulcer and an antral gastric ulcer 
were found. The donor heart showed 
evidence of acute rejection, subendo­
cardial ischemic necrosis, cardiomeg- 
aly with biventricular hypertrophy 
and left atrial dilatation with mural 
thrombi.
In patient 11, acute cholecystitis 
and pancreatitis resolved without sur­
gery. Patient 12 was admitted to hos­
pital with a clinical diagnosis of viral 
myocarditis and progressive deterio­
ration in cardiac function. At the time 
of transplantation she was on a high 
dosage of inotropic drug and the pe­
ripheral arterial circulation was poor. 
Postoperatively, dry gangrene devel­
oped in the left forefoot and the entire 
right foot. On postoperative day 35, 
under spinal anesthesia, she under­
went a left Symes amputation and a 
right below-knee amputation. There 
was good bleeding from the transected 
left tibial and peroneal arteries but 
the right leg vessels were thrombosed. 
Concern for satisfactory stump heal­
ing delayed her rehabilitation but at 
14 weeks she was able to walk unaid­
ed.
Patient 13 sustained a cardiac ar­
rest during induction of anesthesia, 
and while successful external cardiac 
massage was performed, urgent cardio­
pulmonary bypass was instituted 
using femoral cannulation. A lym- 
phocele developed before he was dis­
charged from hospital. It did not re­
spond to conservative management 
and required open exploration later.
Most patients were discharged 10 
to 20 days postoperatively. The unsta­
ble clinical condition of these patients 
at the time of surgery was reflected by 
the fact that 8 of the 13 had to remain 
in hospital until a donor heart became 
available, 4 suffered cardiac arrest 
during induction of anesthesia and 1 
before diagnostic laparotomy. The 
mean preoperative left ventricular 
ejection fraction was 0.16 (normal 
more than 0.60).
Discussion
Previous reports of cardiac surgery 
have brought attention to the spec­
trum of general surgical complications 
after operations requiring cardiopul­
monary bypass;2 5 the incidence has
varied between 0.6% and 1%. Wall- 
work and Davidson4 have highlighted 
the diagnostic difficulties encountered 
in sedated, ill patients and the high 
death rate associated with manage­
ment of the acute abdomen after car­
diopulmonary bypass.
Cardiac transplant patients are a 
highly selected group at high risk for 
postoperative complications. At the 
time of acceptance for cardiac trans­
plantation, they are in New York 
Heart Association functional class IV 
with a life expectancy of less than 12 
months. Anesthesia imposes a signifi­
cant risk because of their marginal 
cardiovascular stability;6 the danger­
ous period between the moment of its 
induction and the start of cardiopul­
monary bypass is reflected by the fact 
that four patients suffered cardiac ar­
rest during this period. After trans­
plantation the patient’s cardiovascu­
lar status remains suboptimal while 
the newly perfused donor heart con­
tinues to recover from the hypotherm­
ic cardioplegic arrest. Postoperatively, 
natural defence mechanisms are com­
promised not only by surgery, but also 
by the sequelae of chronic organ hy­
poperfusion and the selective reduc­
tion of the leukocyte count by the 
immunosuppressive regimen that in­
cludes ALG and cyclosporine and, 
especially, high doses of steroids.
During the initial period of high- 
dose immunosuppression, antacid 
prophylaxis with ranitidine is routine. 
Cimetidine alters cyclosporine metab­
olism, making it more difficult to 
obtain stable serum cyclosporine lev­
els during the important early postop­
erative period.
In our series, the overall incidence 
(13%) of general surgical problems 
and acute abdominal complications 
requiring laparotomy (6%) early after 
cardiac transplantation indicates an 
increased susceptibility in these pa­
tients. Three deaths were related to 
early postoperative complications and 
a fourth to late complications. The 
first patient recovered fully from clo­
sure of a perforated peptic ulcer but 
died of graft rejection; the second 
died of pancreatitis and the third as a 
result of pulmonary sepsis preceded 
by acute pancreatitis. The cause of 
death in the fourth (no. 10, Table I) is 
unclear, but it is likely that the autop­
sy findings of a perforated peptic 
ulcer in the presence of acute cardiac 
rejection were the principal factors in 
her death. The occurrence of pan­
creatitis after open-heart surgery is 
well known and is associated with a 
high mortality and morbidity;7 it has 
been reported following both cardiac 
and cardiopulmonary transplanta­
tion.8'9 The occurrence of normal or 
marginally elevated serum amylase 
levels was noted in our series and 
those reported by Aziz and associates8 
and Adiseshiah and colleagues.9 In 
such circumstances a firm diagnosis 
of pancreatitis is not possible, so the 
persistence of abdominal signs will 
indicate laparotomy. The cause of this 
complication is unclear but may be 
secondary to the use of corticos­
teroids, azathioprine or cimeti­
dine, 10-11 to viral infection or possibly 
to pancreatic ischemia during by­
pass.12 In patient 1, the preoperative 
use of bretylium, which is known to 
cause a build-up of catecholamines, 
combined with the need for postoper­
ative pressor support may have 
brought about vasoconstriction and 
the development of ischemic bowel 
disease and pancreatitis.
In 1985, Steed and colleagues13 re­
ported general surgical complications 
arising in 40 (28%) of 143 patients 
who underwent cardiac or cardiopul­
monary transplantation; only 2 of 
these required laparotomy in the early 
postoperative period; one had free air 
intraperitoneally and the other had 
cholecystitis. Any intra-abdominal ca­
tastrophe will be progressive in the 
presence of immunosuppression, 
which cannot be discontinued for risk 
of graft rejection. In this series and 
that reported by Steed’s group, steroid 
therapy did not apparently mask the 
signs of peritoneal irritation. Al­
though these patients present high 
anesthetic and surgical risks, each 
case should be dealt with on its mer­
its, and operative intervention should 
not be rejected because the patient 
has undergone cardiac transplanta­
tion. On the contrary, the need for 
continued immunosuppression should 
indicate early surgery.5 It is clear that 
when complications occur early post­
operatively associated with multisys­
tem failure the death rate is much 
higher.45 In our series complications 
occurring in the presence of addition­
al organ failure were the only source 
of death in the early postoperative 
period.
In patient 9 the colocutaneous fis­
tula that developed after repeat trans­
plantation was probably related to a 
previous laparotomy and adhesion of 
the transverse colon to the abdominal 
wall. Also, the association of a low 
postoperative cardiac output with re­
peated traction on the epigastric por­
tion of the median sternotomy inci­
sion may critically compromise the 
colonic blood supply and cause bowel 
necrosis with fistula formation. Spon­
taneous pneumoperitoneum has been 
reported13 and is presumed secondary
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ANTIBIOTIC
ACTION
In vitro studies demonstrate that the bacteri­
cidal action of cefoxitin, a cephamycin derived 
from cephamycin C, results from the inhibition 
of bacterial cell wall synthesis. Evidence 
suggests that the methoxy group in the 
7a position is responsible for the resistance of 
cefoxitin to degradation by bacterial beta- 
lactamases.
INDICATIONS AND CLINICAL USES 
TREATMENT
The treatment of the following infections when 
due to susceptible organisms:
1 - In tra-abdom ina l in fections such as
peritonitis and intra-abdominal abscess
2 - G yneco log ica l in fe c tio n s  such as
endometritis and pelvic cellulitis
3 - Septicemia
4 - Urinary tract infections (including those
caused by Serratia marcescens and 
Serratla spp.)
5 - Lower respiratory tract infections
6 - Bone and joint infections caused by
Staphylococcus aureus
7 - Soft tissue infections such as cellulitis,
abscesses and wound infections
Appropriate culture and susceptibility studies 
should be performed to determine the sus­
ceptibility of the causative organism(s) to 
MEFOXIN*. Therapy may be started while 
awaiting the results of these tests, however, 
modification of the treatment may be required 
once these results become available.
O rganism s p a rticu la rly  appropria te  fo r 
therapy with MEFOXIN' are:
Gram positive
Staphylococci, penicillinase producing and 
non-producing
Streptococci excluding enterococci 
Gram negative (beta-lactamase producing 
and non-producing strains)
E. coli
Klebsiella species (including K. pneumoniae) 
Proteus, indole positive and negative 
Haemophilus influenzae 
Providencia species 
Anaerobes 
Bacteroides fragilis
MEFOXIN* may also be appropriate for the 
treatment of infections involving susceptible 
strains of both aerobic and anaerobic bacteria.
MEFOXIN* is not active against Pseudomonas, 
most strains of enterococci, many strains of 
Enterobacter cloacae, and m eth icillin- 
re s is ta n t s ta p h y lo co cc i and L is te ria  
monocytogenes.
Clinical experience has demonstrated that 
MEFOXIN* can be administered to patients 
who are a lso  rece iv ing  c a rb e n ic ill in , 
gentamicin, tobramycin, or amikacin (see 
PRECAUTIONS and ADMINISTRATION). 
Intravenous Administration 
The intravenous route is preferable for 
patients with bacteremia, bacterial septicemia, 
or other severe or life-threatening infections, 
or for patients who may be poor risks because 
of lowered resistance resulting from such 
deb ilita tin g  cond itions as m alnu trition , 
trauma, surgery, diabetes, heart failure, or 
malignancy, particularly if shock is present or 
impending.
PROPHYLACTIC USE
MEFOXIN* may be administered periopera- 
tively (preoperatively, intraoperatively and 
postoperative ly) to patients undergoing 
vaginal or abdominal hysterectomy and ab­
dominal surgery when there is a significant 
risk of postoperative infection or where the 
occurrence of postoperative in fection is 
considered to be especially serious.
In patients undergoing cesarean section, intra­
operative (after clamping the umbilical cord)
and postoperative use of MEFOXIN* may 
reduce the incidence of surgery related post­
operative infections.
Effective prophylactic use depends on the 
time of administration. MEFOXIN* usually 
should be given one-half to one hour before 
the operation. Prophylactic administration 
should usually be stopped within 12 hours. It 
has been generally reported that continuing 
adm inistration of any an tib io tic  beyond 
24 hours fo llow ing surgery increases the 
possibility of adverse reactions but, in the 
majority of surgical procedures, does not 
reduce the incidence of subsequent infection. 
If signs of postsurgical infection should 
appear, specimens for culture should be 
obtained for identification of the causative 
organism(s) so that appropriate therapy may 
be instituted.
CONTRAINDICATIONS
MEFOXIN* is contraindicated in persons who 
have shown hypersensitivity to cefoxitin or to 
the cephalosporin group of antibiotics.
WARNINGS
Before therapy with MEFOXIN* is instituted, 
careful inquiry should be made to determine 
whether the patient has had previous hyper­
sensitivity reactions to MEFOXIN*, cephalo­
sporins, penicillins or other drugs. MEFOXIN* 
should be given with caution to penicillin- 
sensitive patients.
There is some clinical and laboratory evidence 
of partia l c ro ss -a lle rg e n ic ity  between 
cephamycins and the other beta-lactam anti­
b io tics, pen ic illins and cephalosporins. 
Severe reactions (including anaphylaxis) have 
been reported w ith most beta-lactam  
antibiotics.
Pseudomembranous colitis has been reported 
with virtually all antibiotics. This colitis can 
range from mild to life threatening in severity. 
Antibiotics should therefore be prescribed 
with caution in individuals with a history of 
gastrointestinal disease, particularly colitis. It 
is important to consider a diagnosis of pseudo­
membranous colitis in patients who develop 
diarrhea in association with antibiotic use. 
While studies indicate that a toxin produced 
by Clostridium difficile is one primary cause of 
antibiotic-associated colitis, other causes 
should also be considered.
Any patient who has demonstrated some form 
of allergy, particularly to drugs, should receive 
antibiotics including MEFOXIN* with caution.
If an allergic reaction to MEFOXIN* occurs, 
administration of the drug should be discon­
tinued. Serious hypersensitivity reactions may 
require treatment with epinephrine and other 
emergency measures.
PRECAUTIONS
The total daily dosage should be reduced 
when MEFOXIN* is administered to patients 
with transient or persistent reduction of 
urinary output due to renal insufficiency (see 
DOSAGE AND ADMINISTRATION) because 
high and prolonged serum antibiotic con­
centrations can occur from usual doses.
In patients treated with MEFOXIN* a false­
positive reaction to glucose in the urine may 
occur with Benedict's or Fehling’s solutions 
but not with the use of specific glucose 
oxidase methods.
Using the Jaffe Method, falsely high creatinine 
values in serum may occur if serum concen­
trations of cefoxitin exceed 100/zg/mL. Serum 
samples from patients treated with MEFOXIN* 
should not be analyzed for creatinine if with­
drawn within two hours of drug administration.
Increased nephrotoxicity has been reported 
fo llow ing concom itant administration of 
cephalosporins and aminoglycoside antibiotics.
The safety of MEFOXIN* in the treatment of 
infections during pregnancy has not been 
estab lished  If the a d m in is tra tio n  of
MEFOXIN* to pregnant patients is considered 
necessary, its use requires that the anticipated 
benefits be weighed against possible hazards 
to the fetus. Reproductive and teratogenic 
studies have been performed in mice and rats 
and have revealed no evidence of impaired 
fertility or harm to the fetus due to MEFOXIN*.
Cefoxitin has been observed in the milk of 
nursing mothers receiving the drug. 
Prolonged use of MEFOXIN* may result in the 
overgrowth of non-susceptible organisms. 
Repeated evaluation of the patient’s condition 
is essential and if superinfection occurs 
during therapy, appropriate measures should 
be taken. Should an organism become 
resistant during antibiotic therapy, another 
antibiotic should be substituted.
In children 3 months of age or older, higher 
doses of MEFOXIN* (100 mg/kg/day and 
above) have been associated w ith an 
increased incidence of eosinophilia and 
elevated SGOT.
ADVERSE REACTIONS
MEFOXIN* is generally well tolerated. Adverse 
reactions rare ly required cessation of 
treatment and usually have been mild and 
transient.
Local Reactions
Thrombophlebitis has occurred with intra­
venous administration. Some degree of pain 
and tenderness is usually experienced after 
in tram uscu la r in je c tio n s  using water. 
Induration has occasionally been reported. 
Allergic
Maculopapular rash, urticaria , pruritus, 
eosinophilia, fever and other allergic reactions 
have been noted.
Gastrointestinal
Symptoms of pseudomembranous colitis can 
appear during or after antibiotic treatment. 
Nausea and vomiting have been reported 
rarely.
Blood
Transient eosinophilia, leukopenia, neutropenia, 
hemolytic anemia, and thrombocytopenia 
have been reported. Some individuals, particu­
larly those with azotemia, may develop 
positive direct Coombs tests during therapy 
with MEFOXIN*.
Liver Function
Transient elevations in SGOT, SGPT, serum 
LDH, and serum alkaline phosphatase have 
been reported.
Kidney
Elevations in serum creatinine and/or blood 
urea nitrogen levels have been observed. As 
with the cephalosporins, acute renal failure 
has been reported rarely. The role of 
MEFOXIN* in changes in renal function tests 
is d ifficu lt to assess, since factors pre­
disposing to prerenal azotemia or to impaired 
renal function have often been present.
TREATMENT OF OVERDOSE
Other than general supportive treatment, no 
specific antidote is known. MEFOXIN* can be 
eliminated by dialysis in patients with renal 
insufficiency.
DOSAGE AND ADMINISTRATION
MEFOXIN* may be administered intravenously 
or intram uscularly when required. (See 
complete monograph on ADMINISTRATION 
and RECONSTITUTION.)
TREATMENT DOSAGE 
Adults
The usual adult dosage is 1 g or 2 g of 
MEFOXIN* every 6 to 8 hours. Dosage and 
route of administration should be determined 
by severity of infection, susceptibility of the 
causative organisms, and condition of the 
patient. The usual adult dosages are shown in 
the Table below.
Usual Adult Dosage
Type of Dally Frequency
infection Dosage and Route
Uncomplicated 3-4 g 1g every 6-8 h
forms* of in- I.V. or I.M.
fections such as
pneumonia,
urinary tract
infection, soft
tissue infection
Moderately 6-8 g 1 g every 4 h
severe or severe or
infections 2gevery6-8hl.V.
Infections 12 g 2 g every 4 h
commonly or
needing anti- 3 g every 6 h I.V.
biotics in higher 
dosage (e.g. gas 
gangrene)
'Including patients in whom bacteremia is 
absent or unlikely
Therapy may be started while awaiting the 
results of susceptibility testing.
Antibiotic therapy for group A beta-hemolytic 
streptococcal infections should be maintained 
for at least 10 days to guard against the risk of 
rheumatic fever or glomerulonephritis. In 
staphylococcal and other infections involving 
a collection of pus, surgical drainage should 
be carried out where indicated.
Adults with Impaired Renal Function
MEFOXIN* may be used in patients with 
reduced renal function but a reduced dosage 
should be employed and it is advisable to 
monitor serum levels in patients with severe 
impairment.
In adults with renal insufficiency, an initial 
loading dose of 1 g to 2 g should be given. 
After a loading dose, the following recommen­
dations for maintenance dosage may be used 
as a guide:
RENAL
FUNCTION
CREATININE
CLEARANCE DOSE FREQUENCY
Mild
impairment
mL/min
50-30 1-2 g every 8-12 h
Moderate
impairment 29-10 1-2 g every 12-24 h
Severe
impairment 9-5 0.6-1 g every 12-24 h
Essentially 
no function <5 0.5-1 g every 24-48 h
In the patient undergoing hemodialysis, the 
loading dose of 1 - 2g should be given after 
each hemodialysis, and the maintenance dose 
should be given as indicated in the Table 
above.
Neonates (Including Premature Infants), 
Infants and Children (See WARNINGS for 
Neonates under ADMINISTRATION in the 
complete monograph.)
Premature Infants 
with Body Weights 
Above 1500 g 20-40 mg/kg every 12 h I.V.
Neonates
0- 1 week of age
1- 4 weeks of age
20-40 mg/kg every 12 h I.V. 
20-40 mg/kg every 8 h I.V.
Infants
1 month to 2 years 
of age
20-40 mg/kg every 6 h or 
every 8 h I.M. or I.V.
Children 20-40 mg/kg every 6 h or 
every 8 h I.M. or I.V.
In severe infections, the total daily dosage in 
infants and children may be increased to 
200 mg/kg, but not to exceed 12 g per day.
MEFOXIN* is not recommended for the
therapy of meningitis. If meningitis is sus­
pected, an appropriate antibiotic should be 
used.
At present there is insu ffic ien t data to 
recommend a specific dosage for children 
with impaired renal function. However, if the 
administration of MEFOXIN* is deemed to be 
essential the dosage should be modified 
consistent with the recommendations for 
adults (see Table above).
PROPHYLACTIC USE
For prophylactic use, a three-dose regimen of 
MEFOXIN* is recommended as follows:
Vaginal or abdominal hysterectomy and 
abdominal surgery
2g administered intramuscularly or intra­
venously just prior to surgery (approximately 
one-half to one hour before initial incision).
The second and third 2g doses should be 
administered at 2-6 hour intervals after the 
initial dose.
Cesarean Section
The first dose of 2g should be administered 
intravenously as soon as the umbilical cord 
has been clamped. The second and third 
2g doses should be given intravenously or 
intramuscularly four hours and eight hours 
after the first dose.
AVAILABILITY
MEFOXIN* is supplied as sterile powder in 
boxes of 10 vials:
3356 Ca - 1 g cefoxitin as sodium salt
3357 Ca - 2 g cefoxitin as sodium salt 
Storage
MEFOXIN* in the dry state should be stored 
below 30° C.
PRODUCT MONOGRAPH AVAILABLE 
ON REQUEST
to a pneumothorax with air tracking 
into the abdomen. In the absence of 
abdominal signs, conservative man­
agement is appropriate.
The incidence of general surgical 
problems in patients who have under­
gone cardiac transplantation is high. 
Early operative intervention for acute 
abdomen is followed by a satisfactory 
outcome, especially for isolated com­
plications in the absence of multior­
gan failure. For surgical problems oc­
curring late, operation is not preclud­
ed by previous cardiac transplanta­
tion. Immunosuppression does pose 
an additional risk to the patient peri- 
operatively, and it is critical that it is 
maintained and carefully monitored, 
especially after laparotomy when drug 
absorption is variable.
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Eosinophilic Granuloma of Bone
This is a review of 48 patients regis­
tered in the University of British Co­
lumbia Bone Tumour Registry as hav­
ing eosinophilic granuloma, with em­
phasis on the historical development, 
treatment and results. Comments on 
the place of scintigraphic imaging are 
included. Eosinophilic granuloma in its 
solitary form is a self-limiting disease 
requiring no treatment. It can, howev­
er, progress to multifocal disease or 
the historically important triad known 
as Hand-Schiiller-Christian syndrome. 
There is some evidence that it may 
have an immunologic basis, but the 
authors have little new to offer with 
respect to its etiology.
Cet article passe en revue 48 cas de 
granulome eosinophile qui etaient ins- 
crits sur la liste des porteurs de tu- 
meurs osseuses de I'Universite de Co- 
lombie britannique. Une attention 
toute particuliere est accordee a I'his- 
toire de cette maladie, a son traite- 
ment et aux resultats de celui-ci. On 
commente la valeur de la scintigraphie 
dans le diagnostic de la maladie. Le 
granulome eosinophile solitaire est une 
maladie spontanement resolutive qui 
ne necessite pas de traitement. II peut 
toutefois evoluer vers une forme multi- 
focale ou vers la triade d'interet histo- 
rique connue sous le nom de syndrome 
de Hand-Schiiller-Christian. II existe 
des arguments a I'effet que cette ma­
ladie pourrait avoir une origine immu- 
nologique mais les auteurs ne peuvent 
ajouter davantage en ce qui concerne 
son etiologie.
From the Department of Orthopaedics, 
University of British Columbia and the 
University of British Columbia Bone Tu­
mour Registry, Vancouver, BC
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The terms eosinophilic granuloma 
and histiocytosis X are familiar to 
many physicians and surgeons, but 
their etiology, pathogenesis, treatment 
and prognosis are not. Eosinophilic 
granuloma is widely accepted as a 
disease of histiocytes—cells originat­
ing in bone marrow but widely dis­
tributed as circulating monocytes, 
Langerhans cells, Kupffer cells, osteo­
clasts and macrophages, and in the 
organs of the reticuloendothelial sys­
tem such as lymph nodes and spleen. 
Hence, any disease of these cells is 
bound to have diverse manifestations.
We review our experience in the 
University of British Columbia Bone 
Tumour Registry with eosinophilic 
granuloma in an attempt to reach 
some useful conclusions with respect 
to treatment and prognosis. To ensure 
that readers understand the place held 
by eosinophilic granuloma in the 
spectrum of histiocytosis, a brief his­
torical review is warranted. We also 
present one case of histiocytic malig­
nancy, and, having seen two patients 
with eosinophilic granuloma that de­
veloped shortly after chemotherapy 
for malignant disease and an unusual 
incidence of apparently unrelated ma­
lignancy, we believe some discussion 
of a possible immunologic basis for 
these diseases is warranted.
History
Wallgren1 in 1940 and Green and 
Farber2 in 1942 had commented on 
the similarities between eosinophilic 
granuloma, Hand-Schiiller-Christian 
syndrome and Letterer-Siwe disease, 
as different manifestations of the 
same disease, but Lichtenstein,3 in 
1953, was the first to champion this 
association. According to Mickelson 
and Bonfiglio,4 Hand first reported 
his syndrome in 1893 and years later 
recognized the same organ system in­
volvement in cases reported by Schu­
ller (1915) and Christian (1920). The 
same authors noted the second dis­
tinct entity, as described by Letterer 
in 1924 and Siwe in 1933.
Eosinophilic granuloma is the 
youthful member of the group, having 
been described simultaneously by 
Hatcher,5 Otani and Ehrlich6 and 
Lichtenstein and Jaffe7 in 1940.
A viral etiology is most likely, but 
has never been proven. No metabolic, 
lipid storage or genetic disorder has 
been identified. In recent years an 
immunologic basis for histiocytosis X 
has been suggested.8'9
General Aspects of Eosinophilic 
Granuloma1011
The World Health Organization has 
defined eosinophilic granuloma as a 
non-neoplastic lesion of unknown eti­
ology characterized by an intensive 
proliferation of reticulohistiocytic ele­
ments with varying numbers of eosin­
ophilic leukocytes, neutrophilic leuko­
cytes, lymphocytes, plasma cells and 
multinucleate giant cells.10
The age incidence for single lesions 
peaks between 5 and 10 years and, 
although the range may be from 1 to 
53 years, the majority of lesions occur 
in patients under 20 years of age. The 
disease is dominant in males in a 
ratio of almost 2:1 and it has a wide 
anatomic distribution. In patients 
over the age of 20 years, lesions are 
more common in ribs, mandible, clav­
icle and scapula and under 20 years in 
the skull, vertebrae and ilium.
Clinical signs and symptoms are 
rarely severe. Pain and tenderness are 
common, occasionally with swelling, 
but pathologic fracture is uncommon. 
The erythrocyte sedimentation rate 
may be elevated.
The radiologic appearance varies, 
depending on the bone involved. The 
lesion is lytic, rounded and usually 
well limited by a slightly sclerotic, 
often scalloped outline. It affects the 
medulla and diaphysis in long bones. 
The cortex can be eroded and the 
resulting periosteal reaction may 
mimic osteomyelitis and Ewing’s sar­
coma.12 Vertebral lesions may be reco­
gnized by the classic vertebra plana 
(Calve) or “silver dollar” sign.
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Reports on scintigraphic imag­
ing13’14 of eosinophilic granuloma in­
dicate a variable response, with per­
haps 50% of radiologically identified 
lesions demonstrating increased up­
take of technetium, a lesser number 
producing negative scans and a few 
appearing as “cold” lesions.
The gross findings are usually of a 
soft, sometimes granular or gelatinous 
material, greyish red-brown to yellow, 
scantily filling the lytic defect, which 
is limited abruptly by bone, although 
not in the sclerotic fashion of, for 
example, unicameral bone cyst. Histo­
logically, the pale histiocytes are usu­
ally overshadowed by the numerous, 
darker staining small round cells. 
Characteristic giant cells (Touton 
cells) may be seen and the appearance 
of eosinophilic leukocytes may quick­
ly suggest the diagnosis.
In established textbooks,10’15'16 the 
suggested treatment ranges from cu­
rettage through radiation to chemo­
therapy, depending on the clinical 
manifestations.
Patients
The records of the University of 
British Columbia Bone Tumour Reg­
istry from 1958 to 1986 included 48 
patients whom we believed appropri­
ate to this review. Of these, 41 pre­
sented with classic solitary eosinophil-
Table 1 - D istribution o f 4 8  Patients by A ge
A ge, yr No. o f  patients
0 - 5 13
5 - 1 0 10
1 0 - 2 0 11
2 0 - 3 0 7
3 0 - 4 0 4
4 0 - 5 0 3
> 50 0
FIG. 1—“Punched out” lytic lesion in 
neck of left scapula of 17-year-old boy.
ic granulomas of bone, but two pro­
gressed to multifocal disease. We ini­
tially interpreted the remaining seven 
as eosinophilic granuloma, but they 
were soon recognized to be multifocal 
in bone, six with soft-tissue lesions 
(two of these merging into the Hand- 
Schuller-Christian syndrome with di­
abetes insipidus) and one as frankly 
malignant.
There were 34 males and 14 fe­
males, a ratio of 2.5:1, which is close 
to the generally accepted figure. The 
age range of 2.5 months to 47 years 
(average 15 years) (Table I) is also 
similar to that quoted in textbooks. 
Fifty percent of cases occurred in 
patients under 10 years of age; 75% 
under 20 years.
The site is probably of little impor­
tance because of the wide distribution 
and multiplicity of lesions. We found 
that vertebral lesions were more com­
mon in children and rib lesions more 
common in adults. It is interesting 
that we recorded only three lesions 
distal to the elbow and two distal to 
the knee.
There was no clearly characteristic 
pattern of symptoms and signs. Sur­
prisingly, pathologic fracture was rare 
and caused no problems, although 
two vertebral lesions were treated sur­
gically, one by laminectomy and fu­
sion in the presence of a normal 
neurologic examination and the other 
by hemilaminectomy and removal of 
an extradural mass in the presence of 
seventh cervical nerve-root signs. 
Most notable in the clinical presenta­
tion was a confusing and misleading
FIG. 2—Classic “silver dollar” appear­
ance of eosinophilic granuloma of T12 ver­
tebra in 11-year-old boy.
picture, undoubtedly related to the 
early childhood incidence. This can 
best be appreciated by reference to 
two patients: one with a vertebral 
lesion at T12 who underwent appen­
dectomy (the appendix was normal) 
before the bony lesion was identified, 
and another investigated for upper 
respiratory, central nervous and uri­
nary tract origins of her problem be­
fore a clavicular and two vertebral 
eosinophilic granulomas were identi­
fied.
Laboratory investigations proved of 
little value, although in 24 of 36 
patients who had erythrocyte sedi­
mentation rate determinations the 
level was elevated (5 borderline).
Radiologic appearances in our se­
ries reiterate the features documented 
elsewhere. Flat bone lesions were fre­
quently “punched out” (Fig. 1) and 
some vertebral lesions progressed to 
the “silver dollar” appearance of ver­
tebra plana (Fig. 2). One humeral 
lesion (Fig. 3) destroyed cortex and 
produced periosteal reaction, to the 
extent that the differential diagnosis 
before biopsy was osteomyelitis or 
Ewing’s sarcoma.
In our tumour registry, standard 
histopathological criteria were used, 
so the gross and microscopic findings 
were not re-examined in these pa­
tients.
There were some interesting find­
ings on the technetium bone scans 
obtained in 20 patients. Solitary le­
sions were seen on x-ray films in 14, 
10 of whom showed increased uptake 
of the radionuclide; of the others, 3 
showed no uptake and 1 showed lim­
ited uptake. In the six patients with 
multiple lesions, evident radiological­
ly, the information gained was simi­
lar.
Twenty lesions were “hot” and 6 
either negative or “cold” . In these 
patients the importance of a “hot” 
scan in the absence of a correspond­
ing radiologic change was not deter­
mined, although a biopsy in one such 
case showed only normal bone.
Treatment (Table II) undoubtedly 
reflects the year of presentation and 
the anatomical site. Radiotherapy was 
used in 11 patients, mostly early in 
the series or in surgically less accessi­
ble lesions. Chemotherapy (predni­
sone or vinblastine), a more recent 
addition, was used for multifocal dis­
ease, and the patient with malignant 
histiocytosis was treated with vincris­
tine, cyclophosphamide and predni­
sone. Uncertainty is also apparent in 
that 10 patients were “treated” by 
biopsy alone, although the majority 
(22) were treated by intralesional cu­
rettage.
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In such a random group presenting 
to various physicians over a period of 
28 years, involving different anatomi­
cal sites and with inconsistent treat­
ment plans, no statistically significant 
conclusions can be reached. However, 
in 35 patients who had a follow-up 
longer than 2 years, a clinically valid 
impression is possible (10 patients 
were lost to follow-up or the follow-up 
was less than 1 year and 3 were 
followed up for 1 to 2 years). Six of 
the 35 had multiple lesions; 4 of them 
were irradiated (1 with additional 
chemotherapy), 1 died of malignant 
histiocytosis at 4 years and of the 
other 3, 1 was alive and well at 20 
years, and 2 were alive with disability 
at 6 and 7 years respectively. Of the 
remaining two patients, untreated, 
one was alive and well at 20 years, the 
other alive with recurrent disease and 
disability at 8 years. Disability con­
sisted chiefly of pain from new le­
sions, but occasionally involved respi­
ratory problems and visceral involve­
ment.
Twenty-nine of the 35 patients had 
solitary lesions and were followed up 
for over 2 years (11 over 20 years). 
Treatment in this group included cu­
rettage (14), excision (3), irradiation 
(4), irradiation plus curettage or exci­
sion (3) and needle or open biopsy 
alone (5). All remain alive, well and 
free of disease.
Discussion
Although controversy continues as 
to whether eosinophilic granuloma,
Hand-Schuller-Christian syndrome 
and Letterer-Siwe disease are mani­
festations of the same process, 
mostn'17>18 seem to accept it as a 
useful concept. We have found that 
we can readily separate those patients 
having Letterer-Siwe disease. We had 
difficulty distinguishing patients who 
presented as having eosinophilic gran­
uloma but who subsequently had mul­
tiple lesions with progression to dia­
betes insipidus and possible visceral 
lesions, although not necessarily the 
exophthalmos of the full-blown 
Hand-Schuller-Christian syndrome. 
In this regard we agree with Lieber- 
man and colleagues19 who believed 
that the Hand-Schuller-Christian ap­
pellation is best reserved for a syn­
drome of clinical signs and symptoms 
(cranial eosinophilic granulomas, ex­
ophthalmos and diabetes insipidus) 
appearing occasionally within a larger 
group of patients with healing lesions 
in bone and various viscera (lungs, 
mucous membranes). We believe it is 
essential for clinicians to be aware 
that a solitary eosinophilic granuloma 
can progress to multifocal and viscer­
al disease and can develop into the 
Hand-Schuller-Christian syndrome.
The incidence in our series general­
ly followed that encountered in the 
literature—almost any bone can be 
involved,1718-20 it is generally a disease 
of children but occurs also in adults 
and most series report a predomi­
nance in males.11-18
Traditionally, histiocytosis X has 
been regarded as a malignant disease, 
but its clinical course and certain
histologic features contradict this as­
sumption. As early as 1947, Schajow- 
icz and Polak21 suggested some sort of 
immunoallergic process and later, ine­
vitably, a viral origin of the disease 
became popular.22-23 Recently there 
has been a return to the idea of an 
immunologic basis for its develop­
ment,8-9-24 but this remains unprov­
en.25
In this connection, our experiences 
of two patients with eosinophilic 
granuloma that developed shortly 
after chemotherapy for malignant dis­
ease is of interest. One of these pa­
tients is reported briefly.
A 17-year-old pregnant girl present­
ed with a typical osteogenic sarcoma 
of the right tibia. After biopsy of the 
bone a thigh amputation was per­
formed, and the baby was delivered 
by cesarean section. She received 
eight cycles of chemotherapy. Eleven 
months after the end of her chemo­
therapy she fell, injuring her right 
shoulder. When the pain persisted the 
shoulder was x-rayed. A lytic expan­
sive lesion of the right clavicle, not 
present in staging studies for the os­
teogenic sarcoma, was seen (Fig. 4). A 
biopsy of this lesion proved it was a 
typical eosinophilic granuloma. Cu­
rettage was done at the same time as 
the biopsy. Two years later she was 
well and was again pregnant.
Four of our patients died, but only 
in one, the patient with malignant 
histiocytosis, was death due to eosino­
philic granuloma itself. A second 
death was due to myocardial infarc­
tion. Two patients died of cancer
FIG. 3—Bone destruction and periosteal reaction in distal humeral lesion in 6-year-old 
girl suggests more aggressive disease such as acute osteomyelitis or Ewing's sarcoma.
T a b le  II -  T re a tm e n t
T re a tm e n t No. o f  p a t ie n ts
N e e d le  b io p s y 5
O p e n  b io p s y 5
In tra le s io n a l c u re tta g e 2 2
E x c is io n 5
R a d ia tio n 6
R a d ia tio n  +  c u re tta g e 1
+  e x c is io n 1
+  c h e m o th e ra p y 3
FIG. 4—Eosinophilic granuloma of inner 
end of right clavicle 13 months after com­
pletion of chemotherapy for osteogenic sar­
coma.
266 VOLUME 31, NO. 4 JULY 1988 /  THE CANADIAN JOURNAL OF SURGERY
originating in the lung and the bowel 
in patients aged 61 and 30 years 
respectively. In one other 65-year-old 
patient breast carcinoma developed. 
The occurrence of three coincidental 
cancers in this small group of pa­
tients, followed up for a sufficient 
length of time, is high and the one 
aged 30 years was unusually young.
In most earlier reports of large 
series1118'20 the recommended treat­
ment was similar to our own, al­
though Cheyne17 used steroids in 10 
of his 34 patients. More recently Nau- 
ert and colleagues26 from the M.D. 
Anderson Hospital in Houston strong­
ly advocated intralesional injection of 
methylprednisolone, a course of man­
agement supported in a more guarded 
manner by Capanna and associates.27 
Others28-30 have suggested that the 
mode of treatment does not exert a 
strong influence on the rate of healing 
and that eosinophilic granuloma is a 
self-limiting disease. Our experience 
of 32 patients who had solitary lesions 
favours the latter opinion. Multiple 
lesions may also be self-limiting, but 
our experience of two patients with 
painful and disabling additional le­
sions, occurring at approximately 
yearly intervals, prompted us to try to 
relieve the symptoms and prevent fur­
ther lesions by chemotherapy. This 
more aggressive approach would seem 
appropriate in patients with visceral 
lesions and Hand-Schuller-Christian 
syndrome.
Finally, what role do bone scans 
play in management of eosinophilic 
granuloma? Information on the value 
of scintigraphic imaging of histiocyto­
sis X is sparse, but it appears that 
these lesions can be either “hot”, 
“cold” or negative. Crone-Miinze- 
brock and Brassow13 studied 17 pa­
tients with 53 bony lesions detected 
radiologically. Thirty-two lesions were 
identified scintigraphically. In 15 in­
stances the bone scans were negative 
and 6 of the lesions were “cold”. They 
and others14 concluded that a conven­
tional radiologic investigation was ap­
propriate in the primary diagnosis of 
histiocytosis X. Scintigraphic appear­
ances vary, but bone scanning may be 
useful in follow-up.13 Our limited ex­
perience with bone scans in eosino­
philic granuloma tends to support 
their conclusions1314 with the added 
comment that these examinations in 
histiocytic lesions must be interpreted 
cautiously.
Conclusions
Surgeons should be aware that the 
radiologic appearance of eosinophilic 
granuloma can mimic more ominous
lesions such as osteogenic sarcoma, 
Ewing’s sarcoma and osteomyelitis, 
and very occasionally may be malig­
nant. A solitary lesion can later be­
come multifocal and in turn exhibit 
visceral manifestations and even dia­
betes insipidus. Otherwise, complica­
tions such as pathologic fracture are 
uncommon.
Solitary lesions appear to be self- 
limiting and, once the diagnosis is 
established by biopsy, treatment is 
unnecessary. If experienced interpre­
tation is available, biopsy may be by 
fine-needle aspiration,31 thus avoiding 
the possible complications of open 
biopsy. Recurrent multifocal disease 
can be disabling and may require 
symptomatic treatment for bone and 
visceral lesions, either by radiothera­
py or chemotherapy. We are not 
aware of any certain means of pre­
venting further lesions.
With respect to the etiology, our 
experience supports the mounting 
opinion that these histiocytic lesions 
may be based on some altered im­
mune state.
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University of Western Ontario 
Memorial Fund
From 1945 to 1974 Angus D. 
McLachlin served as Professor and 
Head of the Department of Surgery at 
the University of Western Ontario. 
During that time he trained 47 resi­
dents, all of whom attained a fellow­
ship in surgery, and became national­
ly and internationally recognized as a 
teacher, researcher and administrator. 
In McLachlin’s memory, $250 000 
has been pledged by former residents 
toward the establishment of a chair in 
general surgery at the University of 
Western Ontario.
Laurel Williamson
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Eosinophilic Enteritis With Perforation
A case of eosinophilic granuloma of 
the gastrointestinal tract with free per­
foration is described. The authors be­
lieve this is the first such case to be 
published. The patient, a 60-year-old 
woman, had no history of allergy. At 
laparotomy. 100 ml of pus was aspi­
rated. A 42-cm section of small bowel, 
containing multiple punched-out ul­
cers, was excised. The mucosa and 
submucosa of the operative specimen 
were edematous; there was a moder­
ate inflammatory infiltrate containing 
numerous eosinophils and neutrophils. 
The lesion appeared to represent a 
local reaction to some antigen with 
resultant eosinophilic infiltration.
On decrit un cas de granulome eosino- 
phile du tractus gastro-intestinal avec 
perforation complete. Les auteurs 
croient qu'il s'agit la du premier cas 
rapporte. La patiente, une femme de 
60 ans, ne possedait aucun an­
tecedent d'allergie. A la laparotomie, 
on a aspire 100 ml de pus. Une section 
de 42  cm d'intestin grele renfermant 
de multiples ulceres arrondis fut exci- 
see. La muqueuse et la sous-muqueu- 
se du prelevement etaient oedemateu- 
ses; on observait un infiltrat inflamma- 
toire de moyenne intensity renfermant 
de nombreux eosinophiles et neutro- 
philes. Cette lesion semble represen­
ter une reaction locale a un antigene 
quelconque avec infiltration 6osinophi- 
le subsequente.
Eosinophilic leukocytes are normally 
present in the gastrointestinal tract, 
but when there is an abnormal con­
centration of eosinophils with no as­
sociated disease to account for the 
increase, the condition is termed eo-
From the Department o f  Surgery and 
Department o f Medicine, Amiri Hospital, 
Kuwait
Accepted for publication Jan. 5, 1988
Reprint requests to: Dr. H.S. Walia, PO 
Box 4077, Amiri Hospital, Kuwait
268
sinophilic infiltration or granuloma of 
the gastrointestinal tract.1'2 Such le­
sions are usually diffuse or circum­
scribed, with or without peripheral 
eosinophilia. The usual presentation 
is with malabsorption, obstruction or 
peritonitis with ascites depending on 
the layer of the bowel involved.
We present a case of eosinophilic 
enteritis with free perforation, which 
we believe is the first to be reported in 
the literature.
Case Report
A 60-year-old woman was seen with an 
8-hour history of acute abdominal pain 
and vomiting. The pain started after her 
breakfast, rapidly increased in severity and 
spread throughout the abdomen. She had a 
history of hypertension and transient cere­
bral ischemic attacks for which she was 
taking (3-blockers and dipyridamole. She 
denied having any allergies.
On examination there was marked rigid­
ity of the abdomen with rebound tender­
ness. Bowel sounds were absent. Laborato­
ry tests on admission gave the following 
results; hemoglobin 142 g/L, leukocyte 
count 17.0 X 109/L with 2% eosinophils,
serum amylase level 45 IU/L; the biochem­
ical profile was normal. A chest x-ray film 
and electrocardiogram were also normal. 
Abdominal x-ray films failed to show gas 
beneath the diaphragm but small calcifica­
tions (calcified fibroids) were present in 
the pelvis.
At laparotomy through a midline inci­
sion, 100 ml of thick intraperitoneal pus 
was aspirated. A free perforation was 
found in a thickened wall of the proximal 
jejunum which was coated with an exu­
date. Indurated nodules were felt along the 
mesenteric border of the small bowel for 
some distance on both sides of the lesion 
and the mesenteric glands were enlarged. 
There was no other evident intraperitoneal 
lesion apart from the uterine fibroids. The 
provisional diagnosis was inflammatory 
bowel disease. A 42-cm length of gut was 
resected, including mesenteric glands and 
a short segment of normal bowel on either 
end.
The resected specimen showed transmu­
ral thickening and exudation with multiple 
punched out mucosal ulcers (up to 0.5 cm 
in size) along its entire length. One ulcer 
had perforated through the wall into the 
mesentery. There was mucosal and sub­
mucosal edema. Thirteen lymph nodes 
were recovered from the mesentery (Fig. 
1 ).
FIG. 1—Segment of jejunum showing mucosal thickening with ulcers (small arrows) 
and perforation (large arrow).
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Microscopically, there was focal ulcer­
ation of small-bowel mucosa, extending 
deep into the muscle wall and serosa. The 
lamina propria was edematous and showed 
moderate chronic inflammatory cell infil­
tration with frequent eosinophils. The sub­
mucosa and muscle coats were markedly 
edematous and heavily infiltrated with eo­
sinophils and neutrophils, with splitting 
and fraying of muscle bundles resulting in 
perforation. The serosa showed edema and 
focal congestion with exudation (Fig. 2). 
There were areas of perivascular eosino­
philic infiltration. Both ends of the speci­
men were free of disease. Mesenteric 
lymph nodes also showed follicular hyper­
plasia, sinus histiocytosis and infiltration 
by eosinophils.
The patient made a smooth postopera­
tive recovery. Because of the pathology 
report we attempted to identify the respon­
sible allergens. Repeated counts did not 
show any peripheral eosinophilia, and the 
biochemical profile and result of immuno- 
electrophoresis were normal. The stool was 
negative for helminthic infestation and the 
erythrocyte sedimentation rate was only 16 
mm (first hour). Skin tests for grasses, 
weeds, house dust, mites, fabrics and food­
stuffs—including cereals, vegetables, milk, 
cheese, chocolate, egg (white and yolk), 
meat, fish (sea and shellfish) and beef— 
were negative. The barium meal with fol­
low-through examination revealed only a 
hiatus hernia and sigmoid diverticular dis­
ease. Because there was no eosinophilia or 
allergies, steroids were not administered. 
The patient continued to take her (3-block­
ers and dipyridamole. She has remained 
well for the past 3 years without evidence 
of vasculitis or granulomatous disease.
Discussion
The caiuse of the eosinophilic infil­
tration of the gastrointestinal tract is 
still not known although various fac-
FIG. 2—Infiltrative eosinophilic lesion 
with perforation (hematoxylin and eosin, X 
3000).
tors have been incriminated in the 
pathogenesis, including allergy, infec­
tions and collagen3 diseases. Allergy 
and asthma are reported in 50%> of 
the cases while peripheral eosino­
philia may be present in 80%.'
The diversity of this hypereosino- 
philic syndrome was emphasized by 
Chusid and colleagues4 and by Suen 
and Burton.2 The relation of Loffler’s 
and Harkavy’s syndromes to eosino­
philic gastroenteritis was suggested by 
Higgins and colleagues5 and Salmon 
and Paulley,6 while similarities o f  dif­
fuse and circumscribed forms were 
reported by Vanek7 and Suen and 
Burton.2
The general picture of eosinophilic 
lesions favours the theory o f hyper­
sensitivity. The presence of granulo­
matosis, angiitis or other complexes 
in association with eosinophilic gas­
troenteritis has been noted.8 9 Review­
ing their own 10 cases and other 
published reports, Suen and Burton2 
concluded that eosinophilic gastroen­
teritis, Churg-Strauss syndrome and 
periarteritis nodosa are related condi­
tions and belong to the larger entity o f  
hypereosinophilic syndrome.
The role of eosinophils in these 
diseases has been demonstrated by 
Venge and colleagues10 and Tai and 
associates.11'12 Activated and de- 
granulated eosinophils produce eosin­
ophil cationic protein, eosinophil 
major basic protein and eosinophil 
protein-x, all of which have considera­
ble cytotoxic capacity.
Bowel perforations have been re­
ported in association with periarteritis 
nodosa13 and Churg-Strauss syn­
drome14 but not in a case o f eosino­
philic gastroenteritis. Ours is the first 
such report, having all the features o f  
an infiltrative eosinophilic lesion, 
showing large numbers of eosinophils 
in addition to dissecting, splitting and 
fraying of the muscle bundles, result­
ing in free perforation. It resembles 
closely the features of cases o f periar­
teritis nodosa and Churg-Strauss syn­
drome. This leads us to believe that 
toxic cationic proteins are the respon­
sible agents in all these lesions.
We thank Dr. Hilal A1 Sayer, MCh, 
FRCS, Chairman, Department of Surgery, 
Amiri Hospital, Kuwait for allowing us to 
publish this case and Mr. Jayakumar for 
secretarial work.
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sive testing—is well illustrated. The ratio­
nale for using these tests in acute situa­
tions is explained well. In Canada, acute 
traumatic arterial and venous injuries are 
rare compared with those in the United 
States. The chapters on vascular trauma 
are excellent and allow us to learn from 
this large experience. Some chapters, such 
as those on reimplantation of limbs and 
the balloon pump, are not necessarily rele­
vant to the peripheral vascular surgeon but 
are of interest.
There are a few drawbacks to this book. 
The chapters vary in quality, which is to 
be expected from a multiauthored book. A 
few areas are either not dealt with or 
covered only superficially. I hope that 
future editions will contain chapters on 
deep venous thrombosis and axillary vein 
thrombosis. The chapter on acute throm­
bosis of vascular grafts deals only with 
femoropopliteral bypass. It would be ap­
propriate if chapters on failed aortobifem- 
oral and axillofemoral bypasses were add­
ed.
Overall, this is an excellent book that 
should be in the library of all vascular 
surgeons. It should be required reading for 
all general and vascular surgery residents. 
Others who would benefit from the avail­
ability of this book would be emergency 
room physicians and general surgeons who
continued on page 294
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patients previously found to be hypersensitive to this compound, the parent compound, clindamycin, or 
clindamycin palmitate. Although cross-sensitization with Lincocin® (lincomycin hydrochloride) has not 
been demonstrated, it is recommended that Dalacin C Phosphate not be used in patients who have 
demonstrated lincomycin sensitivity.
Until further clinical experience is obtained, Dalacin C Phosphate is not indicated in the newborn (in­
fants below 30 days ot age), or in pregnant women.
Warnings: Some cases of severe and persistent diarrhea have been reported during or after therapy 
with Dalacin C Phosphate (clindamycin phosphate). This diarrhea has been occasionally associated with 
blood and mucus in the stools and has at times resulted in acute colitis. When endoscopy has been 
performed, some of these cases have shown pseudomembrane formation.
If significant diarrhea occurs during therapy, this drug should be discontinued or, if necessary, con­
tinued only with close observation. Significant diarrhea occuring up to several weeks post-therapy 
should be managed as if antibiotic-associated.
If colitis is suspected, endoscopy is recommended. Mild cases showing minimal mucosal changes 
may respondtosimpledrugdiscontinuance.Moderatetoseverecases.includingthoseshowing ulcera­
tion or pseudomembrane formation, should be managed with fluid, electrolyte, and protein 
supplementation as indicated, Corticoid retention enemas and systemic corticoids may be of help in 
persistent cases. Anticholinergics and antiperistaltic agents may worsen the condition. Other causes 
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Studies indicate a toxin(s) produced by Clostridia (especially Clostridium difficile) may be a principal 
cause of clindamycin and other antibiotic-associated colitis. These studies also indicate that this 
toxigenic Clostridium is usually sensitive in-vitro to vancomycin. When 125 mg to 500 mg ot vanco­
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served disappearance of the toxin from faecal samples and a coincidental recovery from the diarrhea.
It should be noted that serious relapses have occurred up to one month after apparently successful 
treatment. A relatively prolonged period of continuing observation is therefore recommended.
Precautions: Dalacin C Phosphate (clindamycin phosphate), like any drug, should be prescribed with 
caution in atopic individuals. Dalacin C Phosphate must be diluted for intravenous administration. 
(See Dosage and Administration)
The use of antibiotics occasionally results in overgrowth of nonsusceptible organisms - particularly 
yeasts. Should superinfections occur, appropriate measures should be taken as dictated by the 
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As with all antibiotics, perform culture and sensitivity studies in conjunction with drug therapy.
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Adverse Reactions: Local
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the site of the infusion.
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Rash.......................................................................................................................................................... 7
Urticaria....................................................................................................................................................  1
Pruritus.....................................................................................................................................................  1
Fever, Leucocytosis.................................................................................................................................   1
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Hypotension.............................................................................................................................................. 1
Hypertension............................................................................................................................................  1
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Superinfection*........................................................................................................................................ 4
Cardiac arres t**......................................................................................................................................  1
Bad or bitter taste in mouth....................................................................................................................  5
Superinfection is a complication of antibiotic therapy in general and is not necessarily a true side 
effect of clindamycin phosphate.
Due to underlying myocarditis in this patient.
Clinical and Laboratory Findings: Patients treated during clinical trials of Dalacin C Phosphate 
(clindamycin phosphate) were followed with clinical laboratory tests, including complete hematology, 
urinalysis and liverand kidney function tests. Some of these tests were abnormal initially and returned 
to normal during therapy with Dalacin C Phosphate, while others were normal initially and became 
abnormal,during therapy. Overall evaluation of clinical laboratory values in these patients does not 
indicate that Dalacin C Phosphate therapy has a toxic effect on the hematopoietic, hepatic or renal 
systems. Transient elevations of serum transaminases have occured in some patients, but other liver 
function tests (alkaline phosphatase, serum bilirubin) have not shown any tendency to increase and 
there have not been clinical signs of drug-induced hepatic toxicity.
Symptoms and Treatment of Overdosage: No cases of overdosage have been reported. No specific 
antidote is known. Doses as high as 1200 mg every six hours (4800 mg/day) by infusion for five days 
have been given without adverse effects.
DOSAGE AND ADMINISTRATION
Adults
Intramuscular Injection: 600 mg/day in 2 equal doses.
Moderately severe infections: 600 to 1200 mg/day in 2 or 3 equal doses.
Severe infections: 1200 to 2400 mg/day in 2,3 or 4 equal doses. Intramuscular injections of more than 
600 mg into a single site are not recommended.
Intravenous Administration: Dalacin C Phosphate (clindamycin phosphate) must be diluted prior to 
I.V. administration to a dilution of 300 mg in 50 m l of diluent (6mg/mL) or more, and infused in not less 
thanlOminutes. Administration of more than 1200mg inasinglel hourinfusionisnot recommended. 
Dalacin C Phosphate should not be injected intravenously undiluted as a bolus.
Moderately severe infections: 900 to 1800 mg/day by continuous drip or in 2 or 3 equal doses, each 
infused over 20 minutes or longer.
Rapid
infusion rate 
10mg/min.for30min. 
15mg/min.for30min. 
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Severe Infections: 1800 to 2700 mg/day by continuous drip or in 3 or 4 equal doses, each infused over 
20 minutes or longer. In life-threatening infections, doses of 2700 to 4800 mg/day by continuous drip or 
in 3 or 4 equal doses each infused over 20 minutes or longer may be given.
Dilution and infusion rates:
Dose Diluent Time
300 mg 50 mL 10 min.
600 mg 100 mL 20 min.
900 mg 150 mL 30 min.
1200 mg 200 mL 45 min.
Alternatively, drug may be administered in the form of a single rapid infusion of the first dose followed 
by continuous I.V. infusion as follows:
To maintain serum 
clindamycin levels 
Above 4 mcg/mL 
Above 5 mcg/mL 
Above 6 mcg/mL 
Children: (Over one month of age)
Intramuscular injection: 10 to 15 mg/kg/day in 2,3 or 4 equal doses.
Moderately severe infections: 15 to 20 mg/kg/day in 3 or 4 equal doses.
Severe infections: 20 to 30 mg/kg/day in 3 or 4 equal doses.
Intravenous Administration:
Moderately severe infections: 15 to 25 mg/kg/day by continuous drip or in 3 or 4 equal doses, each 
infused over 20 minutes or longer.
*
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Severe infections: It is recommended that children be given no less than 300 mg/day regardless of body 
weight. (Dilute Dalacin C Phosphate Sterile Solution in the same manner as for adults.)
Dilution and Compatibility:
4 mL (600 mg) Dalacin C Phosphate when diluted with 1000 mL of the following commonly used in­
fusion solutions was found to be physically compatible and demonstrated no significant change in pH 
or antimicrobial potency over a period of 24 hours:
Sodium chloride injection 
Dextrose 5% in water 
Dextrose 5% in saline 
Dextrose 5% in Ringer's Solution
Dextrose 5% in half-strength saline plus 40 mEq potassium chloride 
Dextrose 21/2% in Lactated Ringer's Solution (Hartmann’s Solution)
4
Dalacin C Phosphate was not stable when added to Dextrose 5% in water plus vitamins. Therefore it is 
not recommended that Dalacin C Phosphate be mixed with any infusion solution containing B vitamins.
4 ' r
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Dalacin C Phosphate contains the following per mL of sterile solution:
Clindamycin phosphate equivalent to clindamycin base 150 mg 
Benzyl alcohol 5 mg 
Disodium edetate 0.5 mg 
Waterfor injection q.s.
When necessary the pH is adjusted with sodium hydroxide and/or hydrochloric acid to maintain a pH 
range of 5.5 to 7.0.
Dalacin C Phosphate is available in 2 mL and 4 mL ampoules.
NOTE: Do not store below 15°C.
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1-DESAM INO-8-D-ARGININE-VASOPRESSIN (DDAVP) 
DOES NOT REDUCE BLOOD LOSS IN OPEN-HEART SUR­
GERY. T. Hackmann, G.H. Growe, S.C. Naiman, G. Townsend, 
R.D. Gascoyne, W.R.E. Jamieson, S. Sheps. Department of Anaes­
thesia, Division of Hematopathology, Division of Cardiothoracic 
Surgery, Vancouver General Hospital and Department of Health 
Care and Epidemiology, University of British Columbia, Vancou­
ver, BC
A triple-blinded, randomized study was undertaken to determine 
the effects of intravenous administration of DDAVP on blood 
product utilization and postoperative blood loss in patients 
undergoing routine cardiac surgery.
One hundred and fifty patients were randomized to receive 
either placebo or DDAVP 0.3 /ig/kg, to a maximum of 20 fig, 
following protamine reversal of heparin post cardiopulmonary 
bypass.
The mean blood loss after administration of the drug within the 
first 24 hours after surgery was 1389 ± 914 ml in the treatment 
group and 1362 ± 1165 in the placebo group, p = 0.44. No 
statistically significant differences between groups were found 
with respect to the intra- or postoperative use of packed red blood 
cells, plasma, autotransfusion or 6% hydroxyethylstarch. Von 
Willebrand factor (vWF) at 90 minutes and at 24 hours was 
elevated from baseline, but there were no differences between 
groups. Multivariate regression analysis showed OR time, vWF at 
90 minutes, type of surgery and bypass time to be significant 
predictors of blood loss after drug infusion, but when these factors 
were controlled for by analysis of covariance, DDAVP, surgeon, 
use of internal mammary artery, preoperative use of antiplatelet 
agents and intraoperative blood loss were not significant predic­
tors of blood loss after drug infusion. The power to detect 
differences in blood loss of at least 40%, which equals 520 ml, was 
greater than 90%.
In contrast to two previous reports, we conclude that DDAVP 
offers no therapeutic value to patients undergoing routine cardiac 
surgery in regard to blood loss or blood product utilization.
R64
SURGICAL MANAGEMENT FOR ACUTE MECHANICAL 
COMPLICATIONS OF MYOCARDIAL INFARCTION. M.F. 
Matangi, R.R. Singh, J.J. Burgess, A. Maitland, E.F.G. Busse. 
Department of Surgery, Plains Health Centre, Regina, Sask.
Eleven patients, 9 males and 2 females, suffered myocardial 
rupture (MR) following acute myocardial infarction (AMI) and 
required surgery. There were six ventricular septal ruptures 
(VSR), four papillary muscle ruptures (PMR) and one free wall 
rupture (FWR). Rupture occurred a median of 5 days following 
AMI. Four patients had rupture on the first or second day. Free 
wall rupture was heralded by sudden loss of consciousness, apnea, 
junctional bradycardia and absent blood pressure. Following 
resuscitation the patient was in profound shock. Free wall rupture
was confirmed by 2-D echocardiography and surgery performed 
urgently. The patients made a good recovery. Ventricular septal 
rupture was suspected by a new loud systolic murmur with a thrill 
at the lower left sternal border and confirmed by bedside oximetry 
using a Swan-Ganz catheter. Five of the six VSR had an 
intra-aortic balloon pump (IABP) insertion attempted prior to 
cardiac catherization (CC). Two were unsuccessful for technical 
reasons. Five VSR were operated on acutely, and three patients 
died. One was operated on at 10 days and survived. Ventricular 
septal rupture with inferior AMI was associated with a high 
mortality (three of four patients died). Papillary muscle rupture 
onset was with sudden acute severe pulmonary edema, usually 
with hypotension. Three patients had an IABP inserted prior to 
CC. All had emergency surgery with mitral valve replacement, 
with or without coronary artery bypass grafting. One patient died 
of multiorgan failure and sepsis postoperatively. Eleven patients 
had emergency surgery for MR. Surgical mortality was 36%. 
Prompt evaluation with CC and early surgical intervention is 
needed for PMR and VSR associated with an anterior AML For 
FWR a high index of suspicion, echocardiography and immediate 
surgery are required. For VSR with inferior AMI we believe in 
delaying surgery because of the poor outcome with early surgery.
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MODERN OPERATIVE MORBIDITY FOR ELECTIVE SUR­
GICAL RESECTIONS IN LUNG CANCER. J. Deslauriers, R.J. 
Ginsberg, P. Dubois, M. Beaulieu, M. Goldberg, M. Piraux. Centre 
de Pneumologie de Laval, Ste-Foy, PQ and Department of Surgery, 
Mount Sinai Hospital, Toronto, Ont.
Modern operative morbidity rates for elective resection in lung 
cancer are not readily available from the current literature. In 
order to determine the prevalence of minor and major complica­
tions we analysed 1076 consecutive patients who underwent 
resection during a 6-year period (1978 to 1984) in two major 
teaching hospitals. Seven hundred and thirty-one patients (68%) 
had a normal course. Minor complications occurred in 206 
patients (19%) and were predominantly atrial fibrillation (100 
patients) and atelectasis (41 patients). Non-fatal major complica­
tions occurred in 105 patients (9.7%) and the overall 30-day 
operative mortality was 3.2%. Age, sex, preoperative hemoglobin, 
weight loss and pulmonary function, associated illnesses, stage of 
cancer, extent and completeness of operation, duration of surgery 
and peroperative blood loss were studied as risk factors. For all 
complications (minor and major), pulmonary function, associated 
diseases and weight loss were significant variables (p < 0.001). 
For major complications only, all risk factors were significant at a 
“p” level of < 0.05. The similarity of complication rate in the two 
centres suggests that these data are a reasonably accurate analysis 
of modem surgical morbidity.
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VOLUME 31, NO. 4 JULY 1988 /T H E  CANADIAN JOURNAL OF SURGERY 271
R67
RECENT PULMONARY INFARCTION DOES NOT PRE­
CLUDE CARDIAC TRANSPLANTATION. A.H. Menkis, D.J. 
Thomson, S. Patel, W.J. Kostuk, P. Pflugfelder, F.N. McKenzie. 
University Hospital, University of Western Ontario, London, Ont.
Conventional selection criteria for cardiac transplantation include 
the absence of pulmonary infection and infarction. Transplanta­
tion has traditionally been delayed 4 to 6 weeks for anticipated 
resolution. Many patients deteriorate and succumb during this 
delay. Of 139 transplants (134 patients) done before Nov. 30, 
1987, 10 patients had significantly abnormal chest x-ray findings. 
There were nine males and one female with a mean age of 38.2 
years (20 to 55 years). Eight patients were treated for pulmonary 
embolus or infarction. Mean pulmonary vascular resistance (PVR) 
for the group was 2.9 wood units (< 1 to 5.0). The PVR was 2.2 
and 3.7 in the two patients who died. At surgery, clot was found 
in the right ventricle in three, and pulmonary infarction was 
confirmed in six. Two patients died, both at transplantation. One 
was transplanted early in the series with a donor heart that was 
unsuitable. The second died of acute right heart failure. Five of 
the eight survivors with infarction had gradual resolution of their 
chest x-ray changes and uneventful postoperative courses. Al­
though delay to allow resolution of pulmonary infiltrates is 
theoretically preferable, one should not deny cardiac transplanta­
tion to these critically ill patients. In patients with pulmonary 
infarction, cardiac transplantation may be carried out with 
acceptable morbidity and mortality.
R68
COMPLICATIONS OF OPERATIONS FOR LUNG CANCER. 
F.M. Shamji, H.J. Sachs, S. Sundaresan. Division of Thoracic 
Surgery, Ottawa Civic Hospital, University of Ottawa, Ottawa, 
Ont.
To evaluate the safety of pulmonary resection for primary lung 
cancer, we reviewed the charts of 300 patients—196 males (age 42 
to 81 years) and 104 females (age 40 to 78 years)—who underwent 
pulmonary resection in the past 48 months. In 51 patients, 
pneumonectomy was performed with intrapericardial dissection 
in 12 and chest wall resection in 6 patients. Two hundred and 
thirty-three patients underwent lobectomy with the extent of 
resection as follows: standard lobectomy (190), sleeve resection 
(8), bilobectomy (15) and with wedge or segment (20). Decortica­
tion of the lung in 10 and chest wall resection in 15 patients were 
also required. Lesser pulmonary resections, wedge or segment, 
were carried out in the remaining 16 patients, who had inade­
quate pulmonary reserve. The major non-fatal postoperative 
pulmonary complications noted were supraventricular arrhyth­
mias in 30 (10.4%), hemorrhage requiring re-exploration in 3 
(1%), late empyema with or without bronchopleural fistula in 3 
(1%), prolonged air leak beyond 10 days in 8 (2.7%), myocardial 
infarction in 2 (0.7%), atelectasis in 50 (17.3%) and respiratory 
failure in 3 patients (1%). There were 11 (3.6%) in-hospital deaths, 
8 (3.4%) in the lobectomy group and 3 (5.8%) in the pneumonec­
tomy group, the causes of death being cardiac failure in 4, massive 
pulmonary embolism in 3 and respiratory failure in 4 patients.
Thus, pulmonary resection for primary lung cancer carries an 
acceptably low risk of death and a relatively small rate of serious 
postoperative complication.
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PROLONGED VENTRICULAR SUPPORT (PVS) USING THE 
CENTRIFUGAL PUMP (CP). F. Hoy, R.C. Gomez, J.R. Munns, 
D.M. Geiss, C. Stables, D. Flack. University of Illinois, College of 
Medicine, Peoria, 111.
Six patients, aged 6 weeks to 68 years, required PVS with the 
Biomedicus CP for hemodynamic instability following cardiac 
surgical procedures. Three patients required left ventricular sup­
port post myocardial revascularization. One patient required right
ventricular support post redo aortic valve replacement and 
coronary artery bypass grafting. Two patients required biventricu­
lar support—one post repair of truncus arteriosus and one post 
transplant graft failure.
Duration of support ranged from 3 hours to 73 hours (average 
28 hours). Complications included bleeding (two patients), renal 
insufficiency (two) and CNS deficit (two).
Three patients were successfully weaned from PVS (50%). The 
patient with graft failure hyperacutely rejected a second heart. 
There has been one death, 8 months postoperatively.
Prolonged ventricular support with CP may allow recovery of 
potentially reversible ventricular dysfunction in selected patients 
post cardiac surgical procedures.
R70
AORTIC DISSECTION—A DIAGNOSTIC CHALLENGE. 
EXPERIENCE WITH 259 PATIENTS OVER A 20-YEAR 
PERIOD. G. Fradet, W.R.E. Jamieson, M.T. Janusz, H. Ling, 
R.T. Miyagishima, A.I. Munro. University of British Columbia, 
Vancouver, BC
The incidence of acute aortic dissection in North America has 
been established to be 50 000 to 60 000 per annum. This clinical 
entity remains a diagnostic enigma associated with a high mortali­
ty when treatment is delayed. We have reviewed our last 20 years’ 
experience (1966 to 1986), including 259 patients found to have 
dissection at angiography, computed tomography, operation or 
autopsy. Sixty-nine patients were diagnosed postmortem (59A, 
10B). One-hundred and fifty-six patients were type A (136 acute 
[Ac], 20 chronic [Ch]) and 103 type B (65 Ac, 38 Ch).
Type A Type B
Clinical presentation (%)
Chest pain 45 33
Back pain 19 45
Abdominal pain 8 13
Neck pain 17 2
Collapse 14 4
Survival
T reatment AcA ChA AcB ChB
Surgical 5 100 75 92
Medical 63 66 62 90
Early dissection, especially of type A, remains a lethal condi­
tion. Early recognition and aggressive early medical and/or 
surgical management is most important. Twenty-six percent of 
patients in our series were diagnosed post mortem. This stresses 
the complex presentation of this entity and the need for aggressive 
investigation.
R71
CARDIAC DYSRHYTHMIA FOLLOWING TOTAL ESOPH­
AGECTOMY. G. Bhatnagar, L. Brownscombe, R. Inculet, R. 
Finley. University of Western Ontario, Victoria Hospital, London, 
Ont.
New cardiac dysrhythmias (CD) occurred in 15 of 60 consecutive 
patients undergoing total esophagectomy. Cardiac dysrhythmia 
included atrial fibrillation (14 of 15) and atrial flutter (1 of 15). 
One person had ventricular tachycardia. There were no significant 
differences in age, sex, cardiopulmonary history, preoperative 
electrocardiogram, type of anesthetic, duration of operative proce­
dure, periods of intraoperative hypotension, volume of crystalloid 
or blood replacement, duration of postoperative ventilation, pre- 
and postoperative blood gases and chemistry, or frequency of 
postoperative complications, between patients with or without 
CD. Cardiac dysrhythmia occurred more frequently in patients 
undergoing thoracotomy (5 of 10) versus transhiatal esophagecto­
my (10 of 50) (p < 0.05), and in patients receiving postoperative 
aminophylline (3 of 5 versus 12 of 55) (p = 0.06). Patients with
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CD had a significant incidence of hypotension (4 of 15 versus 0 of 
45) (p < 0.01) and mortality (2 of 15 versus 0 of 45) (p < 0.001). 
Despite treatment with verapamil and digoxin (9 of 15) or digoxin 
alone (5 of 15), 5 of 15 patients had recurrent or persistent CD. 
Preoperative digoxin administration did not decrease the inci­
dence of CD (4 of 10 versus 11 of 50).
We conclude that CD after esophagectomy is associated with 
significant mortality, appears more frequently following trans­
thoracic esophagectomy and cannot be predicted by preoperative 
tests. Preoperative digoxin did not decrease the frequency of CD.
R72
COARCTATION OF THE AORTA—LATE DEVELOPMENT 
OF THORACIC ANEURYSMS FOLLOWING PRIMARY RE­
PAIR WITH END-TO-END ANASTOMOSIS. J. Barwinsky, C. 
Brown, J. Parrott, K. Warrian. University of Manitoba, Winnipeg, 
Man.
The development of thoracic descending aortic aneurysms 
(TDAA) following prosthetic patch aortoplasty repair of coarcta­
tion is a well-recognized phenomenon. Review of the literature 
did not reveal any reports of late aneurysm formation following 
repair of coarctation using autogenous tissue, namely, resection 
and end-to-end anastomosis, or subclavian flap aortoplasty.
Within the last year three such patients have presented to our 
cardiac surgical services at the University of Manitoba affiliated 
hospitals with TDAA following repair of coarctation using autoge­
nous tissues. The age at coarctation repair was 10, 17 and 26 
years. The time interval between coarctation repair and presenta­
tion with aneurysm was 9.7, 8.7 and 24.8 years respectively. The 
mode of presentation was rupture in all three cases with one case 
complicated by aortotracheal fxstulization and pneumomedias­
tinum.
All patients underwent operative repair of the TDAA on an 
emergent basis through a left thoracotomy with the use of 
cardiopulmonary bypass, profound hypothermia and circulatory 
arrest. Incision/excision of the aneurysm and prosthetic graft 
interposition was accomplished. Two patients expired in the 
operating room. One patient survived and has had no clinical or 
radiographic complications at 1 year following repair.
R73
SALVAGE OF ISCHEMIC MYOCARDIUM BY NON-SYN- 
CHRONIZED CORONARY SINUS RETROPERFUSION IN 
THE PIG. G. Ropchan, G. Wilson, J. Cruz, C. Feindel. Toronto 
Western Hospital, University of Toronto, Toronto, Ont.
We studied a new non-synchronized coronary sinus retroperfusion 
system in a pig infarct model. In 25 open-chested animals the left 
anterior descending (LAD) artery was occluded between the first 
and second diagonal branches for 4 hours and then reperfused for 
1 hour prior to sacrifice. An Evans blue/tetrazolium red counter- 
staining technique was used to measure the area of infarction 
within the area at risk to calculate percent salvage. In the control 
group (n = 12) no therapy was used. The mean weight ± SEM of 
the region at risk was 12.5 ± 0.97 g, of which the percentage that 
went on to infarct was 80 ± 1.8%. In the experimental group (n = 
13) non-synchronized retrovenous coronary sinus perfusion thera­
py was applied during the 4 hours that the LAD was occluded. 
Therapy consisted of intermittent balloon occlusion of the coro­
nary sinus (5 seconds inflated, 5 seconds deflated) with retroperfu­
sion of arterialized blood at 1 ml/s during the inflation part of the 
cycle. The mean weight of the region at risk was 9.5 ± 0.86 g, of 
which the percentage ± SEM that went on to infarct was 41.5 ± 
4.4%. This reduction in the infarct size within the area at risk is 
statistically significant (p < 0.001) compared with the untreated 
group. The mean coronary sinus pressure was 62 ± 8 mm Hg in 
the treated group, although the peak pressures often approached 
systemic values. We conclude that non-synchronized retrovenous 
coronary sinus perfusion is able to achieve significant salvage of 
ischemic myocardium in the pig model where coronary collateral 
circulation is minimal.
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PLEURAL-PULMONARY COMPLICATIONS FOLLOWING 
OPEN-HEART SURGERY. F.M. Shamji, R.S. Sundaresan, H.J. 
Sachs, W.J. Keon, A. Koshal, P. Bedard, W. Goldstein, Y. 
Akyurekli, R. Masters. Division of Cardiothoracic Surgery, Univer­
sity of Ottawa Heart Institute, Ottawa Civic Hospital, Ottawa, 
Ont.
The incidence of pleural-pulmonary complications following open- 
heart surgery at the University of Ottawa was prospectively 
analysed in 287 adults (197 males [M] and 90 females [F], with 
age range from 21 to 83 [M] and 31 to 76 [F] [NS]). There were 
193 smokers, 145 M and 48 F. All but four procedures were 
performed through a median sternotomy approach and the rest 
through a thoracotomy incision. The cardiac procedures per­
formed were: aortocoronary bypass grafting using saphenous vein 
grafts in 65, using left internal mammary artery (LIMA) 127, 
using right internal mammary artery (RIMA) 1 and combined 
LIMA-RIMA 13; valvular surgery 44; bypass graft with valve 
replacement 12; cardiac transplant 3; and “other” procedures 
(e.g., atrial septal defect closure, aneurysm repair) in 24. The 
pleural-pulmonary complications documented were: major and 
minor atelectasis (229), pneumonia (12), prolonged ventilatory 
support (beyond 48 hours) (14), pneumothorax (19), hemothorax 
(4), hydrothorax (81), empyema (1) and persistent diaphragmatic 
elevation (34). Of the complications, 92.6% were non-fatal. While 
69.5% of complications arose in smokers and 30.5% in nonsmok­
ers, prior smoking did not affect the incidence of prolonged 
ventilatory support or the development of pneumonia (NS). In 
141 cases utilizing the IMA grafts, the ipsilateral pleural space was 
entered in 111, and 55 pleural complications ensued (39.0%); in 
the remaining 148 cases not utilizing IMA grafts, there were 49 
pleural complications (33.1%, NS), and there was no difference in 
the incidence of persistent ipsilateral diaphragm elevation.
R75
LONG-TERM RESULTS IN NEONATES WITH PULM O­
NARY ATRESIA INTACT VENTRICULAR SEPTUM. J.G. 
Coles, N.E. Lightfoot, H.K. Dasmahapatra, W.G. Williams, G.A. 
Trusler, R.M. Freedom. Division of Cardiovascular Surgery, The 
Hospital for Sick Children, Toronto, Ont.
Our entire institutional experience with pulmonary atresia intact 
ventricular septum (PAIVS) (1965 to 1987) included 115 patients: 
100 patients had classical PAIVS and 15 patients had Ebstein’s 
anomaly (EA) with anatomical pulmonary atresia; 50 patients had 
angiographic evidence of right ventricular (RV) sinusoids. Sixteen 
patients died prior to operation. The overall survival of surgical 
patients (n = 99) was 24.7 ± 6% at 13 years postoperatively. The 
early mortality rate was 25%; 13 of 15 patients with EA died. 
Multivariate analysis indicated that the presence of sinusoids (p = 
0.06), EA (p = 0.01) and lower weight at operation (p = 0.001) 
were incremental risk factors for postoperative death. Nearly all 
long-term survivors underwent at least one reoperation. The risk 
of reoperation was high, especially with decompression or throm- 
boexclusion of the RV in patients with sinusoids and an RV- 
dependent coronary circulation. We conclude that multiple staged 
procedures which successfully decompress the right ventricle will 
usually result in a biventricular circulation and long-term survival 
in patients with PAIVS not complicated by EA or coronary- 
sinusoid fistulas.
R76
TRACHEOBRONCHIAL TRAUMA: A 10-YEAR EXPERI­
ENCE AT A UNIVERSITY CENTRE. K. Reid, G. Hooper, H. 
Sachs, A. Crepeau, R. Belanger, F.M. Shamji. University of 
Ottawa Heart Institute, Ottawa Civic Hospital, Ottawa, Ont.
Tracheobronchial trauma, whether from blunt trauma or penetrat­
ing injury of the chest and neck often poses a major diagnostic 
and therapeutic challenge. Up to 78% of patients with tracheo­
bronchial injuries are dead on arrival at hospital with up to 21%
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of those arriving alive dying in the first 2 hours. Thus, the need 
for recognition and early aggressive treatment of patients with 
such injuries is imperative. During the period 1977 to 1987 at two 
teaching hospitals in Ottawa, a total of 11 cases of tracheobron­
chial disruption or laceration were recognized. Four cases in­
volved blunt trauma from motor vehicle or industrial accidents. 
The injuries consisted of two mainstem bronchial tears, one lower 
lobe bronchus tear, one transected trachea and esophagus. There 
were four penetrating injuries, three accidental and one assault, 
resulting in one lacerated bronchus and three tracheal lacerations. 
Two instances of attempted suicide by hanging were encountered, 
one acutely, and one as a remote incident with subsequent 
tracheal stricture. One intubation injury was documented in the 
10-year period. The operative procedures performed included two 
mainstem bronchial reimplantations (right), two lower lobecto­
mies, three tracheal laceration repairs, one bronchial repair, one 
tracheal resection with tracheoplasty and one tracheoplasty with 
stent (previous stricture). The intubation injury was treated 
expectantly and no sequelae developed. There was one death due 
to tracheo-innominate fistula on day 7 postoperatively. Two 
patients undergoing tracheal repair were left with a hoarse voice; 
one of them also has a residual tracheal stenosis which has been 
stable for 4 years. There were no other long-term sequelae noted 
to date.
R77
EXTRATHORACIC MUSCLE TRANSPOSITION IN THE 
MANAGEMENT OF POST-PNEUMONIC EMPYEMA. H.W. 
Unruh, I. Ali. Department of Surgery, University of Manitoba, 
Winnipeg, Man.
Over a 3-year period 18 patients with post-pneumonic empyema 
(PPE) were treated by the Thoracic Surgical Service of the Health 
Sciences Centre. This represented 46% of all empyemas seen. 
Sixteen were males and 2 were females. The most common cause 
of infection was pure aerobic infection, 39%, followed by pure 
anaerobic infection and mixed infection, each accounting for 28% 
of infections. Peptostreptococcus, Streptococcus viridans and Pep- 
tococcus accounted for 55% of bacterial isolates. Ten patients had 
a chest tube placed as an initial procedure but all 18 required rib 
resection and chronic drainage with daily irrigations. Six patients 
ultimately required thoracotomy with decortication. In five pa­
tients following decortication latissimus dorsi and seratus anterior 
were transposed into the thoracic cavity to fill residual spaces 
thereby avoiding disfiguring thoracoplasty. Follow-up ranged 
from 3 months to 2.5 years. There was no recurrence of infection 
or mortality seen with this procedure. No significant shoulder or 
arm disability was reported following convalescence. Extrathorac- 
ic muscle transposition is extremely useful for filling residual 
thoracic spaces and stopping air leaks from the surface of the lung 
following decortication of the lung for PPE. The viable, trans­
posed muscle also has theoretical advantages in clearing residual 
infection.
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SURGICAL EXPERIENCE WITH LEFT VENTRICULAR 
OUTFLOW TRACT OBSTRUCTION IN PATIENTS WITH 
COMPLETE TRANSPOSITION OF THE GREAT ARTERIES 
UNDERGOING THE MUSTARD OPERATION. H.K. Dasma- 
hapatra, R.M. Freedom, J.G. Coles, F. Moes, N. Mnsewe, H. 
Sherret, W.G. Williams, G.A. Trusler. Division of Cardiovascular 
Surgery, The Hospital for Sick Children, Toronto, Ont.
During a 20-year period (1967 to 1987), 46 of 392 (11.7%) 
patients with complete transposition of the great arteries (CTGA) 
undergoing the Mustard operation had fixed left ventricular 
outflow tract obstruction (LVOTO). The obstruction was valvular 
in 2 patients, subvalvular in 43 and combined in 1; the ventricular 
septum was intact in 42, and 4 patients had a small ventricular 
septal defect. The presence of LVOTO was evident in only 4 of 46 
patients at the neonatal catheterization and was not predictable
from left ventricular pressures. Forty-five patients had operations 
for LVOTO at the initial Mustard operation: pulmonary valvoto- 
my (n = 3), resection of fibrous ring (n = 8), myectomy (n = 33), 
resection of membranous aneurysm (n = 1), left ventricle to 
pulmonary artery valved conduit (VC) (n = 1); 2 patients 
underwent VC early postoperatively for severe residual LVOTO 
(both died). The early mortality rate was 17%, and the overall 
survival 71% at 2.5 years postoperatively. By multivariate analy­
sis, the preoperative left ventricle/right ventricle peak systolic 
pressures (p = 0.008) and the nonuse of cardioplegia (p = 0.05) 
were incremental risk factors for early and late postoperative 
death. Postoperative catheterization (n = 24) demonstrated mild 
(< 20 mm Hg) residual LVOTO in 10, moderate (20 to 40 mm 
Hg) in 7 and severe (> 40 mm Hg) in 5. We conclude that (1) 
direct resection of LVOTO in patients with CTGA undergoing the 
Mustard operation will result in a satisfactory long-term clinical 
outcome, (2) sequential studies prior to the Mustard operation 
demonstrate the acquired nature of LVOTO and argue in favour 
of a protocol of early arterial switch operation in patients with 
CTGA.
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EXPERIMENTAL USE OF SOMATOSENSORY EVOKED 
POTENTIAL FOR INTRAOPERATIVE IDENTIFICATION 
OF SPINAL CORD BLOOD SUPPLY. M. Janusz, A.K. Qayumi, 
M.D. Low, K. Barry, J. Mitchell, D. Fairholm, W.R.E. Jamieson, 
A. Wong. University of British Columbia, Vancouver, BC
Intraoperative use of somatosensory evoked potentials (SEP) was 
tested in a canine model. In group 1 (six dogs), all intercostal 
arteries were divided and in group 2 (six), all intercostal, lumbar 
and median sacral arteries were divided. Somatosensory evoked 
potentials were recorded before surgery, after interruption of the 
arteries and 18 hours following surgery. Other methods of 
investigation included clinical assessment, histology and electron 
microscopy. Two of the six animals in group 1 became paraplegic, 
and five of the six animals in group 2 became paraplegic. 
Somatosensory evoked potentials were completely ablated in 1 of 
the 12 animals and it became paraplegic. In one animal a marked 
diminution in amplitude of SEP occurred, which improved 
spontaneously over 30 minutes, and this animal was also paraple­
gic. In the other 10 animals, intraoperative SEP changes (in 
amplitude or latency) did not correlate with the development of 
paraplegia, as follows: in the other five animals that became 
paraplegic, intraoperative SEP amplitudes were 62%, 67%, 98%, 
100% and 104% of baseline and SEP latencies were 110%, 101%, 
94%, 125% and 106% of baseline. In the five animals that 
remained neurologically normal the intraoperative SEP ampli­
tudes were 39%, 54%, 82%, 103% and 176% of baseline, and the 
latencies were 103%, 95%, 91%, 144% and 128% of baseline. 
Electron microscopic studies showed moderate ischemic changes 
in those animals that were not paraplegic and severe changes in 
those that were paraplegic. We conclude that complete loss of SEP 
intraoperatively does predict paraplegia, but this occurs infre­
quently. The presence or absence of less marked changes in SEP 
do not appear to predict paraplegia reliably.
R80
BEHAVIOUR OF BARRETT’S EPITHELIUM AFTER ANTI­
REFLUX OPERATION. F.M. Shamji, H.J. Sachs. Division of 
Thoracic Surgery, Ottawa Civic Hospital, Ottawa, Ont.
The behaviour of Barrett’s epithelium after surgical correction of 
gastroesophageal reflux forms the basis of this report.
Eighteen patients, 9 males and 9 females, ranging from 26 to 70 
years of age, presented with symptoms of heartburn (17), dyspha­
gia (9) and bleeding from Barrett’s ulcer (5). The presence of 
Barrett’s epithelium, gastric type in 10 patients and intestinal type 
in 8, was confirmed by histologic examination. Nine patients had 
esophageal stricture. Five of the 18 patients had previously 
undergone unsuccessful fundoplication with and without vagoto­
my.
The operative procedures undertaken at our institution were 
Collis-Belsey antireflux repair in 16 patients, total esophagectomy
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in 1 patient and proximal esophagogastrectomy in 1 patient. The 
patients who underwent antireflux repair have been followed from 
8 to 40 (average 21) months with clinical and endoscopic 
assessment at 6-monthly intervals. Significant progression of the 
Barrett’s epithelium with mild dysplastic changes was noted in 
only one patient at 18 months’ follow-up and the patient 
underwent total esophagectomy. Stabilization of the Barrett’s 
epithelium in seven patients and partial regression in eight 
patients was observed. None of the 18 patients has shown 
evidence of malignant change.
Our limited experience shows that in the majority of patients 
with Barrett’s epithelium, surgical control of gastroesophageal 
reflux produces either stabilization or regression of Barrett’s 
epithelium.
R81
COMPARISON OF FOUR CRYSTALLOID CARDIOPLEGIC 
SOLUTIONS FOR LONG-TERM HEART PRESERVATION. 
P.J. Hendry, Y.A. Barry, D. Ayers, W J. Keon. University of 
Ottawa Heart Institute, Ottawa Civic Hospital and Ottawa Centre, 
Canadian Red Cross, Ottawa, Ont.
Heart transplantation is limited by the availabilty of donor hearts, 
therefore, the possibility of preserving donor hearts for 12 to 24 
hours would facilitate transport of organs over greater distances 
and provide more extensive donor-recipient matching. In this 
study, we compared four solutions using the in vitro human atrial 
preparations in regard to long-term heart storage during moderate 
hypothermia.
Atrial trabeculae were divided into four groups, arrested and 
maintained for 24 hours at 12°C in one of the following solutions: 
group 1 was in St. Thomas’ Hospital cardioplegic solution #2 
(K*: 16 meq/L), group 2 was in Krebs-Henseleit (K-H) solution 
(K+:4.75 meq/L), group 3 was in modified K-H solution (K+:16 
meq/L) and group 4 was in isotonic saline.
The recovered developed force after 30 minutes at 34°C, 
following the 24-hour preservation period was the best in groups 1 
and 2 (100 ± 14%, 73 ± 16% respectively), less satisfactory in 
group 3 (50 ± 20%) and poor recovery was observed in group 4 
(10 ± 9%). The resting force increased significantly in all groups 
with the highest rise in group 4 and the lowest in group 2. Edema, 
as measured by the dry to wet weight ratio (15%), was observed 
only in group 4.
These findings reveal that St. Thomas’ Hospital cardioplegic 
solution #2 and the modified K-H solution are more effective in 
preserving human atrial tissue for 24 hours during moderate 
hypothermia than saline and K-H solution.
R82
PRESERVATION TECHNIQUES FOR HEART TRANSPLAN­
TATION-COMPARISON OF HYPOTHERMIC STORAGE 
AND HYPOTHERMIC PERFUSION. W.R.E. Jamieson, A.K. 
Qayumi, L.J. Rosado, C.W. Tomlinson, B. McConville, A. Wong. 
University of British Columbia, Vancouver, BC
Simple hypothermic storage and a perfusion technique were 
compared in a swine model of heart transplantation (n = 14). The 
donor hearts of group A (n = 7) were placed in simple hypotherm­
ic storage for 5 hours. In group B (n = 7), donor hearts were 
placed onto a perfusion apparatus for 5 hours with pressure 
maintained at 28 cm H20  and a myocardial temperature of 8 to 
10°C. The ischemic interval within both groups was 6 hours 
including orthotopic transplantation. Cardioplegia was initiated 
using a standard iso-osmolar (Tyers’) solution in both groups. In 
group B, the perfusate contained Na - 112 meq/L, K - 18 meq/L, 
Cl - 83 meq/L, Ca - 1.8 meq/L, Mg - 8 meq/L, HCO3 - 14 meq/L 
at a pH of 7.8, temperature of 10°C and an osmolality of 302 
mOsm/kg. Glucose (12.5 g/L), mannitol (2 g/L) and insulin (5 
units/L) were added to the perfusate.
Following transplantation and volume challenge, indices of 
cardiac function were significantly better for group B.
G r o u p C l v c f E D V E S V H L
W a l l
s t r e s s
A 11 ±  14 - 8  ±  2 6 3 6  ±  4 7 2 4  ±  3 3 1 ±  8 - 5  ±  3 7  ±  5
B 4 7  ±  31 - 3 5  ±  19 3 2  ±  51 3 6  ±  3 0 2 1  ±  12 -  1 ±  2 18 ±  9
p  <  0 .0 5 p  <  0 .0 5 N S N S p  <  0 .0 1 p  <  0 .0 1 N S
Pressure volume relationships were assessed for volume load­
ing. Myocardial performance (CI/LVEDV, LVSWI/PCWP, 
CI/PCWP), systolic function (SBP/LVESVI) and diastolic compli­
ance (PCWP/LVEDVI). Group A myocardial performance slopes 
shifted downward with diastolic compliance upward (NS). We 
conclude that both techniques provide satisfactory protection for 
heart transplant' ion following 6 hours of ischemia, and contrac­
tile capacity is significantly better following the hypothermic 
pefusion technique.
R83
MEDIAN STERNOTOMY FOR PULMONARY RESECTION. 
F.M. Shamji, H.J. Sachs, W. Goldstein, W.J. Keon. Division of 
Thoracic Surgery and Division of Cardiac Surgery, Ottawa Civic 
Hospital, University of Ottawa, Ottawa, Ont.
The selective use of median sternotomy for pulmonary resection 
forms the basis of this report.
From 1980 to 1987, 32 patients underwent resection of both 
benign and malignant lesions through a median sternotomy. Of 
the seven patients who had a combination of pulmonary resection 
and coronary artery bypass operation, heparinization and institu­
tion of cardiopulmonary bypass prior to lung resection was 
necessary in only one patient for a left lower lobe lesion. 
Pulmonary resection alone was performed in nine patients for 
severe bilateral emphysematous bullae (three), metastatic lung 
cancer (three), synchronous bilateral primary lung cancers (two) 
and metachronous primary lung cancer following pneumonectomy 
(one). The remaining 16 patients underwent pulmonary resection 
in continuity with resection of malignant mediastinal tumour. 
One perioperative death from adult respiratory distress syndrome 
occurred in the combined coronary artery bypass grafting-pulm­
onary resection group, and one additional patient required re­
exploration for hemorrhage in the pulmonary resection alone 
group.
Our experience (1) confirms the usefulness of median sternoto­
my for both major and minor bilateral pulmonary resections in 
selected cases and (2) demonstrates the feasibility of simultaneous 
correction of cardiac lesion and pulmonary resection.
R84
OMENTAL PEDICLE GRAFT IN THE TREATMENT OF 
POST-STERNOTOMY MEDIASTINITIS. P. Bedard, F. 
Shamji, W.J. Keon. University of Ottawa Heart Institute, Ottawa 
Civic Hospital, Ottawa, Ont.
Mediastinitis is a life-threatening complication after median 
sternotomy for cardiac surgery. The basic principles of its man­
agement include adequate mediastinal drainage, removal of all 
foreign material (including infected and dead tissues) and obliter­
ation of dead space.
Obliteration of dead space may be difficult to obtain using the 
usual method of creating a vacuum with large bore tubes. 
Alternative methods consist of using muscle and/or omental 
transpositions. We are presenting two male patients with postop­
erative mediastinitis 1 week and 3 months following coronary 
artery bypass grafting (CABG) treated with an omental pedicle 
graft. One patient developed sternal dehiscence and mediastinitis 
after his fourth operation for CABG. A large dead space was 
present following appropriate debridement.
The other patient presented with hemoptysis, fever and chest 
pain 3 months following CABG. A large mycotic aneurysm 
draining in the left lung was excised. In both these patients an 
omental pedicle was obtained to fill up the dead space. Appropri­
ate antibiotics were given for 3 and 4 weeks respectively and chest 
tube irrigation was used with the mycotic aneurysm. The patients 
were discharged home 1 month postoperatively with their wounds
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well healed. They are free of infection 6 and 12 months postopera- 
tively respectively.
With this experience we propose the use of omental graft as a 
method of closing a large mediastinal dead space which cannot 
otherwise be closed by conventional methods when the sternal 
edges can be reapproximated.
R85
COLD POTASSIUM CARDIOPLEGIA AND EARLY POST­
OPERATIVE MYOCARDIAL FUNCTION: INFLUENCE OF 
CALCIUM FLUX AND FREE OXYGEN RADICAL FORMA­
TION INHIBITION. A CLINICAL STUDY. G. Fradet, W.R.E. 
Jamieson, L. Rosado, M.T. Janusz, C.W. Tomlinson, G. Town­
send. University of British Columbia, Vancouver, BC
Forty patients (elective CAB, LVEF > 50%) were randomized into 
four groups (n = 10 each). I - Tyers’ (T) iso-osmolar potassium 
cardioplegia; II - T with verapamil (V) (0.25 mg with initial and 
final infusion of cardioplegia); III - T with high magnesium 
Plegisol (P) as final infusion; IV - T with preoperative allopurinol 
(A) (300 mg bid for 36 to 48 hours). Hemodynamic assessment 
before (a) and after (b) bypass and response to an acute preload 
increase (c) were measured.
G r o u p C l  ( m e a n  ±  S E M ) S I  ( m e a n  ±  S E M )
a b c a b c
I 2 . 6 4  ±  0 .1 6 3 .3 6  ±  0 .3 4 3 .5  ± 0 . 2 8 3 0 .4  ±  1 .6 3 4 .1  ±  3 .3 3 6 .6  ±  2 .9
II 2 .6 5  ±  0 .2 1 3 .0  ± 0 . 1 5 3 .6 2  ± 0 . 1 5 2 9 .1  ± 2 . 4 3 3 .0  ±  1.9 4 0 .5  ±  1.7
II I 2 . 6 9  ±  0 .2 2 . 5 7  ± 0 . 2 1 2 .9 2  ±  0 .2 5 2 9 .9  ±  1 .9 2 8 .6  ±  2.1 3 2 . 4  ±  2 .4
IV 2 . 9 8  ±  0 .2 5 3 .8 2  ±  0 .2 7 4 .0 1  ±  0 .2 4 3 3 .1 6  ± 2 . 7 4 2 .2  ±  2 .8 4 4 .9  ±  2 .7
The indices of all groups were comparable before bypass. Post 
bypass, the SI of group IV (A) was better than III (P), II (V) and I 
(T) (p < 0.05). After the acute preload increase, A was again 
significantly better than P and T (p < 0.05). Assessing Cl, A 
performed better than P and V post bypass and better than P after 
volume loading. However, there was no significant difference with 
the control group (T). Myocardial performance indices (Cl, SI, 
LVSWI versus PCWP), diastolic complicance (PCWP versus 
LVEDVI) and systolic elastance (SBP versus LVESVI) did not 
differentiate the groups (p NS). The manipulations on Ca1” flux or 
oxygen free radical control failed to show further beneficial 
protection over potassium and hypothermia.
R86
A PROSPECTIVE EVALUATION OF CARDIAC RISKS IN 
MAJOR PULMONARY RESECTIONS. J.N.K. Odim, H. 
Shennib, G. Hedderich, J. Wilson, R.C-J. Chiu. The Montreal 
General Hospital, McGill University, Montreal, PQ
With improved respiratory support and increasing age of patients, 
cardiac complications are becoming more important in patients 
undergoing major pulmonary resections. To assess the predictive 
value of cardiac risk index devised by Goldman and associates, 
we prospectively scored and assigned into four risk categories 157 
patients who were undergoing pulmonary resections. They were 
then correlated with postoperative cardiac events, which included 
arrhythmias, life-threatening cardiac complications and cardiac 
deaths.
The overall hospital mortality was 6% (9 of 157), of which 3% 
(4 of 157) were cardiac deaths. Although there were 33% of 
patients undergoing pneumonectomies in this series, two deaths in 
this group accounted for 50% (2 of 4) of cardiac deaths.
The mean age of patients in classes I through IV was 58, 67, 69 
and 75 years respectively. There was a 2:l male to female ratio. 
The incidence of cardiac events increased with each risk class; 5% 
(9 of 97) for class I, 29% (15 of 52) for II, 43% (3 of 7) for III and 
100% (1 of 1) for IV. Overall, 15% (24 of 157) had a cardiac event. 
In 4% (7 of 157), they were life-threatening or lethal, as compared 
with the 6% incidence reported in Goldman’s original retrospec­
tive series which, however, included nonpulmonary cases.
We conclude that “cardiac risk index” in conjunction with the 
extent of pulmonary resection is useful in assessing the risk of 
cardiac complications in patients undergoing major elective pul­
monary resections.
R87
THE CARPENTIER-EDWARDS STANDARD PORCINE BIO­
PROSTHESIS—LONG-TERM EVALUATION OF THE 
HIGH-PRESSURE FIXED PROSTHESIS. W.R.E. Jamieson, 
M.T. Janusz, R.T. Miyagishima, A.I. Munro, A.N. Gerein, P. 
Allen, L.H. Burr, G.F.O. Tyers, J. MacNab, F. Chan. University of 
British Columbia, Vancouver, BC
The Carpentier-Edwards standard porcine bioprosthesis (CE-S) 
was implanted in 1184 patients (1204 operations, 1320 valves) 
between 1975 and 1986, the majority prior to 1982. Previous 
cardiac procedures had been performed in 12.4% (149), while 
concomitant procedures were performed in 26.7% (321). The early 
mortality was 7.6% (91). The overall survival at 12 years was 
53.5% ± 4.6% (3.9%/pt-yr, 260 deaths). The freedom from 
valve-related complications and composites of complications are 
as follows at 10 years:
Thromboembolism 81.4 ± 2.7%
Antithromboembolism-related hemorrhage 95.8 ± 0.9%
Periprosthetic leak 95.5 ± 1.0%
Structural valve deterioration 77.2 ± 0.9%
Prosthetic valve endocarditis 94.1 ± 1.1%
Clinical valve dysfunction 97.4 ± 0.8%
Reoperation 70.2 ± 3.0%
Mortality 85.9 ± 2.3%
Mortality, reoperation and residual morbidity 59.6 ± 3.2%
Valve complications contributed to early mortality (TE, 2; 
ATH, 1; PVE, 3; PPL, 4) and late mortality (TE, 22; ATH, 8; 
CVD, 1; PVE, 12; PPL, 7; SVD, 13); total 73 (early, 10; late, 63 
patients). There were 145 reoperations (2.2%/pt-yr) with 20 
fatalities (0.3 - SVD, 10; PPL, 6; PVE, 2; CVD, 1; TE, 1). 
Structural valve deterioration (primary tissue failure) was identi­
fied in 98 patients contributing to 13 deaths (10 at reopera­
tion— 10%). Structural valve deterioration is the significant com­
plication, freedom at 10 years for AVR, 83.0 ± 3.7, MVR, 71.9 ± 
48.8%.
R88
DOES THE SURGICAL TRAUMA OF “EXPLORATORY 
THORACOTOMY” AFFECT SURVIVAL OF PATIENTS 
WITH BRONCHOGENIC CARCINOMA? A. Paul, D. Marelli, 
J.A.S. Wilson, R.C-J. Chiu, D.S. Mulder. The Montreal General 
Hospital, McGill University, Montreal, PQ
Surgical trauma has been reported to shorten the survival of 
patients with certain advanced malignant tumours, and, experi­
mentally, an immunosuppressive effect of operation per se has 
been postulated. A retrospective review was carried out in order 
to assess the possible effect of exploratory thoracotomy in patients 
with a non-small cell carcinoma of the lung with N2 nodal 
metastases (stage III).
Between 1960 and 1982, lung resection was not done in 48 
patients during exploratory thoracotomy due to the presence of 
mediastinal lymph-node involvement. The survival of these pa­
tients was compared to that of 64 consecutive patients in whom 
mediastinoscopy established N2 disease, precluding the need for 
thoracotomy.
There were no significant differences (x2 test, p > 0.4) between 
these two groups of patients in their age, sex, tumour pathology 
(30 squamous and 18 adenocarcinomas versus 43 squamous and 
21 adenocarcinomas) and adjunctive radiotherapy (54% versus 
56%). There were slightly more T4 tumours in the thoracotomy 
group (50% versus 30%, p = 0.15). The hospital stay was longer in 
the thoracotomy group (2.3 ±1.1 versus 1.5 ± 0.9 months, p = 
0.01). Follow-up studies show that the actuarial survival curves 
for the two groups were virtually identical, and the 12-month 
survival rates were less than 20% for both groups. The power of 
these data in detecting a 15% difference in the 12-month actuarial 
survival rate is 0.80.
Thus, our study failed to demonstrate the adverse immunosup­
pressive effect of thoracotomy in lung cancer patients as reflected 
in their survival.
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R89
CARDIAC EXPOSURE TO PLASTICIZERS FROM MEDI­
CAL PROCEDURES. Y.A. Barry, R.S. Labow, W.J. Keon, M. 
Tocchi, G. Rock. Ottawa Centre, Canadian Red Cross, B.T.S., 
Department of Medicine, Department of Biochemistry and Depart­
ment of Laboratory Medicine, University of Ottawa Heart Institute, 
Ottawa Civic Hospital, Ottawa, Ont.
Di(2-ethylhexyl)phthalate (DEHP) imparts flexibility to polyvi­
nylchloride that is used in extracorporeal circulation. Earlier, we 
showed that DEHP and its primary metabolite mono(2-ethylhex- 
yl)phthalate (MEHP) accumulated in the circulation of patients 
undergoing cardiopulmonary bypass, increasing almost 10-fold 
from the beginning to the end of the procedure and in some cases 
remaining elevated several days post surgery. In order to assess 
the toxic effects of these plasticizers, samples of human atrial and 
ventricular tissue were incubated in Krebs-Henseleit buffer con­
taining DEHP and MEHP (15 to 80 Mg/ml) for 5, 24 and 48 hours. 
Intracellular accumulation of these phthalate esters occurred, and 
the concentration of DEHP and MEHP measured in the tissue 
samples varied from 15% to 106% that of the incubation medium. 
When the ultrastructural changes were analysed by light and 
transmission electron microscopy cell damage, vacuolization and 
swelling were observed in all tissues exposed to either plasticizer 
for 5 hours or longer. Earlier, MEHP was shown to have a 
dose-dependent negative inotropic effect and induced arrhythmias 
in an in vitro human atrial preparation. This cardiodepressive 
effect of MEHP can be blocked with atropine (40 Mg/ml), shifting 
the IC50 of MEHP from 80 to 150 Mg/ml- Atropine (25 Mg/ml) also 
blocked the cell damage which was observed when atrial tissue 
was incubated with MEHP (160 Mg/ml), suggesting that atropine 
may be preventing MEHP transport across cell membranes.
R90
ALLOPURINOL IN THE PREVENTION OF ISCHEMIA- 
REPERFUSION INJURY FOR HEART-LUNG TRANSPLAN­
TATION-OXIDANT STRESS ASSESSMENT BY METHOD 
OF “FORCED PEROXIDATION”. W.R.E. Jamieson, A.K. 
Qayumi, D.V. Godin, S. Lam, R. Ko. University of British 
Columbia, Vancouver, BC
Heart-lung transplantation was performed in two groups of pigs 
subjected to hypothermic storage (ischemic time 5 hours) follow­
ing cardiac protection (iso-osmolar Tyers’ solution) and pulmo­
nary protection (modified Collins’ solution)—Group A, no addi­
tional protection (n = 7), group B, pretreatment with allopurinol, 
50 mg/kg for 5 days (n = 7). Measured and calculated parameters 
of cardiac and pulmonary function were performed in donor as 
control (Tl) and recipient at 30 minutes (T2) and 2 hours (T3).
G r o u p  A G r o u p  B
T l T 2 T 3 T l T 2 T 3
L u n g  w a te r 2 5 4  ±  2 3 3 5 2  ±  5 9 4 4 6  ±  5 4 2 0 6  ±  2 5 2 8 6  ±  5 8 4 9 1  ±  9 0
A a  g r a d i e n t 2 .7  ±  1 4 .5  ±  2 9 .3  ±  2 2 .0  ±  0 .1 2 .6  ±  0 .4 8 .8  ±  2
d p / d t 5 3  ±  2 6 0  ±  7 5 5  ±  7 5 3  ±  4 7 3  ±  6 4 7  ±  3
L V S W I 2 4  ±  2 9 ±  2 9  ±  1 2 7  ±  2 11 ±  3 1 0  ±  3
P V R 9 6  ±  5 6 2 5 5  ±  3 6 2 5 0  ±  8 1 3 3  ±  16 2 2 2  ±  2 8 2 1 1  ±  31
Repeated measures ANOVA with orthogonal contrasts did not 
demonstrate significance between groups, but a strong time effect 
(p < 0.05). Group A demonstrated progressive deterioration of 
lung function. Group B animals responded variably from mainte­
nance of good function to rapidly deteriorating function at 2 
hours. The MDA assay results correlated with post-ischemic 
functional status, rapid lowering of blood MDA levels to day 3 
correlated with tolerance of ischemia and reperfusion while 
minimal or nonresponders tolerated the insult poorly. Allopurinol 
can be protective of ischemia reperfusion in a model deficient of 
xanthine oxidase; the mechanism requires elucidation.
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R305
PARATHYROID LOCALIZATION: PROSPECTIVE EVALUA­
TION OF ULTRASOUND AND THALLIUM/TECHNETIUM  
SCINTIGRAPHY IN HYPERPARATHYROIDISM. B.L. Stein, 
R. Lisbona, M.J. Wexler. Department of Surgery, Royal Victoria 
Hospital, Montreal, PQ
Preoperative ultrasound (U/S) and dual tracer (T1-2D1 [2mCi], 
Tc-99m [lmCi]) scintigraphy (N/S) were performed in 19 con­
secutive patients to assess their capability to localize abnormal 
parathyroids. Preoperative PTH levels, weight and location of 
abnormal glands at surgery were recorded. Localization studies 
were tabulated in three ways: (a) ability to correctly predict each 
gland as normal or abnormal; (b) to correctly detect the side(s) of 
the abnormality; (c) to make the correct localization(s) in the 
patient as a whole. Thirteen patients had solitary adenomas (A) 
and 6 hyperplasia (H). Of 17 U/S, 2 were inadequate; of 18 N/S, 1 
was inadequate. Results are tabulated.
Ultrasound
Per pt (15), 
total
Per side (30) Per gland (60), 
totalTotal A H
True + 7 10 9 1 10
True - - 12 12 0 36
False + 2 0 0 0 2
False — 6 8 3 5 12
Sens, % 54 56 75 20 45
Spec, % - 100 100 - 95
+ Pred, % 78 100 100 100 83
Per pt (18), Per side (36) Per gland (72),
Nuclear scan total Total A H total
True + 6 7 5 2 8
True — 1 14 13 1 45
False + 0 0 0 0 0
False — 12 15 8 7 19
Sens, % 33 32 38 22 30
Spec, % - 100 100 100 100
+ Pred, % 100 100 100 100 100
The weight (size) of the abnormal gland and the PTH levels, a 
measure of physiological hyperfunction, did not correlate with 
U/S or N/S detection ability; thus the false-negative rate is not 
accounted for by size or function of the gland. The coexistence of 
multinodular goitre (five patients) did not adversely affect detec­
tion. Both U/S (sensitivity 54%/patient) and N/S (sensitivity 
33%/patient) miss significant pathology; however, when abnor­
malities are detected it is with a high degree of reliability (78% to 
100%). Detection rates are considerably better for adenomas than 
hyperplasia. Ultrasound is far superior to N/S and can be a useful 
preoperative localization modality especially to detect the side of 
pathology when an adenoma is suspected (sensitivity 75%, speci­
ficity 100%).
R306
TISSUE PLASMINOGEN ACTIVATOR (t-PA) RESTORES 
COLONIC HEALING IMPAIRED BY LOCAL INFECTION. 
K.A. Houston, C. Swallow, O.D. Rotstein. University of Toronto, 
Toronto Western Hospital, Toronto, Ont.
Colonic anastomotic healing is impaired by local infection. Since 
we have previously shown that the fibrinolytic agent t-PA pre­
vents intra-abdominal abscess formation, we hypothesized that 
intraperitoneal (ip) lavage with t-PA might lead to an improve­
ment in colonic anastomotic healing by preventing local infection. 
An end-to-end anastomosis of divided sigmoid colon was per­
formed in Wistar rats. Animals were randomly assigned to four 
treatment groups, receiving ip lavage with 4 ml of either balanced 
salt solution (HBSS) or t-PA (0.01 mg/ml); in groups III and IV an 
infected fibrin clot (Escherichia coli 2 X 109 + Bacteroides fragilis 
2 X 109) was inserted ip prior to lavage. All animals received a 
single intramuscular dose of clindamycin-gentamicin. Anastomot­
ic bursting pressure (ABP) was assessed at day 5 and the abdomen 
was inspected for abscesses.
G ro u p ip  lav ag e
ip  f ib r in  
c lo t N A B P , m m  Hg*
A bscess  
ra te , %
i H B S S - 19 1 24 .7  ( ±  8 .0) 15.8
i i t-P A - 9 1 06 .7  ( ±  11.6) 22 .2
i n H B S S + 9 7 4 .2  ( ±  11.6)b 100.0*
IV t-P A + 10 111.8  (±  11.1) 30 .0
a: m e a n  (±  S E M ) b : p  <  0 .0 3  v e rs u s  I a n d  IV  c: p  <  0 .01  v e rsu s  o th e r  g ro u p s.
Intraperitoneal lavage with t-PA in animals inoculated with an 
infected fibrin clot reduced ip abscess rates and restored ABP 
back to control levels. Furthermore, t-PA alone had no direct 
deleterious effect on wound healing. Thus, t-PA reversed the 
infection-induced inhibition of colonic anastomotic healing by 
preventing local infection. Combined with antibiotics and careful 
surgical technique, its use may improve the safety of colonic 
anastomosis in the presence of local infection.
R307
EXPERIENCE WITH THE NISSEN FUNDOPLICATION. G. 
Beauchamp, M. Dube, G. Jobin. Department of Surgery, Hopital 
Maisonneuve-Rosemont, Universite de Montreal, Montreal, PQ
The Nissen fundoplication is the most popular operation for the 
control of gastroesophageal reflux. However, this operation is not 
without complications.
During the period 1980 to 1986, 121 patients had a transab­
dominal Nissen fundoplication. All patients were documented 
with endoscopy, radiology and manometry, before surgery and at 
1 year after. The fundoplication was done on a no. 52F bougie 
with a length of 2 to 3 cm. There was no operative mortality, no 
intraoperative complication, no splenectomy. The patients were 
followed at 3 to 6-month intervals, for a mean follow-up of 3 
years.
Our clinical evaluation shows 77 of 121 with an excellent to 
good result, 15 patients with a fair result and 8 with unacceptable 
result. Four patients needed reoperation for a paraesophageal 
hernia, seven patients for an incisional hernia and two for a 
postoperative intestinal occlusion. All eight patients with bad 
results were reoperated on, seven for a severe gas-bloat syndrome 
and one for dysphagia.
The Nissen fundoplication is not without complications neces­
sitating reoperation. A very close follow-up and objective evalua­
tion were necessary to know what we are performing with this 
operation.
R308
THE EFFECT OF COLI ENDOTOXIN ON HUMAN INSU­
LIN RECEPTORS. S. Meterissian, D. St. Vil, R.A. Forse. 
Department of Surgery, Royal Victoria Hospital, McGill Universi­
ty, Montreal, PQ
The septic state is associated with hypermetabolism, hyperglyce­
mia and insulin resistance. The etiology of the insulin resistance is 
poorly understood in part due to the lack of measurement of 
insulin receptors. This study was carried out to determine if the 
adipose tissue of septic patients has insulin resistance and to
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assess if Escherichia coli endotoxin (ECE) affects the insulin 
receptor. Adipose tissue was biopsied from 10 nondiabetic sub­
jects undergoing elective surgery and 3 septic patients. Lipolysis 
was measured by using an in vitro dual isotope technique and is 
expressed as the lipolysis factor (LF). Insulin receptors were 
stimulated by using varying concentrations of insulin, and the 
responsiveness of the insulin receptor (Vmax), a measure of the 
post-receptor mechanism, was obtained. As insulin inhibits adipo­
cyte lipolysis, the LF is negative. The results are:
Log (In s) - 8  - 8 . 3 - 9 - 9 .3 - 1 0 V nu»
N orm als  -  9.62 ±  5.86 -  8.33 ±  2.84 
S ep tic  -  8 .78 ±  2.44 -  18.19 ±  6.80*
-  12.18 ±  4.04 
- 1 6 .6 4  ± 4 .7 3
- 9 .8 3  ±  2.64 
-  15.26 ±  11.29
- 6 .9 8  ±  2.29 
- 2 2 .2 2  ±  2.5*
13.60 ±  3.85 
26 .90  ± 0 .6 8 *
*p < 0.05 using  unpaired  S tu d en t’s  /-test.
Log (In s) - 8  - 8 . 3 - 9 - 9 .3 - 1 0 V nuu
Saline  - 8 .7 8  ±  2.44 - 8 .3 3  ± 2 .8 4  
E C E  - 1 .7 7  ± 1 .1 9  - 3 .0 9  ± 1 .1 4 *
-  12.18 ±  4.04 
- 2 .6 8  ±  1.61*
- 9 .8 3  ±  2.64 
- 1 .8 5  ±  1.77*
- 6 .9 8  ±  2.29 
- 2 .4 3  ±  1.47*
-  13.60 ±  3.85 
- 6 .1 8  ±  1.57*
• p  < 0.05 using  paired  S tu d en t’s  /-test.
These data show an increased response to insulin in vitro. This 
hypersensitivity is an in vitro indication of insulin resistance in 
the septic patient. Adipose tissue from non-septic, non-diabetic 
patients was incubated with either saline or ECE in the presence 
of varying insulin concentrations as presented below.
This study indicates that the adipose tissue of septic patients 
has insulin resistance. The data show that ECE significantly 
inhibits adipose tissue insulin receptors and may play a role in the 
insulin resistance of sepsis.
R309
ALLOTRANSPLANTATION OF SINGLE DONOR PURIFIED 
CANINE ISLETS INTO THE SPLEEN OR RENAL SUBCAP- 
SULAR SPACE WITH CYCLOSPORINE. M. Cattral, G. War- 
nock, R. Rajotte, N. Kneteman. University of Alberta, Edmonton, 
Alta.
Effective immunosuppression is required to promote clinical islet 
cell transplantation. In this study we evaluate survival of freshly 
isolated islet grafts (mean ± SE wt = 0.45 ± 0.04 g containing 119 
=t 7 x 103 islets, purity 91% by electron microscopy, n = 26) 
transplanted into four groups of pancreatectomized outbred 
mongrel dogs: group 1, auto-spleen without cyclosporine (CsA) 
(5444 ± 688 islets/kg body weight, n = 6); group 2, allo-spleen 
without CsA (6669 ± 1744, n = 4); group 3, allo-spleen with CsA 
(8645 ± 1149, n = 10); and group 4, allo-kidney with CsA (10263 
± 1418, n = 6). Daily intramuscular injections of CsA were given 
for 4 days before and 30 days after transplantation. Fasting 
plasma glucose (PG, mg/dL) and serum CsA trough levels by 
radioimmunoassay were determined daily. Intravenous glucose 
tolerance was measured before and after transplantation and K 
values were computed (preop K = 4 ± 0.2). In group 1 all were 
normoglycemic, PG = 98 ± 2 and K. = 1.8 ± 0.2 at 1 month. In 
group 2, islets failed at 4 ± 1 days. In group 3, 9 of 10 were 
initially normoglycemic and 6 remained so, PG = 128 ± 8 at 1 
month, K = 0.93 ± 0.2 (p < 0.05 versus group 1). Cyclosporine 
levels before and after transplantation were 627 ± 179 and 359 ± 
40 Mg/L. After stopping CsA, the grafts failed at 12.3 ± 3.1 days. 
Two dogs developed intussusceptions and died and two other 
dogs with initial CsA levels < 300 pg/L, rejected at 2 and 8 days. 
Group 4 recipients, all with CsA levels > 300 pg/'L, were 
normoglycemic for 4.3 ± 1.5 days; three showed marginal graft 
function (PG < 225) for 13 ± 2.1 days. These data are unique in 
showing prolonged function of allogeneic purified islets trans­
planted from a single outbred large mammal, but glucose toler­
ance is impaired. Cyclosporine at serum levels > 300 pg/L induces 
prolonged survival of purified canine islets and rejection is 
prompt when it is stopped.
R310
LONG-TERM RESULTS OF VERTICAL BANDED GASTRO­
PLASTY. L.D. MacLean, B.M. Rhode, B. Karam, R.A. Forse. 
Department of Surgery, Royal Victoria Hospital, McGill Universi­
ty, Montreal, PQ
Vertical banded gastroplasty was performed in 201 patients with a 
preoperative obesity index > 40 kg/m2. They were followed for 2 
to 5 years. The gastric outlet orifice in 90% of patients was
constructed with a circumference of 42 to 45 mm because of 
dissatisfaction with weight loss when a larger orifice was used. 
Patients were examined and endoscoped at regular intervals. A 
good result was defined as weight loss to within 30% of ideal; 
satisfactory result a loss of > 25% of preoperative weight; and 
unsatisfactory result a loss of < 25% of preoperative weight. 
Results appear below. A significant incidence of late perforations 
of the vertical staple line occurred (43%), prompting reoperation 
in 21%. An additional 9% required reoperation for abnormalities 
of the gastroplasty orifice. We conclude that evaluation of results 
solely by consideration of mean percent weight loss may fail to 
identify unsatisfactory results (11 to 18%) and may obscure 
significant late complications. Preoperative definitions of criteria 
for success and long-term follow-up are essential for determina­
tion of efficacy of these procedures.
T im e , y r 1 2 3 4 5
N 201 2 0 0 152 6 4 14
G o o d , % 32 38 32 3 4 4 6
S a tis fa c to ry , % 51 49 57 4 8 39
U n s a tis fa c to ry , % 17 13 11 18 15
M ean  % w e ig h t  lo ss 3 0 .9 33 .8 33.1 3 2 .9 3 1 .8
L o s t to  fo llo w -u p , % 4 .5 14.5 11 6 .2 5 7
D e a th s , n o . 1 1 1 0 0
D is ru p tio n  s ta p le  l in e , n o . 3 9 22 21 4 0
R e o p e ra t io n s , n o . 7 21 2 4 3 5
R311
CONTROL OF HUMAN ADIPOCYTE LIPOLYSIS BY SEP­
TIC PLASMA MEDIATORS. D. St. Vil, S. Meterissian, M. 
Gagner, R.A. Forse. Department of Surgery, Royal Victoria Hospi­
tal, McGill University, Montreal, PQ
Adipocyte lipolysis is controlled by the adrenergic system in 
sepsis. The object of this study was to determine the effect of 
plasma mediators on the adrenergic control of adipocyte lipolysis. 
Plasma was obtained from patients with gram negative sepsis. 
Adipose tissue and control plasma were obtained from patients 
undergoing elective surgery. The adipose tissue was incubated in 
media with septic plasma or one of three plasma fractions which 
were separated by micropore filtration. The adrenergic beta-1 
receptors (stimulating lipolysis) were stimulated with iso­
proterenol (ISO), and the alpha-2 receptors (inhibiting lipolysis) 
with clonidine (CLON). Lipolysis was determined in vitro by a 
dual isotope technique and the result is expressed as the lipolysis 
factor (LF) ± SEM. The results for the plasma fractions were 
similar between early and late sepsis and are presented together.
ISO ____________ CLON______________
Control Septic Control Septic
Total plasma
Earlv septic 89.2 ± 17.9 43.3 ± 6.8* -6 7 .8  ± 12.6 33.9 ± 7.6*
Late septic 56.4 ± 17.0 99.8 ± 37.5* -36 .1  ± 11.9 -6 9 .6  ±  16.5*
Plasma fractions
> 50 000 MW 75.5 ± 17.6 50.8 ±11.9* -46 .1  ± 13.2 -5 1 .4  =t 16.8
10 to 50 000 MW 68.6 ± 15.3 96.4 ± 24.9 -4 8 .5  ± 15.2 -8 6 .3  ±  28.8*
< 10 000 MW 46.3 ± 10.5 168.6 ±40.1* -6 5 .4  ± 8.2 -9 6 .0  ±  18.7*
•Significantly different from control by Student’s paired /-test.
These data demonstrate decreased lipolysis with early septic 
plasma. The adrenergic control is decreased and this is due to a 
plasma inhibiting factor greater than 50 000 MW. In late sepsis, 
basal and adrenergic stimulated lipolysis are increased. This 
increased lipolysis appears to be due to an adrenergic potentiating 
factor (APF) of an MW less than 10 000. These data indicate that 
adipocyte lipolysis in early and late sepsis is controlled by 
different plasma mediators.
R312
GORE-TEX AND MARLEX IN ABDOMINAL WALL RECON­
STRUCTION. J. Murphy, P. Dionne, J. Freeman. Division of 
General Surgery, Ottawa General Hospital, University of Ottawa, 
Ottawa, Ont.
When primary closure of the abdomen is not feasible, a prosthesis 
is commonly used. Marlex adheres to surrounding tissues and 
viscera which may lead to intestinal fistula. Gore-Tex, extensively 
used for vascular conduits, is available as soft-tissue patch. A
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comparison of the two materials was carried out with respect to 
strength and adhesion formation. Under halothane anesthesia, a 
2.5 X 3.5 cm full-thickness area of abdominal wall was excised in 
32 CD rats. Identical patches of Marlex or 1-mm Gore-Tex, 
determined by alternate assignment, were sutured with continu­
ous 4-0 Gore-Tex to repair the defect. The wound was irrigated 
with cefazolin-saline and closed with subcutaneous Vicryl and 
subcuticular Prolene. The animals were killed 107 to 140 (x = 
114) days later. Ten rats in the Gore-Tex group developed early 
wound seromas which resolved by the third week without inter­
vention. One inflamed wound in the Marlex group resolved. 
Adhesion formation was graded at necropsy and recorded photo­
graphically in each animal. The mean adhesion index (none = 0, 
maximal = 4) was 1.37 ± 0.2 and 2.62 ±0.12 (mean ± SEM) for 
the Gore-Tex and Marlex groups respectively (p < 0.005, un­
paired t-test). A template was used to fashion 2-cm coronal strips 
of abdominal wall for tensile strength testing on a TTLD Instrom 
tensiometer: 2.67 ± 0 .14  and 3.02 ± 0 .16  kg/cm (mean ± SEM) 
for the Gore-Tex and Marlex groups respectively (NS). Histologic 
examination revealed a greater number of epitheloid giant cells 
and less collagen formation in the Gore-Tex group. Abdominal 
wall reconstruction with Gore-Tex resulted in wound strength 
equal to that of Marlex. Gore-Tex formed less adhesions and is 
indicated when the prosthesis and viscera are in proximity.
R313
DETERMINANTS OF MORTALITY IN SURGICALLY 
TREATED ACUTE SMALL-BOWEL OBSTRUCTION. G.M. 
Fried, S. Suissa, L.T. Glickman, C. Huckell. Montreal General 
Hospital, McGill University, Montreal, PQ
We analysed factors which predicted mortality in 145 patients 
treated surgically for acute small-bowel obstruction (SBO) from 
1980 to 1985. Variables evaluated included age, sex, etiology of 
SBO, WBC, venous C 0 2 (VCO2), amylase, bilirubin, SGOT, 
albumin (alb), glucose, calcium, phosphate, BUN, chronic health 
score (CHS) (defined as + if there was disease or failure of a major 
organ system), cancer (CA), acute physiological index (APACHE) 
and delay from diagnosis to operation. Mortality was defined as 
death in < 30 days of operation. Multiple stepwise logistic 
regression was used to relate variables to mortality and to obtain 
odds ratios (OR). Odds ratios indicate relative odds of death in 
the presence versus absence of the variable in question. Overall 
mortality was 13.1%. Predictors of death were alb < 3.0 (OR = 
6.6; p = 0.005), VC02 < 24 (OR = 6.1, P = 0.008), + CHS 
including CA (OR = 42.9, p = 0.001) or excluding CA (OR = 
11.9, p = 0.026). Predicted mortality rates are:
Variable Mortality, % Variable Mortality, %
vco2 1.4 CHS + Alb 15.2
Alb 1.5 CA + VC02 37.3
CHS 2.6 CA + Alb 39.2
CA 8.9 CHS + VC02 + Alb 52.3
Alb + V C02 8.4 CA + VC02 + Alb 79.8
CHS + V C02 14.2 All variables absent 0.2
Mortality from acute SBO remains high. Patients at risk have 
low serum albumin, metabolic acidosis and chronic disease 
(especially cancer). Age, APACHE score, WBC, amylase and delay 
of operation were not independent predictors of mortality. This 
type of analysis can be used to identify high risk patients with 
acute SBO and to account for mortality in terms of a few 
variables.
R314
DETERMINANTS OF FASCIAL RESISTANCE TO SUTURE 
PULLOUT. J.A. Campbell, W.J. Temple, C.B. Frank, S.A. 
Huchcroft. Department of Surgery, University of Calgary and 
Department of Epidemiology, Alberta Cancer Board, Calgary, Alta.
The relationship of suture bite size, suture diameter and fascial 
thickness to strength of wound closure was studied in cadaveric 
linea alba. All soft tissue was removed from the fascia of 12
abdominal walls. Each was divided in the midline and cut at 1.5 
cm intervals perpendicular to the midline yielding 346 test 
sections. Thickness of sections was measured 0.5 cm from 
midline. A steel suture was placed in each section with randomly 
assigned bite size (0.3, 0.6, 0.9, 1.2, 1.5, 1.8 cm) and gauge (00, 0, 
1, 2). Suture was pulled out at 100 mm/min and pull-out force was 
measured at the yield point beyond which tissue tearing occurred. 
Pullout energy to yield point was calculated.
Multiple linear regression analysis assigned 32% variability in 
pullout force to fascial thickness (p < 0.0001) and 28% to bite size 
(p < 0.0001). Suture gauge was not a significant determinant. 
Pullout force increased with bite size up to 0.9 cm and reached a 
plateau at this level. Mean force for bites > 0.9 cm was 61.9 N (SE 
= 19.4, n = 229). Pullout energy increased with bite size and 
reached a plateau at 1.2 cm. Mean pullout energy with bites > 1.2 
cm was 0.477 J (SE = 0.021, n = 165). Mean pullout force was 
58.2 N above linea semicircularis and 31.6 N below (p < 0.001). 
Mean fascial thickness was 1.19 mm above the linea and 0.77 mm 
below (p < 0.001).
Linea alba is thicker and stronger above the linea semicircula­
ris. Fascial thickness and bite size, but not suture diameter, 
determine suture security in this model. Bites of 0.9 cm are 
optimal considering pullout force, but energy analysis suggests 
additional safety with bites of at least 1.2 cm.
R315
SCREENING FOR BREAST CANCER—HOW SENSITIVE 
SHOULD A “POSITIVE” MAMMOGRAM BE? C.J. Wright, 
J.H.K. Wallace, S. Gilmour. Department of Surgery and Depart­
ment of Medical Imaging, University of Saskatchewan, Saskatoon, 
Sask.
The positive predictive value (PPV) of mammography varies 
widely with the prevalence of breast cancer and the level of 
sensitivity at which a “positive call” is made. In this study the 
correlation between the criteria used to determine sensitivity and 
the PPV was examined.
All 143 patients having mammography and subsequent breast 
biopsy in 1986 were included. The mammograms were re­
examined (blind to the pathology) and the following information 
recorded: presence or absence of a mass, architectural distortion, 
asymmetry, skin changes, microcalcifications. If a mass was 
present the shape and definition of the margins were recorded on 
an ordinal scale from smooth to spiculated; the size and shape of 
microcalcifications were noted. The histopathology was correlated 
with various combinations of the mammographic findings to 
manipulate the sensitivity, specificity and PPV.
Breast cancer was proven histologically in 57 of the 143 
patients (39.9%). The design of this study set the sensitivity at 
100%, with a PPV of 39.9%. A large number of different 
combinations of findings were then analysed for the effect on 
sensitivity, specificity and PPV. When a “positive” was defined as 
a spiculated mass or rod or Y-shaped microcalcifications, the best 
overall results were obtained, with sensitivity 82% and PPV 78%.
It is suggested that compromise is appropriate in reading 
mammograms from a very low prevalence group (e.g., a screened 
population). A less than optimal sensitivity (e.g., 82%) should be 
accepted to avoid the current high level of inappropriate interven­
tion.
R316
EARLY GASTRIC CANCER: IS IT A DISTINCT CLINICAL 
ENTITY? L.G. Hampson, H. Shennib, J. Lough, G.M. Fried. 
Montreal General Hospital, Montreal, PQ
With more frequent use of diagnostic endoscopy and improved 
radiologic techniques, gastric cancer is being diagnosed at an 
earlier stage. The term “early gastric cancer” (EGC) has been 
applied to lesions with invasion superficial to the muscularis 
propria. Early gastric cancer is accepted as a distinct entity with a 
very favourable prognosis. We reviewed the pathological features 
of a series of 101 patients with gastric cancer resected for cure 
over 12 years (1970 to 1981) and followed for > 5 years or until 
death. Tumours were classified by depth of invasion in the gastric
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wall: (A) mucosa, (B) submucosa, (C) muscularis propria, (D) 
serosa. Other pathological features studied were lymph-node 
involvement (LN+), presence of intestinal metaplasia in the 
gastric mucosa (IM+) and tumour growth pattern (expanding 
[EXP] or infiltrating [INF]). Outcome was defined as crude 5-year 
survival. Results:
Level n LN+, % IM+, % EXP, % 5-yr survival, %
A 10 0 100 90 90
B 15 20 67 67 73
C 18 28 50 61 67
D 58 53 50 38 35
Total 101 39 56 51 51
Twenty-five of the 101 patients had lesions with invasion level 
A or B and would be considered as having EGC. There was a 
progressive increase in LN involvement, decrease in IM and 
decrease in likelihood of expanding growth pattern with increas­
ing depth of invasion. These pathological features are associated 
with a progressive decrease in survival. These data suggest that 
EGC is not a discrete entity but a part of the continuity of gastric 
cancer. There appears to be no abrupt cut-off between level B and 
C in either pathological features or prognosis.
R317
EFFECT OF SURGERY ON TUMOUR GROWTH. A.L. 
Schneeberger, R.I. Inculet, M. Keeney, R.J. Finley. Victoria 
Hospital, London, Ont.
To determine whether remote operation or excision of tumour 
stimulates residual tumour growth (TG), male Fisher 344 rats 
with bilateral inoculations of a non-metastasizing methylcholan- 
threne-induced sarcoma were studied. Rats were randomized to 
three groups—group I control (n = 15), group II laparotomy at 
day 10 (n = 13) and group III tumour excision at day 10 leaving 
contralateral tumour focus (n = 15). At day 13 (early TG changes) 
and at day 17 (late TG changes), tumours were analysed for 
weight (TW), tumour burden as a percent of body weight (TB) and 
by flow cytometry to determine the proportion of cells in the 
proliferative S phase of the cell cycle.
T u m o u r  w e ig h t ,  g T u m o u r  b u r d e n ,  % %  S  p h a s e
G r o u p D a y  13 D a y  17 D a y  13 D a y  17 D a y  13 D a y  17
I
( 2  t u m o u r s )
1 7 .9  ±  1 .7 5 2 .3  ±  5 .9 8 .3  ±  0 .7 1 9 .7  ±  2 .4 2 8 .6  ±  1 .0 3 0 .8  ±  0 .9
II
(2  t u m o u r s )
1 4 .7  ±  2 .2 4 6 .0  ±  2 .4 6 .9  ±  0 .9 1 9 .0  ±  0 .4 2 9 .2  ±  0 .9 2 9 .5  ±  1 .2
I I I
(1  t u m o u r )
6 .5  ±  1 .3 2 2 .6  ±  5 .5 3 .1  ±  0 .6 9 .4  ±  2 .3 3 1 .6  ±  1.1 3 5 .9  ±  1 .9
No significant difference was observed in TW, TB or % S phase 
between groups I and II at days 13 and 17. The % S phase of the 
residual tumour in group III at day 17 was significantly different 
from groups I and II (p < 0.05), however, this was not reflected in 
TW or TB.
Conclusions: Operation on the host at a site remote from the 
tumour does not stimulate tumour growth. Excision of one 
tumour focus results in increased numbers of proliferative cells in 
the residual tumour; however, this does not result in an increase 
in tumour weight or burden.
R318
CAROTID BODY TUMOURS: A STUDY OF 17 PATIENTS. 
F.A. Daudi, O.G. Thurston. Department of Surgery, University of 
Alberta, Edmonton, Alta.
This study reviews the experience with 17 patients with carotid 
body tumours seen at University of Alberta Hospital over a 
38-year period (1950 to 1988).
The patients consisted of 7 males and 10 females with a mean 
age of 48 years (range 25 to 79 years). All patients presented with 
neck mass present for 2 months to 13 years. Three patients had 
bilateral tumours and three patients had a family history of 
carotid body tumour. Diagnosis was confirmed by arteriography 
alone or combined with other studies in 11 cases. In five cases, the
diagnosis was made by operative exploration. In a recent case the 
diagnosis was made by CT scanning without the need for invasive 
testing.
Fourteen patients were operated upon and the lesion was 
excised. Immediate complication was hematoma requiring reoper­
ation in two cases. Late complications included voice change (six 
patients), hypoglossal nerve palsy (three patients) and facial nerve 
palsy (one patient). Although all patients operated on were 
diagnosed as having benign carotid body tumour histologically, 
three tumours have subsequently behaved aggressively—metasta­
sis in two patients and local recurrence in one patient. Fifteen 
patients have been followed an average of 8 years since surgery. 
Eight patients are alive and free of disease, two are alive with 
tumour, one died of metastases and four died of unrelated causes.
The results of this study indicate a high incidence of neurologic 
defects associated with excision of carotid body tumours. The 
results of the follow-up study indicate that 3 of 14 tumours 
excised behaved in an aggressive or frankly malignant manner 
despite a benign histologic appearance initially.
R319
58 ANNEES/PATIENTS D’EXPERIENCE AVEC LE PORT-A- 
CATH. E. Nassif. Departement de chirurgie, Hopital Saint-Luc, 
Universite de Montreal, Montreal, PQ
Le Port-A-Cath represente une nouvelle methode d’acces veineux 
central a longue duree. Nous rapportons ici notre experience de 
octobre 1984 a fevrier 1988. Cent-onze catheters ont ete installes 
chez 106 patients. Ces catheters sont constitues d’une chambre en 
acier avec un diaphragme au Silastic permettant jusqu’a 2000 
ponctions. L’acces veineux par dissection de la jugulaire externe 
est possible meme chez les patients thrombcytopeniques. Les 111 
catheters ont ete installes pour une duree totale de 21 432 jours 
(58 annees/patients). La duree d’implantation varie de 6 jours a 
1145 jours. Les reservoirs furent ponctionnes de 1 a 1500 fois. 
Deux catheters ont du etre retires, l’un pour cause d’infection et 
1’autre du a un probleme de thrombocytose (31 et 69 jours apres 
[’installation). Une rupture de catheter est survenue 4 mois apres 
l’installation suite a un traumatisme. Quatre coudures ont neces­
sity la revision et la relocalisation de la chambre (2, 5, 18 et 36 
mois post-installation). Les catheters ont ete utilises pour preleve- 
ments, transfusions et chimiotherapie ou pour infusion continue 
d’analgesique. En conclusion, on considere que ces catheters sont 
efficaces, fiables et d’entretien facile. Ils sont actuellement utilises 
de facon routiniere dans notre milieu avec un taux de satisfaction 
elevee.
R320
IMMUNODEFICIENCY FOLLOWING SPLENECTOMY IN 
THE EARLY POST-IMMUNIZATION PERIOD. P.T. Barron, 
M. Richter. Department of Surgery and Department of Immunolo­
gy, University of Ottawa, Ottawa Civic Hospital, Ottawa, Ont.
Rabbits immunized intravenously with sheep red blood cells 
(RBCs) go through a period from 30 to 120 days post immuniza­
tion during which detectable antibody forming cells are found 
only in the spleen. Prior to day 30, antibody forming cells are 
detected in the circulation and bone marrow as well as the spleen. 
By day 120, cells can be detected in the thymus and lymph nodes.
The purpose of this experiment was to determine if an 
immunodeficiency state existed following splenectomy between 
days 30 to 120.
Forty rabbits were immunized with 109 sheep RBCs. Twelve 
animals served as controls. Splenectomy was performed in 28 
animals at day 40. Secondary immune responses as measured by 
the in vivo and in vitro plaque-forming cell assay techniques were 
performed at 2, 6 and 9 months. Agglutinating antibody titres pre- 
and post-secondary immunization were also performed.
All animals showed a greater than 60% reduction in secondary 
immune responses at the various time periods.
This model may provide an immunologic explanation for the 
post-splenectomy syndrome. Such individuals following exposure
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to an organism may have been splenectomized early in the 
post-immunization period and thus lack the capacity to evoke a 
strong response on subsequent exposure to the organism.
R321
THE EFFECT OF THE PNEUMATIC ANTI-SHOCK GAR­
MENT (PASG) ON SPLENIC HEMORRHAGE. J. Ali, K. 
Duke. University of Manitoba, Winnipeg, Man. and University of 
Toronto, Toronto, Ont.
Blood flows in the abdominal aorta (AF), carotid artery (CF) and 
splenic artery (SF) were measured by flow probes in 12 dogs 
which had their splenic artery occluded by an exteriorized vessel 
occluder. The spleen was then crushed, returned to the abdomen 
and the abdomen closed. The occluding clamp was released 
followed by PASG inflation until an increase in intra-abdominal 
pressure of 60 torr was measured through an intraperitoneal 
catheter in six dogs (group I); another six dogs (group II) did not 
have PASG inflation. After 2 hours or at death, the vessel 
occluder was reapplied and the peritoneal cavity opened followed 
by measurements of intra-abdominal blood loss (from suction and 
sponge weight). Death occurred in all six group II dogs by 58 
minutes from hemorrhage (422 ± 82 ml), the time of death being 
27 to 58 minutes after occluder release. All six group I animals 
survived for the 2 hours—the blood loss being measured at 184 ± 
36 ml. Group I animals had a drop of mean carotid artery blood 
pressure of 15 ± 7 torr and CF of 35 ± 9.4 ml/min in spite of 
PASG inflation while group II animals showed a progressive fall 
in carotid artery blood pressure and flow from a mean of 120 torr 
and 284 ml respectively to 0. Splenic artery and AF (in ml/min) 
decreased from 190 ± 26 and 279 ± 1 6  respectively to 39 ± 6 and 
45 ± 11 with PASG inflation. These flows were initially main­
tained at baseline and progressively decreased to 0 in group II 
animals. We conclude that PASG does not completely arrest 
splenic hemorrhage but decreases it significantly by decreasing 
aortic and splenic blood flow while maintaining a higher carotid 
artery pressure and blood flow compared with animals not treated 
with PASG.
R322
THE REVERSAL OF HYPOTHERMIA: AN EXPERIMENTAL 
MODEL IN THE STUDY OF REWARMING DYNAMICS. 
R.R. Papenburg, M. English, E. Farias, E.J. Hinchey. Department 
of Anesthesia and Department of Surgery, The Montreal General 
Hospital, Montreal, PQ
Pigs were subjected to either mild or moderate hypothermia and 
then rewarmed under controlled conditions to assess the heat-flow 
dynamics of rewarming.
Eight pigs, weighing approximately 20 kg, were subjected to 
mild and moderate hypothermia (2° and 6° below basal tempera­
ture). A midline incision was made which remained opened 
during rewarming. External and internal body temperatures were 
measured using thermocouples, and heat flow was monitored 
using heat-flux transducers. Rewarming was accomplished using a 
circulatory pump in which inflow and outflow temperatures were 
measured. No other form of active rewarming was used. Net 
energy input was calculated as the product of the pump flow rate, 
pump temperature difference and the specific heat of blood.
Mean energy requirements were 203 kJ and 482 kj to rewarm 
the mildly and moderately hypothermic animals. Circulatory 
volumes were 22.9 and 24.2 L respectively. Measured heat losses 
during the rewarming phase in the mildly hypothermic animals 
were variable, according to site. Skin heat losses averaged 66.2 
W/M2 while dry exposed bowel and wet exposed bowel lost heat at 
a rate of 181 and 350 W/M2 respectively.
Energy requirements to actively rewarm hypothermic and 
surgically stressed pigs are large. During rewarming, heat losses 
due to radiation, convection and evaporation are considerable. A 
model for the study of heat-flow dynamics in surgical/trauma 
patients is presented.
R323
A RANDOMIZED CONTROLLED TRIAL (RCT) TO DETER­
MINE THE EFFECTIVENESS OF FASCIAL INFILTRATION 
OF BUPIVACAINE IN PREVENTING ATELECTASIS FOL­
LOWING ABDOMINAL SURGERY. T.M. Egan, S. Herman, 
E.J. Doucette, S.L. Normand, R.S. McLeod. Toronto General 
Hospital, Toronto, Ont.
An RCT was undertaken to determine whether infiltration of the 
fascia with bupivacaine, a long-acting local anesthetic, at the time 
of closure following laparotomy, would reduce the rate of postop­
erative atelectasis.
Four-hundred and fifteen patients undergoing elective surgery 
at the Toronto General Hospital were randomly allocated to 
receive bupivacaine 0.25% (2 ml/cm incision) infiltrated into the 
fascia along both sides of the incision (treatment group—202 
patients) or no bupivacaine (control group—213 patients). There 
were 214 males and 201 females with a mean age of 52 years 
(range 18 to 85 years). Ninety-one were smokers. One hundred 
had upper, 20 had lower and 295 had upper and lower abdominal 
incisions. All had chest x-rays (CXR) preoperatively (preop) and 
on postoperative day (POD) 2. Pulmonary function tests were 
performed preop and for the first 2 PODs. Chest x-rays were 
scored by a blinded observer.
Postoperatively, 44% of the control and 36% of the treatment 
group had normal CXR’s (p = NS). There were no significant 
differences in the distribution of nor the mean atelectasis scores 
between the treatment and control groups. Both groups had 
similar decrements in vital capacity (VC) on POD1 and POD2. 
There was no significant difference in the mean dose of analgesia 
required postoperatively, although the mean time to first analgesic 
was significantly longer in the treatment group (2.2 hours versus 
1.3 hours, p < 0.05).
We conclude that infiltration of fascia with 0.25% bupivacaine 
2 ml/cm incision is not effective in preventing atelectasis. It does 
not reduce analgesic use, although it may delay the requirement.
R324
PHYSICAL STABILITY OF A TOTAL NUTRIENT ADM IX-' 
TURE (TNA) FOR TOTAL PARENTERAL NUTRITION 
(TPN). M. Deitel, K.L. Friedman, H.K.H. Giang, T.B. To, P.J. 
Lea, D.J.W. Grant, G. Go, B. Calvieri. Department of Surgery, 
Department of Nutritional Sciences, Department of Anatomy and 
Department of Pharmacy, University of Toronto, St. Joseph’s 
Health Centre, Toronto, Ont.
Development of ethyl-vinyl-acetate bags has enabled administra­
tion of all nutrients for TPN in a single daily 3-L bag. With time, 
lipid particles (liposomes) coalesce and rise to the surface (cream­
ing). Liposomes > 6 n can obstruct capillaries. Stability of TNA is 
postulated to be from 48 hours to 7 days in the refrigerator and 24 
hours at room temperature. Thus, a TNA, which consisted of 
1500 ml 7% Vamin, 1000 ml 50% dextrose and 500 ml 10% 
Intralipid, containing daily requirements of electrolytes, vitamins 
and trace elements, was studied.
Studies were performed on Intralipid and on TNA at 0 hours, 2 
days at 22°C, 7 days at 4°C followed by 2 days at 22°C and 14 
days at 4°C followed by 2 days at 22°C. Observation found no 
creaming on the surface at any of the times. Light microscopy (X 
1000) found liposomes of size 5 to 15 m were 2.0 per 20 high 
power fields (HPF) at 0 hours and 3.9 ± 2.4 per 20 HPF at the 
various times up to 16 days (i.e. among thousands < 5 m per 
HPF). Size distribution using Coulter Counter TA II found that 
lipid particle size increased up to 16 days, but 99.8% of liposomes 
were < 1.9 m> with 0% > 6.0 n- Electron micrscopy found that 
particle size increased up to 16 days, but 100% of liposomes were 
still < 2.0 m (0.5 ± 0.3 m)- Osmolalities and pH of TNA over the 
study times were 1472 ± 31 mOsm/kg and 5.5 ± 0.1 respectively, 
with a slight increase in osmolality and decrease in pH with time 
(not significant). Thus, the TNA is physically stable when refriger­
ated for 14 days and at room temperature for a further 2 days 
(corresponding to patient delivery).
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R325
PERFORATED BENIGN GASTRIC ULCER. O.G. Thurston. 
Department of Surgery, University of Alberta, Edmonton, Alta.
This report reviews the problems encountered in the treatment of 
36 patients with perforated benign gastric ulcer seen over a 
12-year period. The report also attempts to identify risk factors in 
these patients associated with a poor prognosis.
The 36 patients consist of 15 males and 21 females with a mean 
age of 63 years (range 35 to 94 years). Factors predisposing to 
perforation, including steroids, nonsteroidal anti-inflammatory 
drugs, alcoholism and previous acid peptic disease, were present 
in 31 patients (86%). Serious underlying disease, including malig­
nancy, cardiovascular disease and chronic pulmonary disease, was 
present in 18 patients (50%). Thirty-five of the 36 patients were 
operated upon, with simple closure of the perforation being done 
on 32 patients. The immediate failure rate for this procedure was 
12.5% (four patients) due to reperforation, gastrocutaneous fistula 
and hemorrhage. For the entire group of 36 patients, the hospital 
mortality rate was 25% (9 patients) and the morbidity rate in the 
survivors was 59%, with most of the complications related to 
sepsis and pulmonary failure. Risk factors related to mortality 
were serious underlying disease (p < 0.02) and delay in diagnosis 
and treatment beyond 24 hours (p < 0.01). Postoperative septic 
complications were closely associated with a positive culture from 
the peritoneal cavity at operation (p < 0.02).
The results show high mortality and morbidity rates for 
patients with perforated benign gastric ulcer related to serious 
underlying disease, delay in diagnosis and treatment and positive 
cultures from the peritoneal cavity. Although simple closure of the 
perforation has a significant failure rate, it is unlikely results 
would be improved by more aggressive treatment (i.e., gastrecto­
my) in this high-risk group of patients.
R326
BILIARY TRACT RECONSTRUCTION AND COMPLICA­
TIONS IN LIVER TRANSPLANTATION. W.J. Wall, D.R. 
Grant, J.H. Duff. University of Western Ontario, University 
Hospital, London, Ont.
Biliary tract complications are the most frequent technical com­
plication of liver transplantation and a major cause of morbidity. 
We reviewed 127 consecutive orthotopic liver transplants per­
formed in 112 recipients over a 5-year period to determine the 
frequency, type and consequences of biliary complications. The 
mean follow-up was 14 months. There were 107 duct-to-duct 
(D-D) anastomoses, 18 Roux loop to donor duct (R-D) and 2 
Roux loop to donor gallbladder. No stents were used. In 105 
transplants, radiologic access to the biliary tree was provided by a 
Malecot catheter exiting from the fundus of the in situ donor 
gallbladder.
There were 18 biliary complications (14.1%). Common duct 
stricture or leak occurred in 11 patients, all in D-D reconstruc­
tions. Two strictures were dilated percutaneously; six strictures 
and two leaks were revised to R-D anastomoses; one leak was 
managed by T-tube insertion. Seven gallbladder complications 
occurred. There were four leaks at the cholecystostomy tube exit 
site, one gallbladder hematoma and two patients developed 
cholelithiasis. In the group of 26 R-D anastomoses (18 primary 
reconstructions and 8 revisions) there were no biliary complica­
tions. Only one patient who had a biliary complication (gallblad­
der leak) died.
Biliary complications remain frequent overall but early recogni­
tion and prompt surgical treatment usually avoids mortality. 
Although a D-D anastomosis had acceptable morbidity, R-D 
reconstruction in this series had a zero complication rate and was 
a superior method of reconstruction.
R327
ACUTE PANCREATITIS: 30 YEARS’ EXPERIENCE IN A 
TEACHING HOSPITAL. E. Amurawaiye, R. Brown. McGill 
University, Montreal General Hospital, Montreal, PQ
Between 1955 and 1985, 629 patients with acute pancreatitis were
admitted to our hospital. Four retrospective reviews by different 
residents in consecutive time frames under the supervision of one 
staffman have been done to document etiology, mortality and 
morbidity. Modern diagnostic and treatment modalities were 
introduced after each review in an attempt to eliminate and 
reduce the latter two factors.
Biliary tract disease is the leading cause of pancreatitis in the 
female patient during the total review and in the male patient 
until 1972. During the past 10 years alcoholism shares equally 
with gallbladder disease as a cause of acute pancreatitis in the 
male. Mortality and morbidity from massive upper gastrointesti­
nal hemorrhage, hypovolemic shock and malnutrition have been 
eliminated since 1972.
Mortality and Complication Rate from Acute Pancreatitis 
(1955 to 1985)
Overall Complications
Mortality, complication related to Mortality in 
Period % rate, % sepsis, % sepsis, %
1955 -  1965 9.2 39.2 5.0 21.0
1966- 1971 6.0 41.5 18.0 33.3
1972- 1980 4.5 20.0 45.0 50.0
1981 -  1985 6.8 17.6 18.6 21.0
Despite the introduction of new diagnostic modalities, critical 
care units with hemodynamic monitoring, Cimetidine, new anti­
biotics and the application of Ranson’s criteria as it affects triage, 
the mortality of this disease has not changed significantly. 
Gram-negative sepsis remains a constant concern. Acute pan­
creatitis requires vigilant medical and surgical management.
R328
THE FATE OF THE GALLBLADDER AFTER ENDOSCOPIC  
SPHINCTEROTOMY FOR CHOLEDOCHOLITHIASIS AND  
CHOLELITHIASIS. D. Lamont, R.B. Passi. Department of Sur­
gery, University of Western Ontario, University Hospital, London, 
Ont.
Endoscopic sphincterotomy (ES) was done in 75 high operative 
risk patients with choledocholithiasis and gallbladder in situ 
between January 1981 and July 1987. Common-bile-duct stones 
were successfully removed in 72 patients. One patient required 
emergency and two patients required elective operative interven­
tion. There were three complications of bleeding, pancreatitis or 
cholangitis and no mortality. Fifty-four patients between 32 and 
98 years of age (average 75 years) had associated cholelithiasis 
and were followed for an average of 30.4 months (5 to 68 
months). Fourteen patients died of causes unassociated with 
biliary tract disease. Fourteen of the remaining 40 patients 
underwent cholecystectomy because ES failed in 2, 4 developed 
acute cholecystitis and 8 had persistent biliary tract symptoms. 
Twenty-six patients remain alive and well with only 1 having mild 
biliary tract symptoms. Ultrasonography in 16 (62%) of these 26 
patients showed cholelithiasis in 12 and none in 4. Life-table 
analysis indicates a probability of 15% for emergency and 30% for 
elective cholecystectomy over 5 years. Endoscopic sphincterotomy 
is considered a safe and definitive management in high operative 
risk patients with choledocholithiasis and associated cholelithia­
sis. The majority of these patients will not require subsequent 
cholecystectomy, and if they do, they will be better operative 
candidates.
R329
MEDICAL VERSUS SURGICAL TREATMENT OF THE 
SHORT BOWEL SYNDROME. D.L. Sigalet, G. Lees, J. Van 
Aerde, A.B.R. Thomson. Department of Surgery, Department of 
Neonatology and Department of Gastroenterology, University of 
Alberta, Edmonton, Alta.
We have examined the physiology of adaptation to resection and 
current treatments for the short bowel syndrome (SBS) using a 
domestic pig model. After weaning, animals underwent a resec-
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tion of the mid-75% of the small bowel. After 6 weeks of 
adaptation they were randomly assigned to one of four treatment 
groups (n = 6 in each): (a) nonresected controls (C); (b) medical 
treatment with Cimetidine (Med); (c) proximal isoperistaltic 
interposition of 15 cm of colon (Cln) and d) intestinal lengthening 
as described by Bianchi (BL). Animals were followed for 10 weeks 
of treatment and then sacrificed.
R e s u l t s C M e d C ln B L
W e i g h t  g a i n ,  k g /d  
B o w e l  l e n g th ,  c m  
I le a l  d i a m e t e r ,  c m  
V i l l u s  h e i g h t ,  Mm 
C r y p t  d e p t h .  Mm
1 .41  ±  0 .4 0  
111  ±  16 
3 .3  ±  0 .3 6  
6 3 0  ± 4 1  
4 9 1  ±  2 2 *
2 .2 9  ±  0 . 5 0  
2 4 7  ±  19*  
4 .8  ±  0 .4 7 *  
8 0 0  ±  4 5 *  
5 0 6  ±  1 9 *
1 .8 0  ±  0 .5 5  
2 2 9  ±  2 3 *  
5 .4  ±  0 .5 7 *  
7 0 6  ±  3 3 *  
4 9 2  ±  2 0 *
2 .4 1  ±  0 .4 8  
1 1 9  ±  7 
5 .2  ±  2 6 *  
7 5 5  ±  4 5 *  
4 9 5  ±  2 3 *
R e s u l t s  ±  S E M ,  * in d ic a t e s  p  <  0 .0 5 ,  h i s t o l o g i c  v a l u e s  a r e  c o m p a r e d  t o  c o n t r o l  a n im a l s .
In summary, after 75% resection of small bowel in the pig, the 
residual bowel undergoes significant adaptive changes. Our results 
suggest that medical treatment and bowel lengthening improve 
weight gain, bowel length and diameter. These may have impor­
tant implications in the treatment of SBS in humans.
R330
EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY (ESWL): 
A VALUABLE ADJUNCT IN THE MANAGEMENT OF DIF­
FICULT BILIARY TRACT CALCULI. M.C. Taylor, J.C. Mar­
shall, P.B. LeBrun, L. Fried, R.W. Norman. Department of 
Surgery, Department of Radiology and Department of Urology, 
Victoria General Hospital, Dalhousie University, Halifax, NS
Extracorporeal shock-wave lithotripsy (ESWL) has been an impor­
tant advance in the management of patients with urinary tract 
calculi. We have treated 12 patients with complicated biliary tract 
calculi (10 in the distal common duct, 1 in the right hepatic duct 
and 1 in Hartmann’s pouch) using an unmodified Domier HM3 
waterbath lithotripter. In each case, a relative contraindication to 
the use of other nonoperative measures was present, including 
unfavourable anatomy (one duodenal diverticulum, one previous 
Billroth II gastrectomy), inaccessible stone location (hepatic duct, 
cystic duct remnant), previous failed basket extraction and imma­
ture T-tube tract. Intubation of the common bile duct was 
performed prior to the procedure in all patients to permit contrast 
visualization of the stones and to ensure free drainage of stone 
fragments. Regional or general anesthesia was used in all cases.
All stones were successfully eliminated; three patients required 
two sessions each for complete stone fragmentation. Stone frag­
ments passed spontaneously or were easily retrieved with simple 
basket extraction techniques. Morbidity was minimal; transient 
hematuria and elevation of LDH and AST levels were the most 
common side effects. Pancreatitis did not occur. Extracorporeal 
shock-wave lithotripsy represents a significant new adjunctive 
measure in the management of the patient with difficult residual 
biliary tract stone disease.
R331
SURVEILLANCE BY COLONOSCOPY AFTER SURGERY 
FOR COLORECTAL CARCINOMA. D. Bernard, S. Morgan, D. 
Tasse, R. Wassef. Department of Surgery, Universite de Montreal, 
Division of Gastrointestinal Surgery, Hopital St-Luc, Montreal, 
PQ
Individuals who have undergone curative surgery for colorectal 
carcinoma form a high-risk group for developing metachronous 
tumours in the adenoma-adenocarcinoma sequence, and long­
term surveillance is recommended. According to a protocol 
established in 1980 in our centre, 317 patients have been 
submitted to one or more interval colonoscopic examinations 
with systematic removal of all adenomas. At index or periopera­
tive colonoscopy (IC) one or more adenomas were found in 21%. 
At any subsequent or surveillance colonoscopy (SC) adenomas 
were present in 24.4%. This rate of newly formed adenomas 
varied from 19% when no adenomas were present at IC to 45% 
when at least one adenoma was found (p = 0.021). Also when the 
adenoma(s) size was 1 cm or more at IC, 62% presented adenomas 
at SC compared with 35% when the adenoma at IC was smaller 
than 1 cm (p = 0.06). Carcinoma was found in six cases, three 
synchronous at IC and three metachronous at SC as well as five
endoluminal recurrences. The overall risk of developing adeno­
mas between 1 and 5 years was established at 24% and was greater 
when adenomas were present initially and more so if they were 
larger than 1 cm. We hypothesize that surveillance by a colonos­
copy and systematic polypectomy follow-up program after carci­
noma resection will have a more important impact by preventing 
the development of carcinoma than by screening new ones.
R332
OUTCOME OF ANAL FISTULOTOMY IN CROHN’S DIS­
EASE. D. Bernard, S. Morgan, D. Tasse, R. Wassef. Department 
of Surgery, Universite de Montreal, Division of Gastrointestinal 
Surgery, Hopital St-Luc, Montreal, PQ
Fistulotomy is considered standard procedure for the treatment of 
conventional anal fistula. Its use in patients with Crohn’s disease 
(CD) is controversial because of the perspective of unhealed 
wounds and continence problems from sphincter damage, leading 
to a high incidence of proctectomy. Recurrent abscesses after 
incision and drainage (I & D) and persistent symptomatic fistula 
remain unsolved unless a more aggressive approach is used. We 
present 56 cases in which we attempted anal fistulotomy in 
patients with CD, when the fistula tract was (a) symptomatic, (b) 
single, (c) requiring minimal division of the sphincters, (d) 
unassociated with other complications such as stenosis or rec­
tovaginal fistula. In 11, the fistula was considered to be independ­
ent of CD. Results:
Indication N Healed
Failed 
to heal
Lost to 
follow-up
Primary for abscess 17 12 2 3
Failure of I & D or Seton 10 6 4 _
Chronic fistula 29 21 4 4
56 39(70%) 10 7
Proctectomy was required in only two of the group that failed 
to heal. During this study period, 21 other patients with anal 
fistula were treated by conservative measures (14) or rectal 
excision or diversion (7) because they were either asymptomatic 
or presented with complicated fistula or severe anorectal disease. 
We estimate that fistulotomy should not be denied to symptomat­
ic patients. If careful selection is exercised the majority will heal 
completely within the period of normal wound healing.
R333
LIVER TRANSPLANTATION FOR ACUTE AND SUBACUTE 
FULMINANT HEPATIC FAILURE. S. Gallinger, P.D. Greig, G. 
Levy, L.M. Blendis, E. Roberts, R. Superina, S.M. Strasberg, B.R. 
Taylor, B. Langer. University of Toronto, Toronto, Ont.
Fulminant hepatic failure (FHF) with stage III-IV encephalopathy 
is associated with mortality > 80%. Orthotopic liver transplanta­
tion (OLT) has been successful in this disease. From 1985 to 
1987, 15 patients with FHF were referred for OLT. Age ranged 
from 10 to 44 years and 11 were female. The etiology was viral 
hepatitis, non-A non-B (11) or HBsAg positive (3) or toxic 
hepatitis (1); all were biopsy proven. All eight with acute FHF had 
stage IV encephalopathy and in the seven with subacute FHF the 
stage was 3.0 ± 0.3 (mean ± SEM). The AST with acute FHF was 
higher (1320 ± 360) than subacute (240 ± 100) but both groups 
had similar coagulopathy with PT and aPTT of 24 ± 4 and 55 ± 5 
seconds respectively and Factors V and VII of 24 ± 3% and 10 ± 
2% of normal respectively. The mean delay for OLT was 4.6 ± 1.8 
days from time of listing. Three patients died awaiting a donor. 
Fourteen transplants were performed in 12 patients; 3 were 
ABO-incompatible. Seven patients are alive from 3 to 14 months 
(mean 9.4 ± 1.6). Recurrent disease has not been identified in the 
graft. In the early survivors, neurologic function was normal by 
day 5 in all but two who had delayed recovery. Three died at 2 to 
95 days, of rejection (two) and sepsis (one). Two other patients 
returned to the ICU with functioning grafts but brain dead from 
cerebral edema. The use of intracranial pressure (ICP) monitoring
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in a subsequent patient facilitated successful treatment of acute 
perioperative rises in ICP with survival. The 58% survival of 
those transplanted may be improved with perioperative ICP 
monitoring for stage IV encephalopathy.
R334
CLINICAL EVALUATION OF BILIOPANCREATIC BYPASS 
FOR MORBID OBESITY. S. Biron, P. Marceau, H. Plamondon, 
R-A. Bourque, M. Potvin, P. Piche. Hopital Laval, Ste-Foy, PQ
Since January 1984, biliopancreatic bypass was used in our 
institution as the treatment of choice for morbid obesity. This is a 
preliminary report of our results with this operation.
Forty-one patients (27 women, 14 men) aged from 19 to 59 
years (mean 38 years) underwent a biliopancreatic bypass as a 
primary surgical treatment for morbid obesity. Patients who had 
this operation performed after failed gastroplasty are excluded. 
The technique used was that described by Scopinaro as type III 
(i.e., a common tract 50 cm long and the biliopancreatic and 
alimentary tracts of equal length). Minor modification was made 
to simplify bowel measurement.
Follow-up visits were planified on a regular basis to check on 
patient’s general condition, bowel and eating habits as well as on 
blood chemistry, namely vitamin A and /3-carotenemia. Baromet­
ric measures were calculated for body mass index; weight lost 
expressed as percentage loss of initial weight and grouped as 
“excellent” (30% loss or over), “good” (24% to 29% weight loss) 
and “poor” (under 25% weight lost). Mean rate of weight lost per 
week and mean rate of percentage loss of initial weight are also 
available. There were two deaths. Results at 18 months are 
excellent in 79% of patients, good in 7% and poor in 14%. Normal 
blood level of vitamin A is easily maintained with appropriate 
medication. For those whose follow-up is greater than 18 months, 
93% stated that the result obtained was as good as expected.
Granted that the duration of follow-up needs to be at least 10 
years for final evaluation, our opinion is that the operation is the 
best operation available for morbid obesity.
R335
QUALITY OF LIFE (QL) OF PATIENTS WITH ULCER­
ATIVE COLITIS (UC) PREOPERATIVELY (PREOP) AND 
POSTOPERATIVELY (POSTOP). R.S. McLeod, Z. Cohen, 
A.M. Lock, S.R. Isbister, D.N. Churchill. Department of Surgery 
and Department of Psychiatry, University of Toronto, Toronto, 
Ont. and Department of Clinical Epidemiology and Biostatistics, 
McMaster University, Hamilton, Ont.
A study was undertaken to measure QL of patients with UC preop 
and of patients with conventional ileostomies (Cl), Kock pouches 
(KP) and pelvic pouches (PP) postop.
Two groups of patients were studied. Seventeen patients (11 
males, 6 females, mean age 32 years) were studied preop and 3 
months postop (group 1). The indications for surgery were acute 
colitis 4, failure of medical treatment 11 or dysplasia 2. Seventy- 
eight patients (36 males, 42 females, mean age 32 years) were 
studied who had surgery at least 1 year ago (group 2). This 
included 27 with Cl, 18 with KP and 33 with PP. Mean length of 
time since surgery was 6.5 years. The three groups were well 
matched.
All patients were interviewed by a research assistant. The Time 
Trade-off Technique (TTO) and Direct Questioning of Objectives 
(DQO) were used to assign a utility to each patient’s QL. Utilities 
ranged from 0-1 with 0 signifying death and 1 normal health. 
Results:
Group 1 Group 2
Preop Postop Cl KP PP
TTO 0.60* 0.81* 0.96 0.95 0.97
DQO 0.47** 0.84** 0.89 0.86 0.87
*p < 0.05, **p < 0.005.
Our results suggest that QL is improved following surgery for 
UC. Patient satisfaction is high, irrespective of the procedure.
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R790
ABDOMINAL AORTIC ANEURYSM: THE CONSE­
QUENCES OF A POSITIVE FAMILY HISTORY. C.W. Cole, 
G.G. Barber, A. Bouchard, N.V. McPhail, C. Roberge, T.K. Scobie, 
W. Waddell, J.L. Wellington. University of Ottawa, Ottawa, Ont.
To assess the frequency of abdominal aortic aneurysm (AAA) in 
family members of patients with AAA, a sample of 586 patients 
treated at our institutions over a 5-year period was reviewed 
retrospectively by telephone interview. Two-hundred and seventy- 
five probands were alive and provided details about other family 
members; in 30 cases the proband had died and a relative 
provided these data. Of 305 families about which information was 
known, 41 gave a history of at least one other family member 
having an AAA. In 34 families, coexisting AAA affected 1° 
relatives (52) and two families had AAA in 2° relatives (2). Five 
families reported other AAA (five), but in family members 
without direct relationship to the proband. There were 17 
probands with at least one affected parent, which represented a 
high-risk group: in their 54 siblings, 10 (5 brothers and 5 sisters) 
had an AAA (18.5%); 2 died as a result of a ruptured AAA.
Mortality Mortality
Relation to 
proband
No. at 
risk
No. with 
AAA(%)
Rupture,
%
with
rupture, %
overall (rupture 
+ elective), %
Mother 34 11(32) 9 0 0
Father 34 6(18) 50 75 67
Sister 83 14(17) 29 100 36
Brother 86 20(23) 45 78 40
Total 237 52(22)* 33 82 35
•One female proband had an affected son. ______________ _______
These data suggest that the siblings of patients with AAA have 
nearly a one-in-five chance of themselves having an AAA if there 
is a positive parental history. Failure to detect other aneurysms in 
relatives of our patients was responsible for one third of them to 
go unrecognized until they ruptured. A patient with AAA and a 
positive parental history should inform his/her siblings of these 
risks.
R791
EARLY EXPERIENCE WITH LASER ASSISTED BALLOON 
ANGIOPLASTY. D.L. Doyle, P.D. Fry. University of British 
Columbia, Health Sciences Centre Hospital, Vancouver, BC
Laser-assisted balloon angioplasty (LBA) of human superficial 
femoral artery (SFA) and popliteal artery (pop) occlusions was 
first begun at Health Sciences Centre Hospital in June 1987. 
Following discussion of risks in this new procedure, patients with 
lesions felt suitable for LBA who agreed to participate were 
scheduled for LBA with a Trimedyne argon laser and LaserProbe. 
Twenty-one limbs in 19 patients have undergone LBA. Five limbs 
had frank gangrene, 1 rest pain without gangrene, 5 claudication 
at less than one block, 10 with claudication at more than one 
block. All three diabetics had gangrene. Thirteen SFA, 4 peri- 
Hunter’s canal and 4 popliteal occlusions were attempted. A 
percutaneous approach was employed in 14 cases. Five patients 
had sheaths placed at time of common and/or profunda femoris 
thromboendarterectomy. Two further femoral cutdowns followed 
failed percutaneous approaches.
Complications were common. Ten LBA sites were patent at the 
end of the procedure. Four LBA segments thrombosed—one 
intraprocedure, one at 24 hours, one at 4 days and one at 14 days. 
One dissection occurred. There were 10 laser perforations, 2 were 
successfully rescued and there was 1 guidewire perforation. There 
were no sequelae from perforation. One patient developed a 
puncture site false aneurysm. Two deaths, one at 3 days and one 
at 3 months post LBA occurred—both in patients with gangrene
and other problems previously refused other limb salvage proce­
dures. One patient was slightly worse post LBA.
Early patency results demonstrate a learning curve. Attention to 
detail is critical. Improvements in tip material, steerability and 
guidance are still required to achieve truly satisfactory results. 
Our results show LBA is a safe if not reliable procedure.
R792
CAN SUPEROXIDE RADICAL SCAVENGERS REPLACE 
FASCIOTOMY IN THE MANAGEMENT OF COMPART­
MENT SYNDROME? M. Ricci, R. Corbisiero, F. Mohammed, A. 
Graham, J. Symes. Cardiovascular Research Unit, Royal Victoria 
Hospital, Montreal, PQ
Compartment syndrome (CS) following acute arterial occlusion 
may be due to reperfusion injury mediated by superoxide radicals. 
To assess the role of radical scavengers in this setting, we utilized 
a previously established in vivo canine model of CS to compare: 
(I) no treatment, (II) fasciotomy at time of reperfusion (F), (III) 
intravenous superoxide dismutase (SOD) and (IV) both F and 
SOD. The anterior compartments of both hind limbs were 
isolated to a single vascular pedicle; the left underwent 8 hours of 
ischemia followed by 16 hours of reperfusion while the right 
served as a control. Compartment pressure and transfascial Po2 
were monitored. Muscle necrosis was assessed by a ratio of 
technetium pyrophosphate uptake between the experimental and 
control limbs (L/R ratio).
Ischemia was confirmed by a fall in oxygen tension from 88 ±
11 mm Hg to 7 ± 5 mm Hg. With reperfusion, compartment 
pressure rose from baseline, 6.2 ± 6.5 mm Hg, to 106.2 ± 30.7 
mm Hg in group I and to 69.4 ± 34.2 mm Hg in group III. 
Fasciotomy (groups II and IV) prevented this pressure rise. The 
L/R ratio was significantly lower in the treatment groups com­
pared with no therapy: I: 8.9 ± 5.0; II: 2.6 ± 0.8; III: 2.8 ± 0.8; IV: 
1.85 ± 0.7 (I versus II, III, IV, p < 0.01). Superoxide dismutase 
and F (group IV) was significantly better than SOD alone (p = 
0.04) but not fasciotomy alone (p = 0.07).
Both fasciotomy and SOD are effective in ameliorating the 
muscle damage associated with CS. The combination of both 
treatments, however, was better than SOD alone. Further, since 
SOD did not prevent the rise in compartment pressure seen with 
reperfusion, fasciotomy remains the treatment of choice for 
prevention of CS following acute arterial ischemia.
R793
THE LONG SLOW BURN—THE LIMITATIONS OF SYMPA­
THECTOMY IN THE SYMPATHETIC DYSTROPHY SYN­
DROME (SDS). Charles J. Wright. University of Saskatchewan, 
Saskatoon, Sask.
The results of sympathectomy for SDS were assessed in 21 
patients followed up to 15 years.
There were 11 men and 10 women, 15 to 62 years. Severe 
burning pain in a limb (causalgia) was present in every case, with 
sympathetic dysfunction, including hyperhidrosis, abnormal dry­
ness, shiny skin, vasomotor signs or bone demineralization, of 
which vasomotor disturbances (57%) and hyperhidrosis (33%) 
were the commonest. The signs varied from patient to patient, but 
were constant in any one case. The initiating injury was blunt in 
14 cases (67%) and penetrating in 7 (33%). The blunt injuries were 
often insignificant or minor. All four limbs were affected with 
similar frequency.
In every case, sympatholysis with local anesthetic relieved the 
symptoms temporarily. The immediate result of subsequent sym­
pathectomy was excellent in all but one case, but 10 patients
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(50%) developed recurrent manifestations of SDS at intervals 
varying from 3 weeks to 1 year after operation and have 
continued to defy successful management. The recurrent symp­
toms ranged from unpleasant sensation of heat or cold to severe 
causalgia. The others have remained well in follow-up ranging 
from 1 to 15 years.
The pathophysiology of SDS is speculative and none of the 
theories is fully compatible with all the clinical manifestations. 
This study demonstrates poor long-term results in 50% of patients 
undergoing unilateral sympathectomy, supporting the concept of 
cross-lateral sympathetic innervation and the recent suggestion 
that bilateral sympathectomy may be required in selected cases.
R794
CURRENT POSTOPERATIVE MANAGEMENT OF AORTIC 
RECONSTRUCTIONS. G. Hayes, P. Kalman, K.W. Johnston, P. 
Walker. Division of Vascular Surgery, Toronto General Hospital, 
Toronto, Ont.
Postoperative management of aortic reconstructions has become 
progressively dependent upon invasive monitoring in intensive 
care units (ICU). However, the usefulness of this type of manage­
ment has not been critically evaluated. The purpose of this study 
is to document current ICU management of these patients, 
including pharmacologic manipulations, ventilatory requirements 
and fluid balance, as well as final outcome. Information on 150 
patients admitted to the surgical ICU was analysed. Two-thirds 
had repair of abdominal aneurysms. Sixty-five percent had Swan- 
Ganz catheters; all had arterial lines; 95% were ventilated postop- 
eratively. Mean age was 65 ± 9 years. Postoperative hemodynam­
ic changes are recorded below.
Time
postop,
h Temp HR BP (sys BP(dias) CO PCWP PVR
1
8
24
35.1 ±1.1 
37.7 ±0.9 
37.5 ±0.5
77 ± 21 
87 ± 16 
93 ±15
150 ±27 
136 ±25 
147 ±20
77 ± 13 
70± 12 
71 ±0.9
4.2 ±0.85
6.2 ± 1.42 
6.5 ± 1.1
14 ± 5
15 ± 5.3 
13 ±4.5
2000± 156 
1077 ±308 
880± 184
Nitroprusside was used in 58% of patients, /3-blockers in 23%. 
Peripheral vascular resistance (PVR) was reduced and cardiac 
output (CO) increased significantly (p < 0.05) by these interven­
tions. Mean ventilation time was 24.1 ± 1.1 hours. Early 
mortality was 2.5%, primarily cardiac.
In conclusion, significant interventions are initiated in current 
ICU management of these patients, aimed at reducing myocardial 
stress and maintaining hemodynamic stability. The greatly in­
creased cost of this form of care remains to be justified.
R79S
ACUTE AORTIC OCCLUSION. H. Fong, A. Downs, C. Lye. 
Department of Surgery, University of Manitoba, Winnipeg, Man.
During the period 1973 to 1987, 17 patients (mean age 63 years) 
were treated for acute aortic occlusion, of which 6 patients had 
occlusion due to aortic saddle embolus (ASE) and 11 patients had 
acute aortic thrombosis (AAT). All six patients with ASE had 
cardiac abnormalities: atrial fibrillation in five and prosthetic 
mitral valve replacement in one. Duration of symptoms from 
onset to operating room was 6 to 48 hours with a mean of 15 
hours. Two patients with unilateral renal infarction were treated 
conservatively. Successful bilateral transfemoral embolectomy 
under local anesthesia was performed in all. Two patients died of 
acute myocardial infarction. All patients were placed on oral 
anticoagulant for life, and there was no recurrence in 4 to 8 years 
of follow-up.
Significant history of claudication was presented in all 11 
patients with AAT. Two patients with irreversible ischemia below 
the umbilicus had no surgery and died. Cardiogenic shock was the 
cause of death in eight patients, of which acute myocardial 
infarction (MI) in five patients and sepsis with peritonitis in three 
patients were the major contributing factors. All except two 
patients had bilateral transfemoral thrombectomy under general 
anesthesia in addition to: one aortobifemoral graft with postoper­
ative paraplegia, three axillofemoral grafts (two bilateral) and two 
cross-femoral grafts. The only survivor in the AAT group was a 
65-year-old female who had right axillofemoral grafting and left 
hip disarticulation performed 14 days post MI. She survived 27 
months and died of acute MI.
We conclude that although the associated cardiac disease may 
cause early or late deaths, in ASE with early diagnosis the 
immediate prognosis is good, while in AAT associated with severe 
cardiac disease the outlook is grave and aggressive surgery is 
indicated.
R796
THORACIC OUTLET SYNDROME: FACT OR FANCY? W.G. 
Jamieson, G. DeRose. Division of Vascular Surgery, Victoria 
Hospital, University of Western Ontario, London, Ont.
The surgical treatment of 118 patients with thoracic outlet 
syndrome was analysed to assess diagnostic methods, surgical 
results and factors predictive of outcome. The majority of patients 
(84%) were female with a mean age of 30 years (20 to 49 years). 
The mean duration of symptoms was 2 years (6 months to 10 
years). Prior to surgery, each patient had been assessed by an 
average of 6.2 medical consultants. Fourteen patients with chronic 
pain were referred by a psychiatrist.
Symptoms included arm pain (66%), hand weakness (66%), 
hand and arm paresthesia (60%) and headache (30%). Trauma 
precipitated the symptoms in 59 patients (50%), work-related 
trauma (38%) and motor vehicle trauma (12%). Physical signs 
were variable, but brachial plexus tenderness (92%) and arm 
weakness on elevation (90%) were consistent findings. Nerve 
conduction studies and electromyography were disappointing for 
the patients with neurologic symptoms. Arteriography was diag­
nostic for three patients with arterial symptoms, as was venogra­
phy for the patients with venous symptoms.
Surgical treatment included 106 first rib resections, 8 cervical 
rib resections and 4 scalenectomies alone. Postoperative follow-up 
ranged from 0.5 to 14 years (mean 3 years). All five patients with 
vascular symptoms alone had excellent results. Of the 113 patients 
with brachial plexus symptoms 85% had significant improvement. 
Long-term results are discussed with special reference to those 
patients related to compensation board, pending litigation and 
personal motivation. These groups make the management of this 
syndrome extremely complex.
R797
A COMPARISON BETWEEN TRANSCUTANEOUS OXIME­
TRY AND ANKLE/BRACHIAL PRESSURE RATIO IN THEIR 
ASSESSMENT OF RUNOFF AND OUTCOME PREDICTION  
IN PATIENTS UNDERGOING AORTOBIFEMORAL BY­
PASS. F.M. Ameli, M. Stein, J.L. Provan, L. Aro, R. Prosser. 
Division of Vascular Surgery, The Wellesley Hospital, University 
of Toronto, Toronto, Ont.
This study was done to compare ankle/brachial systolic pressure 
index (ABI) measurements and transcutaneous oxygen tension 
(Ptco2) in their ability to reflect the runoff status determined by 
angiography and to predict the outcome of surgery in 105 patients 
undergoing aortobifemoral bypass. Postoperatively, ABI better 
reflected runoff status. The difference in ABI means for normal 
versus impaired runoff was 0.17 (p < 0.05). The difference in 
Ptco2BK means for two runoff categories was relatively small (6.3 
mm Hg; p < 0.05) and so was the difference between means of 
PtcOiDF (5.1 mm Hg; p > 0.05). Post- minus preoperative 
increases in ABI also reflected better the runoff status than Ptco2. 
For normal runoff, the mean ABI increase was 0.25 and for 
impaired runoff it was only 0.14 (p < 0.05). Transcutaneous 
oxygen tension increases were not significantly different for 
normal versus impaired runoff. Proportional-hazards stepwise 
regression analysis comparing runoff, ABI and Ptc02 indicated 
that runoff and Ptco2 were the best predictors of symptomatic 
recurrence. Impaired runoff was associated with a relative risk of 
2.5 (95% confidence interval, 1.2 to 5.4; p = 0.017) and Ptco2BK
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of less than 40 mm Hg implied a relative risk of 2.3 (95% 
confidence interval, 1.1 to 4.9; p = 0.029) for symptomatic 
recurrence. The most significant predictor of graft failure was 
preoperative ABI, while postoperative ABI and runoff showed 
weaker associations. We conclude that Ptco2 and ABI are two 
noninvasive techniques which can contribute to predictions con­
cerning management and prognosis of peripheral vascular disease.
R798
USE OF THE GREENFIELD FILTER IN PREVENTION OF 
PULMONARY EMBOLISM. I.F. Smith. Memorial University of 
Newfoundland, St. John’s, Nfld.
Attempts to prevent pulmonary emboli have led to the use of a 
wide variety of medications and surgical techniques. A contraindi­
cation to anticoagulation or embolization while on anticoagulants 
presents a particularly challenging surgical dilemma. Fifty con­
secutive patients treated since October 1982 with insertion of a 
Greenfield filter were analysed for indication for surgery, success 
in prevention of pulmonary embolization, surgical mortality and 
complications of the procedure.
Thirty-nine of the 50 procedures were carried out under local 
anesthesia with or without intravenous sedation. There were no 
patients who had documented pulmonary embolization following 
insertion of the filter. Two patients died within 48 hours of 
insertion, both deaths being attributable to their general condition 
prior to insertion of the filter. In one patient a filter could not be 
inserted for technical reasons. All 47 remaining patients are free 
of further pulmonary emboli.
Insertion of a Greenfield filter is a safe, highly effective means 
of preventing pulmonary emboli and can usually be performed 
under local anesthesia in even the most critically ill patients. The 
efficacy of this procedure suggests it is appropriate to modify the 
classic indications for vena caval plication or ligation.
R799
NONINVASIVE PREDICTION OF CARDIAC COMPLICA­
TIONS IN PATIENTS UNDERGOING VASCULAR SUR­
GERY. M.D. Sauve, T.D. Ruddy, N.V. McPhail, J.E. Calvin, R.A. 
Davies, L.L. Vigus, G.G. Barber, C.W. Cole, T.K. Scobie. Division 
of Cardiology and Division of Vascular Surgery, Ottawa Civic 
Hospital, Ottawa, Ont.
The predictive value of noninvasive cardiac testing for cardiac 
complications was prospectively studied in 60 patients scheduled 
to undergo vascular surgery. Patients underwent exercise ECG 
testing (EX), measurement of left ventricular ejection fraction by 
gated blood-pool scanning (EF) and thallium imaging (TL). Ten 
patients with markedly abnormal test results (> 2 mm ST segment 
depression on exercise testing, EF < 20%, or TL evidence of 
multivessel ischemia) were excluded. The final study group 
consisted of 50 patients (40 males, 10 females; mean age 66 ± 10 
years) who underwent surgery (48 aortic and 2 femoral-femoral 
grafts). One or more complications occurred in 22 patients (17 
pulmonary edema, 6 myocardial infarctions, 3 deaths). Exercise 
ECG testing was positive (> 1 mm ST segment depression) in 9 of 
50 patients. Thallium imaging showed myocardial ischemia in 28 
of 50 patients. Ejection fraction was less than 50% in 11 of 50 
patients. Results:
Test Sensitivity Specificity
Positive predictive 
value
EX 0.23“ 0.86* 0.55
EF 0.36** 0.89* 0.73
TL 0.86 0.68 0.68
EFandTL 0.32** 0.96“ 0.88
* = p < 0.05, ** = p < 0.01 [versus TL],
Compared to EX and EF, TL had significantly greater sensitivi­
ty and lower specificity but similar positive predictive value. The
combination of myocardial ischemia on TL and reduced EF 
resulted in greater specificity than TL and tended to the greatest 
positive predictive value. These data suggest that high risk 
patients may be best identified by TL initially and then gated 
blood-pool scanning in patients with positive TL.
R800
IDENTIFICATION OF CLINICALLY SIGNIFICANT SKELE­
TAL MUSCLE NECROSIS IN THE LOWER EXTREMITY BY 
SINGLE PHOTON EMISSION COMPUTERIZED TOMOG­
RAPHY. I. Forrest, T. Lindsay, G. Hayes, K. Yip, A. Romaschin, 
P.M. Walker. Department of Vascular Surgery and Department of 
Nuclear Medicine, Toronto General Hospital, Toronto, Ont.
The identification of post-ischemic skeletal muscle necrosis con­
tinues to be a significant clinical problem. Following revasculari­
zation, injurious events induced by ischemia-reperfusion may 
persist, but can be combatted by compartment release, debride­
ment and appropriate fluid electrolyte management, if the extent 
of ongoing skeletal muscle necrosis can be determined. The 
purpose of this study was to determine the clinical usefulness of 
single photon emission computerized tomography (SPECT) in 
identifying and quantifying skeletal muscle necrosis in humans. In 
an initial study, SPECT was compared to our standard laboratory 
method (tetrazolium staining and computerized planimetry) in 
the canine gracilis muscle model (n = 8). Next, eight limbs which 
had suffered profound ischemia and were successfully revascula­
rized were studied prospectively. The patients were injected 
with"Tc PYP and the volume of necrotic muscle determined by 
SPECT. Our results indicate a high correlation between SPECT 
and tetrazolium staining in the animal model (r = 0.94, p < 0.05), 
in determining the amount of necrotic muscle present. In each 
clinical situation the extent of muscle necrosis was quantified 
(mean = 341 ± 2 5  ml) and the evaluation of the extent of necrosis 
correlated well with the subsequent clinical course, including 
resolution of motor dysfunction (n = 6), the need for fasciotomy 
(n = 8) and the incidence of myoglobinuria (n = 2).
In summary we feel that SPECT is an acceptable clinical 
method for quantifying skeletal muscle necrosis following an 
ischemia-reperfusion injury and may aid in determining appropri­
ate management of these patients.
R801
VIBRATORY INDUCED WHITE HAND DISEASE. A.R. 
Downs, I. Morrow, B. Hardy. Department of Surgery and Depart­
ment of Radiology, University of Manitoba, Winnipeg, Man.
White finger disease is a compensable disorder of the hands 
characterized by cold-induced vasospasm which occurs in under­
ground miners using a vibratory tool. The symptoms can be 
severe enough to interfere with work. Clinical examination and 
laboratory assessment for occlusive disease and autoimmune 
disorders were performed on 24 miners. All patients had digital 
artery pressures and upper extremity angiography. Forty-four 
hand angiograms were performed. Arterial occlusions were dem­
onstrated in 27 hands. Arterial spasm was present in 7 hands and 
12 hands were normal. Eight patients demonstrated occlusion or 
aneurysm formation of the ulnar artery over the hook of the 
hamate. The palmar artery and the digital arteries to the index 
finger demonstrated the highest incidence of occlusion. The 
clinical symptoms did not correlate well with the angiographic 
findings. Thirty percent of the 27 digits with severe symptoms 
demonstrated angiographic abnormalities. Twenty-seven of the 34 
digits with the angiographic abnormalities did not have the 
symptoms localized to the affected digits. None of the patients 
had tissue necrosis of the fingers. Although there is not good 
correlation between symptoms and angiographic findings, there 
appears to be a high incidence of digital occlusive disease in these 
patients. None of these patients had evidence of peripheral 
arterial occlusive disease at any other site. The presence of organic 
disease supports the need for reduced exposure to this mechanism 
of trauma by modification of machinery used. The only treatment 
recommended is a cessation of exposure to the vibratory trauma.
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R802
THE UNINVOLVED SUPERIOR MESENTERIC ARTERY 
ORIGIN ON CT SCAN—A CONSISTENT MARKER FOR 
INFRARENAL ABDOMINAL AORTIC ANEURYSM. P.M. 
Brown, B. Westerberg, R. Nolan, J.R. Gutelius. Kingston General 
Hospital and Queen’s University, Kingston, Ont.
The relationship between the superior mesenteric artery (SMA) 
origin and the upper extent of abdominal aortic aneurysm on CT 
scan was analysed in 100 consecutive surgical patients. All 
aneurysms involving the SMA origin were excluded. In 94 
patients, the SMA origin was clearly identified. In six patients, the 
SMA origin was not seen on CT scan but the aneurysm was found 
to be infrarenal at surgery. One or more renal artery origins were 
seen on CT scan in only 62 patients. The distance between the 
SMA origin and aneurysm neck was measured in each patient. In 
73 patients with 3 cm or greater between SMA origin and 
aneurysm neck, only 1 required a suprarenal clamp. Of 21 
patients with less than 3 cm separating the SMA origin and 
aneurysm neck, 4 required suprarenal clamping. In all patients 
except one, standard infrarenal repairs could be performed with 
only a single renal artery reimplantation required. The SMA 
origin is almost always seen on CT scan as compared with renal 
artery origins which are less commonly identified. If the SMA 
origin is uninvolved, the surgeon can be confident that an 
infrarenal abdominal aortic aneurysm repair can be done with 
only occasional use of suprarenal clamping, and renal artery 
reimplantation is rarely required.
R803
ARTERIAL RECONSTRUCTION TO THE FOOT VESSELS: 
IS IT WORTH THE TROUBLE? R. Labbe, Y. Douville, H-P. 
Noel. Departement de chirurgie, Hopital du Saint-Sacrement, 
Universite Laval, Quebec, PQ
Thirty-two patients underwent 35 arterial reconstructions to the 
foot vessels, below the level of malleoli, between 1974 and 1987. 
There were 26 men and 6 women; 15 patients had diabetes 
mellitus, 11 had dyslipidemia and the majority were smokers or 
previous smokers and presented systemic manifestations of ath­
erosclerosis. The mean age was 63.8 years (40 to 83 years). 
Indication for surgery was limb salvage in each patient. Among 
the procedures, there were 19 femoropedal bypasses (17 in situ 
and 2 mixed venous-venous), 15 femoroplantar arch or posterior 
tibial bypasses (14 in situ and 1 mixed venous-venous) and 1 
popliteal-pedal mixed venous-venous bypass. No synthetic mate­
rial was used. There was one perioperative death from massive 
pulmonary embolism and three patients were lost to follow-up. Of 
the remaining 28 patients, 7 experienced early graft failure (< 30 
days), resulting in limb loss in 5 patients. Follow-up information 
was obtained at 6-month intervals. The cumulative patency rates 
of the 35 procedures, calculated by life-table analysis, were 65.7% 
at 30 days, 51.3% at 6 months, 45.5% at 1 year and 34.7% at 3 and 
5 years. The limb salvage rates were 71.4% at 30 days, 63.9% at 1 
year, 49.7% at 3 years and 41.4% at 5 years. We believe that 
arterial reconstruction to the foot, in a properly selected popula­
tion of patients, is worth doing and results in acceptable limb 
salvage rate.
R804
ERGOTISM: A RARE CAUSE OF ARTERIAL ISCHEMIA. F. 
Laurendeau, J. Lassonde. Department of Surgery, Hopital Maison- 
neuve-Rosemont, Universite de Montreal, Montreal, PQ
A 48-year-old female was referred for numbness of both upper 
extremities and absence of pulsation below the axillary artery on 
both sides. An intravenous digital angiogram through the right 
common femoral vein revealed thrombosis of the distal part of 
both brachial arteries.
Four days later, she presented for rest pain, coldness and
cyanosis of the right leg with no pulsation below the femoral 
artery. Arteriogram showed thread-like superficial femoral arter­
ies.
The patient had taken Cafergot for migraine for 10 years. 
Amputation appeared to be inevitable but the cyanosis regressed 
and the leg was saved.
Ergot poisoning is an iatrogenic disease related to an overuse of 
medications containing ergot alkaloids prescribed for migraine 
headaches. The pathophysiology of ergotism is related to vasocon­
striction. Symptomatic vasospasm is most common in the extrem­
ities, although it may involve any organ system.
Arteriography usually demonstrates involvement of large and 
medium-sized arteries with abruptly tapered smooth stenosis. 
Extremity arterial spasm is usually bilateral and symmetrical.
Central to the treatment of ergotism is discontinuance of the 
drug. Improvement can be expected in a matter of days once 
metabolism of the drug is complete. In the presence of severe 
ischemia, heparinization is recommended to assist in the mainte­
nance of patent collaterals. Parenteral use of vasodilators is 
controversial since ergotamine is bound to the alpha receptors. 
Intravenous niacin, intravenous alcohol, papaverine, intravenous 
sodium nitroprusside, intra-arterial tolazoline, calcium channel 
blocker and regional sympathectomy have also been used in the 
treatment of this condition.
R805
AXILLARY VASCULAR INJURIES. D. Rathbone, A.R. Downs, 
C. Lye, H. Fong. Department of Surgery, University of Manitoba, 
Winnipeg, Man.
This study consists of 15 axillary artery and 2 axillary vein 
injuries. A retrospective study was undertaken to determine the 
clinical presentation and management of patients with axillary 
vascular injuries from blunt and penetrating trauma. Twelve male 
and 5 female patients, age 17 to 82 years, were identifed from a 
chart review for the years 1976 to 1987. Penetrating trauma 
occurred in 11 patients. Blunt trauma occurred in six patients; 
four had associated fractures of the humerus, the other two had 
anterior dislocations of the shoulder. Brachial plexus injuries 
occurred in 12 patients. Five of the 15 patients with an arterial 
injury had distal pulses present on initial assessment. Five 
patients presented with a false aneurysm. All patients were 
investigated preoperatively with angiography. There was one 
false-negative arteriogram. Fifteen patients were treated surgical­
ly. Nine patients with arterial injuries required a saphenous vein 
interposition graft. Only one patient with a brachial plexus injury 
had a nerve laceration treated with an interposition nerve graft. 
All surgically treated patients left hospital with normal pulses. 
There were no deaths or amputations. Long-term follow-up was 
available on 9 of the 12 patients with brachial plexus injury. Five 
had full recovery (taking up to 2 years). Three had no recovery 
and one had partial recovery. We feel that angiography should be 
done in all stable patients to determine accurately the level of 
injury and therefore avoid excess dissection and possible iatrogen­
ic injury to the brachial plexus. Some patients, especially those 
with blunt trauma, may present with minimal symptoms of a 
vascular injury. A thorough examination and a high index of 
suspicion is required.
R806
THE ROLE OF ISOLATED PROFUNDAPLASTY. P.G. 
Kalman, K.W. Johnston, P.M. Walker. University of Toronto, 
Toronto, Ont.
The profunda femoris artery serves as the major collateral channel 
when the superficial femoral artery (SFA) is occluded. However, 
the clinical effectiveness of isolated profunda reconstruction 
remains unclear. The purpose of this study is to determine our 
results with this procedure and identify the subgroups with 
superior results. One hundred and twenty-one isolated profunda- 
plasties were performed at our institution from 1977 to 1987. The
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indication for operation was disabling claudication in 41% and 
limb salvage in 59%. Twenty-five percent of the patients were 
diabetic. Adequate femoral inflow was determined by physical 
examination, Doppler waveform analysis and multiplane arterio­
graphy. The length of profundaplasty was recorded as local or 
intermediate (past one perforator) in 48% and extended (past two 
perforators) in 52%. The clinical success rate (both a patent repair 
and clinical improvement) at 1, 2 and 3 years was 67 ± 4.8%, 57 
± 5.9% and 49 ± 6.8% respectively. There was a significant 
increase in ankle/brachial index (ABI) for the entire group (0.33 ± 
0.18 to 0.45 ± 0.19, p < 0.001), and the early postoperative 
increase in ABI was predictive of patients with long-term success 
(0.34 ± 0.19 to 0.50 ± 0.18, p < 0.001), as compared with the 
failures (0.32 ± 0.18 to 0.37 ± 0.19). Patients were stratified into 
several subgroups and clinical success was compared. There was a 
significant difference based on operative indication (claudication 
versus limb salvage, p < 0.05) and tibial outflow (good two, three 
patent) versus poor (zero, one patent) (p < 0.05). There was no 
significant difference for diabetes, prior vascular procedure, 
patency of the popliteal artery and length of profundaplasty. In 
conclusion, isolated profundaplasty is a successful operation for 
selected patients with infrainguinal occlusive disease and should 
be considered an alternative to distal bypass.
R807
COMBINED SCALENECTOMY AND TRANSAXILLARY 
FIRST-RIB RESECTION IN THE TREATMENT OF THO­
RACIC OUTLET SYNDROME. C. Cina, L. Whiteacre, E. 
Edwards, R. Maggisano. University of Toronto, Sunnybrook Medi­
cal Centre, Toronto, Ont.
Between 1980 and 1986, 221 patients were evaluated for neuro­
vascular symptoms of the upper limb. Thirty-seven (16%) were 
diagnosed to have thoracic outlet syndrome with symptoms severe 
enough to require surgical management. Twenty-four had unilat­
eral and 13 had bilateral symptoms. In the latter group, only eight 
required bilateral operations.
Five patients had cervical ribs and one had a prominent C7 
transverse process. In the remainder, various combinations of 
soft-tissue anomalies were found at operation. One patient had 
arterial insufficiency, one had axillary vein thrombosis and the 
remainder exhibited symptoms compatible with brachial plexus 
irritation.
Forty operations were performed of which 34 were simulta­
neous scalenectomy and transaxillary first-rib resection (TARR). 
Six patients with the diagnosis of upper plexus involvement 
underwent scalenectomy alone, and four required a subsequent 
TARR (66%).
Follow-up from 6 to 60 months (x = 17) was available for 38 
scalenectomies and TARRs. In order to improve the assessment 
of the results of surgery, a dual system was used which included 
the patient’s own evaluation, communicated to an independent 
observer, and the surgeon’s clinical evaluation. Overall, results 
were excellent in 54%, good in 28%, fair in 10%, and 8% had 
recurrent symptoms.
Thoracic outlet syndrome can be caused by more than 15 
different anomalies. This can explain the ambiguity of results 
obtained with operations aiming to correct a single anatomical 
feature of the thoracic outlet. To minimize the recurrence rate and 
improve results, we advocate a radical surgical approach, combin­
ing scalenectomy and TARR.
R808
FRESH VENOUS AUTOGRAFTS AND ALLOGRAFTS AS 
CAROTID SUBSTITUTES IN MATCHED DOGS FROM THE 
SAME LITTER. Y. Merhi, R. Roy, Y. Douville, S. BenSlimane, J. 
Hebert, P-E. Roy, R. Guidoin. Laboratory of Experimental Surgery, 
Universite Laval and Biomaterials Unit, Hopital St-Francois d’As- 
sise, Quebec, PQ
This study was performed to assess the pathological and the 
biochemical characteristics of femoral veins used as fresh auto­
graft and allograft substitutes in the carotid arteries in both 
compatible and incompatible dogs derived from the same litter 
and matched by a mixed lymphocyte culture technique. After 5 
months of implantation, the pathological analyses were conducted 
by light and scanning electron microscopy. The prostacyclin 
(PGIi) and the thromboxane (TXA2) syntheses were determined 
by radioimmunoassay, and the endothelial phenotype of the cells 
was determined by immunostaining. The results indicate that all 
the blood conduits were patent. The occurrence of pathological 
changes was more pronounced in the incompatible group. The 
immunostaining reveals a better preservation of the endothelium 
on the autografts, whereas in the allografts it was less intense, and 
was absent in some incompatible allografts. In all implants, the 
ratios of PGI2/TXA2 were much lower than the observed carotid 
artery ratio. This study confirms the stability of venous autografts. 
The pathological changes on venous allografts may be related to 
the immunologic reactions. Further studies may help elucidate the 
factors that would contribute to developing such viable allografts.
R809
CONSERVATIVE TREATMENT OF GRAFT INFECTION. 
J.C. Coles, B. Bjorgaard, A. Casson, E. Grigore, A. Panos. Division 
of Cardiovascular and Thoracic Surgery, University of Western 
Ontario, London, Ont.
Infection of a vascular prosthesis is a sinister complication with a 
high incidence of loss of life or limb. Conventional treatment, 
including removal of the entire prosthesis and restoration of 
pulsatile flow with one of the extraterritorial techniques, is the 
treatment of choice in the vast majority of patients.
This presentation suggests that more conservative treatment 
(drainage, appropriate antibiotic, local graft resection and replace­
ment) should be considered in a very highly selected group of 
patients.
Since January 1977, 606 double velour prostheses have been 
utilized on our service (CVT), with five patients developing 
infection in the intermediate and late postoperative period (0.24 
to 2.9 years).
Maintenance of life and limb up to 9 years has been possible in 
four patients (80%); the fifth eventually died from multiple causes 
(not related).
We submit that in a very highly selected group of patients with 
“late” development of graft infection, a conservative surgical 
approach should be considered an option.
R810
ARTERIAL INJURIES OF THE EXTREMITIES. H. Scarth, R. 
Maggisano, G. Pagliarello. Vascular Service and Division of 
General Surgery, Sunnybrook Medical Centre, Toronto, Ont.
A retrospective review of arterial injuries of the extremities was 
performed to identify factors that might influence management 
and outcome.
Between September 1981 and August 1987, 53 patients with 56 
limb injuries (proximal to the wrist and ankle) were managed by 
the vascular service at Sunnybrook Medical Centre. Males ac­
counted for 94% of the group. The mean age was 31.3 ± 15.8 
years. There was a preponderance (81%) of severely injured 
multiple trauma patients (mean injury severity score [ISS] of 29 ± 
15.9) and a similar preponderance of blunt injuries (79%). Lower 
extremity injuries occurred in 70%. Treatment included: group I 
primary amputation (8), group II observation and medical treat­
ment (10) and group III operative intervention (38). In group III, 
2 had fasciotomy alone, 1 had fasciotomy plus vasodilator infusion 
for spasm, while 35 had a vascular repair by arterial debridement 
and primary repair (10) or venous interposition graft (25). 
Concomitant fasciotomy was performed on 57% of revascularized 
limbs.
There were seven deaths. Three deaths were due to causes other
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than the limb injury and four were attributed to severe limb 
injury.
After at least 6 months of rehabilitation, the following results 
were assessed on a numerical scale based on the degree of 
disability.
Group I Group II Group III
No disability 0 3 9
Moderate disability 6 5 14
Severe disability 1 2 8
Limb-related death 0 0 4
Other death, paraplegia 1 0 3
Despite arterial conduit patency, two of group II and seven of 
group III limbs required subsequent amputation to achieve 
survival or improve functional results.
On detailed statistical analysis of the data, concomitant knee 
disruption or nerve injury were the only two factors identified as 
being associated with a poor functional result. Ischemia time, 
level of injury, method of revascularization, fasciotomy, level of 
arterial injury, age and bony injuries were not found to be 
associated with the functional result in this series.
R811
EXTRA-ANATOMIC BYPASS GRAFTING: RATIONAL AP­
PROACH. K.A. Harris, S.E. Carroll, G.E. Meads, J.P. Sweeney. 
University of Western Ontario, St. Joseph’s Health Centre, Lon­
don, Ont.
To determine the predictors of long-term patency in extra-ana­
tomic bypass grafting, a retrospective study was conducted of 17 
patients having axillofemoral (AIF), 32 axillobifemoral (A2F) and 
85 femoral-femoral bypass grafts (Xfem) in our centre over the 
past 10 years. The mean age was 65 =t 12 years, with 64% of 
patients being male. The indications were limb salvage in 102 
patients, claudication in 27 and replacement of septic grafts in 5. 
The indications for extra-anatomic routes were high medical risk 
(83), intra-abdominal or graft sepsis (8) and unilateral disease 
(Xfem only) (34). Operative mortality was 6% with an early graft 
occlusion rate of 7.4%. At the present time the patency rate is 77% 
with 24 patients having required thrombectomy. The late mortali­
ty rate was 44%. Smoking significantly (p < 0.05) decreased the 
patency rate, but diabetes did not. Conversely, amputations were 
more frequently required in diabetics. Indications for operation 
did not alter patency rates but did affect operative mortality. At 3 
years, the patency rates calculated by the life-table method were 
A1F 56.9%, A2F 67.7%, Xfem 82.4%. From this study we 
conclude that extra-anatomic bypass grafting may be used with a 
high degree of success, although not equal to the anatomic route. 
Continued smoking, diabetes and operative indications contribute 
to postoperative morbidy and mortality. Where possible, the 
axillobifemoral graft is preferred over ther axillo-unifemoral graft, 
due to its increased patency. Cross-femoral grafts must be 
carefully followed to ensure that no donor limb stenosis occurs 
and should not be attempted unless the disease is truly unilateral.
R812
TRANSABDOMINAL SUPRACELIAC AORTIC CLAMP­
ING—A SURGICAL APPROACH WITH MANY INDICA­
TIONS. P. Brown, J.R. Gutelius. Kingston General Hospital, 
Queen's University, Kingston, Ont.
Transabdominal, trans-diaphragmatic supraceliac clamping of the 
thoracic aorta has been used on an increasing basis for a wide 
variety of indications at our centre. Our purpose is to review the 
details of this surgical approach with its many indications:
(a) Ruptured abdominal aortic aneurysms (six patients)—when
the hematoma is extensive, making a direct approach to the aortic 
neck hazardous.
(b) Elective juxtarenal abdominal aortic aneurysm (five pa­
tients).
(c) Aortobifemoral bypass for the aorta occluded at the renal 
arteries (three patients)—instead of the champagne cork opera­
tion, a controlled thromboendarterectomy can be performed.
(d) Redo aortic surgery (one patient)—supraceliac clamping 
allowed redo aortic anastomosis to an aorta previously stapled.
(e) Renovascular (one patient)—renal artery endarterectomy is 
greatly facilitated.
(f) Trauma (one patient)—repair of gunshot wound of the 
superior mesenteric artery and juxtarenal aorta was made possible 
with supraceliac clamping.
(g) Inferior vena caval surgery (one patient)—supraceliac 
clamping along with intrapericardial caval clamping allowed 
removal of a huge caval tumour thrombus with control.
The wide variety of indications for supraceliac clamping makes 
this technique an important addition to the vascular surgeon’s 
armamentarium. No morbidity occurred from this technique in 
our series and many operations were greatly facilitated.
R813
ALLEVIATION OF PERIPHERAL ISCHEMIA BY INTER­
MITTENT PNEUMATIC COMPRESSION. A.M.N. Gardner, 
R.H. Fox, R.H. Morgan. Torbay Hospital, Torquay, Devon, En­
gland and University Hospital of Wales, Cardiff, S. Glam., Wales
Following the discovery in 1984 of a venous pump in the foot 
actuated by weight-bearing and not by muscular action, a pneu­
matic device was developed for stimulating venous return in those 
unable to walk, thus preventing deep vein thrombosis. Early in the 
investigation, a marked post-weight-bearing hyperemia was noted 
in normal feet on Doppler velocimetry. Similar post-compression 
hyperemia follows actuation of the device. This was also shown to 
increase arterial flow in those with peripheral vascular disease. 
The hyperemia is far more than debt repayment of the reduction 
in arterial flow during the brief compression phase.
A pilot study on 12 patients with rest pain showed significant 
benefit within 30 minutes of commencement of pumping in 10 
patients, some being completely relieved of symptoms, the others 
requiring less analgesics. Two patients refused to wear the device. 
In 10 normal subjects popliteal arterial flow was increased by an 
average of 93% using the device. In patients with intermittent 
claudication an average increase in popliteal arterial flow of 84% 
was noted. The pump shows great potential in limb salvage and in 
those with rest pain awaiting investigation or surgery. A similar 
device has been developed for the hand, marked improvement 
being achieved in patients with Sudek’s atrophy, venous insuffi­
ciency having been shown to be an important etiologic factor in 
Sudek’s atrophy of the hand and foot. The pump may also be used 
with a plaster cast.
R814
A BIOLOGICAL AND STRUCTURAL EVALUATION OF 83 
SURGICALLY EXCISED HUMAN UMBILICAL VEIN 
GRAFTS. S. Julien, R. Guidoin, M. Marois, P-E. Roy. Depart­
ment of Surgery, Universite Laval, Quebec, PQ
We report the pathologic changes in 83 human umbilical vein 
grafts excised from 71 patients after implantation ranging from 24 
hours to 5 years. Gross morphologic examination, light microsco­
py and scanning electron microscopy demonstrated that the 
umbilical vein grafts appeared to be fragile and easily delaminat­
ed. Bacteremic colonization on the luminal surface was present in 
29 grafts, but only 14 were removed because of infection. The 
accumulation of lipids on the surface and in the subintimal layer 
was observed in five grafts, several of which had been implanted 
for less than 1 month. We concluded that human umbilical vein 
grafts pathologically exhibit fragility, biodegradation, lipid accu-
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mutation and bacterial colonization, and these characteristics may 
adversely affect the durability and long-term success of the 
prosthesis.
R815
TRANSILIAC BYPASS FOR INFECTED FEMORAL END OF 
AN AORTICOFEMORAL GRAFT—A CASE REPORT. W. 
Brzezinski, J.C. Callaghan. Division of Thoracic and Cardiovascu­
lar Surgery, University of Alberta Hospitals, Edmonton, Alta.
Fabric graft infection is among the most serious complications of 
reconstructive arterial surgery. Reported rates of mortality and 
limb loss are high in the presence of graft dependency. To bypass 
the infected groin is indeed a challenge to the vascular surgeon.
We have chosen a transosseal (iliac bone) approach to permit 
the graft to be carried down to the periphery without risk of 
contamination or pressure on the conduit by patient position.
A 71-year-old man presented to our service with a purulent, 
exposed, right femoral end of an aorticobifemoral graft, inserted 
14 years earlier. The graft was open and the periphery was 
dependent on its flow. By a right retroperitoneal exposure a 
Hemashield 8-mm graft was placed from the right limb of the 
previous graft into the thigh laterally via a drilled passage through 
the right ileum. The graft entered the superficial femoral artery in 
the mid-thigh. Infected graft was later removed and the patient 
discharged 8 days later without complications. Three months later 
a follow-up angiogram demonstrated excellent peripheral perfu­
sion.
Details of the management of this patient and extensive review 
of the literature will be presented.
R816
IS “TUBE” PROSTHETIC REPAIR OF ABDOMINAL AOR­
TIC ANEURYMS FOLLOWED BY POSTOPERATIVE DILA­
TATION OF THE COMMON ILIAC ARTERIES? J.L. Provan, 
J.A. Fialkov, F.M. Ameli, E.L. St. Louis. University of Toronto, 
The Wellesley Hospital, Toronto, Ont.
Abdominal aortic aneurysms are often repaired by means of a 
tube prosthesis, but is not known whether this leads to dilatation 
in the unoperated common iliac artery (CIA). A follow-up study 
of the CIAs of 23 patients was therefore undertaken. Maximum 
internal CIA diameters measured from preoperative CT scans 
from intima to intima were compared with the same diameters of 
the corresponding arteries determined from postoperative CT 
scans undertaken from 3 to 5 years postoperatively. Fourteen of 
the 23 patients did not have CIA ectasia preoperatively, and 
neither these nor those with mild ectasia developed evidence of 
aneurysmal change on follow-up CT scan. Overall, the CIA 
diameter exhibited no significant change (p > 0.85) between the 
pre- and postoperative CIA diameters in 46 arteries. This was true 
for the right arteries (n = 23) (mean pre-diameter 1.4809 cm and 
mean post-diameter 1.5204 cm) (p > 0.4) as well as the left 
arteries (n = 23) (mean pre-diameter 1.2904 cm and mean 
post-diameter 1.2835 cm) (p > 0.9). The time period between 
preoperative and postoperative follow-up measurements showed 
no significant correlation with change in maximum CIA diameter 
(p > 0.05, F = 0.149) as change in diameter was shown to be 
insignificant for patients at the 3, 4 and 5-year follow-up periods. 
This study shows that up to 5 years postoperatively there is no 
significant dilatation of common iliac arteries after “tube” repair 
of abdominal aortic aneurysm and suggests that this procedure 
can safely be used without increasing the subsequent need for a 
second operation for iliac aneurysm.
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are called on to perform emergency vascu­
lar surgery.
F. M ic h a e l  A m e l i , m b , c h  b , 
FRCS(EDIN), FRCSC, FACS 
Ste. 313,
E.K. Jones Building,
The Wellesley Hospital,
160 Wellesley St. E,
Toronto, Ont.
M4Y 1J3
THE WRIST. Julio Taleisnik. 442 pp.
Illust. Churchill Livingstone, New York,
1985. $ 129.25(US). ISBN 0-443-08134-4.
The expanding body of knowledge of wrist 
anatomy, kinematics, pathologic character­
istics and treatment has been clearly orga­
nized and presented by the author in this 
book. The 20 chapters are well illustrated 
with photographs, x-ray films and draw­
ings, making it an exceptionally interesting 
and educational volume. Carpal instabili­
ty, scaphoid fractures and rheumatoid ar­
thritis are particularly well covered, al­
though the new area of wrist arthroscopy is 
omitted. The extensive reference list fol­
lowing each chapter indicates how thor­
oughly each topic has been reviewed.
This excellent, comprehensive book on 
the wrist will rapidly find its way into the 
libraries of hand surgeons and general 
orthopedic surgeons and orthopedic resi­
dents, for whom it was specifically intend­
ed.
A .A . GlACHINO, MD, FRCSC
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FELLOWSHIP FOR SURGERY: ON -  For
cardiac arrhythmia, University Hospital, London, 
Ontario. Available July 1988. One to two year 
program providing extensive experience with 
surgical treatment of supraventricular and ven­
tricular tachyarrhythmias. Training includes ex­
perimental and clinical research. Please respond 
to: Dr. G.M. Guiraudo, 339 Windemere 
Road, London, ON N6A 5A5. -S88-25
GENERAL SURGEON: ON -  Replacement re­
quired for retiring general surgeon. Modern 
113-bed community hospital. Calls shared with 
second surgeon. Hospital located in the Annap­
olis Valley 1 V2 hours drive from Halifax: Catch­
ment population 35 000. Reply to: D.A. Biggs, 
Executive Director, Soldiers Memorial Hos­
pital, Middleton, NS BOS 1 PO. -S88-27
GENERAL SURGEON: NWT -  required for 
expanding northern community. One active sur­
geon on staff. Expansion of surgical work will 
occur with opening of new hospital shortly. 
This post is both challenging and lucrative. The 
city has excellent facilities and schools. Please 
forward enquiries to: Family Medical Clinic, 
PO Box 1559, Yellowknife, NWT X1A 2P2.
-S88-28
HEAD, DIVISION OF CARDIOVASCULAR 
SURGERY -  The Hospital for Sick Children, the 
largest pediatric hospital in North America with 
an extremely active cardiovascular service in­
vites applications for the position of Head, 
Division of Cardiovascular Surgery. Located in 
downtown Toronto, the hospital is in close 
proximity to the University of Toronto and 
other major teaching and research activities. 
Essential requirements for the position include a 
clear commitment to patient care, demonstrat­
ed clinical and management expertise and prov­
en leadership in teaching and research. Applica­
tions must have certification by the Royal Col­
lege of Physicians and Surgeons of Canada or 
equivalent. The successful candidate will be 
jointly appointed to the Department of Surgery 
in the Faculty of Medicine at the University of 
Toronto. In accordance with the immigration 
requirements, priority will be given to Canadian 
citizens and permanent residents of Canada. 
Please apply with curriculum vitae by July 31, 
1988 to: Dr. R.M. Filler, Surgeon-in-Chief, 
The Hospital for Sick Children, 555 Universi­
ty  Ave., Toronto, ON M5G 1X8. Tel: (416) 
598-6398. -S88-26
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